data_1oqa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oqa _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.749 0.309 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 pt -76.44 -21.08 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.711 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.501 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 13.1 m-30 -93.74 -48.25 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.609 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 45.32 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.09 77.47 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.205 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.8 OUTLIER -144.22 158.76 43.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HB3' HG21 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -136.95 113.37 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' A' ' 56' ' ' VAL . 2.2 mt -127.17 128.97 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 0.0 111.443 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.5 p -115.97 131.42 56.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.9 p -97.07 106.33 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.526 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 130.03 39.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.56 164.03 28.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.42 -16.19 10.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.748 2.299 . . . . 0.0 112.726 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 121.227 0.536 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.43 -24.84 50.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.95 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.9 tp -74.15 -48.75 27.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.801 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -27.61 68.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 0.0 110.462 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.1 t90 -69.56 -49.82 50.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.421 ' HG3' ' CE3' ' A' ' 29' ' ' TRP . 34.5 mtp -54.3 -48.57 71.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.783 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 32' ' ' GLN . 30.3 m -62.31 -45.16 99.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.191 0.519 . . . . 0.0 109.863 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.436 ' N ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.86 -36.52 72.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.156 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -70.07 -21.11 63.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.778 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 10.3 m -92.98 -3.21 54.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.738 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 -14.66 17.43 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.113 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -76.21 179.71 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.167 0.508 . . . . 0.0 111.537 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 135.77 46.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.452 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.74 114.44 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.928 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 5.3 t -95.26 123.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -49.55 74.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -141.22 -176.9 4.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.278 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 19.2 mt -72.19 -39.02 68.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -7.05 52.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.49 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -23.71 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.61 0.243 . . . . 0.0 111.23 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 29.6 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.836 0.35 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -93.96 135.43 24.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.14 137.12 9.41 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 0.0 112.713 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.416 ' CG1' HD21 ' A' ' 11' ' ' LEU . 8.8 mm -144.44 152.43 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.28 151.14 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 0.0 111.255 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 85.6 t -129.09 146.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.427 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 2.8 m -139.1 -175.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.49 93.29 0.28 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 61.78 2.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.357 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.71 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.667 0.27 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 30.7 mm -71.75 -63.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.83 -25.24 58.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.313 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.29 -24.81 50.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.991 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 mtp -93.92 -31.07 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.9 p -106.73 150.66 26.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.83 31.61 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.61 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.9 121.74 6.81 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.693 2.262 . . . . 0.0 112.464 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.427 ' CG1' ' CG1' ' A' ' 57' ' ' VAL . 12.1 t -92.87 124.0 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 3.9 m -137.16 131.75 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.699 0.285 . . . . 0.0 111.431 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -50.87 157.2 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.9 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -24.32 2.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.355 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 1.3 tp10 -45.55 -39.82 7.94 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.765 0.317 . . . . 0.0 110.673 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.9 t90 -60.7 -57.29 13.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.517 0.675 . . . . 0.0 109.903 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.5 t -54.23 -41.46 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.251 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -50.5 27.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -60.02 -33.08 71.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' TYR . 51.0 m -77.1 -47.44 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.16 -26.21 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.291 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -58.52 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.85 -13.42 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 69.22 80.91 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.759 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 179.16 129.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.93 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -68.67 159.08 32.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.7 126.02 27.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.403 ' CB ' HG13 ' A' ' 80' ' ' VAL . 3.0 mp -66.03 -32.17 73.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.339 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -23.21 13.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.555 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.418 HG21 ' CE1' ' A' ' 100' ' ' TYR . 87.0 m -75.48 -19.75 59.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.617 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 21.1 m-85 -134.66 19.8 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 0.0 111.306 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.969 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.0 mmtt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.794 0.331 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.445 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.1 pp -82.38 -17.94 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.624 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.51 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 14.6 m-30 -93.63 -42.81 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 5.1 ptm180 35.85 84.34 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 111.854 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.95 66.77 1.55 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.772 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 1.5 tt -138.78 152.52 47.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.312 . . . . 0.0 110.792 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -130.85 119.36 22.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.775 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -130.51 123.8 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.709 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.627 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 31.9 p -107.64 135.33 49.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.7 p -94.33 99.2 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.676 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -93.82 112.84 24.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.31 159.73 11.9 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.49 -13.53 9.69 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.791 2.327 . . . . 0.0 112.827 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.414 ' CD2' ' HG3' ' A' ' 58' ' ' GLN . 6.0 m-85 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.296 0.57 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 -28.23 58.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.998 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.1 tp -72.11 -50.94 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -27.54 69.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.564 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.426 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.4 t90 -69.93 -50.17 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.426 ' HG3' ' CE3' ' A' ' 29' ' ' TRP . 37.3 mtp -54.04 -48.37 70.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.774 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 HG21 ' N ' ' A' ' 32' ' ' GLN . 23.1 m -61.89 -44.6 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.189 0.518 . . . . 0.0 109.947 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.428 ' N ' HG21 ' A' ' 31' ' ' VAL . 1.9 mt-30 -58.33 -35.23 71.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.198 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.009 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 19.4 m -93.04 -3.44 54.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.851 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.05 -3.96 22.43 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.253 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' A' ' 13' ' ' ILE . . . -86.67 -179.61 6.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 111.402 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -133.54 133.95 42.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.32 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.62 114.39 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.6 t -93.66 134.4 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -80.51 -36.01 33.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.256 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -131.99 164.74 25.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.137 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 37.8 mt -73.29 -37.07 66.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -75.95 -6.05 49.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.427 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.02 2.08 36.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 13.7 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.84 122.44 62.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.84 126.78 5.97 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.559 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 11' ' ' LEU . 12.6 mm -142.91 160.5 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 t -142.31 151.18 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 3.0 t -117.42 157.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 111.107 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.01 -178.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HG3' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.68 92.66 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 59.48 5.92 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.576 2.184 . . . . 0.0 112.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.749 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.7 mm -72.84 -61.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.143 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.06 -27.24 62.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.44 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -78.43 -23.26 46.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.007 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -93.96 -29.19 15.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.881 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.94 151.5 33.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.9 -26.01 17.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . . . -84.15 159.46 59.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.99 147.95 75.02 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.14 . . . . 0.0 112.432 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.16 128.76 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 27.2 m -140.1 157.05 25.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 111.263 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.4 p -70.19 158.91 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.321 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -22.19 3.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.428 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.15 -43.7 21.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.85 0.357 . . . . 0.0 110.77 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.51 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 78.0 t90 -55.16 -57.25 12.53 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.54 0.686 . . . . 0.0 110.102 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.2 t -53.63 -46.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.176 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -49.72 66.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -61.82 -33.0 73.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -77.08 -46.81 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.08 -31.45 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.4 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 tp -82.51 -19.53 38.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 71.46 76.89 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.045 0.45 . . . . 0.0 110.613 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -177.68 132.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.772 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.38 83.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.85 168.79 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -77.2 133.84 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.735 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' CB ' HG13 ' A' ' 80' ' ' VAL . 2.1 mp -74.52 -32.03 62.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -22.66 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.426 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.9 m -73.54 -20.67 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.467 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -140.09 28.24 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.402 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 12.8 pttm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.837 0.351 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.408 HD12 ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -123.73 -14.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.018 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.516 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 9.4 m-30 -93.45 -44.07 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.535 0.207 . . . . 0.0 110.648 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 41.05 87.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.259 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.22 72.72 0.98 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.382 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . 2.4 tt -146.23 125.15 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.648 0.261 . . . . 0.0 110.838 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -104.31 123.33 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.699 0.285 . . . . 0.0 110.939 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.401 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -129.96 123.77 57.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.864 0.364 . . . . 0.0 111.449 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.656 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.1 p -110.77 144.08 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 m -107.13 114.16 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.408 ' CZ ' ' HE1' ' A' ' 74' ' ' MET . 2.0 t80 -97.18 110.0 22.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.0 148.47 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.26 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.608 2.205 . . . . 0.0 112.261 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.149 0.499 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.36 -30.57 60.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.236 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -50.83 22.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.348 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -68.7 -51.61 39.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.401 ' HB3' HG21 ' A' ' 89' ' ' VAL . 54.9 mtm -53.11 -49.61 66.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.815 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 32' ' ' GLN . 29.7 m -62.01 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.136 0.493 . . . . 0.0 109.844 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.418 ' N ' HG22 ' A' ' 31' ' ' VAL . 7.8 mt-30 -57.16 -35.54 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.002 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.54 -21.4 63.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.699 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 1.8 m -93.42 -3.25 53.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.58 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.86 25.24 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.87 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -72.25 178.11 4.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.48 150.9 49.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.462 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 13.9 p -86.51 120.66 36.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.828 0.346 . . . . 0.0 111.214 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.3 t -93.89 128.47 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -48.42 81.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -144.71 179.95 6.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 30.3 mt -66.16 -42.8 88.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -70.02 -20.8 63.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.271 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.5 m -66.82 -15.28 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 9.7 m-85 . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.743 0.306 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -94.09 127.6 44.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.3 131.38 8.61 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.639 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.1 mm -143.44 161.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.617 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.11 151.2 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 4.0 t -126.31 149.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.316 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 3.6 m -144.43 -177.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 3.6 tp60 178.06 70.73 0.11 Allowed Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.77 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.07 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.248 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.762 0.315 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 33.8 mm -75.66 -59.44 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.02 -21.91 70.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.544 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -85.97 -19.79 29.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.408 ' HE1' ' CZ ' ' A' ' 16' ' ' TYR . 54.2 ttp -93.92 -29.08 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 29.8 p -107.49 151.35 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.25 30.25 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.81 159.22 65.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.0 123.16 7.68 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.75 2.3 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' A' ' 57' ' ' VAL . 5.5 t -91.62 140.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 6.7 m -152.11 133.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.788 0.327 . . . . 0.0 111.629 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 14.7 p -47.64 159.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.793 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.416 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.17 -21.01 11.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.273 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 3.0 tt0 -47.34 -41.24 19.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.888 0.375 . . . . 0.0 110.714 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.516 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.2 t90 -57.43 -57.37 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 110.07 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -53.65 -44.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.323 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -53.12 21.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -57.87 -29.98 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 92' ' ' TYR . 64.8 m -76.94 -49.15 16.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 30' ' ' MET . 26.9 t -71.14 -28.38 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.366 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.21 -57.27 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 tp -90.25 -11.44 40.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 62.53 76.96 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.652 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -178.67 132.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.78 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.993 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -69.06 166.62 17.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 156.85 35.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CB ' HG13 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -101.94 -20.93 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -25.59 65.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.011 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.4 m -74.71 -14.88 60.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.579 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 14.0 m-85 -139.23 16.55 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.566 0.222 . . . . 0.0 111.269 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.147 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 3.2 mmtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 34' ' ' CYS . 5.8 pt -63.36 -20.6 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.533 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.438 ' CG ' HD13 ' A' ' 11' ' ' LEU . 4.8 m-30 -93.83 -49.7 5.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.418 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 45.21 90.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.351 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.95 75.7 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.303 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.438 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -143.0 159.3 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.798 0.333 . . . . 0.0 111.039 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -142.3 109.89 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.508 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.402 ' CG1' ' HB ' ' A' ' 54' ' ' ILE . 1.6 mt -121.96 125.55 73.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.941 0.4 . . . . 0.0 111.558 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.594 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.9 p -101.28 144.33 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.996 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 25.0 p -101.48 102.93 13.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.806 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -93.87 136.34 34.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.495 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . 87.01 144.72 8.78 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 16.5 Cg_exo -66.65 -9.63 25.09 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.826 2.35 . . . . 0.0 112.757 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 17' ' ' GLY . 69.5 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.713 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 121.275 0.559 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.26 -27.2 56.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.317 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.81 -48.84 28.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.44 -27.68 68.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.679 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -71.12 -49.68 41.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.409 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 53.7 mtm -54.52 -48.32 72.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.9 m -62.08 -44.92 99.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.3 0.571 . . . . 0.0 109.881 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.437 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.2 mt-30 -58.91 -35.52 73.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.2 tp -70.13 -21.9 63.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.407 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 23.4 m -94.02 -3.44 51.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.919 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 109.1 31.41 3.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.23 175.61 5.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.01 0.433 . . . . 0.0 111.038 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.9 38.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.68 116.13 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.565 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -93.81 120.3 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.964 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -33.67 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -155.46 177.48 11.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.403 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 15.6 mt -68.89 -39.95 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -18.5 63.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.32 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -77.11 -4.33 43.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.58 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.3 m-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.77 128.42 41.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.94 127.34 6.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.601 2.201 . . . . 0.0 112.781 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.425 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 11.6 mm -134.96 161.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.05 139.76 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.067 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 53.6 t -115.75 158.59 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' N ' ' CG1' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -150.39 175.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.555 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.424 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER 177.27 63.06 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.684 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.03 115.08 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.615 2.21 . . . . 0.0 112.395 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.728 0.299 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 71' ' ' ILE . 28.2 mm -80.56 -48.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.11 -18.79 73.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.273 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -14.63 20.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.463 0.173 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 mtp -93.6 -28.46 16.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 25.4 p -115.85 149.22 38.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.816 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.93 30.08 3.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.24 164.4 35.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.16 131.69 19.72 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.657 2.238 . . . . 0.0 112.771 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.8 t -101.07 128.91 52.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 27.2 m -143.7 154.94 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 0.0 111.667 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 p -62.55 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.467 ' HD3' ' CD2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -88.61 -15.1 35.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.127 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -55.5 -34.59 64.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -57.98 -57.56 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.289 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 43.5 t -58.34 -48.22 85.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.132 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -45.22 94.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.57 -36.46 83.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 92' ' ' TYR . 22.5 m -77.05 -44.72 29.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 30' ' ' MET . 38.7 t -71.22 -26.66 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.397 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.42 -52.74 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.36 . . . . 0.0 111.441 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.94 -2.14 47.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.58 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 57.0 80.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 110.894 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -178.88 126.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.3 t -59.31 87.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.7 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.57 130.96 35.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.4 -29.07 69.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.25 -24.82 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.336 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.424 HG23 ' CZ ' ' A' ' 100' ' ' TYR . 91.1 m -80.29 -12.03 59.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.536 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.424 ' CZ ' HG23 ' A' ' 99' ' ' THR . 17.5 m-85 -142.18 29.77 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.768 0.318 . . . . 0.0 111.018 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.405 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.806 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.1 mmtp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.755 0.312 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -91.23 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.916 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 11.3 m-85 -93.43 -47.4 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.28 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 38.96 86.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.377 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.45 66.47 1.68 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.503 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.424 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.9 tt -145.64 122.21 11.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.489 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 54' ' ' ILE . 3.7 mt-10 -94.63 123.6 38.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.331 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.424 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 3.6 mt -132.77 136.18 56.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.261 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.0 p -135.61 142.82 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.9 p -107.01 109.4 21.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.13 103.51 15.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.98 161.96 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.657 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.23 -15.84 14.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.599 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 58' ' ' GLN . 5.4 m-85 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 41.8 m-20 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.084 0.468 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -31.29 56.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.4 tp -74.96 -46.37 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -64.69 -27.35 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.483 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -68.72 -50.84 47.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.187 0.518 . . . . 0.0 109.84 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -55.11 -48.21 73.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.84 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.6 m -60.52 -44.84 97.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 0.0 110.17 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 31' ' ' VAL . 12.5 tt0 -58.39 -33.47 69.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -70.02 -21.44 63.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.749 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 2.6 m -93.28 -3.25 53.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 110.84 -29.74 8.67 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.435 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -58.3 156.98 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 132.17 45.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.044 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 28' ' ' GLU . 15.1 m -71.76 114.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.053 0.454 . . . . 0.0 110.898 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 24.8 t -100.27 117.93 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.907 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -47.24 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.34 171.0 14.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.072 0.463 . . . . 0.0 111.448 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 9.4 mt -65.37 -44.59 87.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.854 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 m -60.69 -27.22 67.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -23.28 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 16.2 m-85 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.31 134.69 24.09 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.66 125.53 5.59 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.639 2.226 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.417 HG13 ' CD2' ' A' ' 11' ' ' LEU . 29.3 mm -134.71 148.34 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 58.7 t -126.58 151.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.362 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 16.4 t -123.71 131.26 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.2 m -143.26 120.39 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.556 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.433 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -140.82 86.06 12.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.16 135.24 39.57 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.515 2.143 . . . . 0.0 112.314 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.1 mm -62.84 -39.36 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.25 -25.65 61.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -27.91 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.5 mtp -93.83 -30.7 14.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.1 t -134.58 145.59 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.56 31.34 4.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.51 166.15 11.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.08 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.08 108.43 2.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.788 2.325 . . . . 0.0 112.524 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 3.2 m -91.12 127.44 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.588 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 35.9 m -137.09 139.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.793 0.33 . . . . 0.0 111.736 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 p -52.02 161.97 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -21.51 9.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.476 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.26 -43.92 15.97 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.521 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.4 t90 -56.57 -57.42 12.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.931 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.9 t -54.34 -43.75 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.269 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -56.34 7.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.016 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.3 -31.37 63.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.0 m -77.1 -49.92 14.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.24 -27.27 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.467 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.05 -58.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.7 tp -89.45 -12.16 40.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.271 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 66.05 77.83 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 110.776 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -177.82 134.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 t -59.6 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -72.69 159.05 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -63.67 153.02 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mp -102.15 -33.38 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.281 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -57.2 -21.67 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.595 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.9 m -80.51 -20.48 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.564 0.221 . . . . 0.0 111.482 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.8 23.75 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 111.068 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.6 mmtt . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.739 0.304 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.457 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.1 pp -76.33 -23.49 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.92 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.511 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 16.4 m-30 -93.71 -47.68 6.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 45.54 90.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.333 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.21 76.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.931 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.18 162.27 38.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -140.65 109.78 6.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.5 mt -121.11 130.72 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 111.666 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.611 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 21.9 p -115.04 139.03 50.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.6 p -107.12 108.49 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.597 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.98 119.66 33.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.94 166.38 25.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.594 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.35 -10.38 9.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.864 2.376 . . . . 0.0 112.75 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.5 m-85 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.058 0.456 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -31.48 41.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.415 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.6 tp -75.91 -44.24 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.396 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -65.44 -27.54 68.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.449 ' CD1' HD23 ' A' ' 33' ' ' LEU . 18.4 t90 -67.47 -51.94 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.162 0.506 . . . . 0.0 109.734 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.2 mtm -55.03 -50.52 68.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.615 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 28' ' ' GLU . 26.1 m -58.98 -45.02 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' N ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.96 -33.83 67.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.497 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.449 HD23 ' CD1' ' A' ' 29' ' ' TRP . 0.6 OUTLIER -70.44 -21.46 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.021 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 4.0 m -93.45 -3.26 53.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.745 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.51 -18.21 17.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.851 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 8' ' ' PHE . . . -72.63 177.93 4.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.28 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -131.98 139.18 48.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.565 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 p -71.93 122.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.2 t -93.92 130.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.04 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -65.3 -42.3 93.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -147.73 -179.59 7.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.43 -41.1 69.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 t -72.95 -9.11 58.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.428 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 -19.11 60.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.607 0.241 . . . . 0.0 111.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 . . . . . 0 C--N 1.332 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 111.09 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.76 0.314 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -93.87 126.84 47.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.53 130.73 10.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.697 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.418 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 8.1 mm -138.82 147.74 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.666 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 39.9 t -123.01 151.1 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 15.2 t -129.95 144.41 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' N ' HG11 ' A' ' 56' ' ' VAL . 2.5 m -135.3 -177.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 172.98 78.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.05 88.06 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.644 2.23 . . . . 0.0 112.402 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.836 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.431 ' CG2' ' CG2' ' A' ' 79' ' ' VAL . 23.0 mm -74.3 -54.3 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.39 -20.76 71.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.42 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -18.09 40.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.92 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.0 ttp -93.67 -25.53 17.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.801 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 46.0 t -133.5 156.41 47.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.856 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -103.34 32.63 3.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.91 164.52 28.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.39 120.87 5.01 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.431 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 10.7 t -94.62 121.29 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 28.0 m -137.58 135.57 46.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.586 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 p -50.65 170.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.668 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -16.32 60.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.36 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -42.24 52.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 110.664 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.511 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 80.2 t90 -59.46 -57.26 13.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.491 0.663 . . . . 0.0 109.766 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.2 t -55.06 -43.48 69.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.133 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -46.14 66.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -64.48 -32.94 74.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.518 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -77.11 -47.13 21.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.24 -30.92 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.38 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.73 -56.79 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.84 -16.54 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 67.57 77.76 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.02 136.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.707 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -58.93 91.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -74.57 160.39 30.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.66 139.04 56.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.425 ' CB ' HG11 ' A' ' 80' ' ' VAL . 1.6 mp -88.34 -33.06 18.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.349 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -22.25 24.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.583 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.7 m -77.74 -23.38 49.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.433 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -128.1 18.46 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.618 0.247 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.406 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 7.5 pttm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.415 HD13 ' CE1' ' A' ' 8' ' ' PHE . 1.1 pp -111.56 -16.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 9.7 m-30 -93.78 -43.84 8.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.893 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 49.26 92.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 75.38 0.51 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -139.58 162.04 36.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.142 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.76 109.81 5.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -118.05 124.96 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.413 . . . . 0.0 111.762 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.636 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.9 p -108.35 129.5 55.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 14.2 m -97.33 115.06 26.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -93.52 108.71 20.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.097 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.67 168.77 33.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.3 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.681 2.254 . . . . 0.0 112.621 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.9 m-85 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 121.105 0.478 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -75.88 -30.96 59.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.146 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.0 tp -72.37 -50.58 25.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.279 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -60.95 -27.44 68.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 110.465 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -64.0 -49.16 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 mtm -51.67 -55.57 18.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.704 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 28' ' ' GLU . 20.1 m -57.06 -44.26 82.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.079 0.466 . . . . 0.0 110.222 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt-30 -59.72 -36.87 77.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.079 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.08 -21.04 63.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.883 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 1.4 m -93.23 -3.31 53.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.839 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.33 25.4 5.81 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.118 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.35 178.42 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.102 0.477 . . . . 0.0 111.296 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.64 132.57 44.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.612 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.4 p -71.88 119.43 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -93.92 124.29 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.862 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -45.47 77.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -146.73 -179.21 6.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 29.6 mt -67.26 -44.13 80.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -17.57 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.276 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 m -65.66 -17.36 64.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.444 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 77' ' ' ALA . 14.0 m-85 . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.458 -0.034 0 CA-C-O 120.921 0.391 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -131.96 120.17 17.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.76 133.18 11.25 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.561 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 11' ' ' LEU . 9.4 mm -139.79 146.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.929 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 t -124.5 138.22 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 24.0 t -124.16 158.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 111.404 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.431 ' CG2' ' CG1' ' A' ' 79' ' ' VAL . 1.4 t -152.89 177.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.689 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 6.4 tm0? -179.2 86.89 0.21 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.75 116.91 3.95 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.488 2.125 . . . . 0.0 112.33 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.697 0.284 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.3 mm -74.2 -53.62 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.265 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.31 -27.85 68.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.421 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.36 -13.47 40.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.579 0.228 . . . . 0.0 111.334 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -28.89 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.2 p -117.44 157.19 26.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -107.03 41.93 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -154.33 165.95 16.93 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.5 124.26 12.6 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.496 2.131 . . . . 0.0 112.323 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.431 ' CG1' ' CG2' ' A' ' 57' ' ' VAL . 25.7 t -92.53 128.37 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 31.2 m -143.15 177.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 10.5 p -96.86 163.99 12.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 109.941 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -19.39 17.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.349 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -47.87 -45.09 30.0 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.502 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 63.4 t90 -55.99 -57.26 12.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.39 0.614 . . . . 0.0 110.114 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.07 -43.16 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.359 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -50.46 38.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.09 -32.84 71.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.772 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -77.03 -48.49 17.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.1 t -71.01 -25.91 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.334 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.66 -55.09 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.315 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 tt -98.07 2.95 49.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.585 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.36 83.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.8 131.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.56 79.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.82 173.05 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.03 153.49 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mp -94.07 -27.34 16.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -58.79 -31.86 68.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.93 -16.63 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.43 29.55 3.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -111.95 -20.72 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.506 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 14.6 m-30 -93.7 -46.16 7.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 43.15 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.039 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.32 73.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.303 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.415 HD23 ' CG1' ' A' ' 54' ' ' ILE . 2.1 tt -148.36 119.01 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.707 0.289 . . . . 0.0 110.82 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.89 124.06 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 3.2 mt -132.66 129.78 58.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.678 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.1 p -121.52 146.4 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.211 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HA ' HG23 ' A' ' 56' ' ' VAL . 25.1 p -106.92 127.86 53.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -93.89 105.07 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.065 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.86 44.22 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.667 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -166.71 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.42 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 26.3 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.102 0.477 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.59 -33.2 68.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.481 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -50.83 20.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.349 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -65.36 -27.78 68.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.425 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -71.39 -50.35 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.1 mtm -54.87 -48.41 73.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.54 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.403 HG21 ' N ' ' A' ' 32' ' ' GLN . 28.9 m -62.65 -45.14 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 0.0 109.656 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.403 ' N ' HG21 ' A' ' 31' ' ' VAL . 5.1 mt-30 -56.42 -35.91 68.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.071 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 tp -70.07 -21.41 63.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.928 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 2.3 m -93.19 -3.24 54.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.706 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.93 25.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . . . -71.59 174.33 6.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.485 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.08 136.93 52.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.547 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.3 p -71.88 123.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.0 t -93.86 146.51 6.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -42.82 62.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.154 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 -175.91 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.904 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 30.5 mt -63.64 -50.38 69.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.007 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -66.65 -19.16 65.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.413 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.5 m -61.67 -23.32 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.332 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 17.5 m-85 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.791 0.329 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 130.55 34.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.57 135.36 13.01 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.54 2.16 . . . . 0.0 112.471 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.415 ' CG1' HD23 ' A' ' 11' ' ' LEU . 9.3 mm -144.3 151.35 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.65 140.79 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -114.48 160.71 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 111.15 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' THR . 6.1 m -152.23 -177.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.507 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 174.54 94.93 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.29 68.67 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.488 2.126 . . . . 0.0 112.334 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 29.1 mm -72.32 -65.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.75 -26.66 68.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -22.98 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 0.0 111.192 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtm -93.92 -43.85 8.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.4 p -86.97 162.33 17.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.925 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -113.08 33.85 4.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.41 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -144.68 166.32 18.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.97 125.98 13.24 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.281 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 57' ' ' VAL . 17.6 t -93.05 123.64 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.978 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 35.8 m -141.16 134.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 1.9 p -54.76 159.99 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.472 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -19.8 6.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.578 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.96 -40.58 10.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.9 t90 -58.93 -57.42 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.46 0.648 . . . . 0.0 110.145 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.69 -42.93 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.267 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.29 -56.24 8.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -57.99 -30.7 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 92' ' ' TYR . 69.3 m -76.99 -49.16 16.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.32 -27.23 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.371 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.91 -54.69 19.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.177 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -97.41 -2.28 42.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.323 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 58.05 84.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 110.887 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -177.53 139.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.7 t -67.9 74.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.1 158.84 6.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.58 151.46 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 mp -95.98 -34.8 11.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.65 -25.51 39.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.511 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 100' ' ' TYR . 13.4 t -74.88 -24.73 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.454 ' CD2' HG22 ' A' ' 99' ' ' THR . 9.8 m-85 -125.74 15.0 8.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.13 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.317 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.69 0.281 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pt -110.44 -19.83 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.506 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 15.7 m-30 -93.7 -50.42 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.637 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 47.72 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.35 76.2 0.83 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.066 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.438 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -145.5 162.01 38.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 111.008 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' CG ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.22 109.82 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.334 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.424 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 1.8 mt -125.29 130.46 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.361 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 6.1 p -111.08 143.18 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 p -106.46 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.756 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.01 131.27 39.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.6 158.73 34.16 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.56 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.15 0.26 10.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.644 2.229 . . . . 0.0 112.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 19.9 m-85 . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.734 0.302 . . . . 0.0 111.056 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -77.96 -33.35 51.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.523 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.5 tp -75.07 -44.12 49.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.43 ' HA ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.99 -27.48 67.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.507 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.484 ' CD1' HD21 ' A' ' 33' ' ' LEU . 10.3 t90 -69.24 -50.05 50.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.858 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.429 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 2.3 mtm -57.34 -48.61 78.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.575 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.4 m -60.51 -45.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.203 0.525 . . . . 0.0 109.621 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.431 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.57 -34.58 69.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.666 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 29' ' ' TRP . 0.6 OUTLIER -70.28 -21.27 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.005 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 38.5 m -93.42 -3.08 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.667 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.3 -23.44 11.3 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.741 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.424 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . . . -67.02 177.08 1.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.054 0.454 . . . . 0.0 111.231 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.61 138.6 51.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -71.82 114.77 10.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.782 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 3.0 t -93.91 121.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.022 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -58.44 -47.16 84.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.336 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -132.69 176.03 8.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.086 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.446 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 13.1 mt -70.87 -43.51 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -5.01 44.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -15.98 61.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.561 0.22 . . . . 0.0 111.389 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 21.2 m-85 . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 111.013 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.718 0.294 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -100.99 120.64 54.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.98 133.74 12.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.593 2.195 . . . . 0.0 112.635 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.438 HG13 ' CD2' ' A' ' 11' ' ' LEU . 7.5 mm -142.49 162.31 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.622 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 t -137.99 150.74 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.666 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 4.1 t -121.85 158.43 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.32 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.39 -179.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.473 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 1.1 tt0 176.52 66.93 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.579 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.58 94.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.422 HG21 ' CG1' ' A' ' 79' ' ' VAL . 24.0 mm -69.82 -67.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.01 -24.25 71.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.372 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.93 -27.82 64.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.311 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.0 mtm -93.92 -39.28 10.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.5 p -98.37 147.08 25.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 38.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . . . -147.3 169.3 9.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 54' ' ' ILE . 73.6 Cg_endo -74.94 125.87 9.64 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.741 2.294 . . . . 0.0 112.456 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.422 ' CG1' HG21 ' A' ' 71' ' ' ILE . 8.4 t -98.02 136.61 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 26.7 m -147.59 159.56 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.659 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 p -73.7 159.3 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.246 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -53.6 -22.51 8.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.446 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.45 -38.07 8.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 72.6 t90 -63.46 -57.23 10.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.492 0.663 . . . . 0.0 109.818 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -54.3 -39.22 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.377 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -48.47 17.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -60.25 -35.72 76.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -77.05 -47.91 19.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 73.7 t -71.22 -25.87 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.439 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.45 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 111.041 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tp -85.07 -18.48 34.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 73.44 77.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.672 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.43 136.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 t -61.17 86.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -67.34 163.42 20.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.99 140.12 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.858 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mp -83.33 -29.52 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.12 -29.15 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -72.08 -17.45 62.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.84 22.32 2.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.671 0.272 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.424 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.34 . . . . 0.0 110.789 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 10.4 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.434 HD13 ' CE1' ' A' ' 8' ' ' PHE . 1.3 pp -79.13 -21.16 12.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.738 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.507 ' CE1' ' CH2' ' A' ' 84' ' ' TRP . 9.8 m-30 -93.8 -34.81 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.72 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 8' ' ' PHE . 2.3 ppt_? 28.54 79.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.795 0.438 . . . . 0.0 111.96 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.94 72.16 1.29 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.632 -0.795 . . . . 0.0 111.554 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD11 ' CD1' ' A' ' 8' ' ' PHE . 1.8 tt -144.68 152.67 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.71 0.29 . . . . 0.0 110.754 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 54' ' ' ILE . 6.8 mt-10 -129.07 119.64 24.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.647 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.433 HD11 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -129.07 123.56 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.54 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.624 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 24.6 p -110.09 137.7 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.5 107.24 19.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -93.61 111.78 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.76 168.56 35.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.354 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.97 -0.55 10.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.739 2.292 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.7 m-85 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -76.99 -32.5 57.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.291 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.1 tp -70.72 -50.14 39.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.384 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -60.9 -27.45 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -65.52 -50.41 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.254 0.549 . . . . 0.0 109.607 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 66.8 mtt -51.46 -51.53 54.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.866 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 32' ' ' GLN . 31.4 m -61.9 -45.65 98.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.056 0.455 . . . . 0.0 110.181 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.63 -35.59 72.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.193 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 tp -69.97 -20.92 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.029 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.4 m -93.0 -3.2 54.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.988 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.23 -15.96 11.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.083 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 13' ' ' ILE . . . -76.65 -179.12 5.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.58 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -134.89 135.23 41.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.404 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 12.1 p -71.88 118.59 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -93.85 118.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -42.63 85.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.13 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -148.69 177.26 9.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.9 mt -67.4 -46.53 72.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -23.48 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -24.37 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.1 m-85 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.024 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.423 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 2.6 t-80 -95.37 127.82 40.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 52' ' ' HIS . 73.3 Cg_endo -75.89 135.39 17.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.129 . . . . 0.0 112.479 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' GLU . 16.0 mm -142.24 150.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.803 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.05 149.18 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.916 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 57.9 t -120.59 159.68 21.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.416 ' N ' HG11 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -149.14 -178.74 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.008 0.432 . . . . 0.0 111.494 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 169.47 81.11 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.873 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 110.59 2.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.078 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.3 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.3 mm -67.79 -66.85 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.896 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.06 76.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.382 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -25.51 61.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.027 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtp -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.9 t -104.29 155.93 18.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.49 35.46 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.47 165.96 23.83 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.0 136.2 22.27 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.658 2.239 . . . . 0.0 112.39 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.94 126.11 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.638 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 35.0 m -138.18 159.24 32.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.494 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -72.04 166.0 23.12 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.415 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -59.44 -18.33 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.39 -42.0 30.58 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.507 ' CH2' ' CE1' ' A' ' 8' ' ' PHE . 73.9 t90 -60.43 -57.31 13.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 110.172 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.12 -36.93 41.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.338 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -54.57 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.049 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -56.94 -31.14 64.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 92' ' ' TYR . 61.2 m -77.1 -50.11 13.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.9 t -71.25 -25.99 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.619 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 -56.7 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.337 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 tp -90.11 -13.79 35.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.296 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 68.31 81.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.45 137.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.93 85.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.78 170.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.52 118.52 31.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' CB ' HG11 ' A' ' 80' ' ' VAL . 2.6 mp -61.08 -35.57 77.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.301 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.59 -24.36 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.4 m -80.63 -20.22 43.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.449 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -134.74 32.78 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.433 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.755 0.312 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.425 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.2 pp -72.47 -23.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.681 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.499 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 13.2 m-30 -93.66 -46.18 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.78 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.631 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 76.93 1.02 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.028 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.445 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -146.35 162.09 38.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.949 0.404 . . . . 0.0 111.211 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.42 109.93 6.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.35 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.416 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -122.54 127.46 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 111.795 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.612 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.3 p -112.64 133.45 54.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -98.97 108.36 21.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.731 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -93.94 126.16 38.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.48 163.31 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.1 -5.02 12.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.696 2.264 . . . . 0.0 112.735 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 10.9 m-85 . . . . . 0 C--N 1.333 -0.141 0 CA-C-O 120.846 0.355 . . . . 0.0 111.033 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.167 0.508 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -27.5 60.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.054 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.5 tp -72.85 -51.2 19.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.578 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -27.74 69.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.356 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -71.19 -50.77 29.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.8 mtm -53.88 -48.0 70.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 32' ' ' GLN . 29.3 m -61.86 -45.23 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.149 0.499 . . . . 0.0 109.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.444 ' N ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -56.56 -36.62 69.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.997 178.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.97 -20.97 63.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.769 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 95.0 m -92.95 -3.18 54.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.92 -31.96 5.14 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.69 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -62.51 -179.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.114 0.483 . . . . 0.0 111.358 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.3 139.17 40.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.585 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.8 122.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 3.2 t -99.11 123.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -58.86 -48.09 82.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -139.13 172.33 12.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.016 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 15.8 mt -65.91 -50.56 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -58.94 -21.24 57.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.158 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -23.4 67.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 25.2 m-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.43 133.51 22.71 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.59 135.56 10.45 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.149 . . . . 0.0 112.615 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 11' ' ' LEU . 9.6 mm -140.42 142.71 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.635 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.9 t -123.28 136.91 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.628 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 42.6 t -122.12 158.51 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -152.43 -173.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.517 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.464 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.14 89.19 0.34 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.845 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.01 83.86 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.538 2.159 . . . . 0.0 112.271 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.653 0.263 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 8.3 mm -64.37 -47.19 90.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.75 50.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.374 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.72 -17.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.628 0.252 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -93.87 -33.68 13.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.4 t -122.62 154.72 37.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.966 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.39 31.35 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.35 168.7 9.97 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.07 121.59 7.4 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.605 2.204 . . . . 0.0 112.569 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.426 ' CG1' ' CG2' ' A' ' 57' ' ' VAL . 18.3 t -88.59 125.51 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 27.7 m -143.21 177.15 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.835 0.35 . . . . 0.0 111.418 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 p -98.24 166.9 11.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.304 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -18.42 32.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.362 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.89 -47.86 51.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.499 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 59.3 t90 -50.72 -57.37 8.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.265 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.3 t -53.84 -49.1 60.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.301 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -50.0 72.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -61.83 -32.48 72.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.752 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.2 m -77.07 -46.48 23.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.032 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.0 t -71.16 -28.2 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.339 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.83 -56.65 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.28 -4.19 52.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.65 80.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.834 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -179.18 141.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.0 t -66.57 83.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.23 165.0 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.52 140.65 44.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.04 -30.97 19.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.45 -32.55 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.105 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.412 HG22 ' CE1' ' A' ' 100' ' ' TYR . 85.1 m -77.29 -10.22 59.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.324 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE1' HG22 ' A' ' 99' ' ' THR . 12.4 m-85 -138.68 30.5 2.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 110.686 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.779 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.5 mmtm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.455 HG22 ' CD1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -76.4 -22.87 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.555 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.505 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 15.5 m-30 -93.64 -49.51 5.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 44.96 90.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.83 76.15 1.0 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.968 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -147.33 160.85 42.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.855 0.359 . . . . 0.0 111.118 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -140.8 109.8 6.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.434 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.7 mt -120.38 125.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.646 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.697 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 28.3 p -113.45 142.7 45.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.0 p -106.95 119.31 39.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.525 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.76 117.56 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.36 146.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.473 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.69 150.42 28.76 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.543 2.162 . . . . 0.0 112.315 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.442 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 4.2 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.433 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 24.4 m-20 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.193 0.521 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.21 -36.7 82.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.553 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.16 -55.61 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.171 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.47 -27.3 67.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.007 0.432 . . . . 0.0 110.212 179.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -63.13 -49.34 74.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 109.556 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.2 mtt -51.15 -55.15 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.706 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 28' ' ' GLU . 22.9 m -58.82 -45.04 91.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.426 ' N ' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -59.57 -33.77 71.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.288 179.358 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.06 -21.17 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.931 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 3.8 m -93.28 -3.16 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.753 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.62 -22.26 10.16 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.927 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.434 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . . . -67.98 178.03 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.85 135.21 46.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.82 117.92 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.882 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.4 t -93.89 124.49 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -25.51 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.358 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -174.85 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.318 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.07 -46.34 87.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.973 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -11.38 60.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.426 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m -96.0 24.73 5.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.674 0.273 . . . . 0.0 111.312 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 39' ' ' VAL . 3.4 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.725 0.298 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -94.09 136.26 23.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.973 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -83.16 132.89 6.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.705 2.27 . . . . 0.0 112.787 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.421 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 10.8 mm -137.73 151.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 t -129.07 149.96 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.955 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 7.3 t -128.2 146.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.339 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 1.9 m -133.1 173.03 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -176.95 88.08 0.25 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.68 64.04 3.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.549 2.166 . . . . 0.0 112.28 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.776 0.322 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.41 HG22 ' CG1' ' A' ' 79' ' ' VAL . 23.3 mm -69.31 -64.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.4 -15.35 81.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -79.03 -24.22 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mtm -93.97 -27.3 16.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.5 t -118.94 156.22 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.77 32.33 4.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.829 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.77 172.32 6.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.087 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.71 127.1 4.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.786 2.324 . . . . 0.0 112.888 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 71' ' ' ILE . 18.8 t -98.57 130.96 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.329 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 28.7 m -145.26 136.88 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.639 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 p -50.82 168.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.772 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.424 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -63.94 -16.44 61.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.07 -39.19 55.45 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.86 0.362 . . . . 0.0 110.608 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.505 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 79.0 t90 -62.7 -57.3 11.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 109.888 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.66 -38.18 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.222 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.06 -47.79 19.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.78 -33.53 73.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.742 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -77.16 -49.53 15.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.2 t -71.38 -27.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.42 -55.09 17.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 111.104 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.65 -3.08 46.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.315 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CD1' HG22 ' A' ' 7' ' ' ILE . 6.7 t80 57.64 76.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.59 133.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.674 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.15 97.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.099 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.6 163.67 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.53 142.09 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.69 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.411 ' CB ' HG11 ' A' ' 80' ' ' VAL . 1.6 mp -87.13 -34.28 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.27 -22.88 32.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -15.29 60.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.61 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -139.4 20.58 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.701 0.286 . . . . 0.0 111.235 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.422 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.4 mmtp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.64 -23.83 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.464 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 14.3 m-30 -93.37 -50.88 5.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 110.555 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.8 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.374 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.61 75.12 1.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.817 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -149.43 162.66 39.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.934 0.397 . . . . 0.0 111.241 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -138.64 109.68 6.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.408 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.3 mt -124.54 138.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 29.1 p -126.54 144.62 50.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.45 ' HA ' HG21 ' A' ' 56' ' ' VAL . 14.8 p -97.62 104.5 16.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.0 102.63 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.61 162.59 17.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.44 -2.7 10.61 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.762 2.308 . . . . 0.0 112.801 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.0 m-85 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.037 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 121.057 0.456 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -34.46 65.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.57 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.422 HD23 ' CZ ' ' A' ' 19' ' ' PHE . 44.6 tp -73.18 -48.34 36.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.355 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.508 ' O ' HG21 ' A' ' 31' ' ' VAL . 32.6 mt-10 -62.56 -27.42 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.504 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -65.32 -49.28 70.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 109.802 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.8 mtt -52.97 -52.33 58.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.853 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 28' ' ' GLU . 35.3 m -58.8 -46.5 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 110.615 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.477 ' N ' HG23 ' A' ' 31' ' ' VAL . 16.5 tt0 -57.95 -34.47 69.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.2 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.14 -21.51 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.8 m -93.59 -3.35 52.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.782 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.9 -34.84 4.55 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.408 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . . . -56.15 169.16 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.486 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.37 134.62 54.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 28' ' ' GLU . 2.4 m -72.1 125.75 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 111.18 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 17.6 t -114.67 128.08 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -33.52 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.926 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -121.85 155.3 35.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.364 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 16.2 mt -70.78 -32.47 69.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.676 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -21.03 59.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.83 -20.46 61.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.189 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 20.3 m-85 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.71 0.29 . . . . 0.0 111.073 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -93.8 126.06 50.93 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.43 129.59 10.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.568 2.179 . . . . 0.0 112.707 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.474 HG13 ' CD2' ' A' ' 11' ' ' LEU . 7.5 mm -141.66 154.71 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.818 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.9 t -138.21 140.31 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.86 156.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 111.115 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 3.2 m -144.01 -179.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.538 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.487 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.89 67.18 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.754 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.02 107.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.715 0.293 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 mm -69.59 -34.27 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 110.804 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.27 -20.91 59.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.312 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -77.32 -25.25 51.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 mtp -93.85 -29.28 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 54.0 t -132.35 153.5 50.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.753 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.88 -36.69 12.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.56 170.26 0.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.11 161.82 32.19 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 57' ' ' VAL . 12.1 t -127.04 121.49 58.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 33.8 m -141.32 140.09 32.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.5 p -55.21 163.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.705 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -20.05 15.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -47.0 -40.98 15.59 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.464 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.7 t90 -58.84 -57.35 13.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.368 0.604 . . . . 0.0 110.106 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -55.93 -42.37 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.225 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.59 -56.56 6.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -56.7 -30.87 63.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -77.19 -50.5 12.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.087 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.27 -28.53 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.431 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -58.15 5.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.882 0.372 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.79 -10.63 47.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.203 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.9 79.77 0.25 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.857 0.36 . . . . 0.0 110.708 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -177.07 129.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -64.14 85.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -68.69 172.45 6.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.94 157.53 29.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.635 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.402 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -96.7 -25.06 15.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.057 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -21.66 66.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 100' ' ' TYR . 25.5 m -77.08 -17.76 58.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.465 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CE1' ' HB ' ' A' ' 99' ' ' THR . 1.6 m-85 -138.91 23.61 2.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.661 0.267 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.004 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 9.0 mmtm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.733 0.302 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.444 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -80.26 -20.19 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.748 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.518 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 18.0 m-30 -93.63 -48.12 6.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 39.3 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.23 68.85 1.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.772 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -137.2 160.66 38.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -137.64 111.11 8.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -122.2 121.84 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.378 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.614 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 19.4 p -107.51 132.02 53.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 m -95.31 101.65 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.535 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.88 102.73 14.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.108 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.91 144.02 7.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.801 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 23.9 Cg_exo -63.1 -13.41 35.29 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.8 2.334 . . . . 0.0 112.515 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.6 m-30 . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.144 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.025 0.44 . . . . 0.0 110.558 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.87 -31.36 51.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -45.89 42.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.346 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -63.03 -27.72 69.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -66.77 -52.05 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 109.776 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.9 mtm -53.71 -50.52 65.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.668 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 28' ' ' GLU . 28.0 m -60.78 -45.46 97.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.427 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt-30 -56.74 -34.77 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.019 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.5 tp -70.19 -21.57 63.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 21.3 m -93.41 -3.53 53.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.729 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.82 15.67 17.81 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.156 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -101.69 173.53 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.145 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.57 132.52 51.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.655 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 13.8 p -71.98 122.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.1 t -93.91 127.55 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -59.27 -40.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.67 -177.13 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.74 -38.86 67.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.04 -8.71 56.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -92.89 18.17 9.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE1' HG22 ' A' ' 39' ' ' VAL . 6.0 m-85 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.802 0.334 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.31 118.46 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.02 128.55 7.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.567 2.178 . . . . 0.0 112.643 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.407 HG12 HD21 ' A' ' 11' ' ' LEU . 7.6 mm -144.76 156.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.7 t -137.98 144.49 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.029 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 22.0 t -128.21 159.32 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 111.246 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.453 ' CG2' ' CG1' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -152.45 -169.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -179.17 72.25 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.25 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.645 2.23 . . . . 0.0 112.439 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.716 0.293 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 31.2 mm -68.69 -60.19 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.5 -21.83 65.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.478 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.96 -16.2 45.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.686 0.279 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -27.45 16.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.957 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.08 156.64 47.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -100.61 30.27 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.16 156.51 66.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.018 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.11 150.11 89.01 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.298 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.453 ' CG1' ' CG2' ' A' ' 57' ' ' VAL . 34.2 t -121.14 128.49 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 28.6 m -144.0 177.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.9 p -93.7 173.98 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -11.64 58.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.243 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -56.86 -40.62 76.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.887 0.375 . . . . 0.0 110.242 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.518 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.5 t90 -56.82 -57.42 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 110.029 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.09 -46.53 80.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.113 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -56.59 12.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.45 -31.55 67.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -77.14 -48.89 16.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.954 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.32 -28.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.66 -59.07 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.064 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 tp -88.48 -11.99 44.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.74 83.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -177.11 133.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.23 78.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.83 169.01 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -82.68 142.23 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 mp -79.85 -28.87 39.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.97 -30.49 47.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.3 p -76.11 -13.39 60.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.363 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.6 27.88 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.735 0.302 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -101.9 -20.91 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.517 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 17.1 m-30 -93.49 -47.9 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.782 0.325 . . . . 0.0 110.446 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.74 87.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.555 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.54 72.64 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.077 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.482 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -144.31 162.4 36.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' ILE . 3.6 mt-10 -138.41 109.77 6.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.157 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.01 141.1 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.608 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.5 p -126.43 147.46 49.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.078 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 14.9 m -105.61 113.42 26.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.609 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.58 120.0 33.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.9 168.75 45.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.579 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.79 1.23 9.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.821 2.348 . . . . 0.0 112.738 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.048 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.172 0.51 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.7 -32.13 67.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.371 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.424 ' CD2' ' CZ ' ' A' ' 19' ' ' PHE . 18.0 tp -70.94 -50.31 36.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.364 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 31' ' ' VAL . 14.5 mt-10 -59.83 -27.42 66.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.979 0.418 . . . . 0.0 110.547 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -64.88 -50.08 67.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.238 0.542 . . . . 0.0 109.646 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.5 mtt -51.22 -51.29 55.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.072 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 28' ' ' GLU . 28.6 m -59.38 -45.67 93.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.923 0.392 . . . . 0.0 110.528 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 31' ' ' VAL . 1.7 tm0? -58.5 -34.47 70.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.044 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.01 -21.09 63.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.78 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.7 m -93.1 -3.25 54.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.615 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.91 -20.9 19.27 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.982 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.49 174.61 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 111.314 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.84 135.48 55.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.1 m -71.77 123.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 14.4 t -102.99 122.39 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -49.48 76.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.576 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.15 177.7 7.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.375 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 14.5 mt -67.36 -48.17 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.793 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 m -59.06 -21.13 58.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -21.01 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.218 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 17.9 m-85 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 111.063 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -94.03 136.03 24.09 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.71 138.51 11.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.677 2.252 . . . . 0.0 112.565 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 11' ' ' LEU . 8.5 mm -144.29 150.89 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.21 139.0 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 60.9 t -124.67 157.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 0.0 111.371 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -156.68 -173.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 -179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 4.7 tt0 178.66 80.47 0.16 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.574 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.53 112.24 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.649 2.232 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.731 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 25.4 mm -71.42 -60.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.38 -22.95 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.691 0.282 . . . . 0.0 111.103 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -30.66 14.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.2 p -105.6 162.9 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -116.05 37.64 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -148.79 168.22 11.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 77' ' ' ALA . 56.6 Cg_endo -70.22 112.48 3.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.656 2.237 . . . . 0.0 112.517 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.45 ' CG1' ' CG2' ' A' ' 57' ' ' VAL . 34.8 t -81.3 127.1 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.784 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 57' ' ' VAL . 28.2 m -140.27 176.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 11.6 p -94.4 159.24 15.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.14 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -22.06 6.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.312 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.81 -40.59 21.46 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.95 0.405 . . . . 0.0 110.684 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 84.4 t90 -62.16 -57.23 12.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.363 0.602 . . . . 0.0 110.027 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -56.1 -37.09 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 -54.55 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.83 -30.44 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.772 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.4 m -77.17 -50.96 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.19 -28.56 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.365 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.17 -54.33 22.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tt -97.52 2.7 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.339 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.5 82.86 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 111.054 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.68 128.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 p -66.08 86.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.91 170.71 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.9 125.96 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.11 -29.53 70.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -54.47 -29.29 49.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.247 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -77.56 -17.28 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -134.31 29.49 3.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.812 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.2 p -119.2 -64.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -125.45 26.88 6.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.7 176.05 10.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.92 -62.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER 64.08 134.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.644 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 pt -76.44 -21.08 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.711 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.501 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 13.1 m-30 -93.74 -48.25 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.609 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 45.32 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.09 77.47 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.205 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.8 OUTLIER -144.22 158.76 43.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HB3' HG21 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -136.95 113.37 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.416 ' CG2' ' CG2' ' A' ' 56' ' ' VAL . 2.2 mt -127.17 128.97 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 0.0 111.443 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.582 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.5 p -115.97 131.42 56.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.9 p -97.07 106.33 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.526 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 130.03 39.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.56 164.03 28.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.42 -16.19 10.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.748 2.299 . . . . 0.0 112.726 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 63.22 -80.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.1 -78.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -172.41 51.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.421 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 4.2 ttm 178.95 -51.1 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.463 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 21.3 Cg_exo -66.0 64.11 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.734 2.289 . . . . 0.0 112.429 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -73.1 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.441 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -87.24 -31.33 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.536 . . . . 0.0 109.693 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.43 -24.84 50.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.95 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.9 tp -74.15 -48.75 27.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.801 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.02 -27.61 68.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 0.0 110.462 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.421 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.1 t90 -69.56 -49.82 50.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.421 ' HG3' ' CE3' ' A' ' 29' ' ' TRP . 34.5 mtp -54.3 -48.57 71.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.783 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' N ' ' A' ' 32' ' ' GLN . 30.3 m -62.31 -45.16 99.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.191 0.519 . . . . 0.0 109.863 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' N ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.86 -36.52 72.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.156 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -70.07 -21.11 63.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.778 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 10.3 m -92.98 -3.21 54.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.738 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 -14.66 17.43 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.113 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.444 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -76.21 179.71 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.167 0.508 . . . . 0.0 111.537 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 135.77 46.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.452 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.74 114.44 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.928 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 5.3 t -95.26 123.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -49.55 74.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -141.22 -176.9 4.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.278 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 19.2 mt -72.19 -39.02 68.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -7.05 52.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.49 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -23.71 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.61 0.243 . . . . 0.0 111.23 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.407 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 29.6 m-85 -52.58 135.77 33.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 111.11 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -132.04 129.75 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.61 85.64 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.1 -105.5 0.27 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.575 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 p -127.96 -45.42 1.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.86 30.08 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.513 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.29 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 111.203 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -93.96 135.43 24.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -82.14 137.12 9.41 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 0.0 112.713 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.416 ' CG1' HD21 ' A' ' 11' ' ' LEU . 8.8 mm -144.44 152.43 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.28 151.14 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 0.0 111.255 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 85.6 t -129.09 146.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.427 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 2.8 m -139.1 -175.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.49 93.29 0.28 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 61.78 2.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.357 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.33 -67.96 0.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.71 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.3 -24.11 30.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.106 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -29.84 62.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.069 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 t 45.96 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.35 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.03 126.88 55.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -177.34 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -97.49 -50.09 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.93 115.03 1.86 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CZ ' HG13 ' A' ' 71' ' ' ILE . 43.1 t80 -102.08 7.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.573 0.225 . . . . 0.0 111.483 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -91.38 55.27 2.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 111.031 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -176.26 36.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.45 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 30.7 mm -71.75 -63.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.83 -25.24 58.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.313 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.29 -24.81 50.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.991 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 mtp -93.92 -31.07 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.9 p -106.73 150.66 26.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.83 31.61 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.61 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.9 121.74 6.81 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.693 2.262 . . . . 0.0 112.464 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.427 ' CG1' ' CG1' ' A' ' 57' ' ' VAL . 12.1 t -92.87 124.0 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 3.9 m -137.16 131.75 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.699 0.285 . . . . 0.0 111.431 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -50.87 157.2 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.9 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -24.32 2.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.355 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.419 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 1.3 tp10 -45.55 -39.82 7.94 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.765 0.317 . . . . 0.0 110.673 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.9 t90 -60.7 -57.29 13.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.517 0.675 . . . . 0.0 109.903 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.5 t -54.23 -41.46 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.251 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -50.5 27.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -60.02 -33.08 71.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' TYR . 51.0 m -77.1 -47.44 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.9 t -71.16 -26.21 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.291 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -58.52 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.85 -13.42 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 69.22 80.91 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.759 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 179.16 129.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.93 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -68.67 159.08 32.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.7 126.02 27.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.403 ' CB ' HG13 ' A' ' 80' ' ' VAL . 3.0 mp -66.03 -32.17 73.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.339 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -23.21 13.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.555 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.418 HG21 ' CE1' ' A' ' 100' ' ' TYR . 87.0 m -75.48 -19.75 59.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.617 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 21.1 m-85 -134.66 19.8 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 0.0 111.306 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.63 173.72 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.969 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.6 mt -59.98 110.08 2.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.027 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.97 -63.89 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.37 2.047 . . . . 0.0 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.42 88.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.944 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 pt -141.54 156.23 66.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.72 154.5 60.11 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.68 2.253 . . . . 0.0 112.146 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.62 -174.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 t -152.5 -57.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -117.0 115.89 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.875 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 p -107.16 157.34 17.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 59.0 98.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.29 -51.26 2.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 56.93 94.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.735 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.0 mmtt -116.05 138.98 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.445 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.1 pp -82.38 -17.94 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.624 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.51 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 14.6 m-30 -93.63 -42.81 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 5.1 ptm180 35.85 84.34 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 111.854 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.95 66.77 1.55 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.772 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 1.5 tt -138.78 152.52 47.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.312 . . . . 0.0 110.792 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -130.85 119.36 22.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.775 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -130.51 123.8 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.709 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.627 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 31.9 p -107.64 135.33 49.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.7 p -94.33 99.2 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.676 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -93.82 112.84 24.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.31 159.73 11.9 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.49 -13.53 9.69 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.791 2.327 . . . . 0.0 112.827 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.414 ' CD2' ' HG3' ' A' ' 58' ' ' GLN . 6.0 m-85 63.87 -79.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.857 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.72 -76.38 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -178.2 39.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 178.23 -52.14 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.979 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 22' ' ' MET . 47.1 Cg_exo -56.58 83.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.133 . . . . 0.0 112.464 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 -54.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.531 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.75 -27.95 24.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.57 . . . . 0.0 109.845 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 -28.23 58.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.998 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.1 tp -72.11 -50.94 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.62 -27.54 69.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.564 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.426 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.4 t90 -69.93 -50.17 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.426 ' HG3' ' CE3' ' A' ' 29' ' ' TRP . 37.3 mtp -54.04 -48.37 70.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.774 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 HG21 ' N ' ' A' ' 32' ' ' GLN . 23.1 m -61.89 -44.6 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.189 0.518 . . . . 0.0 109.947 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.428 ' N ' HG21 ' A' ' 31' ' ' VAL . 1.9 mt-30 -58.33 -35.23 71.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.198 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.009 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.441 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 19.4 m -93.04 -3.44 54.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.851 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.05 -3.96 22.43 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.253 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' A' ' 13' ' ' ILE . . . -86.67 -179.61 6.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 111.402 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -133.54 133.95 42.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.32 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.62 114.39 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.6 t -93.66 134.4 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -80.51 -36.01 33.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.256 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -131.99 164.74 25.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.137 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 37.8 mt -73.29 -37.07 66.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -75.95 -6.05 49.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.427 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.02 2.08 36.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 77' ' ' ALA . 13.7 m-85 -68.06 157.15 35.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.71 96.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.17 -32.44 10.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.71 -98.21 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.556 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 m -140.21 -45.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.73 0.3 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.86 70.03 1.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.521 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.2 t -146.27 123.98 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.84 122.44 62.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -80.84 126.78 5.97 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.559 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.409 HG12 HD23 ' A' ' 11' ' ' LEU . 12.6 mm -142.91 160.5 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.9 t -142.31 151.18 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.902 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 3.0 t -117.42 157.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 111.107 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.9 m -147.01 -178.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HG3' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.68 92.66 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 59.48 5.92 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.576 2.184 . . . . 0.0 112.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -41.85 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.749 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.58 30.18 7.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.967 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 -49.06 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 61.26 154.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.93 86.31 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -132.41 -61.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -46.34 12.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.74 104.76 1.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.407 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.447 ' CE2' HG13 ' A' ' 71' ' ' ILE . 41.0 t80 -101.23 7.06 43.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.521 0.201 . . . . 0.0 111.407 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.47 49.6 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.51 36.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.447 HG13 ' CE2' ' A' ' 68' ' ' PHE . 29.7 mm -72.84 -61.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.143 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.06 -27.24 62.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.44 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -78.43 -23.26 46.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.007 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -93.96 -29.19 15.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.881 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.4 p -114.94 151.5 33.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.9 -26.01 17.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . . . -84.15 159.46 59.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.99 147.95 75.02 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.14 . . . . 0.0 112.432 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.16 128.76 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 27.2 m -140.1 157.05 25.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 111.263 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.4 p -70.19 158.91 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.321 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -22.19 3.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.428 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.15 -43.7 21.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.85 0.357 . . . . 0.0 110.77 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.51 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 78.0 t90 -55.16 -57.25 12.53 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.54 0.686 . . . . 0.0 110.102 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 85.2 t -53.63 -46.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.176 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -49.72 66.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -61.82 -33.0 73.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -77.08 -46.81 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.9 t -71.08 -31.45 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.4 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 tp -82.51 -19.53 38.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 71.46 76.89 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.045 0.45 . . . . 0.0 110.613 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -177.68 132.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.772 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.38 83.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.85 168.79 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -77.2 133.84 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.735 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.416 ' CB ' HG13 ' A' ' 80' ' ' VAL . 2.1 mp -74.52 -32.03 62.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -22.66 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.426 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.9 m -73.54 -20.67 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.467 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -140.09 28.24 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.402 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -88.7 152.2 21.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.952 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.28 149.23 83.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.18 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.9 -179.44 4.61 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.577 2.185 . . . . 0.0 112.382 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -169.72 90.02 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.804 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -74.75 121.69 85.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 -30.31 9.4 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.414 2.076 . . . . 0.0 112.323 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.95 144.05 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.9 t -113.06 83.13 1.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.953 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.62 111.43 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 t -170.31 -42.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -83.1 96.45 8.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.15 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 69.64 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 12.8 pttm -80.83 174.51 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.408 HD12 ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -123.73 -14.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.018 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.516 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 9.4 m-30 -93.45 -44.07 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.535 0.207 . . . . 0.0 110.648 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 41.05 87.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.259 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.22 72.72 0.98 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.382 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . 2.4 tt -146.23 125.15 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.648 0.261 . . . . 0.0 110.838 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -104.31 123.33 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.699 0.285 . . . . 0.0 110.939 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.401 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -129.96 123.77 57.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.864 0.364 . . . . 0.0 111.449 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.656 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.1 p -110.77 144.08 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 m -107.13 114.16 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.408 ' CZ ' ' HE1' ' A' ' 74' ' ' MET . 2.0 t80 -97.18 110.0 22.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.0 148.47 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.26 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.608 2.205 . . . . 0.0 112.261 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 5.5 m-85 -127.11 -78.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -121.4 -43.35 2.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.664 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -129.58 -75.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.47 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -167.71 54.59 0.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.0 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 22' ' ' MET . 61.4 Cg_endo -88.46 20.28 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.82 2.347 . . . . 0.0 112.865 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -41.67 77.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 111.138 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -85.45 -25.27 27.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.499 . . . . 0.0 110.165 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.36 -30.57 60.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.236 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -50.83 22.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.348 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -68.7 -51.61 39.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.401 ' HB3' HG21 ' A' ' 89' ' ' VAL . 54.9 mtm -53.11 -49.61 66.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.815 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 32' ' ' GLN . 29.7 m -62.01 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.136 0.493 . . . . 0.0 109.844 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.418 ' N ' HG22 ' A' ' 31' ' ' VAL . 7.8 mt-30 -57.16 -35.54 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.002 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.54 -21.4 63.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.699 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 1.8 m -93.42 -3.25 53.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.58 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.86 25.24 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.87 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -72.25 178.11 4.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.48 150.9 49.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.462 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 13.9 p -86.51 120.66 36.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.828 0.346 . . . . 0.0 111.214 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.656 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.3 t -93.89 128.47 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -48.42 81.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -144.71 179.95 6.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 30.3 mt -66.16 -42.8 88.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -70.02 -20.8 63.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.271 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 61.5 m -66.82 -15.28 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 9.7 m-85 -51.97 104.52 0.09 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.222 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -137.43 155.82 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.5 136.88 15.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.05 -28.57 3.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.411 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -114.81 -60.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.851 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.56 86.57 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.635 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.85 131.67 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.979 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -94.09 127.6 44.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.3 131.38 8.61 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.639 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 8.1 mm -143.44 161.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.617 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 t -138.11 151.2 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 4.0 t -126.31 149.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.316 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 3.6 m -144.43 -177.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 3.6 tp60 178.06 70.73 0.11 Allowed Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.77 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.07 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.248 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -161.74 -44.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.76 42.67 2.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.91 -5.99 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.349 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 84.8 m 65.38 -76.16 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 111.075 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.91 131.45 36.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.85 79.21 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -89.13 -59.38 2.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.769 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.41 104.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.324 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.448 ' CE1' HD13 ' A' ' 71' ' ' ILE . 4.7 t80 -96.35 7.25 46.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.63 50.66 1.94 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.53 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.234 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.448 HD13 ' CE1' ' A' ' 68' ' ' PHE . 33.8 mm -75.66 -59.44 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.02 -21.91 70.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.544 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -85.97 -19.79 29.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.408 ' HE1' ' CZ ' ' A' ' 16' ' ' TYR . 54.2 ttp -93.92 -29.08 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.928 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 29.8 p -107.49 151.35 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.25 30.25 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.81 159.22 65.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.0 123.16 7.68 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.75 2.3 . . . . 0.0 112.248 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.412 ' CG1' ' CG1' ' A' ' 57' ' ' VAL . 5.5 t -91.62 140.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 6.7 m -152.11 133.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.788 0.327 . . . . 0.0 111.629 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 14.7 p -47.64 159.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.793 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.416 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.17 -21.01 11.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.273 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 3.0 tt0 -47.34 -41.24 19.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.888 0.375 . . . . 0.0 110.714 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.516 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.2 t90 -57.43 -57.37 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 110.07 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.0 t -53.65 -44.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.323 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -53.12 21.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -57.87 -29.98 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 92' ' ' TYR . 64.8 m -76.94 -49.15 16.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.401 HG21 ' HB3' ' A' ' 30' ' ' MET . 26.9 t -71.14 -28.38 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.366 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.21 -57.27 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 tp -90.25 -11.44 40.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 62.53 76.96 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.652 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -178.67 132.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.78 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.993 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -69.06 166.62 17.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 156.85 35.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CB ' HG13 ' A' ' 80' ' ' VAL . 1.0 OUTLIER -101.94 -20.93 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -25.59 65.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.011 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.4 m -74.71 -14.88 60.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.579 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 14.0 m-85 -139.23 16.55 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.566 0.222 . . . . 0.0 111.269 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 98.51 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.147 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.3 mt 63.62 128.36 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.64 -178.44 3.74 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.364 2.043 . . . . 0.0 112.293 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -177.43 153.79 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.59 136.45 96.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.068 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.25 164.88 34.11 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.48 105.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.6 t -150.28 123.89 9.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 m80 60.56 44.57 11.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.805 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.47 -175.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -81.46 60.32 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.8 -34.15 5.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 -69.5 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 3.2 mmtt 63.87 123.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 34' ' ' CYS . 5.8 pt -63.36 -20.6 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.533 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.438 ' CG ' HD13 ' A' ' 11' ' ' LEU . 4.8 m-30 -93.83 -49.7 5.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.418 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 45.21 90.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.351 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.95 75.7 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.303 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.438 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -143.0 159.3 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.798 0.333 . . . . 0.0 111.039 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -142.3 109.89 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.508 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.402 ' CG1' ' HB ' ' A' ' 54' ' ' ILE . 1.6 mt -121.96 125.55 73.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.941 0.4 . . . . 0.0 111.558 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.594 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.9 p -101.28 144.33 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.996 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.406 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 25.0 p -101.48 102.93 13.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.806 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -93.87 136.34 34.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . 87.01 144.72 8.78 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 16.5 Cg_exo -66.65 -9.63 25.09 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.826 2.35 . . . . 0.0 112.757 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 17' ' ' GLY . 69.5 m-85 67.56 -74.39 0.07 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.713 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.9 p -153.71 -75.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.85 39.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.629 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.42 ' CB ' ' CD ' ' A' ' 23' ' ' PRO . 1.7 mtm -173.35 -62.42 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.966 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 22' ' ' MET . 30.7 Cg_endo -63.48 89.62 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.452 2.102 . . . . 0.0 112.47 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.8 -54.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -84.63 -27.06 27.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 109.985 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.26 -27.2 56.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.317 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -73.81 -48.84 28.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.44 -27.68 68.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.679 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -71.12 -49.68 41.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.409 ' HB3' ' CG2' ' A' ' 89' ' ' VAL . 53.7 mtm -54.52 -48.32 72.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.9 m -62.08 -44.92 99.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.3 0.571 . . . . 0.0 109.881 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.437 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.2 mt-30 -58.91 -35.52 73.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.2 tp -70.13 -21.9 63.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.407 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 23.4 m -94.02 -3.44 51.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.919 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 109.1 31.41 3.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.23 175.61 5.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.01 0.433 . . . . 0.0 111.038 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.9 38.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.68 116.13 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.565 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -93.81 120.3 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.964 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -33.67 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -155.46 177.48 11.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.403 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 15.6 mt -68.89 -39.95 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -18.5 63.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.32 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -77.11 -4.33 43.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.58 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.418 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.3 m-85 -56.96 -178.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 t 43.4 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.486 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.5 mt -146.69 98.16 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.41 -113.18 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -66.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.25 91.45 0.34 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.49 139.94 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.77 128.42 41.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.94 127.34 6.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.601 2.201 . . . . 0.0 112.781 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.425 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 11.6 mm -134.96 161.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -139.05 139.76 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.067 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 53.6 t -115.75 158.59 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' N ' ' CG1' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -150.39 175.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.555 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.424 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER 177.27 63.06 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.684 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.03 115.08 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.615 2.21 . . . . 0.0 112.395 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.9 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.67 27.65 4.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.218 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.405 ' CE3' ' O ' ' A' ' 66' ' ' ASN . 4.0 m95 -90.72 -38.43 13.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.55 176.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 62.89 -79.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.126 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -140.2 173.34 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' CE3' ' A' ' 62' ' ' TRP . 2.8 t30 -80.04 -65.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.09 27.14 68.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.672 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CZ ' HG13 ' A' ' 71' ' ' ILE . 14.0 t80 -93.59 7.33 45.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.628 0.251 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -88.2 35.66 0.76 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.713 0.292 . . . . 0.0 111.539 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.91 24.69 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.525 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 28.2 mm -80.56 -48.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.11 -18.79 73.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.273 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -14.63 20.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.463 0.173 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 mtp -93.6 -28.46 16.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 25.4 p -115.85 149.22 38.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.816 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.93 30.08 3.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.24 164.4 35.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.16 131.69 19.72 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.657 2.238 . . . . 0.0 112.771 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.8 t -101.07 128.91 52.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 27.2 m -143.7 154.94 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 0.0 111.667 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 p -62.55 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.467 ' HD3' ' CD2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -88.61 -15.1 35.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.127 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -55.5 -34.59 64.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -57.98 -57.56 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.289 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.404 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 43.5 t -58.34 -48.22 85.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.132 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -45.22 94.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.57 -36.46 83.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 92' ' ' TYR . 22.5 m -77.05 -44.72 29.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.409 ' CG2' ' HB3' ' A' ' 30' ' ' MET . 38.7 t -71.22 -26.66 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.397 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.42 -52.74 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.36 . . . . 0.0 111.441 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.94 -2.14 47.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.58 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 57.0 80.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 110.894 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -178.88 126.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.3 t -59.31 87.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.7 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.57 130.96 35.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 mp -66.4 -29.07 69.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.25 -24.82 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.336 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.424 HG23 ' CZ ' ' A' ' 100' ' ' TYR . 91.1 m -80.29 -12.03 59.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.536 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.424 ' CZ ' HG23 ' A' ' 99' ' ' THR . 17.5 m-85 -142.18 29.77 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.768 0.318 . . . . 0.0 111.018 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.405 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -92.73 150.6 20.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.806 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 28.0 mt -118.11 93.0 43.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.71 -168.42 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -97.05 128.17 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp 59.69 97.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.54 -59.97 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.449 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -94.13 101.69 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 -47.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -153.01 -62.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 179.921 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.35 140.6 32.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -59.93 114.61 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -158.73 -45.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.03 92.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.1 mmtp -111.74 147.12 36.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.59 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -91.23 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.916 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.521 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 11.3 m-85 -93.43 -47.4 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.28 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 38.96 86.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.377 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.45 66.47 1.68 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.503 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.424 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 3.9 tt -145.64 122.21 11.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.489 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 54' ' ' ILE . 3.7 mt-10 -94.63 123.6 38.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.331 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.424 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 3.6 mt -132.77 136.18 56.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.261 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.0 p -135.61 142.82 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.9 p -107.01 109.4 21.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.13 103.51 15.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.98 161.96 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.657 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.23 -15.84 14.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.599 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.433 ' CD2' ' HB3' ' A' ' 58' ' ' GLN . 5.4 m-85 63.47 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.016 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.0 -79.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.983 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -105.82 -71.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.438 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 46.5 ttm -163.47 53.33 0.37 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.438 ' HD3' ' N ' ' A' ' 22' ' ' MET . 95.3 Cg_endo -83.57 10.27 3.75 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.65 2.233 . . . . 0.0 112.803 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -40.62 84.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.755 0.312 . . . . 0.0 111.172 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.403 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 41.8 m-20 -87.36 -26.2 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.468 . . . . 0.0 110.4 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -31.29 56.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.4 tp -74.96 -46.37 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -64.69 -27.35 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.483 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -68.72 -50.84 47.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.187 0.518 . . . . 0.0 109.84 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 74.0 mtm -55.11 -48.21 73.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.84 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.6 m -60.52 -44.84 97.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 0.0 110.17 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 31' ' ' VAL . 12.5 tt0 -58.39 -33.47 69.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -70.02 -21.44 63.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.749 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 2.6 m -93.28 -3.25 53.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 110.84 -29.74 8.67 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.435 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 11' ' ' LEU . . . -58.3 156.98 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 132.17 45.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.044 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 28' ' ' GLU . 15.1 m -71.76 114.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.053 0.454 . . . . 0.0 110.898 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 24.8 t -100.27 117.93 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.907 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -47.24 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.34 171.0 14.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.072 0.463 . . . . 0.0 111.448 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 9.4 mt -65.37 -44.59 87.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.854 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 m -60.69 -27.22 67.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -23.28 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 16.2 m-85 -53.72 123.57 12.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -144.12 108.73 4.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.1 mp -60.42 149.66 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -143.24 -116.78 1.17 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.9 p -82.66 -30.86 29.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.95 36.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.673 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m -93.94 118.77 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.31 134.69 24.09 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.66 125.53 5.59 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.639 2.226 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.417 HG13 ' CD2' ' A' ' 11' ' ' LEU . 29.3 mm -134.71 148.34 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 58.7 t -126.58 151.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.362 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 16.4 t -123.71 131.26 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.2 m -143.26 120.39 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.556 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.433 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -140.82 86.06 12.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.16 135.24 39.57 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.515 2.143 . . . . 0.0 112.314 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -177.42 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.67 30.02 5.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 68' ' ' PHE . 4.8 m95 -87.66 -34.19 18.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.17 -67.84 0.21 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.79 164.32 14.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.72 65.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.0 -29.98 67.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.86 84.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.395 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.431 ' CD1' ' CZ2' ' A' ' 62' ' ' TRP . 5.9 t80 -100.48 7.1 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.548 0.213 . . . . 0.0 111.433 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -91.69 49.74 1.61 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.18 29.52 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.42 HD13 ' CD1' ' A' ' 68' ' ' PHE . 14.1 mm -62.84 -39.36 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.25 -25.65 61.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -27.91 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.5 mtp -93.83 -30.7 14.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.1 t -134.58 145.59 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.56 31.34 4.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.51 166.15 11.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.08 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.08 108.43 2.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.788 2.325 . . . . 0.0 112.524 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 3.2 m -91.12 127.44 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.588 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 35.9 m -137.09 139.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.793 0.33 . . . . 0.0 111.736 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 p -52.02 161.97 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -21.51 9.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.476 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.26 -43.92 15.97 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.521 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.4 t90 -56.57 -57.42 12.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.931 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 52.9 t -54.34 -43.75 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.269 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.12 -56.34 7.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.016 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.3 -31.37 63.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.0 m -77.1 -49.92 14.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.24 -27.27 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.467 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.05 -58.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.7 tp -89.45 -12.16 40.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.271 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 66.05 77.83 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 110.776 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -177.82 134.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 t -59.6 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -72.69 159.05 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -63.67 153.02 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.4 mp -102.15 -33.38 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.281 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -57.2 -21.67 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.595 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.9 m -80.51 -20.48 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.564 0.221 . . . . 0.0 111.482 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.8 23.75 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.61 144.96 25.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 111.068 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.9 mp 63.66 135.81 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.098 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.74 -172.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.398 2.065 . . . . 0.0 112.184 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.17 85.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.1 pp -152.67 120.95 3.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.24 121.88 8.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.398 2.065 . . . . 0.0 112.366 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -161.49 30.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.2 p -140.21 37.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -145.1 92.93 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.895 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.66 111.72 14.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.758 0.313 . . . . 0.0 110.847 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -122.71 120.77 34.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -140.29 176.44 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.19 90.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.6 mmtt -74.42 136.81 42.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.341 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.457 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.1 pp -76.33 -23.49 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.92 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.511 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 16.4 m-30 -93.71 -47.68 6.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 45.54 90.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.333 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.21 76.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.931 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.18 162.27 38.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -140.65 109.78 6.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.5 mt -121.11 130.72 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 111.666 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.611 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 21.9 p -115.04 139.03 50.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.6 p -107.12 108.49 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.597 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.98 119.66 33.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.94 166.38 25.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.594 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.35 -10.38 9.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.864 2.376 . . . . 0.0 112.75 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.5 m-85 62.88 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.3 p -125.15 -71.7 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.98 -70.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.434 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -167.89 56.1 0.32 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.983 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HD3' ' N ' ' A' ' 22' ' ' MET . 69.2 Cg_endo -86.94 17.09 1.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.828 2.352 . . . . 0.0 112.847 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -41.76 99.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.36 -25.17 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.476 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -31.48 41.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.415 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.6 tp -75.91 -44.24 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.396 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -65.44 -27.54 68.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.449 ' CD1' HD23 ' A' ' 33' ' ' LEU . 18.4 t90 -67.47 -51.94 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.162 0.506 . . . . 0.0 109.734 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 6.2 mtm -55.03 -50.52 68.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.615 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 28' ' ' GLU . 26.1 m -58.98 -45.02 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' N ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.96 -33.83 67.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.497 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.449 HD23 ' CD1' ' A' ' 29' ' ' TRP . 0.6 OUTLIER -70.44 -21.46 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.021 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.47 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 4.0 m -93.45 -3.26 53.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.745 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.51 -18.21 17.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.851 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 8' ' ' PHE . . . -72.63 177.93 4.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.28 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -131.98 139.18 48.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.565 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.488 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 p -71.93 122.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.2 t -93.92 130.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.04 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -65.3 -42.3 93.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -147.73 -179.59 7.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 33.1 mt -71.43 -41.1 69.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.933 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 t -72.95 -9.11 58.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.428 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 -19.11 60.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.607 0.241 . . . . 0.0 111.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -53.31 113.8 1.27 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -110.57 128.03 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.43 126.39 40.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.59 28.34 1.91 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.76 36.8 22.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.72 -42.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 t -97.42 118.88 44.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -93.87 126.84 47.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -78.53 130.73 10.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.697 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.418 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 8.1 mm -138.82 147.74 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.666 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 79' ' ' VAL . 39.9 t -123.01 151.1 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 15.2 t -129.95 144.41 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' N ' HG11 ' A' ' 56' ' ' VAL . 2.5 m -135.3 -177.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 172.98 78.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.05 88.06 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.644 2.23 . . . . 0.0 112.402 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.12 -51.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.88 33.57 2.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -83.32 -30.26 27.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.3 m 65.01 -75.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.78 158.7 31.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -111.08 88.07 2.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -81.26 -47.97 12.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.53 94.36 0.16 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CZ ' HG13 ' A' ' 71' ' ' ILE . 42.3 t80 -91.56 7.13 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.506 0.193 . . . . 0.0 111.508 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -91.35 52.47 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.032 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.39 33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.463 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 23.0 mm -74.3 -54.3 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.39 -20.76 71.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.42 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -18.09 40.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.92 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.0 ttp -93.67 -25.53 17.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.801 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 46.0 t -133.5 156.41 47.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.856 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -103.34 32.63 3.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.91 164.52 28.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.39 120.87 5.01 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.431 ' CG2' ' CG2' ' A' ' 71' ' ' ILE . 10.7 t -94.62 121.29 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 28.0 m -137.58 135.57 46.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.586 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 p -50.65 170.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.668 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -16.32 60.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.36 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -42.24 52.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 110.664 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.511 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 80.2 t90 -59.46 -57.26 13.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.491 0.663 . . . . 0.0 109.766 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.2 t -55.06 -43.48 69.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.133 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.87 -46.14 66.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -64.48 -32.94 74.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.518 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -77.11 -47.13 21.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.24 -30.92 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.38 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.73 -56.79 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.84 -16.54 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 67.57 77.76 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.02 136.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.707 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -58.93 91.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -74.57 160.39 30.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.66 139.04 56.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.425 ' CB ' HG11 ' A' ' 80' ' ' VAL . 1.6 mp -88.34 -33.06 18.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.349 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -22.25 24.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.583 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.7 m -77.74 -23.38 49.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.433 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -128.1 18.46 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.618 0.247 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.406 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -87.2 173.93 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.5 mm -111.45 97.29 35.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.18 -171.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.52 2.147 . . . . 0.0 112.209 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -177.36 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.18 154.31 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 107.03 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.536 2.157 . . . . 0.0 112.293 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -140.35 85.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.6 t -118.66 98.25 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.95 -32.09 8.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.8 p -110.5 -33.15 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 61.0 30.24 19.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -134.41 178.59 6.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -161.44 75.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 7.5 pttm -94.16 171.25 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.775 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.415 HD13 ' CE1' ' A' ' 8' ' ' PHE . 1.1 pp -111.56 -16.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.522 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 9.7 m-30 -93.78 -43.84 8.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.893 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 49.26 92.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 75.38 0.51 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -139.58 162.04 36.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.142 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.76 109.81 5.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mt -118.05 124.96 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.413 . . . . 0.0 111.762 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.636 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.9 p -108.35 129.5 55.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 14.2 m -97.33 115.06 26.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -93.52 108.71 20.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.097 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.67 168.77 33.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.3 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.681 2.254 . . . . 0.0 112.621 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.429 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.9 m-85 63.57 -79.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.946 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.98 -78.68 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.882 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.0 31.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.699 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -97.63 147.94 33.74 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 24' ' ' THR . 41.9 Cg_exo -56.83 -18.74 28.5 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.569 2.179 . . . . 0.0 112.5 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER 85.51 -18.05 0.38 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.355 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.33 -25.24 25.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.105 0.478 . . . . 0.0 110.116 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -75.88 -30.96 59.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.146 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.0 tp -72.37 -50.58 25.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.279 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.425 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -60.95 -27.44 68.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 110.465 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -64.0 -49.16 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 mtm -51.67 -55.57 18.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.704 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 28' ' ' GLU . 20.1 m -57.06 -44.26 82.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.079 0.466 . . . . 0.0 110.222 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.419 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt-30 -59.72 -36.87 77.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.079 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.08 -21.04 63.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.883 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 1.4 m -93.23 -3.31 53.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.839 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.33 25.4 5.81 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.118 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -116.35 178.42 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.102 0.477 . . . . 0.0 111.296 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.64 132.57 44.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.612 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.4 p -71.88 119.43 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -93.92 124.29 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.862 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -45.47 77.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -146.73 -179.21 6.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 29.6 mt -67.26 -44.13 80.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -17.57 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.276 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.3 m -65.66 -17.36 64.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.444 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 77' ' ' ALA . 14.0 m-85 -51.48 113.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -96.27 177.41 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.18 -172.84 2.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.06 -123.31 1.37 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -125.7 -52.24 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.44 73.41 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.493 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 t -154.51 138.56 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 110.947 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -131.96 120.17 17.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.76 133.18 11.25 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.561 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.42 HG13 ' CD2' ' A' ' 11' ' ' LEU . 9.4 mm -139.79 146.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.929 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.6 t -124.5 138.22 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 24.0 t -124.16 158.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 111.404 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.431 ' CG2' ' CG1' ' A' ' 79' ' ' VAL . 1.4 t -152.89 177.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.689 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.429 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 6.4 tm0? -179.2 86.89 0.21 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.75 116.91 3.95 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.488 2.125 . . . . 0.0 112.33 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.96 32.62 6.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.65 -32.72 60.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 68.87 -67.5 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.033 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.35 129.9 34.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.39 77.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.59 -41.67 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.3 113.23 0.58 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.343 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.476 ' CE2' HG13 ' A' ' 71' ' ' ILE . 28.0 t80 -99.98 7.15 44.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -91.79 55.83 2.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.71 34.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.37 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.476 HG13 ' CE2' ' A' ' 68' ' ' PHE . 11.3 mm -74.2 -53.62 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.265 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.31 -27.85 68.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.421 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -88.36 -13.47 40.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.579 0.228 . . . . 0.0 111.334 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -28.89 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.2 p -117.44 157.19 26.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.932 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -107.03 41.93 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -154.33 165.95 16.93 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.5 124.26 12.6 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.496 2.131 . . . . 0.0 112.323 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.431 ' CG1' ' CG2' ' A' ' 57' ' ' VAL . 25.7 t -92.53 128.37 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 31.2 m -143.15 177.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 10.5 p -96.86 163.99 12.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 109.941 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -19.39 17.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.349 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -47.87 -45.09 30.0 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.502 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 63.4 t90 -55.99 -57.26 12.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.39 0.614 . . . . 0.0 110.114 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.0 t -54.07 -43.16 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.359 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -50.46 38.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.09 -32.84 71.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.772 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -77.03 -48.49 17.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.1 t -71.01 -25.91 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.334 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.66 -55.09 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.315 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.5 tt -98.07 2.95 49.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.585 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.36 83.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.8 131.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.56 79.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.82 173.05 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.03 153.49 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mp -94.07 -27.34 16.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -58.79 -31.86 68.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.93 -16.63 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.43 29.55 3.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.27 165.52 11.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.19 95.9 16.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.237 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 -168.12 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.539 2.16 . . . . 0.0 112.332 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.27 170.52 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.15 107.32 24.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.21 147.77 15.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.471 2.114 . . . . 0.0 112.344 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -171.36 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 81.1 p -176.06 165.59 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.46 134.1 49.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 48.4 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.845 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -66.82 -68.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -99.01 98.71 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.76 -172.89 2.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.92 -67.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER 59.95 168.84 0.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.325 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pp -111.95 -20.72 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.506 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 14.6 m-30 -93.7 -46.16 7.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 43.15 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.039 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.32 73.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.303 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.415 HD23 ' CG1' ' A' ' 54' ' ' ILE . 2.1 tt -148.36 119.01 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.707 0.289 . . . . 0.0 110.82 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.89 124.06 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.411 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 3.2 mt -132.66 129.78 58.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.678 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.1 p -121.52 146.4 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.211 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.466 ' HA ' HG23 ' A' ' 56' ' ' VAL . 25.1 p -106.92 127.86 53.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -93.89 105.07 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.065 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.86 44.22 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.667 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -166.71 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.42 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 26.3 m-85 -139.85 -53.1 0.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.11 -67.06 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.794 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.97 -74.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.679 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.429 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -167.44 54.82 0.29 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 22' ' ' MET . 69.0 Cg_endo -85.89 15.17 2.26 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.779 2.32 . . . . 0.0 112.993 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -44.67 71.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 111.21 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -85.57 -26.71 25.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.251 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.59 -33.2 68.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.481 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -50.83 20.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.349 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -65.36 -27.78 68.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.425 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -71.39 -50.35 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 8.1 mtm -54.87 -48.41 73.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.54 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.403 HG21 ' N ' ' A' ' 32' ' ' GLN . 28.9 m -62.65 -45.14 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 0.0 109.656 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.403 ' N ' HG21 ' A' ' 31' ' ' VAL . 5.1 mt-30 -56.42 -35.91 68.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.071 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 tp -70.07 -21.41 63.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.928 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 2.3 m -93.19 -3.24 54.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.706 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.93 25.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.411 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . . . -71.59 174.33 6.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.485 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.08 136.93 52.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.547 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.3 p -71.88 123.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.0 t -93.86 146.51 6.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -42.82 62.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.154 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 -175.91 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.904 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 30.5 mt -63.64 -50.38 69.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.007 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -66.65 -19.16 65.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.413 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 56.5 m -61.67 -23.32 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.332 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 17.5 m-85 -49.33 110.83 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.25 127.59 53.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -79.21 110.39 14.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.81 -131.64 4.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.46 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -114.81 -44.73 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.354 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.14 70.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.487 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m -163.52 107.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.002 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 130.55 34.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.57 135.36 13.01 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.54 2.16 . . . . 0.0 112.471 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.415 ' CG1' HD23 ' A' ' 11' ' ' LEU . 9.3 mm -144.3 151.35 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.4 t -130.65 140.79 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -114.48 160.71 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 111.15 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' THR . 6.1 m -152.23 -177.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.507 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.435 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 174.54 94.93 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.29 68.67 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.488 2.126 . . . . 0.0 112.334 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.05 -73.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.28 -17.78 35.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.25 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.59 -40.37 59.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 m 60.75 160.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -89.23 93.42 9.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.76 -65.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -101.03 -29.9 11.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.34 125.71 2.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.444 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' A' ' 71' ' ' ILE . 4.5 t80 -100.34 7.11 44.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.593 0.235 . . . . 0.0 111.524 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -90.44 51.41 2.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -172.35 35.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.027 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.425 HD13 ' CD1' ' A' ' 68' ' ' PHE . 29.1 mm -72.32 -65.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.75 -26.66 68.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -22.98 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 0.0 111.192 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtm -93.92 -43.85 8.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.4 p -86.97 162.33 17.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.925 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -113.08 33.85 4.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.41 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -144.68 166.32 18.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.97 125.98 13.24 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.281 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 57' ' ' VAL . 17.6 t -93.05 123.64 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.978 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 35.8 m -141.16 134.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 1.9 p -54.76 159.99 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.472 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.37 -19.8 6.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.578 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.96 -40.58 10.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.9 t90 -58.93 -57.42 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.46 0.648 . . . . 0.0 110.145 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.69 -42.93 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.267 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.29 -56.24 8.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -57.99 -30.7 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 92' ' ' TYR . 69.3 m -76.99 -49.16 16.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.8 t -71.32 -27.23 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.371 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.91 -54.69 19.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.177 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 tt -97.41 -2.28 42.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.323 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 58.05 84.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 110.887 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -177.53 139.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.7 t -67.9 74.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.1 158.84 6.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.58 151.46 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.8 mp -95.98 -34.8 11.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.65 -25.51 39.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.511 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.454 HG22 ' CD2' ' A' ' 100' ' ' TYR . 13.4 t -74.88 -24.73 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.454 ' CD2' HG22 ' A' ' 99' ' ' THR . 9.8 m-85 -125.74 15.0 8.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.13 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -80.7 87.17 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.317 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 30.0 mt 56.4 108.14 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.496 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.16 172.72 11.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 112.087 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.52 -51.83 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.7 135.82 27.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.53 155.75 62.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.479 2.12 . . . . 0.0 112.32 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -137.95 88.16 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.49 163.79 13.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -159.44 31.65 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.865 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m 60.79 59.56 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 110.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -103.79 100.91 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.23 -46.11 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -76.29 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp 56.48 169.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.66 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.3 pt -110.44 -19.83 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.506 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 15.7 m-30 -93.7 -50.42 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.637 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 47.72 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.35 76.2 0.83 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.066 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.438 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -145.5 162.01 38.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 111.008 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' CG ' ' CG2' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.22 109.82 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.334 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.424 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 1.8 mt -125.29 130.46 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.361 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 6.1 p -111.08 143.18 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.6 p -106.46 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.756 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.01 131.27 39.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.6 158.73 34.16 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.56 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.15 0.26 10.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.644 2.229 . . . . 0.0 112.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 19.9 m-85 62.77 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.734 0.302 . . . . 0.0 111.056 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.6 t -143.71 -49.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -116.88 -78.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.714 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.432 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -170.48 55.78 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.046 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 22' ' ' MET . 65.5 Cg_endo -87.1 15.44 2.18 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.772 2.315 . . . . 0.0 112.751 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -44.23 97.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.281 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.9 -25.78 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -77.96 -33.35 51.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.523 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.5 tp -75.07 -44.12 49.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.43 ' HA ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.99 -27.48 67.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.507 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.484 ' CD1' HD21 ' A' ' 33' ' ' LEU . 10.3 t90 -69.24 -50.05 50.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.858 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.429 ' HG2' ' CE3' ' A' ' 29' ' ' TRP . 2.3 mtm -57.34 -48.61 78.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.575 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.4 m -60.51 -45.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.203 0.525 . . . . 0.0 109.621 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.431 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.57 -34.58 69.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.666 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 HD21 ' CD1' ' A' ' 29' ' ' TRP . 0.6 OUTLIER -70.28 -21.27 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.005 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 38.5 m -93.42 -3.08 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.667 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.3 -23.44 11.3 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.741 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.424 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . . . -67.02 177.08 1.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.054 0.454 . . . . 0.0 111.231 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.61 138.6 51.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -71.82 114.77 10.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.782 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 3.0 t -93.91 121.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.022 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -58.44 -47.16 84.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.336 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -132.69 176.03 8.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.086 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.446 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 13.1 mt -70.87 -43.51 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -5.01 44.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -15.98 61.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.561 0.22 . . . . 0.0 111.389 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 21.2 m-85 -50.9 125.52 13.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 111.013 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 m -58.14 -35.31 71.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 mt 58.71 30.75 20.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.37 -140.39 2.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.552 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 m -114.34 -35.33 5.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.5 36.35 4.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.539 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.2 t -152.17 125.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 0.0 111.209 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -100.99 120.64 54.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -77.98 133.74 12.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.593 2.195 . . . . 0.0 112.635 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.438 HG13 ' CD2' ' A' ' 11' ' ' LEU . 7.5 mm -142.49 162.31 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.622 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 33.9 t -137.99 150.74 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.666 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 4.1 t -121.85 158.43 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.32 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.39 -179.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.473 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 1.1 tt0 176.52 66.93 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.579 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.58 94.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.47 -45.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.97 38.96 3.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -30.79 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.824 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m 78.54 -4.64 2.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.813 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.3 87.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 111.026 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -140.03 -56.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.2 -29.47 34.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.4 114.67 3.98 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CD1' HD12 ' A' ' 71' ' ' ILE . 49.0 t80 -85.86 -2.31 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -84.29 56.93 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.953 0.406 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.96 38.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 68' ' ' PHE . 24.0 mm -69.82 -67.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.01 -24.25 71.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.372 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.93 -27.82 64.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.311 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.0 mtm -93.92 -39.28 10.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 27.5 p -98.37 147.08 25.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 38.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . . . -147.3 169.3 9.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HG2' HG23 ' A' ' 54' ' ' ILE . 73.6 Cg_endo -74.94 125.87 9.64 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.741 2.294 . . . . 0.0 112.456 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.422 ' CG1' HG21 ' A' ' 71' ' ' ILE . 8.4 t -98.02 136.61 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 26.7 m -147.59 159.56 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.659 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 p -73.7 159.3 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.246 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -53.6 -22.51 8.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.446 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.45 -38.07 8.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 72.6 t90 -63.46 -57.23 10.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.492 0.663 . . . . 0.0 109.818 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -54.3 -39.22 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.377 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -48.47 17.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -60.25 -35.72 76.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -77.05 -47.91 19.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 73.7 t -71.22 -25.87 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.439 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.45 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 111.041 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tp -85.07 -18.48 34.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 73.44 77.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.672 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -177.43 136.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 t -61.17 86.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -67.34 163.42 20.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.99 140.12 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.858 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mp -83.33 -29.52 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.12 -29.15 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.1 p -72.08 -17.45 62.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.84 22.32 2.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.671 0.272 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.424 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -86.34 122.01 29.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.34 . . . . 0.0 110.789 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.19 112.8 25.65 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.074 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.96 -158.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.429 2.086 . . . . 0.0 112.213 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -170.76 -49.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.32 113.49 26.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.49 -39.86 63.94 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.423 2.082 . . . . 0.0 112.368 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -127.52 142.96 51.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 t -129.09 100.57 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.11 105.28 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.901 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -122.97 89.75 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.96 163.62 27.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -106.33 -32.33 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.43 81.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 10.4 mmtm -78.98 137.44 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.434 HD13 ' CE1' ' A' ' 8' ' ' PHE . 1.3 pp -79.13 -21.16 12.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.738 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.507 ' CE1' ' CH2' ' A' ' 84' ' ' TRP . 9.8 m-30 -93.8 -34.81 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.72 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 8' ' ' PHE . 2.3 ppt_? 28.54 79.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.795 0.438 . . . . 0.0 111.96 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.94 72.16 1.29 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.632 -0.795 . . . . 0.0 111.554 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD11 ' CD1' ' A' ' 8' ' ' PHE . 1.8 tt -144.68 152.67 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.71 0.29 . . . . 0.0 110.754 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 54' ' ' ILE . 6.8 mt-10 -129.07 119.64 24.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.647 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.433 HD11 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -129.07 123.56 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.54 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.624 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 24.6 p -110.09 137.7 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.5 107.24 19.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -93.61 111.78 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.76 168.56 35.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.354 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.97 -0.55 10.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.739 2.292 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.443 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.7 m-85 63.18 -80.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -73.43 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -177.8 73.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.7 mtm -155.22 165.24 18.71 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.742 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.44 105.42 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.82 -17.25 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.242 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -20.59 38.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.244 0.545 . . . . 0.0 110.017 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -76.99 -32.5 57.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.291 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 68.1 tp -70.72 -50.14 39.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.384 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -60.9 -27.45 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -65.52 -50.41 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.254 0.549 . . . . 0.0 109.607 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 66.8 mtt -51.46 -51.53 54.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.866 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.445 HG23 ' N ' ' A' ' 32' ' ' GLN . 31.4 m -61.9 -45.65 98.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.056 0.455 . . . . 0.0 110.181 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.63 -35.59 72.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.193 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 tp -69.97 -20.92 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.029 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.479 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.4 m -93.0 -3.2 54.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.988 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.23 -15.96 11.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.083 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' A' ' 13' ' ' ILE . . . -76.65 -179.12 5.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.58 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -134.89 135.23 41.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.404 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.418 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 12.1 p -71.88 118.59 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -93.85 118.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -42.63 85.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.13 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -148.69 177.26 9.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.9 mt -67.4 -46.53 72.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.794 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -23.48 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -24.37 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.1 m-85 -55.76 128.72 36.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -132.31 129.1 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.76 79.8 9.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.56 -124.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.54 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 t -118.33 -45.3 2.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 110.831 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -124.15 27.33 5.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.91 112.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.423 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 2.6 t-80 -95.37 127.82 40.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HD2' ' CD2' ' A' ' 52' ' ' HIS . 73.3 Cg_endo -75.89 135.39 17.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.129 . . . . 0.0 112.479 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.409 ' N ' ' O ' ' A' ' 12' ' ' GLU . 16.0 mm -142.24 150.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.803 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.2 t -131.05 149.18 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.916 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 57.9 t -120.59 159.68 21.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.416 ' N ' HG11 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -149.14 -178.74 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.008 0.432 . . . . 0.0 111.494 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 169.47 81.11 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.873 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 110.59 2.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -172.45 -41.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.078 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.66 38.23 3.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -22.28 60.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.081 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.43 -67.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.64 167.45 13.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.87 70.75 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -85.2 -49.99 7.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.769 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.98 99.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.266 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' CD2' HD13 ' A' ' 71' ' ' ILE . 46.2 t80 -92.61 -5.99 50.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -81.72 56.39 3.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.165 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.85 30.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.454 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.446 HD13 ' CD2' ' A' ' 68' ' ' PHE . 18.3 mm -67.79 -66.85 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.896 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.06 76.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.382 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -25.51 61.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.027 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtp -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.9 t -104.29 155.93 18.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.49 35.46 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.47 165.96 23.83 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.0 136.2 22.27 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.658 2.239 . . . . 0.0 112.39 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.94 126.11 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.638 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 35.0 m -138.18 159.24 32.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.494 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -72.04 166.0 23.12 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.415 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -59.44 -18.33 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.39 -42.0 30.58 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.507 ' CH2' ' CE1' ' A' ' 8' ' ' PHE . 73.9 t90 -60.43 -57.31 13.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 110.172 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.2 t -55.12 -36.93 41.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.338 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -54.57 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.049 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -56.94 -31.14 64.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 92' ' ' TYR . 61.2 m -77.1 -50.11 13.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.9 t -71.25 -25.99 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.619 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 -56.7 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.337 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 tp -90.11 -13.79 35.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.296 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 68.31 81.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.45 137.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.93 85.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.78 170.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.52 118.52 31.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' CB ' HG11 ' A' ' 80' ' ' VAL . 2.6 mp -61.08 -35.57 77.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.301 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.59 -24.36 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.4 m -80.63 -20.22 43.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.449 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -134.74 32.78 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.433 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -100.81 175.3 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.87 84.46 53.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.75 -168.23 0.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.866 2.378 . . . . 0.0 112.672 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.66 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.36 137.13 85.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.22 -44.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.499 2.133 . . . . 0.0 112.406 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.49 -169.06 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.945 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.7 135.37 40.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -108.15 132.84 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.927 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.75 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -119.36 90.54 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -36.77 10.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.943 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 57.39 31.78 20.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -98.35 131.32 44.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.425 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.2 pp -72.47 -23.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.681 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.499 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 13.2 m-30 -93.66 -46.18 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.78 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.631 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 76.93 1.02 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.028 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.445 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -146.35 162.09 38.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.949 0.404 . . . . 0.0 111.211 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.42 109.93 6.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.35 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.416 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -122.54 127.46 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 111.795 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.612 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.3 p -112.64 133.45 54.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.2 p -98.97 108.36 21.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.731 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -93.94 126.16 38.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.48 163.31 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.1 -5.02 12.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.696 2.264 . . . . 0.0 112.735 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 10.9 m-85 63.82 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.846 0.355 . . . . 0.0 111.033 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.2 p -143.69 -71.59 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.938 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -176.96 42.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.523 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.465 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -177.91 -61.11 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.934 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 22' ' ' MET . 12.0 Cg_endo -55.69 85.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.546 2.164 . . . . 0.0 112.408 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.11 -69.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.343 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -85.7 -29.24 24.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.735 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -27.5 60.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.054 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.5 tp -72.85 -51.2 19.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.578 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.77 -27.74 69.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.356 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -71.19 -50.77 29.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.8 mtm -53.88 -48.0 70.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 32' ' ' GLN . 29.3 m -61.86 -45.23 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.149 0.499 . . . . 0.0 109.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.444 ' N ' HG22 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -56.56 -36.62 69.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.997 178.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.97 -20.97 63.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.769 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 95.0 m -92.95 -3.18 54.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.92 -31.96 5.14 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.69 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -62.51 -179.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.114 0.483 . . . . 0.0 111.358 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.3 139.17 40.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.585 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.1 p -71.8 122.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 3.2 t -99.11 123.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -58.86 -48.09 82.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -139.13 172.33 12.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.016 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.429 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 15.8 mt -65.91 -50.56 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -58.94 -21.24 57.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.158 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -23.4 67.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 25.2 m-85 -53.77 112.68 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -69.31 -31.92 70.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tt 60.82 74.54 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.23 -173.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -81.18 -30.16 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.3 -27.27 12.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.609 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.97 116.7 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.43 133.51 22.71 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.59 135.56 10.45 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.149 . . . . 0.0 112.615 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 11' ' ' LEU . 9.6 mm -140.42 142.71 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.635 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.9 t -123.28 136.91 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.628 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 42.6 t -122.12 158.51 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -152.43 -173.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.517 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.464 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -174.14 89.19 0.34 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.845 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.01 83.86 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.538 2.159 . . . . 0.0 112.271 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -148.95 -46.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.54 29.66 5.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.116 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 -29.34 26.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 69.54 -66.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 103.53 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.856 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -64.3 86.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.51 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.65 122.94 2.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.415 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CE2' HG13 ' A' ' 71' ' ' ILE . 10.1 t80 -88.0 7.13 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.581 0.229 . . . . 0.0 111.416 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -80.53 -0.72 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.545 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.19 -9.59 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.653 0.263 . . . . 0.0 111.617 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.48 HG13 ' CE2' ' A' ' 68' ' ' PHE . 8.3 mm -64.37 -47.19 90.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.75 50.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.374 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.72 -17.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.628 0.252 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -93.87 -33.68 13.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.4 t -122.62 154.72 37.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.966 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.39 31.35 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -120.35 168.7 9.97 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.07 121.59 7.4 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.605 2.204 . . . . 0.0 112.569 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.426 ' CG1' ' CG2' ' A' ' 57' ' ' VAL . 18.3 t -88.59 125.51 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 27.7 m -143.21 177.15 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.835 0.35 . . . . 0.0 111.418 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 p -98.24 166.9 11.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.304 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -18.42 32.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.362 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.89 -47.86 51.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.499 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 59.3 t90 -50.72 -57.37 8.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.265 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.3 t -53.84 -49.1 60.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.301 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -50.0 72.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -61.83 -32.48 72.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.752 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.2 m -77.07 -46.48 23.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.032 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 33.0 t -71.16 -28.2 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.339 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.83 -56.65 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.1 tt -93.28 -4.19 52.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 58.65 80.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.834 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -179.18 141.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.0 t -66.57 83.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.23 165.0 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.52 140.65 44.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.04 -30.97 19.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.45 -32.55 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.105 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.412 HG22 ' CE1' ' A' ' 100' ' ' TYR . 85.1 m -77.29 -10.22 59.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.324 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE1' HG22 ' A' ' 99' ' ' THR . 12.4 m-85 -138.68 30.5 2.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 110.686 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.04 96.91 8.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.779 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.0 mp 59.69 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.82 -79.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.4 2.067 . . . . 0.0 112.464 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -81.78 -171.1 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.9 mt 61.98 71.14 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.89 178.39 5.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.41 116.5 29.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.39 114.54 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -91.58 -31.56 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.905 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 t -99.92 97.15 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -141.21 -46.99 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -151.24 -64.42 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.805 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.02 -73.13 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.938 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.5 mmtm 62.58 136.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.671 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.455 HG22 ' CD1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -76.4 -22.87 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.555 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.505 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 15.5 m-30 -93.64 -49.51 5.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 44.96 90.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.83 76.15 1.0 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.968 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.422 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -147.33 160.85 42.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.855 0.359 . . . . 0.0 111.118 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -140.8 109.8 6.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.434 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.7 mt -120.38 125.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.646 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.697 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 28.3 p -113.45 142.7 45.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.0 p -106.95 119.31 39.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.525 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.76 117.56 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 62' ' ' TRP . . . 72.36 146.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.473 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.69 150.42 28.76 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.543 2.162 . . . . 0.0 112.315 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.442 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 4.2 m-85 -103.2 -72.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -146.96 29.27 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.659 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -168.53 163.0 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -83.56 -46.53 0.79 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.406 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 22' ' ' MET . 71.1 Cg_exo -48.74 -64.76 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 112.702 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 76.47 -4.26 2.39 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.616 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.433 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 24.4 m-20 -80.92 -25.31 37.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.193 0.521 . . . . 0.0 109.983 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.21 -36.7 82.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.553 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.16 -55.61 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.171 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.433 ' CG ' ' HA ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.47 -27.3 67.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.007 0.432 . . . . 0.0 110.212 179.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -63.13 -49.34 74.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 109.556 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.2 mtt -51.15 -55.15 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.706 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 28' ' ' GLU . 22.9 m -58.82 -45.04 91.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.426 ' N ' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -59.57 -33.77 71.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.288 179.358 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.06 -21.17 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.931 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 3.8 m -93.28 -3.16 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.753 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.62 -22.26 10.16 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.927 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.434 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . . . -67.98 178.03 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.85 135.21 46.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.82 117.92 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.882 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.697 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.4 t -93.89 124.49 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -25.51 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.358 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -174.85 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.318 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.6 mt -63.07 -46.34 87.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.973 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -11.38 60.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.426 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m -96.0 24.73 5.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.674 0.273 . . . . 0.0 111.312 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CE1' HG22 ' A' ' 39' ' ' VAL . 3.4 m-85 -85.67 97.98 10.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.861 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.9 159.77 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mt -136.04 72.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -117.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -140.67 25.49 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 0.0 111.007 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.96 36.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.611 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 m -129.31 116.64 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.725 0.298 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -94.09 136.26 23.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.973 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -83.16 132.89 6.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.705 2.27 . . . . 0.0 112.787 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.421 ' CG1' ' CD2' ' A' ' 11' ' ' LEU . 10.8 mm -137.73 151.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.4 t -129.07 149.96 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.955 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 7.3 t -128.2 146.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.339 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 1.9 m -133.1 173.03 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.442 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -176.95 88.08 0.25 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.68 64.04 3.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.549 2.166 . . . . 0.0 112.28 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.38 -67.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.76 23.92 8.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.337 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.435 ' CE2' ' HA3' ' A' ' 17' ' ' GLY . 0.2 OUTLIER -67.28 -16.71 64.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.254 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.8 t 46.16 -168.58 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.863 0.363 . . . . 0.0 111.319 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.14 132.32 53.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.44 -177.04 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.37 -47.36 15.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 138.68 2.9 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.41 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.445 ' CZ ' HG13 ' A' ' 71' ' ' ILE . 65.6 t80 -102.04 -4.9 25.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.554 0.216 . . . . 0.0 111.52 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.52 56.92 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.397 . . . . 0.0 110.91 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.49 34.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.445 HG13 ' CZ ' ' A' ' 68' ' ' PHE . 23.3 mm -69.31 -64.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.4 -15.35 81.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -79.03 -24.22 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mtm -93.97 -27.3 16.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.5 t -118.94 156.22 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 111.022 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.77 32.33 4.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.829 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.77 172.32 6.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.087 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.71 127.1 4.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.786 2.324 . . . . 0.0 112.888 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 71' ' ' ILE . 18.8 t -98.57 130.96 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.329 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 28.7 m -145.26 136.88 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.639 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 p -50.82 168.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.772 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.424 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -63.94 -16.44 61.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.07 -39.19 55.45 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.86 0.362 . . . . 0.0 110.608 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.505 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 79.0 t90 -62.7 -57.3 11.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 109.888 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.66 -38.18 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.222 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.06 -47.79 19.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.78 -33.53 73.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.742 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -77.16 -49.53 15.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.2 t -71.38 -27.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.42 -55.09 17.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 111.104 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.9 tt -95.65 -3.08 46.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.315 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CD1' HG22 ' A' ' 7' ' ' ILE . 6.7 t80 57.64 76.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.59 133.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.674 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.15 97.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.099 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.6 163.67 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.53 142.09 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.69 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' CB ' HG11 ' A' ' 80' ' ' VAL . 1.6 mp -87.13 -34.28 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.27 -22.88 32.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -76.26 -15.29 60.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.61 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -139.4 20.58 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.701 0.286 . . . . 0.0 111.235 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.422 ' HG ' ' CG1' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -81.23 163.46 22.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.19 138.07 89.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.54 -178.35 3.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.467 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.01 -64.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -148.88 110.6 3.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.99 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.38 90.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -176.71 122.22 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 m -143.69 83.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 -71.72 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.922 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.0 t80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.863 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -107.73 -57.34 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -76.59 113.41 14.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -137.92 -62.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 82.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.996 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.4 mmtp -99.29 134.42 42.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.506 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.64 -23.83 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.464 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 14.3 m-30 -93.37 -50.88 5.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 110.555 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.8 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.374 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.61 75.12 1.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.817 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -149.43 162.66 39.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.934 0.397 . . . . 0.0 111.241 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -138.64 109.68 6.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.408 ' CD1' ' CB ' ' A' ' 36' ' ' ALA . 2.3 mt -124.54 138.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.506 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 29.1 p -126.54 144.62 50.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' HA ' HG21 ' A' ' 56' ' ' VAL . 14.8 p -97.62 104.5 16.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.0 102.63 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.61 162.59 17.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.44 -2.7 10.61 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.762 2.308 . . . . 0.0 112.801 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.0 m-85 63.27 -81.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.037 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.56 -54.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.51 -74.9 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.412 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 5.7 ttt -174.2 57.8 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.157 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 22' ' ' MET . 64.9 Cg_endo -88.62 23.19 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.845 2.363 . . . . 0.0 112.597 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -47.84 83.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.341 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.8 -27.51 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 0.0 110.513 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -34.46 65.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.57 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.422 HD23 ' CZ ' ' A' ' 19' ' ' PHE . 44.6 tp -73.18 -48.34 36.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.355 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.508 ' O ' HG21 ' A' ' 31' ' ' VAL . 32.6 mt-10 -62.56 -27.42 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.504 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -65.32 -49.28 70.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 109.802 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 5.8 mtt -52.97 -52.33 58.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.853 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 28' ' ' GLU . 35.3 m -58.8 -46.5 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 110.615 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.477 ' N ' HG23 ' A' ' 31' ' ' VAL . 16.5 tt0 -57.95 -34.47 69.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.2 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.14 -21.51 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.8 m -93.59 -3.35 52.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.782 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.9 -34.84 4.55 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' CB ' ' CD1' ' A' ' 13' ' ' ILE . . . -56.15 169.16 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.486 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.37 134.62 54.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 28' ' ' GLU . 2.4 m -72.1 125.75 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 111.18 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 17.6 t -114.67 128.08 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -33.52 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.926 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -121.85 155.3 35.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.364 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 16.2 mt -70.78 -32.47 69.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.676 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -21.03 59.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.83 -20.46 61.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.189 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 20.3 m-85 -56.99 100.72 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.0 t -177.27 148.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.27 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.02 60.46 0.27 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.446 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 p 56.07 30.51 16.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.85 -28.01 4.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 m -130.57 147.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 111.073 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -93.8 126.06 50.93 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.43 129.59 10.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.568 2.179 . . . . 0.0 112.707 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.474 HG13 ' CD2' ' A' ' 11' ' ' LEU . 7.5 mm -141.66 154.71 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.818 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.9 t -138.21 140.31 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.86 156.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 111.115 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 79' ' ' VAL . 3.2 m -144.01 -179.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.538 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.487 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.89 67.18 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.754 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.02 107.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -167.21 -43.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.01 29.4 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -68.07 -49.11 63.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -177.45 -77.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.22 31.97 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 61.33 72.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.833 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.42 -66.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.964 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.06 92.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -92.7 7.26 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.611 0.243 . . . . 0.0 111.411 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -87.62 49.2 1.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 111.037 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.93 22.4 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 mm -69.59 -34.27 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 110.804 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.27 -20.91 59.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.312 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -77.32 -25.25 51.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 mtp -93.85 -29.28 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 54.0 t -132.35 153.5 50.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.753 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.88 -36.69 12.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.56 170.26 0.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.11 161.82 32.19 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.404 ' CG1' ' CG1' ' A' ' 57' ' ' VAL . 12.1 t -127.04 121.49 58.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 33.8 m -141.32 140.09 32.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.5 p -55.21 163.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.705 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -20.05 15.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -47.0 -40.98 15.59 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.464 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.7 t90 -58.84 -57.35 13.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.368 0.604 . . . . 0.0 110.106 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -55.93 -42.37 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.225 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.59 -56.56 6.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -56.7 -30.87 63.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -77.19 -50.5 12.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.087 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.4 t -71.27 -28.53 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.431 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -58.15 5.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.882 0.372 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.79 -10.63 47.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.203 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 64.9 79.77 0.25 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.857 0.36 . . . . 0.0 110.708 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -177.07 129.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -64.14 85.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -68.69 172.45 6.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.94 157.53 29.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.635 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' CB ' HG12 ' A' ' 80' ' ' VAL . 0.8 OUTLIER -96.7 -25.06 15.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.057 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -21.66 66.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 100' ' ' TYR . 25.5 m -77.08 -17.76 58.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.465 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CE1' ' HB ' ' A' ' 99' ' ' THR . 1.6 m-85 -138.91 23.61 2.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.661 0.267 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -83.03 101.12 10.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.004 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 22.1 mt 56.79 103.56 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.279 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.37 -173.67 1.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.501 2.134 . . . . 0.0 112.363 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -149.1 31.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.34 118.18 52.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.049 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.19 61.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.373 2.048 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.37 115.38 30.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 p -96.19 -71.65 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -102.29 119.4 38.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.7 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.941 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 34.32 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.836 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.29 85.69 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -177.63 -179.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.9 54.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 9.0 mmtm -81.36 138.08 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.555 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.444 ' CD1' ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -80.26 -20.19 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.748 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.518 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 18.0 m-30 -93.63 -48.12 6.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 39.3 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.23 68.85 1.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.772 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.516 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -137.2 160.66 38.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -137.64 111.11 8.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -122.2 121.84 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.378 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.614 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 19.4 p -107.51 132.02 53.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 m -95.31 101.65 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.535 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -93.88 102.73 14.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.108 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.91 144.02 7.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.801 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 23.9 Cg_exo -63.1 -13.41 35.29 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.8 2.334 . . . . 0.0 112.515 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.6 m-30 67.73 -76.54 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 t -133.89 -56.61 0.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -126.17 -80.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.783 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.47 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -158.62 50.48 0.39 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.106 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' A' ' 22' ' ' MET . 68.4 Cg_endo -85.34 10.75 3.6 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.672 2.248 . . . . 0.0 112.708 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -36.12 67.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.296 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -88.93 -27.18 21.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 110.558 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.87 -31.36 51.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -45.89 42.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.346 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -63.03 -27.72 69.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -66.77 -52.05 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 109.776 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 11.9 mtm -53.71 -50.52 65.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.668 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 28' ' ' GLU . 28.0 m -60.78 -45.46 97.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.427 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt-30 -56.74 -34.77 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.019 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.5 tp -70.19 -21.57 63.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 21.3 m -93.41 -3.53 53.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.729 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.82 15.67 17.81 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.156 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.432 ' HB2' ' CD2' ' A' ' 8' ' ' PHE . . . -101.69 173.53 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.145 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.57 132.52 51.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.655 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 13.8 p -71.98 122.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.1 t -93.91 127.55 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -59.27 -40.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.67 -177.13 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.74 -38.86 67.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.04 -8.71 56.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -92.89 18.17 9.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CE1' HG22 ' A' ' 39' ' ' VAL . 6.0 m-85 -81.2 95.26 6.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.9 174.18 11.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.11 158.1 44.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.7 -112.99 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.589 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.78 -42.03 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -121.7 27.21 6.32 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.526 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.2 t -93.95 147.76 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.965 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.31 118.46 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.02 128.55 7.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.567 2.178 . . . . 0.0 112.643 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.407 HG12 HD21 ' A' ' 11' ' ' LEU . 7.6 mm -144.76 156.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.7 t -137.98 144.49 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.029 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 22.0 t -128.21 159.32 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 111.246 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.453 ' CG2' ' CG1' ' A' ' 79' ' ' VAL . 0.6 OUTLIER -152.45 -169.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.447 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -179.17 72.25 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.25 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.645 2.23 . . . . 0.0 112.439 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.8 -40.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.95 30.76 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.025 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -32.03 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m 61.84 153.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.74 123.33 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.74 -63.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -96.21 -29.77 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.6 122.91 4.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.423 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' CD1' HD13 ' A' ' 71' ' ' ILE . 37.8 t80 -95.74 7.17 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.477 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -91.83 52.68 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.23 34.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.34 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 68' ' ' PHE . 31.2 mm -68.69 -60.19 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.5 -21.83 65.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.478 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.96 -16.2 45.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.686 0.279 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -27.45 16.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.957 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.08 156.64 47.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.943 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -100.61 30.27 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.16 156.51 66.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.018 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.11 150.11 89.01 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.298 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.453 ' CG1' ' CG2' ' A' ' 57' ' ' VAL . 34.2 t -121.14 128.49 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 28.6 m -144.0 177.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.9 p -93.7 173.98 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -11.64 58.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.243 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -56.86 -40.62 76.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.887 0.375 . . . . 0.0 110.242 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.518 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.5 t90 -56.82 -57.42 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 110.029 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 66.3 t -56.09 -46.53 80.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.113 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -56.59 12.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.45 -31.55 67.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -77.14 -48.89 16.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.954 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 49.0 t -71.32 -28.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.393 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.66 -59.07 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.064 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 tp -88.48 -11.99 44.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.74 83.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -177.11 133.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.23 78.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.83 169.01 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -82.68 142.23 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 mp -79.85 -28.87 39.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.97 -30.49 47.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.3 p -76.11 -13.39 60.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.363 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.6 27.88 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.37 106.58 18.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.3 mt 59.59 107.98 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.72 -77.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.324 2.016 . . . . 0.0 112.435 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.18 116.67 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.866 0.365 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 tp -101.99 129.7 25.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.36 157.22 57.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.454 2.102 . . . . 0.0 112.304 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -127.64 168.44 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 p -131.96 33.33 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -93.54 155.36 17.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.892 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -104.52 150.91 24.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -76.15 105.01 6.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.39 -43.7 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -142.49 84.57 1.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp -86.48 154.59 21.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.559 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -101.9 -20.91 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.517 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 17.1 m-30 -93.49 -47.9 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.782 0.325 . . . . 0.0 110.446 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.74 87.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.555 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.54 72.64 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.077 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.482 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -144.31 162.4 36.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' ILE . 3.6 mt-10 -138.41 109.77 6.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.157 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.01 141.1 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.608 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.5 p -126.43 147.46 49.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.078 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.447 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 14.9 m -105.61 113.42 26.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.609 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.58 120.0 33.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.9 168.75 45.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.579 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.79 1.23 9.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.821 2.348 . . . . 0.0 112.738 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 62.96 -81.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.048 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 t -173.1 -55.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.341 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -115.06 -39.38 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.159 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.04 138.05 94.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.812 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 24' ' ' THR . 97.6 Cg_endo -80.17 5.84 5.74 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.703 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER 84.09 -32.41 0.07 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.6 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.66 -29.18 25.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.172 0.51 . . . . 0.0 110.105 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.7 -32.13 67.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.371 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.424 ' CD2' ' CZ ' ' A' ' 19' ' ' PHE . 18.0 tp -70.94 -50.31 36.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.364 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 31' ' ' VAL . 14.5 mt-10 -59.83 -27.42 66.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.979 0.418 . . . . 0.0 110.547 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -64.88 -50.08 67.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.238 0.542 . . . . 0.0 109.646 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 14.5 mtt -51.22 -51.29 55.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.072 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 28' ' ' GLU . 28.6 m -59.38 -45.67 93.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.923 0.392 . . . . 0.0 110.528 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' N ' HG22 ' A' ' 31' ' ' VAL . 1.7 tm0? -58.5 -34.47 70.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.044 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.01 -21.09 63.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.78 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.7 m -93.1 -3.25 54.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.615 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.91 -20.9 19.27 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.982 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.49 174.61 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 111.314 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.84 135.48 55.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.1 m -71.77 123.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 14.4 t -102.99 122.39 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -49.48 76.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.576 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -140.15 177.7 7.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.375 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' O ' ' CD2' ' A' ' 45' ' ' PHE . 14.5 mt -67.36 -48.17 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.793 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 m -59.06 -21.13 58.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.9 -21.01 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.218 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.43 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 17.9 m-85 -52.65 132.19 35.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 111.063 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -150.61 116.24 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.78 103.92 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.99 -105.41 3.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 m -83.28 -60.19 2.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.88 83.48 0.19 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.56 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 m -159.0 110.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.994 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -94.03 136.03 24.09 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.71 138.51 11.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.677 2.252 . . . . 0.0 112.565 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 11' ' ' LEU . 8.5 mm -144.29 150.89 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.21 139.0 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 60.9 t -124.67 157.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 0.0 111.371 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 80' ' ' VAL . 0.6 OUTLIER -156.68 -173.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 -179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 4.7 tt0 178.66 80.47 0.16 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.574 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.53 112.24 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.649 2.232 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.52 -42.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.731 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.37 30.43 6.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.97 -29.19 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m 63.88 159.02 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.912 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.09 86.4 3.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.44 -49.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.819 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -80.86 -29.22 35.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.79 107.51 3.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.426 ' CD1' HD11 ' A' ' 71' ' ' ILE . 36.0 t80 -97.27 7.1 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.509 0.195 . . . . 0.0 111.389 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 51.28 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -175.82 40.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.426 HD11 ' CD1' ' A' ' 68' ' ' PHE . 25.4 mm -71.42 -60.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.38 -22.95 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.691 0.282 . . . . 0.0 111.103 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -30.66 14.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.2 p -105.6 162.9 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.923 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -116.05 37.64 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . . . -148.79 168.22 11.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 77' ' ' ALA . 56.6 Cg_endo -70.22 112.48 3.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.656 2.237 . . . . 0.0 112.517 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.45 ' CG1' ' CG2' ' A' ' 57' ' ' VAL . 34.8 t -81.3 127.1 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.784 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 57' ' ' VAL . 28.2 m -140.27 176.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 11.6 p -94.4 159.24 15.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.14 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -22.06 6.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.312 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.81 -40.59 21.46 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.95 0.405 . . . . 0.0 110.684 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 84.4 t90 -62.16 -57.23 12.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.363 0.602 . . . . 0.0 110.027 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.3 t -56.1 -37.09 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 -54.55 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.83 -30.44 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.772 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.4 m -77.17 -50.96 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.7 t -71.19 -28.56 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.365 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.17 -54.33 22.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 tt -97.52 2.7 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.339 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 53.5 82.86 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 111.054 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.68 128.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 p -66.08 86.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.91 170.71 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.9 125.96 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.7 mp -64.11 -29.53 70.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -54.47 -29.29 49.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.247 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -77.56 -17.28 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -134.31 29.49 3.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.31 136.8 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.4 mt -76.17 111.89 17.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.86 176.3 10.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.396 2.064 . . . . 0.0 112.437 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -129.25 -45.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 tp -149.03 134.93 9.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.902 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.79 -43.72 24.57 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.464 2.109 . . . . 0.0 112.259 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -77.96 79.97 4.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.0 p -113.92 -43.23 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -69.9 -178.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.949 179.878 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.749 0.309 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.749 HD11 ' SG ' ' A' ' 34' ' ' CYS . 5.6 pt -76.44 -21.08 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.711 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 13.1 m-30 -93.74 -48.25 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.609 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 45.32 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.09 77.47 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.205 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.915 HD21 HG13 ' A' ' 54' ' ' ILE . 0.8 OUTLIER -144.22 158.76 43.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.689 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -136.95 113.37 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.722 HD11 HD22 ' A' ' 11' ' ' LEU . 2.2 mt -127.17 128.97 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 0.0 111.443 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.5 p -115.97 131.42 56.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HB3' HD23 ' A' ' 27' ' ' LEU . 25.9 p -97.07 106.33 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.526 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 130.03 39.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.56 164.03 28.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.42 -16.19 10.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.748 2.299 . . . . 0.0 112.726 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 121.227 0.536 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.43 -24.84 50.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.95 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 15' ' ' CYS . 15.9 tp -74.15 -48.75 27.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.801 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -65.02 -27.61 68.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 0.0 110.462 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.44 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.1 t90 -69.56 -49.82 50.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.831 ' HB3' HG21 ' A' ' 89' ' ' VAL . 34.5 mtp -54.3 -48.57 71.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.783 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.3 m -62.31 -45.16 99.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.191 0.519 . . . . 0.0 109.863 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.473 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.86 -36.52 72.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.156 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -70.07 -21.11 63.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.778 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' SG ' HD11 ' A' ' 7' ' ' ILE . 10.3 m -92.98 -3.21 54.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.738 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 -14.66 17.43 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.113 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.661 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -76.21 179.71 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.167 0.508 . . . . 0.0 111.537 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 135.77 46.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.452 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -71.74 114.44 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.928 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.736 HG21 ' CE1' ' A' ' 45' ' ' PHE . 5.3 t -95.26 123.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -49.55 74.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.8 mt-10 -141.22 -176.9 4.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.278 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.733 HD13 ' HB3' ' A' ' 75' ' ' CYS . 19.2 mt -72.19 -39.02 68.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -7.05 52.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.49 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -23.71 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.61 0.243 . . . . 0.0 111.23 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.736 ' CE1' HG21 ' A' ' 39' ' ' VAL . 29.6 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.836 0.35 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -93.96 135.43 24.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.733 ' O ' HD13 ' A' ' 54' ' ' ILE . 85.6 Cg_endo -82.14 137.12 9.41 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 0.0 112.713 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.915 HG13 HD21 ' A' ' 11' ' ' LEU . 8.8 mm -144.44 152.43 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.783 HG23 ' HB3' ' A' ' 77' ' ' ALA . 42.4 t -128.28 151.14 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 13' ' ' ILE . 85.6 t -129.09 146.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.838 HG22 HG12 ' A' ' 79' ' ' VAL . 2.8 m -139.1 -175.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.49 93.29 0.28 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 61.78 2.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.357 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.71 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.667 0.27 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 79' ' ' VAL . 30.7 mm -71.75 -63.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.83 -25.24 58.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.313 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.29 -24.81 50.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.991 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 mtp -93.92 -31.07 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.733 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.9 p -106.73 150.66 26.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.83 31.61 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.45 168.61 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 73.7 Cg_endo -74.9 121.74 6.81 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.693 2.262 . . . . 0.0 112.464 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.024 HG21 HG22 ' A' ' 71' ' ' ILE . 12.1 t -92.87 124.0 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.538 HG11 ' CB ' ' A' ' 97' ' ' LEU . 3.9 m -137.16 131.75 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.699 0.285 . . . . 0.0 111.431 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -50.87 157.2 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.9 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -24.32 2.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.355 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 1.3 tp10 -45.55 -39.82 7.94 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.765 0.317 . . . . 0.0 110.673 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.9 t90 -60.7 -57.29 13.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.517 0.675 . . . . 0.0 109.903 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.754 ' O ' HG23 ' A' ' 89' ' ' VAL . 81.5 t -54.23 -41.46 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -50.5 27.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -60.02 -33.08 71.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' TYR . 51.0 m -77.1 -47.44 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.831 HG21 ' HB3' ' A' ' 30' ' ' MET . 57.9 t -71.16 -26.21 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.291 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -58.52 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.85 -13.42 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.533 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 69.22 80.91 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.759 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.651 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.9 OUTLIER 179.16 129.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.93 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -68.67 159.08 32.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.7 126.02 27.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.78 HD21 ' CG2' ' A' ' 54' ' ' ILE . 3.0 mp -66.03 -32.17 73.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.339 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -23.21 13.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.555 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.0 m -75.48 -19.75 59.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.617 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 21.1 m-85 -134.66 19.8 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 0.0 111.306 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.969 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.0 mmtt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.794 0.331 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.588 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -82.38 -17.94 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.624 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 14.6 m-30 -93.63 -42.81 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 5.1 ptm180 35.85 84.34 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 111.854 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.95 66.77 1.55 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.772 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.923 HD21 HG13 ' A' ' 54' ' ' ILE . 1.5 tt -138.78 152.52 47.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.312 . . . . 0.0 110.792 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.78 ' HG2' HG22 ' A' ' 39' ' ' VAL . 2.5 mt-10 -130.85 119.36 22.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.756 HD11 HD22 ' A' ' 11' ' ' LEU . 2.6 mt -130.51 123.8 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.709 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.841 ' SG ' HG13 ' A' ' 55' ' ' VAL . 31.9 p -107.64 135.33 49.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.714 ' HB3' HD23 ' A' ' 27' ' ' LEU . 22.7 p -94.33 99.2 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.676 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -93.82 112.84 24.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.31 159.73 11.9 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.49 -13.53 9.69 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.791 2.327 . . . . 0.0 112.827 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.0 m-85 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.296 0.57 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 -28.23 58.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.998 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 15' ' ' CYS . 14.1 tp -72.11 -50.94 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -63.62 -27.54 69.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.564 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.4 t90 -69.93 -50.17 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.9 ' HB3' HG21 ' A' ' 89' ' ' VAL . 37.3 mtp -54.04 -48.37 70.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.774 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.1 m -61.89 -44.6 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.189 0.518 . . . . 0.0 109.947 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.463 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.9 mt-30 -58.33 -35.23 71.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.198 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.009 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.496 ' SG ' HG22 ' A' ' 89' ' ' VAL . 19.4 m -93.04 -3.44 54.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.851 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 115.05 -3.96 22.43 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.253 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.699 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -86.67 -179.61 6.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 111.402 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -133.54 133.95 42.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.32 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.3 p -71.62 114.39 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.78 HG22 ' HG2' ' A' ' 12' ' ' GLU . 1.6 t -93.66 134.4 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -80.51 -36.01 33.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.256 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -131.99 164.74 25.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.137 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.832 HD13 ' HB3' ' A' ' 75' ' ' CYS . 37.8 mt -73.29 -37.07 66.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -75.95 -6.05 49.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.427 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.02 2.08 36.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.669 ' CE1' HG21 ' A' ' 39' ' ' VAL . 13.7 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG11 ' CD ' ' A' ' 12' ' ' GLU . 21.2 t . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.84 122.44 62.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.582 ' O ' HD13 ' A' ' 54' ' ' ILE . 89.3 Cg_endo -80.84 126.78 5.97 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.559 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.923 HG13 HD21 ' A' ' 11' ' ' LEU . 12.6 mm -142.91 160.5 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.841 HG13 ' SG ' ' A' ' 14' ' ' CYS . 6.9 t -142.31 151.18 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 13' ' ' ILE . 3.0 t -117.42 157.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 111.107 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.724 HG13 HG12 ' A' ' 79' ' ' VAL . 4.9 m -147.01 -178.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.68 92.66 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 59.48 5.92 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.576 2.184 . . . . 0.0 112.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.749 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.596 HG21 HG11 ' A' ' 79' ' ' VAL . 29.7 mm -72.84 -61.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.143 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.06 -27.24 62.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.44 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -78.43 -23.26 46.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.007 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -93.96 -29.19 15.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.881 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.832 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.4 p -114.94 151.5 33.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.9 -26.01 17.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.608 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -84.15 159.46 59.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 49.6 Cg_endo -67.99 147.95 75.02 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.14 . . . . 0.0 112.432 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.724 HG12 HG13 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -118.16 128.76 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 97' ' ' LEU . 27.2 m -140.1 157.05 25.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 111.263 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.4 p -70.19 158.91 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.321 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -22.19 3.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.428 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.15 -43.7 21.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.85 0.357 . . . . 0.0 110.77 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.51 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 78.0 t90 -55.16 -57.25 12.53 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.54 0.686 . . . . 0.0 110.102 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.783 ' O ' HG23 ' A' ' 89' ' ' VAL . 85.2 t -53.63 -46.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.176 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -49.72 66.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -61.82 -33.0 73.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -77.08 -46.81 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.9 HG21 ' HB3' ' A' ' 30' ' ' MET . 43.9 t -71.08 -31.45 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.4 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 tp -82.51 -19.53 38.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.588 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 71.46 76.89 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.045 0.45 . . . . 0.0 110.613 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.401 ' C ' HD13 ' A' ' 7' ' ' ILE . 23.4 tt0 -177.68 132.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.772 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.38 83.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.85 168.79 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -77.2 133.84 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.735 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.799 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.1 mp -74.52 -32.03 62.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -22.66 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.426 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.9 m -73.54 -20.67 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.467 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -140.09 28.24 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 12.8 pttm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.837 0.351 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.68 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -123.73 -14.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.018 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.595 ' CD1' HD13 ' A' ' 11' ' ' LEU . 9.4 m-30 -93.45 -44.07 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.535 0.207 . . . . 0.0 110.648 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 41.05 87.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.259 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.22 72.72 0.98 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.382 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.939 HD21 HG13 ' A' ' 54' ' ' ILE . 2.4 tt -146.23 125.15 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.648 0.261 . . . . 0.0 110.838 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.719 ' HG2' HG22 ' A' ' 39' ' ' VAL . 1.2 mt-10 -104.31 123.33 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.699 0.285 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.742 HD11 HD22 ' A' ' 11' ' ' LEU . 2.6 mt -129.96 123.77 57.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.864 0.364 . . . . 0.0 111.449 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.694 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.1 p -110.77 144.08 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 m -107.13 114.16 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -97.18 110.0 22.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.0 148.47 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.26 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.608 2.205 . . . . 0.0 112.261 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.149 0.499 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.36 -30.57 60.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.236 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.635 HD12 HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -72.58 -50.83 22.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.348 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -68.7 -51.61 39.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 89' ' ' VAL . 54.9 mtm -53.11 -49.61 66.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.815 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 32' ' ' GLN . 29.7 m -62.01 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.136 0.493 . . . . 0.0 109.844 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.478 ' N ' HG23 ' A' ' 31' ' ' VAL . 7.8 mt-30 -57.16 -35.54 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.002 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.54 -21.4 63.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.699 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HG22 ' A' ' 89' ' ' VAL . 1.8 m -93.42 -3.25 53.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.58 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.86 25.24 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.87 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -72.25 178.11 4.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.48 150.9 49.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.462 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 28' ' ' GLU . 13.9 p -86.51 120.66 36.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.828 0.346 . . . . 0.0 111.214 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.719 HG22 ' HG2' ' A' ' 12' ' ' GLU . 1.3 t -93.89 128.47 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -48.42 81.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -144.71 179.95 6.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 75' ' ' CYS . 30.3 mt -66.16 -42.8 88.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -70.02 -20.8 63.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.271 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.642 ' HB2' HG12 ' A' ' 39' ' ' VAL . 61.5 m -66.82 -15.28 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.606 ' CE1' HG21 ' A' ' 39' ' ' VAL . 9.7 m-85 . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.743 0.306 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -94.09 127.6 44.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.613 ' O ' HD13 ' A' ' 54' ' ' ILE . 92.9 Cg_endo -80.3 131.38 8.61 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.639 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.939 HG13 HD21 ' A' ' 11' ' ' LEU . 8.1 mm -143.44 161.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.617 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 77' ' ' ALA . 21.3 t -138.11 151.2 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 80' ' ' VAL . 4.0 t -126.31 149.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.316 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 79' ' ' VAL . 3.6 m -144.43 -177.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 3.6 tp60 178.06 70.73 0.11 Allowed Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.77 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.07 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.248 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.762 0.315 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.784 HG22 HG21 ' A' ' 79' ' ' VAL . 33.8 mm -75.66 -59.44 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.02 -21.91 70.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.544 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -85.97 -19.79 29.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.2 ttp -93.92 -29.08 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.607 ' HB3' HD13 ' A' ' 42' ' ' LEU . 29.8 p -107.49 151.35 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.25 30.25 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -139.81 159.22 65.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.47 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.3 Cg_endo -75.0 123.16 7.68 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.75 2.3 . . . . 0.0 112.248 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 57' ' ' VAL . 5.5 t -91.62 140.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.7 m -152.11 133.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.788 0.327 . . . . 0.0 111.629 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 14.7 p -47.64 159.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.793 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.17 -21.01 11.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.273 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 3.0 tt0 -47.34 -41.24 19.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.888 0.375 . . . . 0.0 110.714 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.516 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.2 t90 -57.43 -57.37 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 110.07 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.735 ' O ' HG23 ' A' ' 89' ' ' VAL . 59.0 t -53.65 -44.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -53.12 21.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -57.87 -29.98 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 92' ' ' TYR . 64.8 m -76.94 -49.15 16.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 30' ' ' MET . 26.9 t -71.14 -28.38 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.366 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.21 -57.27 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 tp -90.25 -11.44 40.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.68 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 62.53 76.96 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.652 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -178.67 132.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.78 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.993 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -69.06 166.62 17.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 156.85 35.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.654 HD21 ' CG2' ' A' ' 54' ' ' ILE . 1.0 OUTLIER -101.94 -20.93 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -25.59 65.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.011 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.4 m -74.71 -14.88 60.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.579 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 14.0 m-85 -139.23 16.55 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.566 0.222 . . . . 0.0 111.269 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.409 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.147 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 3.2 mmtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.728 HD13 ' N ' ' A' ' 93' ' ' GLN . 5.8 pt -63.36 -20.6 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.533 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.769 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 4.8 m-30 -93.83 -49.7 5.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.418 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 45.21 90.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.351 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.95 75.7 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.303 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.548 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -143.0 159.3 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.798 0.333 . . . . 0.0 111.039 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -142.3 109.89 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.508 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.654 HD12 ' HB1' ' A' ' 36' ' ' ALA . 1.6 mt -121.96 125.55 73.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.941 0.4 . . . . 0.0 111.558 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.9 p -101.28 144.33 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.996 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 25.0 p -101.48 102.93 13.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.806 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -93.87 136.34 34.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.495 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . 87.01 144.72 8.78 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 16.5 Cg_exo -66.65 -9.63 25.09 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.826 2.35 . . . . 0.0 112.757 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 17' ' ' GLY . 69.5 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.713 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 121.275 0.559 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.26 -27.2 56.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.317 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 85' ' ' VAL . 3.0 tm? -73.81 -48.84 28.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.44 -27.68 68.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.679 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -71.12 -49.68 41.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.963 ' HB3' HG21 ' A' ' 89' ' ' VAL . 53.7 mtm -54.52 -48.32 72.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.9 m -62.08 -44.92 99.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.3 0.571 . . . . 0.0 109.881 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.487 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.2 mt-30 -58.91 -35.52 73.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.2 tp -70.13 -21.9 63.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.407 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.883 ' SG ' HG22 ' A' ' 89' ' ' VAL . 23.4 m -94.02 -3.44 51.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.919 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 109.1 31.41 3.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.769 ' HB2' ' HD2' ' A' ' 8' ' ' PHE . . . -116.23 175.61 5.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.01 0.433 . . . . 0.0 111.038 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.9 38.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 38' ' ' VAL . 11.9 p -71.68 116.13 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -93.81 120.3 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.964 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -33.67 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -155.46 177.48 11.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.712 HD22 ' HB2' ' A' ' 75' ' ' CYS . 15.6 mt -68.89 -39.95 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -18.5 63.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.32 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -77.11 -4.33 43.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.58 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.605 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.3 m-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.77 128.42 41.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.905 ' O ' HD13 ' A' ' 54' ' ' ILE . 83.9 Cg_endo -80.94 127.34 6.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.601 2.201 . . . . 0.0 112.781 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.905 HD13 ' O ' ' A' ' 53' ' ' PRO . 11.6 mm -134.96 161.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.69 HG23 ' HB3' ' A' ' 77' ' ' ALA . 38.5 t -139.05 139.76 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG23 ' CG2' ' A' ' 13' ' ' ILE . 53.6 t -115.75 158.59 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.809 HG22 HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -150.39 175.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.555 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER 177.27 63.06 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.684 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.03 115.08 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.615 2.21 . . . . 0.0 112.395 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.728 0.299 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.777 HG22 HG21 ' A' ' 79' ' ' VAL . 28.2 mm -80.56 -48.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.11 -18.79 73.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.273 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -14.63 20.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.463 0.173 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 mtp -93.6 -28.46 16.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.712 ' HB2' HD22 ' A' ' 42' ' ' LEU . 25.4 p -115.85 149.22 38.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.93 30.08 3.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.69 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -141.24 164.4 35.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 57.2 Cg_endo -71.16 131.69 19.72 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.657 2.238 . . . . 0.0 112.771 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.809 HG12 HG22 ' A' ' 57' ' ' VAL . 1.8 t -101.07 128.91 52.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.665 ' CG1' HD23 ' A' ' 97' ' ' LEU . 27.2 m -143.7 154.94 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 0.0 111.667 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 p -62.55 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' HD3' ' CD2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -88.61 -15.1 35.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.127 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -55.5 -34.59 64.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -57.98 -57.56 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.289 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 89' ' ' VAL . 43.5 t -58.34 -48.22 85.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.132 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -45.22 94.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.57 -36.46 83.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 92' ' ' TYR . 22.5 m -77.05 -44.72 29.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.963 HG21 ' HB3' ' A' ' 30' ' ' MET . 38.7 t -71.22 -26.66 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.397 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.42 -52.74 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.36 . . . . 0.0 111.441 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.94 -2.14 47.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.58 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.433 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 57.0 80.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 110.894 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.728 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -178.88 126.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.3 t -59.31 87.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.7 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.57 130.96 35.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.838 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.2 mp -66.4 -29.07 69.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.25 -24.82 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.336 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -80.29 -12.03 59.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.536 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -142.18 29.77 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.768 0.318 . . . . 0.0 111.018 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.806 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.1 mmtp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.755 0.312 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.695 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -91.23 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.916 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.683 ' CD1' HD13 ' A' ' 11' ' ' LEU . 11.3 m-85 -93.43 -47.4 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.28 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 38.96 86.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.377 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.45 66.47 1.68 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.503 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.997 HD21 HG13 ' A' ' 54' ' ' ILE . 3.9 tt -145.64 122.21 11.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.489 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.733 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.7 mt-10 -94.63 123.6 38.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.331 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.709 HD12 ' CB ' ' A' ' 36' ' ' ALA . 3.6 mt -132.77 136.18 56.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.261 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.0 p -135.61 142.82 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.832 ' HB3' HD23 ' A' ' 27' ' ' LEU . 7.9 p -107.01 109.4 21.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.13 103.51 15.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.98 161.96 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.657 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.23 -15.84 14.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.599 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD2' ' HB3' ' A' ' 58' ' ' GLN . 5.4 m-85 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 41.8 m-20 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.084 0.468 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -31.29 56.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.832 HD23 ' HB3' ' A' ' 15' ' ' CYS . 12.4 tp -74.96 -46.37 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -64.69 -27.35 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.483 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -68.72 -50.84 47.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.187 0.518 . . . . 0.0 109.84 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.871 ' HB3' HG21 ' A' ' 89' ' ' VAL . 74.0 mtm -55.11 -48.21 73.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.6 m -60.52 -44.84 97.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 0.0 110.17 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' N ' HG23 ' A' ' 31' ' ' VAL . 12.5 tt0 -58.39 -33.47 69.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -70.02 -21.44 63.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.749 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' SG ' HD11 ' A' ' 7' ' ' ILE . 2.6 m -93.28 -3.25 53.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 110.84 -29.74 8.67 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.435 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.709 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -58.3 156.98 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 132.17 45.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.044 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 38' ' ' VAL . 15.1 m -71.76 114.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.053 0.454 . . . . 0.0 110.898 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 12' ' ' GLU . 24.8 t -100.27 117.93 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.907 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -47.24 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.3 mt-10 -134.34 171.0 14.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.072 0.463 . . . . 0.0 111.448 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 75' ' ' CYS . 9.4 mt -65.37 -44.59 87.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.854 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 m -60.69 -27.22 67.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.715 ' HB3' HG13 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -58.76 -23.28 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 16.2 m-85 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -95.31 134.69 24.09 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.66 125.53 5.59 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.639 2.226 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.997 HG13 HD21 ' A' ' 11' ' ' LEU . 29.3 mm -134.71 148.34 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.755 ' HB ' HG12 ' A' ' 79' ' ' VAL . 58.7 t -126.58 151.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.362 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.749 HG11 HD21 ' A' ' 27' ' ' LEU . 16.4 t -123.71 131.26 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 71' ' ' ILE . 5.2 m -143.26 120.39 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.556 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -140.82 86.06 12.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.16 135.24 39.57 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.515 2.143 . . . . 0.0 112.314 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.828 ' CG2' HG11 ' A' ' 79' ' ' VAL . 14.1 mm -62.84 -39.36 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.25 -25.65 61.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -27.91 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.5 mtp -93.83 -30.7 14.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.767 ' HB2' HD13 ' A' ' 42' ' ' LEU . 42.1 t -134.58 145.59 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.56 31.34 4.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -112.51 166.15 11.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.08 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 83.8 Cg_endo -79.08 108.43 2.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.788 2.325 . . . . 0.0 112.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.828 HG11 ' CG2' ' A' ' 71' ' ' ILE . 3.2 m -91.12 127.44 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.588 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 56' ' ' VAL . 35.9 m -137.09 139.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.793 0.33 . . . . 0.0 111.736 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 p -52.02 161.97 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -21.51 9.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.476 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.26 -43.92 15.97 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.521 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.4 t90 -56.57 -57.42 12.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.931 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 89' ' ' VAL . 52.9 t -54.34 -43.75 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.269 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -69.12 -56.34 7.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.016 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.3 -31.37 63.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.0 m -77.1 -49.92 14.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.5 t -71.24 -27.27 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.467 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.05 -58.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.7 tp -89.45 -12.16 40.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.271 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.695 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 66.05 77.83 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 110.776 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.436 ' N ' HG21 ' A' ' 7' ' ' ILE . 20.9 tt0 -177.82 134.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 t -59.6 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -72.69 159.05 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -63.67 153.02 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.574 HD21 HG23 ' A' ' 54' ' ' ILE . 2.4 mp -102.15 -33.38 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.281 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -57.2 -21.67 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.595 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.9 m -80.51 -20.48 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.564 0.221 . . . . 0.0 111.482 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.8 23.75 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 111.068 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.6 mmtt . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.739 0.304 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.666 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.1 pp -76.33 -23.49 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.92 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.666 ' CD1' HD12 ' A' ' 7' ' ' ILE . 16.4 m-30 -93.71 -47.68 6.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 45.54 90.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.333 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.21 76.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.931 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.18 162.27 38.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -140.65 109.78 6.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.657 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.5 mt -121.11 130.72 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 111.666 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.641 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 21.9 p -115.04 139.03 50.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.748 ' HB3' HD23 ' A' ' 27' ' ' LEU . 8.6 p -107.12 108.49 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.597 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.98 119.66 33.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.94 166.38 25.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.594 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.35 -10.38 9.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.864 2.376 . . . . 0.0 112.75 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.5 m-85 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.058 0.456 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -31.48 41.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.415 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 15' ' ' CYS . 33.6 tp -75.91 -44.24 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.396 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -65.44 -27.54 68.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.431 ' NE1' ' CD2' ' A' ' 33' ' ' LEU . 18.4 t90 -67.47 -51.94 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.162 0.506 . . . . 0.0 109.734 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.788 ' HB3' HG21 ' A' ' 89' ' ' VAL . 6.2 mtm -55.03 -50.52 68.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.615 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 32' ' ' GLN . 26.1 m -58.98 -45.02 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.96 -33.83 67.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.497 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -70.44 -21.46 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.021 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 4.0 m -93.45 -3.26 53.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.745 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.51 -18.21 17.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.851 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.657 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -72.63 177.93 4.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.28 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -131.98 139.18 48.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.565 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 p -71.93 122.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.72 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.2 t -93.92 130.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.04 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -65.3 -42.3 93.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -147.73 -179.59 7.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 75' ' ' CYS . 33.1 mt -71.43 -41.1 69.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 t -72.95 -9.11 58.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.428 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 -19.11 60.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.607 0.241 . . . . 0.0 111.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.72 ' CE1' HG21 ' A' ' 39' ' ' VAL . 24.1 m-85 . . . . . 0 C--N 1.332 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.76 0.314 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -93.87 126.84 47.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.879 ' O ' HD13 ' A' ' 54' ' ' ILE . 91.4 Cg_endo -78.53 130.73 10.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.697 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.879 HD13 ' O ' ' A' ' 53' ' ' PRO . 8.1 mm -138.82 147.74 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.666 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 77' ' ' ALA . 39.9 t -123.01 151.1 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.81 HG13 ' O ' ' A' ' 80' ' ' VAL . 15.2 t -129.95 144.41 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 m -135.3 -177.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 172.98 78.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.05 88.06 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.644 2.23 . . . . 0.0 112.402 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.836 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 79' ' ' VAL . 23.0 mm -74.3 -54.3 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.39 -20.76 71.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.42 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -18.09 40.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.92 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.0 ttp -93.67 -25.53 17.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.801 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.503 ' HB2' HD13 ' A' ' 42' ' ' LEU . 46.0 t -133.5 156.41 47.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.856 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -103.34 32.63 3.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -123.91 164.52 28.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.62 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 94.0 Cg_endo -78.39 120.87 5.01 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.037 HG21 HG22 ' A' ' 71' ' ' ILE . 10.7 t -94.62 121.29 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.81 ' O ' HG13 ' A' ' 56' ' ' VAL . 28.0 m -137.58 135.57 46.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.586 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.8 p -50.65 170.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.668 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -16.32 60.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.36 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -42.24 52.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 110.664 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.511 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 80.2 t90 -59.46 -57.26 13.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.491 0.663 . . . . 0.0 109.766 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 89' ' ' VAL . 63.2 t -55.06 -43.48 69.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.424 HD22 ' HE1' ' A' ' 30' ' ' MET . 0.5 OUTLIER -69.87 -46.14 66.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -64.48 -32.94 74.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.518 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -77.11 -47.13 21.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 85' ' ' VAL . 42.1 t -71.24 -30.92 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.38 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.73 -56.79 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.84 -16.54 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.522 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 67.57 77.76 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.02 136.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.707 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -58.93 91.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -74.57 160.39 30.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.66 139.04 56.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.702 ' HB3' HD12 ' A' ' 101' ' ' LEU . 1.6 mp -88.34 -33.06 18.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.349 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -22.25 24.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.583 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.7 m -77.74 -23.38 49.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.433 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -128.1 18.46 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.618 0.247 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 7.5 pttm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.496 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -111.56 -16.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 9.7 m-30 -93.78 -43.84 8.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.893 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 49.26 92.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 75.38 0.51 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -139.58 162.04 36.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.142 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.76 109.81 5.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.5 mt -118.05 124.96 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.413 . . . . 0.0 111.762 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.669 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.9 p -108.35 129.5 55.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 27' ' ' LEU . 14.2 m -97.33 115.06 26.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -93.52 108.71 20.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.097 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.67 168.77 33.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.3 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.681 2.254 . . . . 0.0 112.621 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.9 m-85 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 121.105 0.478 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -75.88 -30.96 59.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.146 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD23 ' SG ' ' A' ' 15' ' ' CYS . 65.0 tp -72.37 -50.58 25.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.95 -27.44 68.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 110.465 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -64.0 -49.16 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.765 ' HB3' HG21 ' A' ' 89' ' ' VAL . 3.1 mtm -51.67 -55.57 18.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.704 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 85' ' ' VAL . 20.1 m -57.06 -44.26 82.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.079 0.466 . . . . 0.0 110.222 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.436 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt-30 -59.72 -36.87 77.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.079 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.08 -21.04 63.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.883 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 1.4 m -93.23 -3.31 53.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.839 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 6' ' ' LYS . . . 108.33 25.4 5.81 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.118 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -116.35 178.42 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.102 0.477 . . . . 0.0 111.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.64 132.57 44.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.612 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.4 p -71.88 119.43 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.755 HG12 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -93.92 124.29 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.862 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -45.47 77.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -146.73 -179.21 6.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 75' ' ' CYS . 29.6 mt -67.26 -44.13 80.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -17.57 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.276 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.755 ' HB2' HG12 ' A' ' 39' ' ' VAL . 39.3 m -65.66 -17.36 64.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.444 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 39' ' ' VAL . 14.0 m-85 . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.458 -0.034 0 CA-C-O 120.921 0.391 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -131.96 120.17 17.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.845 ' O ' HD13 ' A' ' 54' ' ' ILE . 92.3 Cg_endo -78.76 133.18 11.25 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.561 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.845 HD13 ' O ' ' A' ' 53' ' ' PRO . 9.4 mm -139.79 146.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.929 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.977 HG23 ' HB3' ' A' ' 77' ' ' ALA . 30.6 t -124.5 138.22 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 57' ' ' VAL . 24.0 t -124.16 158.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 111.404 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 58' ' ' GLN . 1.4 t -152.89 177.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.689 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.629 ' H ' HG12 ' A' ' 57' ' ' VAL . 6.4 tm0? -179.2 86.89 0.21 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.75 116.91 3.95 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.488 2.125 . . . . 0.0 112.33 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.697 0.284 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.759 HG21 HG11 ' A' ' 79' ' ' VAL . 11.3 mm -74.2 -53.62 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.265 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.31 -27.85 68.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.421 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -88.36 -13.47 40.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.579 0.228 . . . . 0.0 111.334 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -28.89 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.615 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.2 p -117.44 157.19 26.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -107.03 41.93 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.977 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -154.33 165.95 16.93 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 37.1 Cg_endo -65.5 124.26 12.6 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.496 2.131 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.759 HG11 HG21 ' A' ' 71' ' ' ILE . 25.7 t -92.53 128.37 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' HD23 ' A' ' 97' ' ' LEU . 31.2 m -143.15 177.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 10.5 p -96.86 163.99 12.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 109.941 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -19.39 17.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.349 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -47.87 -45.09 30.0 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.502 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 63.4 t90 -55.99 -57.26 12.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.39 0.614 . . . . 0.0 110.114 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.758 ' O ' HG23 ' A' ' 89' ' ' VAL . 55.0 t -54.07 -43.16 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -50.46 38.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.09 -32.84 71.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.772 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -77.03 -48.49 17.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.1 t -71.01 -25.91 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.334 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.66 -55.09 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.315 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 93' ' ' GLN . 3.5 tt -98.07 2.95 49.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.585 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.496 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 53.36 83.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.474 ' C ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -178.8 131.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.56 79.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.82 173.05 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.03 153.49 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.742 HD21 ' CG2' ' A' ' 54' ' ' ILE . 1.8 mp -94.07 -27.34 16.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -58.79 -31.86 68.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.93 -16.63 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.43 29.55 3.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.503 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.1 pp -111.95 -20.72 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.522 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 14.6 m-30 -93.7 -46.16 7.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 43.15 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.039 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.32 73.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.303 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.855 HD21 HG13 ' A' ' 54' ' ' ILE . 2.1 tt -148.36 119.01 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.707 0.289 . . . . 0.0 110.82 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.89 124.06 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.777 HD12 ' HB1' ' A' ' 36' ' ' ALA . 3.2 mt -132.66 129.78 58.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.711 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.1 p -121.52 146.4 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.211 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' HG23 ' A' ' 56' ' ' VAL . 25.1 p -106.92 127.86 53.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE1' HD11 ' A' ' 42' ' ' LEU . 2.1 t80 -93.89 105.07 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.065 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.86 44.22 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.667 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -166.71 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.42 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 26.3 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.102 0.477 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.59 -33.2 68.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.481 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.858 HD13 HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -73.06 -50.83 20.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.349 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -65.36 -27.78 68.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.425 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -71.39 -50.35 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.805 ' HB3' HG21 ' A' ' 89' ' ' VAL . 8.1 mtm -54.87 -48.41 73.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.54 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 32' ' ' GLN . 28.9 m -62.65 -45.14 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 0.0 109.656 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.1 mt-30 -56.42 -35.91 68.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.071 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 tp -70.07 -21.41 63.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.928 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 7' ' ' ILE . 2.3 m -93.19 -3.24 54.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.706 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.93 25.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.777 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -71.59 174.33 6.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.485 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.08 136.93 52.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.547 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.3 p -71.88 123.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.711 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.0 t -93.86 146.51 6.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -42.82 62.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.154 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 -175.91 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.904 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.68 HD22 ' CB ' ' A' ' 75' ' ' CYS . 30.5 mt -63.64 -50.38 69.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.007 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -66.65 -19.16 65.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.413 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.705 ' HB2' HG12 ' A' ' 39' ' ' VAL . 56.5 m -61.67 -23.32 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.332 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 17.5 m-85 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.791 0.329 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 130.55 34.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.737 ' O ' HD13 ' A' ' 54' ' ' ILE . 93.3 Cg_endo -78.57 135.36 13.01 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.54 2.16 . . . . 0.0 112.471 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.855 HG13 HD21 ' A' ' 11' ' ' LEU . 9.3 mm -144.3 151.35 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 77' ' ' ALA . 23.4 t -130.65 140.79 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -114.48 160.71 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 111.15 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' CG2' HG12 ' A' ' 79' ' ' VAL . 6.1 m -152.23 -177.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.507 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.475 ' NE2' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 174.54 94.93 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.29 68.67 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.488 2.126 . . . . 0.0 112.334 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.475 ' HB2' ' NE2' ' A' ' 58' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 HG11 ' A' ' 79' ' ' VAL . 29.1 mm -72.32 -65.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.75 -26.66 68.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -22.98 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 0.0 111.192 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtm -93.92 -43.85 8.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.68 ' CB ' HD22 ' A' ' 42' ' ' LEU . 31.4 p -86.97 162.33 17.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -113.08 33.85 4.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.988 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.68 166.32 18.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 55.4 Cg_endo -68.97 125.98 13.24 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.281 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.55 HG12 ' CG2' ' A' ' 57' ' ' VAL . 17.6 t -93.05 123.64 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.978 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.682 ' O ' HG12 ' A' ' 56' ' ' VAL . 35.8 m -141.16 134.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 1.9 p -54.76 159.99 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.472 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -54.37 -19.8 6.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.578 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.96 -40.58 10.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.9 t90 -58.93 -57.42 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.46 0.648 . . . . 0.0 110.145 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.858 HG11 HD13 ' A' ' 27' ' ' LEU . 58.9 t -57.69 -42.93 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.29 -56.24 8.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -57.99 -30.7 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 92' ' ' TYR . 69.3 m -76.99 -49.16 16.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.805 HG21 ' HB3' ' A' ' 30' ' ' MET . 48.8 t -71.32 -27.23 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.91 -54.69 19.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.177 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 91' ' ' LEU . 6.2 tt -97.41 -2.28 42.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.323 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 58.05 84.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 110.887 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -177.53 139.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.7 t -67.9 74.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.1 158.84 6.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.58 151.46 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.464 ' HB3' HD12 ' A' ' 101' ' ' LEU . 3.8 mp -95.98 -34.8 11.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.65 -25.51 39.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.511 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.5 HG23 ' CG ' ' A' ' 100' ' ' TYR . 13.4 t -74.88 -24.73 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.5 ' CG ' HG23 ' A' ' 99' ' ' THR . 9.8 m-85 -125.74 15.0 8.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.13 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.518 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.317 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.69 0.281 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.797 HD11 ' SG ' ' A' ' 34' ' ' CYS . 2.3 pt -110.44 -19.83 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.506 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 15.7 m-30 -93.7 -50.42 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.637 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 47.72 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.35 76.2 0.83 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.066 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -145.5 162.01 38.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 111.008 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.695 ' CG ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.22 109.82 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.334 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.678 HD12 ' HB1' ' A' ' 36' ' ' ALA . 1.8 mt -125.29 130.46 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.361 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 6.1 p -111.08 143.18 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.723 ' HB3' HD23 ' A' ' 27' ' ' LEU . 17.6 p -106.46 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.01 131.27 39.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.6 158.73 34.16 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.56 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.15 0.26 10.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.644 2.229 . . . . 0.0 112.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 19.9 m-85 . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.734 0.302 . . . . 0.0 111.056 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -77.96 -33.35 51.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.523 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.79 HD21 HG11 ' A' ' 56' ' ' VAL . 19.5 tp -75.07 -44.12 49.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.99 -27.48 67.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.507 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.548 ' CD1' HD23 ' A' ' 33' ' ' LEU . 10.3 t90 -69.24 -50.05 50.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.858 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.868 ' HB3' HG21 ' A' ' 89' ' ' VAL . 2.3 mtm -57.34 -48.61 78.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.575 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.4 m -60.51 -45.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.203 0.525 . . . . 0.0 109.621 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.57 -34.58 69.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.666 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.548 HD23 ' CD1' ' A' ' 29' ' ' TRP . 0.6 OUTLIER -70.28 -21.27 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.005 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.828 ' SG ' HG22 ' A' ' 89' ' ' VAL . 38.5 m -93.42 -3.08 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.667 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.3 -23.44 11.3 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.741 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.678 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.02 177.08 1.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.054 0.454 . . . . 0.0 111.231 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.61 138.6 51.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.6 p -71.82 114.77 10.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.782 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.695 HG22 ' CG ' ' A' ' 12' ' ' GLU . 3.0 t -93.91 121.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.022 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -58.44 -47.16 84.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.336 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 39' ' ' VAL . 17.5 mm-40 -132.69 176.03 8.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.086 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 75' ' ' CYS . 13.1 mt -70.87 -43.51 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -5.01 44.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -15.98 61.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.561 0.22 . . . . 0.0 111.389 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.669 ' CE1' HG21 ' A' ' 39' ' ' VAL . 21.2 m-85 . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 111.013 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.544 HG11 ' OE1' ' A' ' 12' ' ' GLU . 21.2 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.718 0.294 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.478 ' O ' HD23 ' A' ' 11' ' ' LEU . 3.2 t-80 -100.99 120.64 54.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.848 ' O ' HD13 ' A' ' 54' ' ' ILE . 79.6 Cg_endo -77.98 133.74 12.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.593 2.195 . . . . 0.0 112.635 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 53' ' ' PRO . 7.5 mm -142.49 162.31 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.622 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.616 HG23 ' HB3' ' A' ' 77' ' ' ALA . 33.9 t -137.99 150.74 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.666 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.79 HG11 HD21 ' A' ' 27' ' ' LEU . 4.1 t -121.85 158.43 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.32 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.868 HG22 HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -150.39 -179.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.473 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 1.1 tt0 176.52 66.93 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.579 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.58 94.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.102 HG22 HG21 ' A' ' 79' ' ' VAL . 24.0 mm -69.82 -67.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.01 -24.25 71.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.372 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.93 -27.82 64.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.311 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.0 mtm -93.92 -39.28 10.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.667 ' HB3' HD22 ' A' ' 42' ' ' LEU . 27.5 p -98.37 147.08 25.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 38.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -147.3 169.3 9.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.79 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 73.6 Cg_endo -74.94 125.87 9.64 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.741 2.294 . . . . 0.0 112.456 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.102 HG21 HG22 ' A' ' 71' ' ' ILE . 8.4 t -98.02 136.61 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.612 ' CG1' HD23 ' A' ' 97' ' ' LEU . 26.7 m -147.59 159.56 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.659 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 p -73.7 159.3 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.246 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -53.6 -22.51 8.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.446 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.45 -38.07 8.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 72.6 t90 -63.46 -57.23 10.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.492 0.663 . . . . 0.0 109.818 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 89' ' ' VAL . 60.6 t -54.3 -39.22 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.377 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -48.47 17.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -60.25 -35.72 76.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -77.05 -47.91 19.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.868 HG21 ' HB3' ' A' ' 30' ' ' MET . 73.7 t -71.22 -25.87 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.439 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.45 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 111.041 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tp -85.07 -18.48 34.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 73.44 77.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.672 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.465 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -177.43 136.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 t -61.17 86.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -67.34 163.42 20.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 99' ' ' THR . 0.4 OUTLIER -73.99 140.12 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.858 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.0 mp -83.33 -29.52 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.12 -29.15 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.473 HG23 ' HG3' ' A' ' 96' ' ' GLU . 1.1 p -72.08 -17.45 62.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.84 22.32 2.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.671 0.272 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.34 . . . . 0.0 110.789 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 10.4 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.512 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.3 pp -79.13 -21.16 12.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.738 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CD1' HD13 ' A' ' 11' ' ' LEU . 9.8 m-30 -93.8 -34.81 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.72 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 8' ' ' PHE . 2.3 ppt_? 28.54 79.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.795 0.438 . . . . 0.0 111.96 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.94 72.16 1.29 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.632 -0.795 . . . . 0.0 111.554 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.936 HD21 HG13 ' A' ' 54' ' ' ILE . 1.8 tt -144.68 152.67 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.71 0.29 . . . . 0.0 110.754 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.704 ' N ' HD23 ' A' ' 11' ' ' LEU . 6.8 mt-10 -129.07 119.64 24.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.647 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.711 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -129.07 123.56 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.54 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.666 ' SG ' HG13 ' A' ' 55' ' ' VAL . 24.6 p -110.09 137.7 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.5 107.24 19.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -93.61 111.78 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.76 168.56 35.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.354 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.97 -0.55 10.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.739 2.292 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.7 m-85 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -76.99 -32.5 57.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.291 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' CD1' HG11 ' A' ' 85' ' ' VAL . 68.1 tp -70.72 -50.14 39.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.384 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.9 -27.45 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -65.52 -50.41 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.254 0.549 . . . . 0.0 109.607 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.808 ' HB3' HG21 ' A' ' 89' ' ' VAL . 66.8 mtt -51.46 -51.53 54.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.866 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' CG1' HG13 ' A' ' 85' ' ' VAL . 31.4 m -61.9 -45.65 98.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.056 0.455 . . . . 0.0 110.181 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.473 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.63 -35.59 72.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.193 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 tp -69.97 -20.92 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.029 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.4 m -93.0 -3.2 54.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.988 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 118.23 -15.96 11.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.083 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.711 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -76.65 -179.12 5.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.58 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -134.89 135.23 41.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.404 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.1 p -71.88 118.59 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -93.85 118.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -42.63 85.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.13 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -148.69 177.26 9.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' A' ' 75' ' ' CYS . 23.9 mt -67.4 -46.53 72.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -23.48 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -24.37 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.633 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.1 m-85 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.024 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -95.37 127.82 40.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.585 ' O ' HD13 ' A' ' 54' ' ' ILE . 73.3 Cg_endo -75.89 135.39 17.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.129 . . . . 0.0 112.479 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.936 HG13 HD21 ' A' ' 11' ' ' LEU . 16.0 mm -142.24 150.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.803 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 77' ' ' ALA . 45.2 t -131.05 149.18 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' A' ' 13' ' ' ILE . 57.9 t -120.59 159.68 21.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.876 HG22 HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -149.14 -178.74 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.008 0.432 . . . . 0.0 111.494 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 169.47 81.11 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.873 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 110.59 2.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.078 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.3 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.913 HG21 HG11 ' A' ' 79' ' ' VAL . 18.3 mm -67.79 -66.85 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.896 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.06 76.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.382 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -25.51 61.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.027 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtp -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.807 ' HB2' HD13 ' A' ' 42' ' ' LEU . 53.9 t -104.29 155.93 18.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.49 35.46 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.679 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -142.47 165.96 23.83 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.679 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.7 Cg_endo -74.0 136.2 22.27 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.658 2.239 . . . . 0.0 112.39 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.913 HG11 HG21 ' A' ' 71' ' ' ILE . 2.4 t -105.94 126.11 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.628 ' CG1' HD23 ' A' ' 97' ' ' LEU . 35.0 m -138.18 159.24 32.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.494 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -72.04 166.0 23.12 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.442 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -59.44 -18.33 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.39 -42.0 30.58 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.507 ' CH2' ' CE1' ' A' ' 8' ' ' PHE . 73.9 t90 -60.43 -57.31 13.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 110.172 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.727 ' O ' HG23 ' A' ' 89' ' ' VAL . 74.2 t -55.12 -36.93 41.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.338 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -54.57 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.049 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -56.94 -31.14 64.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 92' ' ' TYR . 61.2 m -77.1 -50.11 13.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.808 HG21 ' HB3' ' A' ' 30' ' ' MET . 44.9 t -71.25 -25.99 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.619 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 -56.7 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.337 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 tp -90.11 -13.79 35.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.296 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 68.31 81.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.45 137.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.93 85.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.78 170.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.52 118.52 31.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.803 ' HB3' HD12 ' A' ' 101' ' ' LEU . 2.6 mp -61.08 -35.57 77.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.301 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.59 -24.36 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.4 m -80.63 -20.22 43.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.449 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -134.74 32.78 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.803 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.755 0.312 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.682 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.2 pp -72.47 -23.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.681 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.682 ' CD1' HD12 ' A' ' 7' ' ' ILE . 13.2 m-30 -93.66 -46.18 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.78 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.631 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 76.93 1.02 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.028 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.501 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.35 162.09 38.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.949 0.404 . . . . 0.0 111.211 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.8 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -140.42 109.93 6.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.35 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.618 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -122.54 127.46 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 111.795 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.3 p -112.64 133.45 54.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.542 ' HB3' HD23 ' A' ' 27' ' ' LEU . 25.2 p -98.97 108.36 21.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -93.94 126.16 38.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.48 163.31 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.1 -5.02 12.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.696 2.264 . . . . 0.0 112.735 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 10.9 m-85 . . . . . 0 C--N 1.333 -0.141 0 CA-C-O 120.846 0.355 . . . . 0.0 111.033 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.167 0.508 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -27.5 60.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.054 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.614 HD12 HG11 ' A' ' 85' ' ' VAL . 36.5 tp -72.85 -51.2 19.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.578 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.43 ' OE2' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -64.77 -27.74 69.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.356 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -71.19 -50.77 29.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.849 ' HG2' HG11 ' A' ' 89' ' ' VAL . 2.8 mtm -53.88 -48.0 70.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 32' ' ' GLN . 29.3 m -61.86 -45.23 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.149 0.499 . . . . 0.0 109.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -56.56 -36.62 69.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.997 178.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.97 -20.97 63.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.769 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.602 ' SG ' HG22 ' A' ' 89' ' ' VAL . 95.0 m -92.95 -3.18 54.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.403 ' CA ' ' HB3' ' A' ' 6' ' ' LYS . . . 119.92 -31.96 5.14 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.69 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.618 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -62.51 -179.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.114 0.483 . . . . 0.0 111.358 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.3 139.17 40.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.585 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG21 ' OE2' ' A' ' 28' ' ' GLU . 10.1 p -71.8 122.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.874 HG21 ' CE1' ' A' ' 45' ' ' PHE . 3.2 t -99.11 123.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -58.86 -48.09 82.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.8 mt-10 -139.13 172.33 12.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.016 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 75' ' ' CYS . 15.8 mt -65.91 -50.56 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -58.94 -21.24 57.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.158 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -23.4 67.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.874 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.2 m-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.43 133.51 22.71 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.856 ' O ' HD13 ' A' ' 54' ' ' ILE . 93.0 Cg_endo -80.59 135.56 10.45 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.149 . . . . 0.0 112.615 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.856 HD13 ' O ' ' A' ' 53' ' ' PRO . 9.6 mm -140.42 142.71 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.635 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.876 HG23 ' HB3' ' A' ' 77' ' ' ALA . 39.9 t -123.28 136.91 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 57' ' ' VAL . 42.6 t -122.12 158.51 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -152.43 -173.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.517 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.665 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -174.14 89.19 0.34 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.845 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.01 83.86 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.538 2.159 . . . . 0.0 112.271 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.653 0.263 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.6 HG21 HG11 ' A' ' 79' ' ' VAL . 8.3 mm -64.37 -47.19 90.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.75 50.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.374 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.72 -17.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.628 0.252 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -93.87 -33.68 13.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.71 ' HB2' HD13 ' A' ' 42' ' ' LEU . 52.4 t -122.62 154.72 37.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.966 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.39 31.35 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.876 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -120.35 168.7 9.97 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.778 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 59.9 Cg_endo -73.07 121.59 7.4 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.605 2.204 . . . . 0.0 112.569 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.6 HG11 HG21 ' A' ' 71' ' ' ILE . 18.3 t -88.59 125.51 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 101' ' ' LEU . 27.7 m -143.21 177.15 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.835 0.35 . . . . 0.0 111.418 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 p -98.24 166.9 11.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.304 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -18.42 32.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.362 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.89 -47.86 51.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.499 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 59.3 t90 -50.72 -57.37 8.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.265 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.828 ' O ' HG23 ' A' ' 89' ' ' VAL . 84.3 t -53.84 -49.1 60.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.301 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -50.0 72.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -61.83 -32.48 72.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.752 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.2 m -77.07 -46.48 23.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.032 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.849 HG11 ' HG2' ' A' ' 30' ' ' MET . 33.0 t -71.16 -28.2 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.83 -56.65 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 93' ' ' GLN . 5.1 tt -93.28 -4.19 52.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.618 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 58.65 80.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.834 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.536 ' HB2' HD23 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -179.18 141.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.0 t -66.57 83.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.23 165.0 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.52 140.65 44.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.494 HD23 ' CG1' ' A' ' 80' ' ' VAL . 4.4 mp -88.04 -30.97 19.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.45 -32.55 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.105 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.1 m -77.29 -10.22 59.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.324 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.68 30.5 2.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 110.686 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.779 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.5 mmtm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.775 HG23 ' CE1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -76.4 -22.87 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.555 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.526 ' CE1' HD12 ' A' ' 7' ' ' ILE . 15.5 m-30 -93.64 -49.51 5.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 44.96 90.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.83 76.15 1.0 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.968 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.469 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -147.33 160.85 42.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.855 0.359 . . . . 0.0 111.118 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -140.8 109.8 6.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.727 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.7 mt -120.38 125.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.646 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.726 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 28.3 p -113.45 142.7 45.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 9.0 p -106.95 119.31 39.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.525 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.76 117.56 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.36 146.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.473 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.69 150.42 28.76 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.543 2.162 . . . . 0.0 112.315 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 4.2 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 24.4 m-20 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.193 0.521 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.21 -36.7 82.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.553 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.16 -55.61 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.171 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' CG ' ' HA ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.47 -27.3 67.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.007 0.432 . . . . 0.0 110.212 179.165 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -63.13 -49.34 74.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 109.556 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.783 ' HB3' HG21 ' A' ' 89' ' ' VAL . 2.2 mtt -51.15 -55.15 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.706 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG13 HG13 ' A' ' 85' ' ' VAL . 22.9 m -58.82 -45.04 91.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -59.57 -33.77 71.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.288 179.358 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.06 -21.17 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.931 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 7' ' ' ILE . 3.8 m -93.28 -3.16 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.753 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.62 -22.26 10.16 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.927 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.727 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.98 178.03 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.85 135.21 46.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -71.82 117.92 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.726 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.4 t -93.89 124.49 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -25.51 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.358 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -174.85 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.318 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.692 HD13 ' HB2' ' A' ' 75' ' ' CYS . 22.6 mt -63.07 -46.34 87.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.973 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -11.38 60.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.426 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.1 m -96.0 24.73 5.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.674 0.273 . . . . 0.0 111.312 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 39' ' ' VAL . 3.4 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.725 0.298 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -94.09 136.26 23.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.973 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.896 ' O ' HD13 ' A' ' 54' ' ' ILE . 87.7 Cg_endo -83.16 132.89 6.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.705 2.27 . . . . 0.0 112.787 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 53' ' ' PRO . 10.8 mm -137.73 151.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 77' ' ' ALA . 22.4 t -129.07 149.96 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.955 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 80' ' ' VAL . 7.3 t -128.2 146.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.339 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.819 HG22 HG12 ' A' ' 79' ' ' VAL . 1.9 m -133.1 173.03 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -176.95 88.08 0.25 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.68 64.04 3.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.549 2.166 . . . . 0.0 112.28 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.776 0.322 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.856 HG22 HG21 ' A' ' 79' ' ' VAL . 23.3 mm -69.31 -64.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.4 -15.35 81.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -79.03 -24.22 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mtm -93.97 -27.3 16.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.692 ' HB2' HD13 ' A' ' 42' ' ' LEU . 49.5 t -118.94 156.22 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.77 32.33 4.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.829 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.777 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -125.77 172.32 6.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.087 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.777 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 95.1 Cg_endo -82.71 127.1 4.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.786 2.324 . . . . 0.0 112.888 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.856 HG21 HG22 ' A' ' 71' ' ' ILE . 18.8 t -98.57 130.96 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.329 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.756 ' O ' HG13 ' A' ' 56' ' ' VAL . 28.7 m -145.26 136.88 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.639 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 p -50.82 168.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.772 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -63.94 -16.44 61.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.07 -39.19 55.45 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.86 0.362 . . . . 0.0 110.608 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.505 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 79.0 t90 -62.7 -57.3 11.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 109.888 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 89' ' ' VAL . 98.0 t -54.66 -38.18 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.222 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.06 -47.79 19.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.78 -33.53 73.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.742 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -77.16 -49.53 15.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -71.38 -27.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.42 -55.09 17.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 111.104 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 91' ' ' LEU . 5.9 tt -95.65 -3.08 46.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.315 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.775 ' CE1' HG23 ' A' ' 7' ' ' ILE . 6.7 t80 57.64 76.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HB3' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -176.59 133.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.674 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.15 97.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.099 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' A' ' 93' ' ' GLN . 61.7 mm-40 -81.6 163.67 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HG3' ' CG2' ' A' ' 99' ' ' THR . 0.4 OUTLIER -71.53 142.09 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.69 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD23 ' CG1' ' A' ' 80' ' ' VAL . 1.6 mp -87.13 -34.28 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.27 -22.88 32.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.401 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -76.26 -15.29 60.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.61 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -139.4 20.58 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.701 0.286 . . . . 0.0 111.235 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.4 mmtp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.604 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -76.64 -23.83 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.559 ' CD1' HD12 ' A' ' 7' ' ' ILE . 14.3 m-30 -93.37 -50.88 5.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 110.555 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.8 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.374 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.61 75.12 1.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.817 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -149.43 162.66 39.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.934 0.397 . . . . 0.0 111.241 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.716 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.7 mt-10 -138.64 109.68 6.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.653 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.3 mt -124.54 138.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' O ' HG23 ' A' ' 56' ' ' VAL . 29.1 p -126.54 144.62 50.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.741 ' HB3' HD23 ' A' ' 27' ' ' LEU . 14.8 p -97.62 104.5 16.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.0 102.63 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.61 162.59 17.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.44 -2.7 10.61 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.762 2.308 . . . . 0.0 112.801 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 6.0 m-85 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.037 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 121.057 0.456 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -34.46 65.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.57 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 15' ' ' CYS . 44.6 tp -73.18 -48.34 36.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.355 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' O ' HG22 ' A' ' 31' ' ' VAL . 32.6 mt-10 -62.56 -27.42 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.504 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -65.32 -49.28 70.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 109.802 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.876 ' HB3' HG21 ' A' ' 89' ' ' VAL . 5.8 mtt -52.97 -52.33 58.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.853 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 28' ' ' GLU . 35.3 m -58.8 -46.5 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 110.615 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.479 ' N ' HG23 ' A' ' 31' ' ' VAL . 16.5 tt0 -57.95 -34.47 69.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.2 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.14 -21.51 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.551 ' SG ' HD11 ' A' ' 7' ' ' ILE . 1.8 m -93.59 -3.35 52.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.782 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 115.9 -34.84 4.55 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.653 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -56.15 169.16 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.486 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.37 134.62 54.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.4 m -72.1 125.75 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 111.18 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 12' ' ' GLU . 17.6 t -114.67 128.08 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -33.52 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.926 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.1 mt-10 -121.85 155.3 35.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.364 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 75' ' ' CYS . 16.2 mt -70.78 -32.47 69.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.676 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -21.03 59.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.83 -20.46 61.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.189 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 20.3 m-85 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG21 ' HG3' ' A' ' 12' ' ' GLU . 30.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.71 0.29 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -93.8 126.06 50.93 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.874 ' O ' HD13 ' A' ' 54' ' ' ILE . 73.1 Cg_endo -77.43 129.59 10.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.568 2.179 . . . . 0.0 112.707 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 53' ' ' PRO . 7.5 mm -141.66 154.71 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.818 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' SG ' ' A' ' 14' ' ' CYS . 30.9 t -138.21 140.31 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.86 156.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 111.115 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.615 ' CG2' HG12 ' A' ' 79' ' ' VAL . 3.2 m -144.01 -179.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.538 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.502 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.89 67.18 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.754 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.02 107.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.715 0.293 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.538 HG21 HG11 ' A' ' 79' ' ' VAL . 12.1 mm -69.59 -34.27 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 110.804 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.27 -20.91 59.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.312 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -77.32 -25.25 51.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 mtp -93.85 -29.28 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.828 ' HB2' HD13 ' A' ' 42' ' ' LEU . 54.0 t -132.35 153.5 50.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.753 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.88 -36.69 12.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.805 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -55.56 170.26 0.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.805 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.0 Cg_endo -77.11 161.82 32.19 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.615 HG12 ' CG2' ' A' ' 57' ' ' VAL . 12.1 t -127.04 121.49 58.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.733 ' O ' HG12 ' A' ' 56' ' ' VAL . 33.8 m -141.32 140.09 32.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.5 p -55.21 163.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.705 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -20.05 15.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -47.0 -40.98 15.59 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.464 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.7 t90 -58.84 -57.35 13.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.368 0.604 . . . . 0.0 110.106 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 89' ' ' VAL . 47.9 t -55.93 -42.37 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.225 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.59 -56.56 6.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -56.7 -30.87 63.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -77.19 -50.5 12.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.087 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.876 HG21 ' HB3' ' A' ' 30' ' ' MET . 47.4 t -71.27 -28.53 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.431 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -58.15 5.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.882 0.372 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.79 -10.63 47.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.203 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.604 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 64.9 79.77 0.25 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.857 0.36 . . . . 0.0 110.708 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.457 ' N ' HG21 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -177.07 129.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -64.14 85.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -68.69 172.45 6.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.94 157.53 29.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.635 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.721 HD21 ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -96.7 -25.06 15.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.057 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -21.66 66.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.412 ' HB ' ' CE1' ' A' ' 100' ' ' TYR . 25.5 m -77.08 -17.76 58.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.465 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE1' ' HB ' ' A' ' 99' ' ' THR . 1.6 m-85 -138.91 23.61 2.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.661 0.267 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.004 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 9.0 mmtm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.733 0.302 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.629 HD12 ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -80.26 -20.19 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.748 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' HD12 ' A' ' 7' ' ' ILE . 18.0 m-30 -93.63 -48.12 6.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 39.3 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.23 68.85 1.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.772 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -137.2 160.66 38.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.666 ' H ' HD23 ' A' ' 11' ' ' LEU . 2.0 mt-10 -137.64 111.11 8.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.718 HD11 HD22 ' A' ' 11' ' ' LEU . 3.0 mt -122.2 121.84 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.804 ' SG ' HG13 ' A' ' 55' ' ' VAL . 19.4 p -107.51 132.02 53.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 m -95.31 101.65 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.535 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.473 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -93.88 102.73 14.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.108 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.91 144.02 7.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.801 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 23.9 Cg_exo -63.1 -13.41 35.29 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.8 2.334 . . . . 0.0 112.515 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.6 m-30 . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.144 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.025 0.44 . . . . 0.0 110.558 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.87 -31.36 51.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -74.55 -45.89 42.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.346 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -63.03 -27.72 69.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -66.77 -52.05 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 109.776 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.889 ' HB3' HG21 ' A' ' 89' ' ' VAL . 11.9 mtm -53.71 -50.52 65.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.668 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 32' ' ' GLN . 28.0 m -60.78 -45.46 97.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt-30 -56.74 -34.77 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.019 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.5 tp -70.19 -21.57 63.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.705 ' SG ' HG22 ' A' ' 89' ' ' VAL . 21.3 m -93.41 -3.53 53.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.729 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 105.82 15.67 17.81 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.156 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.655 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -101.69 173.53 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.145 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.57 132.52 51.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.655 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 13.8 p -71.98 122.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 45' ' ' PHE . 1.1 t -93.91 127.55 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -59.27 -40.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.67 -177.13 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 75' ' ' CYS . 20.2 mt -72.74 -38.86 67.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.04 -8.71 56.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -92.89 18.17 9.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.0 m-85 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.802 0.334 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.31 118.46 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.726 ' O ' HD13 ' A' ' 54' ' ' ILE . 95.8 Cg_endo -80.02 128.55 7.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.567 2.178 . . . . 0.0 112.643 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.918 HG13 HD21 ' A' ' 11' ' ' LEU . 7.6 mm -144.76 156.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.804 HG13 ' SG ' ' A' ' 14' ' ' CYS . 14.7 t -137.98 144.49 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.029 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.6 HG23 ' CG2' ' A' ' 13' ' ' ILE . 22.0 t -128.21 159.32 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 111.246 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -152.45 -169.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.631 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -179.17 72.25 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.25 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.645 2.23 . . . . 0.0 112.439 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.716 0.293 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.529 HG22 HG21 ' A' ' 79' ' ' VAL . 31.2 mm -68.69 -60.19 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.5 -21.83 65.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.478 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.96 -16.2 45.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.686 0.279 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -27.45 16.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.957 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' ' 42' ' ' LEU . 42.6 t -133.08 156.64 47.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.943 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -100.61 30.27 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -124.16 156.51 66.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.018 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 30.3 Cg_endo -64.11 150.11 89.01 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.298 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 71' ' ' ILE . 34.2 t -121.14 128.49 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.566 ' CG1' HD23 ' A' ' 97' ' ' LEU . 28.6 m -144.0 177.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.9 p -93.7 173.98 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.721 ' HB3' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -67.68 -11.64 58.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.243 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -56.86 -40.62 76.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.887 0.375 . . . . 0.0 110.242 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.518 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.5 t90 -56.82 -57.42 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 110.029 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 89' ' ' VAL . 66.3 t -56.09 -46.53 80.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.113 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -56.59 12.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.45 -31.55 67.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -77.14 -48.89 16.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.954 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 30' ' ' MET . 49.0 t -71.32 -28.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.66 -59.07 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.064 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 tp -88.48 -11.99 44.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.74 83.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.474 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 tt0 -177.11 133.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.23 78.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.83 169.01 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.788 ' HG3' HG23 ' A' ' 99' ' ' THR . 2.3 pt-20 -82.68 142.23 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.643 HD21 ' CG2' ' A' ' 54' ' ' ILE . 4.1 mp -79.85 -28.87 39.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.97 -30.49 47.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.788 HG23 ' HG3' ' A' ' 96' ' ' GLU . 41.3 p -76.11 -13.39 60.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.6 27.88 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.553 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.735 0.302 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.623 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -101.9 -20.91 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 17.1 m-30 -93.49 -47.9 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.782 0.325 . . . . 0.0 110.446 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.74 87.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.555 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.54 72.64 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.077 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.506 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -144.31 162.4 36.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.6 mt-10 -138.41 109.77 6.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.157 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -126.01 141.1 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.5 p -126.43 147.46 49.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.078 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.631 ' SG ' HD23 ' A' ' 27' ' ' LEU . 14.9 m -105.61 113.42 26.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.609 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.58 120.0 33.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.9 168.75 45.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.579 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.79 1.23 9.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.821 2.348 . . . . 0.0 112.738 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.048 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.172 0.51 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.7 -32.13 67.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.371 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.631 HD23 ' SG ' ' A' ' 15' ' ' CYS . 18.0 tp -70.94 -50.31 36.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.364 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' HG22 ' A' ' 31' ' ' VAL . 14.5 mt-10 -59.83 -27.42 66.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.979 0.418 . . . . 0.0 110.547 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -64.88 -50.08 67.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.238 0.542 . . . . 0.0 109.646 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.86 ' HB3' HG21 ' A' ' 89' ' ' VAL . 14.5 mtt -51.22 -51.29 55.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.072 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 28' ' ' GLU . 28.6 m -59.38 -45.67 93.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.923 0.392 . . . . 0.0 110.528 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.7 tm0? -58.5 -34.47 70.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.044 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.01 -21.09 63.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.78 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 89' ' ' VAL . 1.7 m -93.1 -3.25 54.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.615 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 112.91 -20.9 19.27 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.982 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -70.49 174.61 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 111.314 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.84 135.48 55.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.1 m -71.77 123.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 14.4 t -102.99 122.39 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -49.48 76.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.576 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 39' ' ' VAL . 3.6 mm-40 -140.15 177.7 7.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.375 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 75' ' ' CYS . 14.5 mt -67.36 -48.17 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.793 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 m -59.06 -21.13 58.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.54 ' HB3' HG13 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -65.9 -21.01 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.218 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HZ ' ' HG ' ' A' ' 14' ' ' CYS . 17.9 m-85 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 111.063 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -94.03 136.03 24.09 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.827 ' O ' HD13 ' A' ' 54' ' ' ILE . 89.5 Cg_endo -80.71 138.51 11.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.677 2.252 . . . . 0.0 112.565 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 53' ' ' PRO . 8.5 mm -144.29 150.89 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.976 HG23 ' HB3' ' A' ' 77' ' ' ALA . 41.6 t -131.21 139.0 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 57' ' ' VAL . 60.9 t -124.67 157.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 0.0 111.371 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -156.68 -173.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 -179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.637 ' H ' HG12 ' A' ' 57' ' ' VAL . 4.7 tt0 178.66 80.47 0.16 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.574 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.53 112.24 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.649 2.232 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.731 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.746 HG21 HG11 ' A' ' 79' ' ' VAL . 25.4 mm -71.42 -60.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.38 -22.95 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.691 0.282 . . . . 0.0 111.103 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -30.66 14.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.714 ' HB2' HD22 ' A' ' 42' ' ' LEU . 31.2 p -105.6 162.9 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -116.05 37.64 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.976 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -148.79 168.22 11.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.777 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 56.6 Cg_endo -70.22 112.48 3.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.656 2.237 . . . . 0.0 112.517 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.746 HG11 HG21 ' A' ' 71' ' ' ILE . 34.8 t -81.3 127.1 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.784 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.623 ' CG1' HD23 ' A' ' 97' ' ' LEU . 28.2 m -140.27 176.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 11.6 p -94.4 159.24 15.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.14 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -22.06 6.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.312 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.81 -40.59 21.46 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.95 0.405 . . . . 0.0 110.684 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 84.4 t90 -62.16 -57.23 12.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.363 0.602 . . . . 0.0 110.027 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 89' ' ' VAL . 60.3 t -56.1 -37.09 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.17 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 -54.55 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.83 -30.44 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.772 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.4 m -77.17 -50.96 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.86 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.7 t -71.19 -28.56 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.365 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.17 -54.33 22.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 93' ' ' GLN . 4.5 tt -97.52 2.7 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.339 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.623 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 53.5 82.86 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 111.054 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.527 ' HB2' HD23 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -178.68 128.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 p -66.08 86.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.91 170.71 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.9 125.96 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.815 HD21 ' CG2' ' A' ' 54' ' ' ILE . 3.7 mp -64.11 -29.53 70.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -54.47 -29.29 49.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.247 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -77.56 -17.28 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -134.31 29.49 3.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.2 p -119.2 -64.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -125.45 26.88 6.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.7 176.05 10.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.92 -62.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER 64.08 134.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.644 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.749 HD11 ' SG ' ' A' ' 34' ' ' CYS . 5.6 pt -76.44 -21.08 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.711 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 13.1 m-30 -93.74 -48.25 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.609 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 45.32 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.09 77.47 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.205 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.915 HD21 HG13 ' A' ' 54' ' ' ILE . 0.8 OUTLIER -144.22 158.76 43.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.689 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -136.95 113.37 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.722 HD11 HD22 ' A' ' 11' ' ' LEU . 2.2 mt -127.17 128.97 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 0.0 111.443 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.5 p -115.97 131.42 56.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HB3' HD23 ' A' ' 27' ' ' LEU . 25.9 p -97.07 106.33 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.526 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 130.03 39.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.56 164.03 28.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 90.0 Cg_endo -80.42 -16.19 10.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.748 2.299 . . . . 0.0 112.726 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CD2' ' HB2' ' A' ' 23' ' ' PRO . 5.5 m-85 63.22 -80.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.1 -78.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -172.41 51.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.421 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 4.2 ttm 178.95 -51.1 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.493 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 21.3 Cg_exo -66.0 64.11 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.734 2.289 . . . . 0.0 112.429 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -73.1 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.441 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -87.24 -31.33 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.536 . . . . 0.0 109.693 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.43 -24.84 50.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.95 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 15' ' ' CYS . 15.9 tp -74.15 -48.75 27.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.801 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -65.02 -27.61 68.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 0.0 110.462 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.44 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.1 t90 -69.56 -49.82 50.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.831 ' HB3' HG21 ' A' ' 89' ' ' VAL . 34.5 mtp -54.3 -48.57 71.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.783 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.3 m -62.31 -45.16 99.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.191 0.519 . . . . 0.0 109.863 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.473 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.86 -36.52 72.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.156 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -70.07 -21.11 63.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.778 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' SG ' HD11 ' A' ' 7' ' ' ILE . 10.3 m -92.98 -3.21 54.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.738 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 -14.66 17.43 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.113 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.661 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -76.21 179.71 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.167 0.508 . . . . 0.0 111.537 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 135.77 46.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.452 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -71.74 114.44 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.928 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.736 HG21 ' CE1' ' A' ' 45' ' ' PHE . 5.3 t -95.26 123.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -49.55 74.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.8 mt-10 -141.22 -176.9 4.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.278 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.733 HD13 ' HB3' ' A' ' 75' ' ' CYS . 19.2 mt -72.19 -39.02 68.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -7.05 52.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.49 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -23.71 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.61 0.243 . . . . 0.0 111.23 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.736 ' CE1' HG21 ' A' ' 39' ' ' VAL . 29.6 m-85 -52.58 135.77 33.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 111.11 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -132.04 129.75 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -78.61 85.64 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.1 -105.5 0.27 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.575 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 p -127.96 -45.42 1.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.86 30.08 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.513 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.29 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 111.203 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -93.96 135.43 24.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.733 ' O ' HD13 ' A' ' 54' ' ' ILE . 85.6 Cg_endo -82.14 137.12 9.41 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 0.0 112.713 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.915 HG13 HD21 ' A' ' 11' ' ' LEU . 8.8 mm -144.44 152.43 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.783 HG23 ' HB3' ' A' ' 77' ' ' ALA . 42.4 t -128.28 151.14 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 13' ' ' ILE . 85.6 t -129.09 146.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.838 HG22 HG12 ' A' ' 79' ' ' VAL . 2.8 m -139.1 -175.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.49 93.29 0.28 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 61.78 2.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.357 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.33 -67.96 0.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.71 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 18' ' ' PRO . . . -84.3 -24.11 30.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.106 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.501 ' O ' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -56.68 -29.84 62.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.069 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 62' ' ' TRP . 14.8 t 45.96 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.35 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.03 126.88 55.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -177.34 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -97.49 -50.09 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.93 115.03 1.86 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.741 ' CD1' HD11 ' A' ' 71' ' ' ILE . 43.1 t80 -102.08 7.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.573 0.225 . . . . 0.0 111.483 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -91.38 55.27 2.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 111.031 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -176.26 36.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 79' ' ' VAL . 30.7 mm -71.75 -63.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.83 -25.24 58.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.313 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.29 -24.81 50.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.991 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 mtp -93.92 -31.07 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.733 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.9 p -106.73 150.66 26.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.83 31.61 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.45 168.61 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 73.7 Cg_endo -74.9 121.74 6.81 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.693 2.262 . . . . 0.0 112.464 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.024 HG21 HG22 ' A' ' 71' ' ' ILE . 12.1 t -92.87 124.0 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.538 HG11 ' CB ' ' A' ' 97' ' ' LEU . 3.9 m -137.16 131.75 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.699 0.285 . . . . 0.0 111.431 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -50.87 157.2 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.9 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -24.32 2.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.355 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 1.3 tp10 -45.55 -39.82 7.94 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.765 0.317 . . . . 0.0 110.673 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.9 t90 -60.7 -57.29 13.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.517 0.675 . . . . 0.0 109.903 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.754 ' O ' HG23 ' A' ' 89' ' ' VAL . 81.5 t -54.23 -41.46 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -50.5 27.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -60.02 -33.08 71.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' TYR . 51.0 m -77.1 -47.44 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.831 HG21 ' HB3' ' A' ' 30' ' ' MET . 57.9 t -71.16 -26.21 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.291 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -58.52 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.85 -13.42 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.533 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 69.22 80.91 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.759 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.651 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.9 OUTLIER 179.16 129.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.93 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -68.67 159.08 32.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.7 126.02 27.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.78 HD21 ' CG2' ' A' ' 54' ' ' ILE . 3.0 mp -66.03 -32.17 73.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.339 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -23.21 13.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.555 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.0 m -75.48 -19.75 59.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.617 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 21.1 m-85 -134.66 19.8 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 0.0 111.306 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -86.63 173.72 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.969 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 79' ' ' VAL . 4.6 mt -59.98 110.08 2.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.027 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.97 -63.89 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.37 2.047 . . . . 0.0 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.42 88.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.944 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 pt -141.54 156.23 66.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.72 154.5 60.11 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.68 2.253 . . . . 0.0 112.146 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.62 -174.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 t -152.5 -57.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -117.0 115.89 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.875 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 p -107.16 157.34 17.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 59.0 98.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.29 -51.26 2.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 56.93 94.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.735 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.0 mmtt -116.05 138.98 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.588 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -82.38 -17.94 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.624 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 14.6 m-30 -93.63 -42.81 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 5.1 ptm180 35.85 84.34 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 111.854 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.95 66.77 1.55 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.772 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.923 HD21 HG13 ' A' ' 54' ' ' ILE . 1.5 tt -138.78 152.52 47.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.312 . . . . 0.0 110.792 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.78 ' HG2' HG22 ' A' ' 39' ' ' VAL . 2.5 mt-10 -130.85 119.36 22.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.756 HD11 HD22 ' A' ' 11' ' ' LEU . 2.6 mt -130.51 123.8 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.709 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.841 ' SG ' HG13 ' A' ' 55' ' ' VAL . 31.9 p -107.64 135.33 49.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.714 ' HB3' HD23 ' A' ' 27' ' ' LEU . 22.7 p -94.33 99.2 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.676 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -93.82 112.84 24.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.31 159.73 11.9 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.49 -13.53 9.69 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.791 2.327 . . . . 0.0 112.827 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.0 m-85 63.87 -79.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.857 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.72 -76.38 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -178.2 39.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 178.23 -52.14 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.979 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 22' ' ' MET . 47.1 Cg_exo -56.58 83.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.133 . . . . 0.0 112.464 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 -54.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.531 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.75 -27.95 24.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.57 . . . . 0.0 109.845 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 -28.23 58.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.998 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 15' ' ' CYS . 14.1 tp -72.11 -50.94 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -63.62 -27.54 69.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.564 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.4 t90 -69.93 -50.17 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.9 ' HB3' HG21 ' A' ' 89' ' ' VAL . 37.3 mtp -54.04 -48.37 70.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.774 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.1 m -61.89 -44.6 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.189 0.518 . . . . 0.0 109.947 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.463 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.9 mt-30 -58.33 -35.23 71.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.198 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.009 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.496 ' SG ' HG22 ' A' ' 89' ' ' VAL . 19.4 m -93.04 -3.44 54.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.851 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 115.05 -3.96 22.43 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.253 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.699 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -86.67 -179.61 6.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 111.402 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -133.54 133.95 42.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.32 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.3 p -71.62 114.39 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.78 HG22 ' HG2' ' A' ' 12' ' ' GLU . 1.6 t -93.66 134.4 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -80.51 -36.01 33.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.256 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -131.99 164.74 25.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.137 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.832 HD13 ' HB3' ' A' ' 75' ' ' CYS . 37.8 mt -73.29 -37.07 66.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -75.95 -6.05 49.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.427 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.02 2.08 36.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.669 ' CE1' HG21 ' A' ' 39' ' ' VAL . 13.7 m-85 -68.06 157.15 35.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.71 96.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.17 -32.44 10.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.71 -98.21 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.556 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 m -140.21 -45.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.73 0.3 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.86 70.03 1.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.521 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG11 ' CD ' ' A' ' 12' ' ' GLU . 21.2 t -146.27 123.98 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.84 122.44 62.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' O ' HD13 ' A' ' 54' ' ' ILE . 89.3 Cg_endo -80.84 126.78 5.97 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.559 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.923 HG13 HD21 ' A' ' 11' ' ' LEU . 12.6 mm -142.91 160.5 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.841 HG13 ' SG ' ' A' ' 14' ' ' CYS . 6.9 t -142.31 151.18 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 13' ' ' ILE . 3.0 t -117.42 157.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 111.107 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.724 HG13 HG12 ' A' ' 79' ' ' VAL . 4.9 m -147.01 -178.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.68 92.66 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 59.48 5.92 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.576 2.184 . . . . 0.0 112.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -41.85 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.749 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.58 30.18 7.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.967 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 -49.06 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 61.26 154.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.93 86.31 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -132.41 -61.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -46.34 12.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.74 104.76 1.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.407 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.74 ' CD1' HD11 ' A' ' 71' ' ' ILE . 41.0 t80 -101.23 7.06 43.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.521 0.201 . . . . 0.0 111.407 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.47 49.6 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.51 36.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 68' ' ' PHE . 29.7 mm -72.84 -61.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.143 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.06 -27.24 62.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.44 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -78.43 -23.26 46.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.007 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -93.96 -29.19 15.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.881 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.832 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.4 p -114.94 151.5 33.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.9 -26.01 17.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.608 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -84.15 159.46 59.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 49.6 Cg_endo -67.99 147.95 75.02 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.14 . . . . 0.0 112.432 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.724 HG12 HG13 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -118.16 128.76 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 97' ' ' LEU . 27.2 m -140.1 157.05 25.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 111.263 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.4 p -70.19 158.91 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.321 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -22.19 3.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.428 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.15 -43.7 21.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.85 0.357 . . . . 0.0 110.77 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.51 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 78.0 t90 -55.16 -57.25 12.53 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.54 0.686 . . . . 0.0 110.102 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.783 ' O ' HG23 ' A' ' 89' ' ' VAL . 85.2 t -53.63 -46.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.176 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -49.72 66.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -61.82 -33.0 73.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -77.08 -46.81 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.9 HG21 ' HB3' ' A' ' 30' ' ' MET . 43.9 t -71.08 -31.45 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.4 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 tp -82.51 -19.53 38.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.588 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 71.46 76.89 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.045 0.45 . . . . 0.0 110.613 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.401 ' C ' HD13 ' A' ' 7' ' ' ILE . 23.4 tt0 -177.68 132.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.772 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.38 83.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.85 168.79 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -77.2 133.84 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.735 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.799 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.1 mp -74.52 -32.03 62.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -22.66 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.426 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.9 m -73.54 -20.67 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.467 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -140.09 28.24 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -88.7 152.2 21.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.952 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.492 HG12 HG23 ' A' ' 79' ' ' VAL . 1.1 pp -61.28 149.23 83.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.18 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.9 -179.44 4.61 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.577 2.185 . . . . 0.0 112.382 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -169.72 90.02 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.804 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -74.75 121.69 85.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 -30.31 9.4 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.414 2.076 . . . . 0.0 112.323 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.95 144.05 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.9 t -113.06 83.13 1.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.953 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.62 111.43 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 t -170.31 -42.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -83.1 96.45 8.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.15 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 69.64 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 12.8 pttm -80.83 174.51 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.68 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -123.73 -14.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.018 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.595 ' CD1' HD13 ' A' ' 11' ' ' LEU . 9.4 m-30 -93.45 -44.07 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.535 0.207 . . . . 0.0 110.648 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 41.05 87.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.259 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.22 72.72 0.98 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.382 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.939 HD21 HG13 ' A' ' 54' ' ' ILE . 2.4 tt -146.23 125.15 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.648 0.261 . . . . 0.0 110.838 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.719 ' HG2' HG22 ' A' ' 39' ' ' VAL . 1.2 mt-10 -104.31 123.33 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.699 0.285 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.742 HD11 HD22 ' A' ' 11' ' ' LEU . 2.6 mt -129.96 123.77 57.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.864 0.364 . . . . 0.0 111.449 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.694 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.1 p -110.77 144.08 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 m -107.13 114.16 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -97.18 110.0 22.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.0 148.47 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.26 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.608 2.205 . . . . 0.0 112.261 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 5.5 m-85 -127.11 -78.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -121.4 -43.35 2.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.664 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -129.58 -75.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.486 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -167.71 54.59 0.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.0 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 22' ' ' MET . 61.4 Cg_endo -88.46 20.28 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.82 2.347 . . . . 0.0 112.865 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -56.73 -41.67 77.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 111.138 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -85.45 -25.27 27.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.499 . . . . 0.0 110.165 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.36 -30.57 60.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.236 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.635 HD12 HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -72.58 -50.83 22.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.348 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -68.7 -51.61 39.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 89' ' ' VAL . 54.9 mtm -53.11 -49.61 66.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.815 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 32' ' ' GLN . 29.7 m -62.01 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.136 0.493 . . . . 0.0 109.844 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.478 ' N ' HG23 ' A' ' 31' ' ' VAL . 7.8 mt-30 -57.16 -35.54 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.002 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.54 -21.4 63.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.699 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HG22 ' A' ' 89' ' ' VAL . 1.8 m -93.42 -3.25 53.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.58 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.86 25.24 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.87 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -72.25 178.11 4.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.48 150.9 49.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.462 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 28' ' ' GLU . 13.9 p -86.51 120.66 36.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.828 0.346 . . . . 0.0 111.214 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.719 HG22 ' HG2' ' A' ' 12' ' ' GLU . 1.3 t -93.89 128.47 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -48.42 81.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -144.71 179.95 6.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 75' ' ' CYS . 30.3 mt -66.16 -42.8 88.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -70.02 -20.8 63.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.271 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.642 ' HB2' HG12 ' A' ' 39' ' ' VAL . 61.5 m -66.82 -15.28 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.606 ' CE1' HG21 ' A' ' 39' ' ' VAL . 9.7 m-85 -51.97 104.52 0.09 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.222 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -137.43 155.82 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.5 136.88 15.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.05 -28.57 3.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.411 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -114.81 -60.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.851 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.56 86.57 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.635 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.85 131.67 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.979 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -94.09 127.6 44.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.613 ' O ' HD13 ' A' ' 54' ' ' ILE . 92.9 Cg_endo -80.3 131.38 8.61 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.639 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.939 HG13 HD21 ' A' ' 11' ' ' LEU . 8.1 mm -143.44 161.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.617 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 77' ' ' ALA . 21.3 t -138.11 151.2 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 80' ' ' VAL . 4.0 t -126.31 149.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.316 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 79' ' ' VAL . 3.6 m -144.43 -177.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 3.6 tp60 178.06 70.73 0.11 Allowed Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.77 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.07 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.248 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -161.74 -44.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.76 42.67 2.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.411 ' O ' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -76.91 -5.99 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.349 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 62' ' ' TRP . 84.8 m 65.38 -76.16 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 111.075 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.91 131.45 36.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.85 79.21 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -89.13 -59.38 2.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.769 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.41 104.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.324 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' CD1' HD11 ' A' ' 71' ' ' ILE . 4.7 t80 -96.35 7.25 46.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.63 50.66 1.94 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.53 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.234 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.784 HG22 HG21 ' A' ' 79' ' ' VAL . 33.8 mm -75.66 -59.44 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.02 -21.91 70.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.544 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -85.97 -19.79 29.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.2 ttp -93.92 -29.08 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.607 ' HB3' HD13 ' A' ' 42' ' ' LEU . 29.8 p -107.49 151.35 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.25 30.25 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -139.81 159.22 65.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.47 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.3 Cg_endo -75.0 123.16 7.68 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.75 2.3 . . . . 0.0 112.248 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 57' ' ' VAL . 5.5 t -91.62 140.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.7 m -152.11 133.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.788 0.327 . . . . 0.0 111.629 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 14.7 p -47.64 159.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.793 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.17 -21.01 11.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.273 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 3.0 tt0 -47.34 -41.24 19.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.888 0.375 . . . . 0.0 110.714 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.516 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.2 t90 -57.43 -57.37 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 110.07 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.735 ' O ' HG23 ' A' ' 89' ' ' VAL . 59.0 t -53.65 -44.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -53.12 21.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -57.87 -29.98 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 92' ' ' TYR . 64.8 m -76.94 -49.15 16.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 30' ' ' MET . 26.9 t -71.14 -28.38 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.366 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.21 -57.27 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 tp -90.25 -11.44 40.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.68 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 62.53 76.96 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.652 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -178.67 132.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.78 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.993 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -69.06 166.62 17.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 156.85 35.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.654 HD21 ' CG2' ' A' ' 54' ' ' ILE . 1.0 OUTLIER -101.94 -20.93 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -25.59 65.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.011 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.4 m -74.71 -14.88 60.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.579 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 14.0 m-85 -139.23 16.55 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.566 0.222 . . . . 0.0 111.269 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.409 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -76.47 98.51 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.147 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.3 mt 63.62 128.36 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.64 -178.44 3.74 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.364 2.043 . . . . 0.0 112.293 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -177.43 153.79 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.59 136.45 96.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.068 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.25 164.88 34.11 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.48 105.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.6 t -150.28 123.89 9.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 m80 60.56 44.57 11.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.805 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.47 -175.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -81.46 60.32 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.8 -34.15 5.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 -69.5 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 3.2 mmtt 63.87 123.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.728 HD13 ' N ' ' A' ' 93' ' ' GLN . 5.8 pt -63.36 -20.6 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.533 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.769 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 4.8 m-30 -93.83 -49.7 5.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.418 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 45.21 90.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.351 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.95 75.7 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.303 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.548 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -143.0 159.3 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.798 0.333 . . . . 0.0 111.039 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -142.3 109.89 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.508 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.654 HD12 ' HB1' ' A' ' 36' ' ' ALA . 1.6 mt -121.96 125.55 73.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.941 0.4 . . . . 0.0 111.558 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.9 p -101.28 144.33 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.996 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 25.0 p -101.48 102.93 13.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.806 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -93.87 136.34 34.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . 87.01 144.72 8.78 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 16.5 Cg_exo -66.65 -9.63 25.09 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.826 2.35 . . . . 0.0 112.757 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 17' ' ' GLY . 69.5 m-85 67.56 -74.39 0.07 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.713 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.704 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 39.9 p -153.71 -75.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.734 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.85 39.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.629 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.42 ' CB ' ' CD ' ' A' ' 23' ' ' PRO . 1.7 mtm -173.35 -62.42 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.966 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 22' ' ' MET . 30.7 Cg_endo -63.48 89.62 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.452 2.102 . . . . 0.0 112.47 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.8 -54.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -84.63 -27.06 27.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 109.985 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.26 -27.2 56.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.317 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 85' ' ' VAL . 3.0 tm? -73.81 -48.84 28.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.44 -27.68 68.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.679 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -71.12 -49.68 41.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.963 ' HB3' HG21 ' A' ' 89' ' ' VAL . 53.7 mtm -54.52 -48.32 72.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.9 m -62.08 -44.92 99.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.3 0.571 . . . . 0.0 109.881 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.487 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.2 mt-30 -58.91 -35.52 73.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.2 tp -70.13 -21.9 63.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.407 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.883 ' SG ' HG22 ' A' ' 89' ' ' VAL . 23.4 m -94.02 -3.44 51.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.919 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 109.1 31.41 3.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.769 ' HB2' ' HD2' ' A' ' 8' ' ' PHE . . . -116.23 175.61 5.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.01 0.433 . . . . 0.0 111.038 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.9 38.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 38' ' ' VAL . 11.9 p -71.68 116.13 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -93.81 120.3 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.964 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -33.67 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -155.46 177.48 11.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.712 HD22 ' HB2' ' A' ' 75' ' ' CYS . 15.6 mt -68.89 -39.95 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -18.5 63.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.32 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.539 ' O ' HD12 ' A' ' 47' ' ' LEU . 1.2 m -77.11 -4.33 43.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.58 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.605 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.3 m-85 -56.96 -178.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 t 43.4 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.486 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 44' ' ' SER . 11.5 mt -146.69 98.16 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.41 -113.18 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -66.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.25 91.45 0.34 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.49 139.94 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.77 128.42 41.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.905 ' O ' HD13 ' A' ' 54' ' ' ILE . 83.9 Cg_endo -80.94 127.34 6.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.601 2.201 . . . . 0.0 112.781 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.905 HD13 ' O ' ' A' ' 53' ' ' PRO . 11.6 mm -134.96 161.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.69 HG23 ' HB3' ' A' ' 77' ' ' ALA . 38.5 t -139.05 139.76 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG23 ' CG2' ' A' ' 13' ' ' ILE . 53.6 t -115.75 158.59 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.809 HG22 HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -150.39 175.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.555 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER 177.27 63.06 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.684 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.03 115.08 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.615 2.21 . . . . 0.0 112.395 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.9 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.704 ' HB2' ' HA ' ' A' ' 20' ' ' THR . . . -98.67 27.65 4.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.218 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.405 ' CE3' ' O ' ' A' ' 66' ' ' ASN . 4.0 m95 -90.72 -38.43 13.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.55 176.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 62.89 -79.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.126 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -140.2 173.34 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' CE3' ' A' ' 62' ' ' TRP . 1.1 t-20 -80.04 -65.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.09 27.14 68.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.672 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 71' ' ' ILE . 14.0 t80 -93.59 7.33 45.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.628 0.251 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -88.2 35.66 0.76 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.713 0.292 . . . . 0.0 111.539 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.91 24.69 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.777 HG22 HG21 ' A' ' 79' ' ' VAL . 28.2 mm -80.56 -48.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.11 -18.79 73.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.273 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -14.63 20.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.463 0.173 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 mtp -93.6 -28.46 16.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.712 ' HB2' HD22 ' A' ' 42' ' ' LEU . 25.4 p -115.85 149.22 38.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.93 30.08 3.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.69 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -141.24 164.4 35.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 57.2 Cg_endo -71.16 131.69 19.72 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.657 2.238 . . . . 0.0 112.771 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.809 HG12 HG22 ' A' ' 57' ' ' VAL . 1.8 t -101.07 128.91 52.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.665 ' CG1' HD23 ' A' ' 97' ' ' LEU . 27.2 m -143.7 154.94 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 0.0 111.667 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.425 HG22 HD11 ' A' ' 102' ' ' ILE . 5.6 p -62.55 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' HD3' ' CD2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -88.61 -15.1 35.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.127 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -55.5 -34.59 64.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -57.98 -57.56 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.289 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 89' ' ' VAL . 43.5 t -58.34 -48.22 85.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.132 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -45.22 94.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.57 -36.46 83.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 92' ' ' TYR . 22.5 m -77.05 -44.72 29.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.963 HG21 ' HB3' ' A' ' 30' ' ' MET . 38.7 t -71.22 -26.66 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.397 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.42 -52.74 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.36 . . . . 0.0 111.441 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.94 -2.14 47.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.58 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.433 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 57.0 80.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 110.894 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.728 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -178.88 126.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.3 t -59.31 87.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.7 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.57 130.96 35.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.838 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.2 mp -66.4 -29.07 69.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.25 -24.82 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.336 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -80.29 -12.03 59.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.536 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -142.18 29.77 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.768 0.318 . . . . 0.0 111.018 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -92.73 150.6 20.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.806 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 81' ' ' THR . 28.0 mt -118.11 93.0 43.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.71 -168.42 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -97.05 128.17 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp 59.69 97.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.54 -59.97 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.449 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -94.13 101.69 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 -47.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -153.01 -62.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 179.921 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.35 140.6 32.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -59.93 114.61 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -158.73 -45.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.03 92.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.1 mmtp -111.74 147.12 36.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.59 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.695 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -91.23 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.916 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.683 ' CD1' HD13 ' A' ' 11' ' ' LEU . 11.3 m-85 -93.43 -47.4 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.28 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 38.96 86.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.377 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.45 66.47 1.68 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.503 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.997 HD21 HG13 ' A' ' 54' ' ' ILE . 3.9 tt -145.64 122.21 11.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.489 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.733 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.7 mt-10 -94.63 123.6 38.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.331 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.709 HD12 ' CB ' ' A' ' 36' ' ' ALA . 3.6 mt -132.77 136.18 56.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.261 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.0 p -135.61 142.82 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.832 ' HB3' HD23 ' A' ' 27' ' ' LEU . 7.9 p -107.01 109.4 21.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.13 103.51 15.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.98 161.96 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.657 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.23 -15.84 14.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.599 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD2' ' HB3' ' A' ' 58' ' ' GLN . 5.4 m-85 63.47 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.016 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -128.0 -79.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.983 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -105.82 -71.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.459 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 46.5 ttm -163.47 53.33 0.37 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 22' ' ' MET . 95.3 Cg_endo -83.57 10.27 3.75 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.65 2.233 . . . . 0.0 112.803 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -40.62 84.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.755 0.312 . . . . 0.0 111.172 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 41.8 m-20 -87.36 -26.2 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.468 . . . . 0.0 110.4 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -31.29 56.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.832 HD23 ' HB3' ' A' ' 15' ' ' CYS . 12.4 tp -74.96 -46.37 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -64.69 -27.35 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.483 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -68.72 -50.84 47.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.187 0.518 . . . . 0.0 109.84 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.871 ' HB3' HG21 ' A' ' 89' ' ' VAL . 74.0 mtm -55.11 -48.21 73.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.6 m -60.52 -44.84 97.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 0.0 110.17 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' N ' HG23 ' A' ' 31' ' ' VAL . 12.5 tt0 -58.39 -33.47 69.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -70.02 -21.44 63.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.749 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' SG ' HD11 ' A' ' 7' ' ' ILE . 2.6 m -93.28 -3.25 53.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 110.84 -29.74 8.67 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.435 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.709 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -58.3 156.98 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 132.17 45.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.044 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 38' ' ' VAL . 15.1 m -71.76 114.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.053 0.454 . . . . 0.0 110.898 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 12' ' ' GLU . 24.8 t -100.27 117.93 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.907 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -47.24 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.3 mt-10 -134.34 171.0 14.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.072 0.463 . . . . 0.0 111.448 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 75' ' ' CYS . 9.4 mt -65.37 -44.59 87.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.854 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 m -60.69 -27.22 67.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.715 ' HB3' HG13 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -58.76 -23.28 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 16.2 m-85 -53.72 123.57 12.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -144.12 108.73 4.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.498 ' HA ' HG23 ' A' ' 51' ' ' VAL . 6.1 mp -60.42 149.66 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -143.24 -116.78 1.17 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.9 p -82.66 -30.86 29.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.95 36.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.673 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 47' ' ' LEU . 5.4 m -93.94 118.77 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -95.31 134.69 24.09 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.66 125.53 5.59 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.639 2.226 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.997 HG13 HD21 ' A' ' 11' ' ' LEU . 29.3 mm -134.71 148.34 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.755 ' HB ' HG12 ' A' ' 79' ' ' VAL . 58.7 t -126.58 151.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.362 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.749 HG11 HD21 ' A' ' 27' ' ' LEU . 16.4 t -123.71 131.26 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 71' ' ' ILE . 5.2 m -143.26 120.39 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.556 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -140.82 86.06 12.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.16 135.24 39.57 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.515 2.143 . . . . 0.0 112.314 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -177.42 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 20' ' ' THR . . . -104.67 30.02 5.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 68' ' ' PHE . 4.8 m95 -87.66 -34.19 18.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.17 -67.84 0.21 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.79 164.32 14.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.72 65.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.0 -29.98 67.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.86 84.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.395 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.573 ' CD1' HD11 ' A' ' 71' ' ' ILE . 5.9 t80 -100.48 7.1 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.548 0.213 . . . . 0.0 111.433 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -91.69 49.74 1.61 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.18 29.52 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.828 ' CG2' HG11 ' A' ' 79' ' ' VAL . 14.1 mm -62.84 -39.36 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.25 -25.65 61.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -27.91 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.5 mtp -93.83 -30.7 14.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.767 ' HB2' HD13 ' A' ' 42' ' ' LEU . 42.1 t -134.58 145.59 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.56 31.34 4.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -112.51 166.15 11.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.08 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 83.8 Cg_endo -79.08 108.43 2.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.788 2.325 . . . . 0.0 112.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.828 HG11 ' CG2' ' A' ' 71' ' ' ILE . 3.2 m -91.12 127.44 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.588 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 56' ' ' VAL . 35.9 m -137.09 139.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.793 0.33 . . . . 0.0 111.736 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 p -52.02 161.97 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -21.51 9.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.476 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.26 -43.92 15.97 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.521 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.4 t90 -56.57 -57.42 12.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.931 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 89' ' ' VAL . 52.9 t -54.34 -43.75 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.269 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -69.12 -56.34 7.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.016 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.3 -31.37 63.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.0 m -77.1 -49.92 14.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.5 t -71.24 -27.27 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.467 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.05 -58.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.7 tp -89.45 -12.16 40.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.271 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.695 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 66.05 77.83 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 110.776 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.436 ' N ' HG21 ' A' ' 7' ' ' ILE . 20.9 tt0 -177.82 134.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 t -59.6 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -72.69 159.05 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -63.67 153.02 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.574 HD21 HG23 ' A' ' 54' ' ' ILE . 2.4 mp -102.15 -33.38 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.281 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -57.2 -21.67 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.595 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.9 m -80.51 -20.48 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.564 0.221 . . . . 0.0 111.482 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.8 23.75 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -88.61 144.96 25.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 111.068 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 101' ' ' LEU . 1.9 mp 63.66 135.81 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.098 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.74 -172.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.398 2.065 . . . . 0.0 112.184 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.17 85.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.593 ' O ' HD12 ' A' ' 105' ' ' ILE . 2.1 pp -152.67 120.95 3.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.24 121.88 8.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.398 2.065 . . . . 0.0 112.366 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -161.49 30.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.2 p -140.21 37.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -145.1 92.93 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.895 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.66 111.72 14.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.758 0.313 . . . . 0.0 110.847 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -122.71 120.77 34.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -140.29 176.44 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.19 90.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.6 mmtt -74.42 136.81 42.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.341 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.666 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.1 pp -76.33 -23.49 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.92 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.666 ' CD1' HD12 ' A' ' 7' ' ' ILE . 16.4 m-30 -93.71 -47.68 6.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 45.54 90.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.333 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.21 76.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.931 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.18 162.27 38.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -140.65 109.78 6.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.657 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.5 mt -121.11 130.72 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 111.666 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.641 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 21.9 p -115.04 139.03 50.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.748 ' HB3' HD23 ' A' ' 27' ' ' LEU . 8.6 p -107.12 108.49 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.597 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.98 119.66 33.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.94 166.38 25.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.594 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.35 -10.38 9.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.864 2.376 . . . . 0.0 112.75 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.5 m-85 62.88 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.3 p -125.15 -71.7 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.98 -70.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.452 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -167.89 56.1 0.32 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.983 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 22' ' ' MET . 69.2 Cg_endo -86.94 17.09 1.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.828 2.352 . . . . 0.0 112.847 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.473 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -62.92 -41.76 99.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.36 -25.17 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.476 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -31.48 41.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.415 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 15' ' ' CYS . 33.6 tp -75.91 -44.24 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.396 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -65.44 -27.54 68.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.431 ' NE1' ' CD2' ' A' ' 33' ' ' LEU . 18.4 t90 -67.47 -51.94 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.162 0.506 . . . . 0.0 109.734 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.788 ' HB3' HG21 ' A' ' 89' ' ' VAL . 6.2 mtm -55.03 -50.52 68.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.615 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 32' ' ' GLN . 26.1 m -58.98 -45.02 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.96 -33.83 67.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.497 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -70.44 -21.46 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.021 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 4.0 m -93.45 -3.26 53.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.745 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.51 -18.21 17.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.851 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.657 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -72.63 177.93 4.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.28 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -131.98 139.18 48.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.565 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 p -71.93 122.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.72 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.2 t -93.92 130.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.04 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -65.3 -42.3 93.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -147.73 -179.59 7.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 75' ' ' CYS . 33.1 mt -71.43 -41.1 69.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 t -72.95 -9.11 58.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.428 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 -19.11 60.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.607 0.241 . . . . 0.0 111.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.72 ' CE1' HG21 ' A' ' 39' ' ' VAL . 24.1 m-85 -53.31 113.8 1.27 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 111.09 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -110.57 128.03 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.43 126.39 40.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.59 28.34 1.91 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.76 36.8 22.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.72 -42.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 t -97.42 118.88 44.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -93.87 126.84 47.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.879 ' O ' HD13 ' A' ' 54' ' ' ILE . 91.4 Cg_endo -78.53 130.73 10.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.697 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.879 HD13 ' O ' ' A' ' 53' ' ' PRO . 8.1 mm -138.82 147.74 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.666 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 77' ' ' ALA . 39.9 t -123.01 151.1 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.81 HG13 ' O ' ' A' ' 80' ' ' VAL . 15.2 t -129.95 144.41 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 m -135.3 -177.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 172.98 78.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.05 88.06 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.644 2.23 . . . . 0.0 112.402 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.12 -51.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.88 33.57 2.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -83.32 -30.26 27.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.3 m 65.01 -75.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.78 158.7 31.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -111.08 88.07 2.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -81.26 -47.97 12.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.53 94.36 0.16 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.734 ' CD1' HD11 ' A' ' 71' ' ' ILE . 42.3 t80 -91.56 7.13 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.506 0.193 . . . . 0.0 111.508 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -91.35 52.47 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.032 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.39 33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 79' ' ' VAL . 23.0 mm -74.3 -54.3 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.39 -20.76 71.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.42 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -18.09 40.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.92 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.0 ttp -93.67 -25.53 17.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.801 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.503 ' HB2' HD13 ' A' ' 42' ' ' LEU . 46.0 t -133.5 156.41 47.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.856 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -103.34 32.63 3.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -123.91 164.52 28.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.62 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 94.0 Cg_endo -78.39 120.87 5.01 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.037 HG21 HG22 ' A' ' 71' ' ' ILE . 10.7 t -94.62 121.29 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.81 ' O ' HG13 ' A' ' 56' ' ' VAL . 28.0 m -137.58 135.57 46.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.586 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.8 p -50.65 170.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.668 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -16.32 60.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.36 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -42.24 52.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 110.664 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.511 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 80.2 t90 -59.46 -57.26 13.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.491 0.663 . . . . 0.0 109.766 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 89' ' ' VAL . 63.2 t -55.06 -43.48 69.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.424 HD22 ' HE1' ' A' ' 30' ' ' MET . 0.5 OUTLIER -69.87 -46.14 66.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -64.48 -32.94 74.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.518 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -77.11 -47.13 21.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 85' ' ' VAL . 42.1 t -71.24 -30.92 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.38 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.73 -56.79 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.84 -16.54 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.522 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 67.57 77.76 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.02 136.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.707 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -58.93 91.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -74.57 160.39 30.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.66 139.04 56.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.702 ' HB3' HD12 ' A' ' 101' ' ' LEU . 1.6 mp -88.34 -33.06 18.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.349 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -22.25 24.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.583 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.7 m -77.74 -23.38 49.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.433 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -128.1 18.46 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.618 0.247 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -87.2 173.93 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.655 ' H ' HD23 ' A' ' 101' ' ' LEU . 31.5 mm -111.45 97.29 35.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.18 -171.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.52 2.147 . . . . 0.0 112.209 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -177.36 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.18 154.31 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 107.03 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.536 2.157 . . . . 0.0 112.293 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -140.35 85.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.6 t -118.66 98.25 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.95 -32.09 8.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.8 p -110.5 -33.15 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 61.0 30.24 19.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -134.41 178.59 6.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -161.44 75.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 7.5 pttm -94.16 171.25 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.775 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.496 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -111.56 -16.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 9.7 m-30 -93.78 -43.84 8.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.893 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 49.26 92.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 75.38 0.51 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -139.58 162.04 36.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.142 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.76 109.81 5.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.5 mt -118.05 124.96 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.413 . . . . 0.0 111.762 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.669 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.9 p -108.35 129.5 55.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 27' ' ' LEU . 14.2 m -97.33 115.06 26.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -93.52 108.71 20.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.097 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.67 168.77 33.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.3 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.681 2.254 . . . . 0.0 112.621 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.9 m-85 63.57 -79.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.946 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.606 HG23 ' OE1' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -124.98 -78.68 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.882 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.0 31.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.699 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -97.63 147.94 33.74 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 24' ' ' THR . 41.9 Cg_exo -56.83 -18.74 28.5 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.569 2.179 . . . . 0.0 112.5 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER 85.51 -18.05 0.38 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.355 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.33 -25.24 25.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.105 0.478 . . . . 0.0 110.116 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -75.88 -30.96 59.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.146 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD23 ' SG ' ' A' ' 15' ' ' CYS . 65.0 tp -72.37 -50.58 25.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.95 -27.44 68.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 110.465 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -64.0 -49.16 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.765 ' HB3' HG21 ' A' ' 89' ' ' VAL . 3.1 mtm -51.67 -55.57 18.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.704 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 85' ' ' VAL . 20.1 m -57.06 -44.26 82.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.079 0.466 . . . . 0.0 110.222 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt-30 -59.72 -36.87 77.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.079 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.08 -21.04 63.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.883 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 1.4 m -93.23 -3.31 53.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.839 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 6' ' ' LYS . . . 108.33 25.4 5.81 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.118 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -116.35 178.42 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.102 0.477 . . . . 0.0 111.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.64 132.57 44.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.612 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.4 p -71.88 119.43 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.755 HG12 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -93.92 124.29 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.862 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -45.47 77.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -146.73 -179.21 6.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 75' ' ' CYS . 29.6 mt -67.26 -44.13 80.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -17.57 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.276 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.755 ' HB2' HG12 ' A' ' 39' ' ' VAL . 39.3 m -65.66 -17.36 64.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.444 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 39' ' ' VAL . 14.0 m-85 -51.48 113.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -96.27 177.41 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.18 -172.84 2.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.06 -123.31 1.37 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -125.7 -52.24 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.44 73.41 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.493 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 t -154.51 138.56 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 110.947 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -131.96 120.17 17.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.845 ' O ' HD13 ' A' ' 54' ' ' ILE . 92.3 Cg_endo -78.76 133.18 11.25 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.561 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.845 HD13 ' O ' ' A' ' 53' ' ' PRO . 9.4 mm -139.79 146.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.929 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.977 HG23 ' HB3' ' A' ' 77' ' ' ALA . 30.6 t -124.5 138.22 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 57' ' ' VAL . 24.0 t -124.16 158.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 111.404 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.748 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 1.4 t -152.89 177.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.689 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.629 ' H ' HG12 ' A' ' 57' ' ' VAL . 6.4 tm0? -179.2 86.89 0.21 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.75 116.91 3.95 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.488 2.125 . . . . 0.0 112.33 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.96 32.62 6.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.65 -32.72 60.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 68.87 -67.5 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.033 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.35 129.9 34.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.39 77.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.59 -41.67 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.3 113.23 0.58 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.343 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.748 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 28.0 t80 -99.98 7.15 44.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.5 m80 -91.79 55.83 2.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -174.71 34.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.37 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.759 HG21 HG11 ' A' ' 79' ' ' VAL . 11.3 mm -74.2 -53.62 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.265 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.31 -27.85 68.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.421 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -88.36 -13.47 40.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.579 0.228 . . . . 0.0 111.334 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -28.89 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.615 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.2 p -117.44 157.19 26.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -107.03 41.93 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.977 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -154.33 165.95 16.93 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 37.1 Cg_endo -65.5 124.26 12.6 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.496 2.131 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.759 HG11 HG21 ' A' ' 71' ' ' ILE . 25.7 t -92.53 128.37 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' HD23 ' A' ' 97' ' ' LEU . 31.2 m -143.15 177.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 10.5 p -96.86 163.99 12.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 109.941 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -19.39 17.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.349 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -47.87 -45.09 30.0 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.502 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 63.4 t90 -55.99 -57.26 12.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.39 0.614 . . . . 0.0 110.114 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.758 ' O ' HG23 ' A' ' 89' ' ' VAL . 55.0 t -54.07 -43.16 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -50.46 38.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.09 -32.84 71.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.772 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -77.03 -48.49 17.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.1 t -71.01 -25.91 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.334 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.66 -55.09 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.315 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 93' ' ' GLN . 3.5 tt -98.07 2.95 49.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.585 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.496 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 53.36 83.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' C ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -178.8 131.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.56 79.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.82 173.05 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.03 153.49 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.742 HD21 ' CG2' ' A' ' 54' ' ' ILE . 1.8 mp -94.07 -27.34 16.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -58.79 -31.86 68.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.93 -16.63 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.43 29.55 3.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -97.27 165.52 11.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.494 HD11 HG11 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -134.19 95.9 16.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.237 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 -168.12 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.539 2.16 . . . . 0.0 112.332 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.27 170.52 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.15 107.32 24.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.21 147.77 15.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.471 2.114 . . . . 0.0 112.344 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -171.36 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 81.1 p -176.06 165.59 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.46 134.1 49.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 48.4 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.845 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -66.82 -68.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -99.01 98.71 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.76 -172.89 2.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.92 -67.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER 59.95 168.84 0.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.325 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.503 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.1 pp -111.95 -20.72 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.522 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 14.6 m-30 -93.7 -46.16 7.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 43.15 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.039 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.32 73.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.303 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.855 HD21 HG13 ' A' ' 54' ' ' ILE . 2.1 tt -148.36 119.01 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.707 0.289 . . . . 0.0 110.82 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.89 124.06 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.777 HD12 ' HB1' ' A' ' 36' ' ' ALA . 3.2 mt -132.66 129.78 58.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.711 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.1 p -121.52 146.4 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.211 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' HG23 ' A' ' 56' ' ' VAL . 25.1 p -106.92 127.86 53.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE1' HD11 ' A' ' 42' ' ' LEU . 2.1 t80 -93.89 105.07 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.065 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.86 44.22 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.667 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -166.71 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.42 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 26.3 m-85 -139.85 -53.1 0.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 0.7 OUTLIER -149.11 -67.06 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.794 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.97 -74.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.679 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.451 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -167.44 54.82 0.29 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 22' ' ' MET . 69.0 Cg_endo -85.89 15.17 2.26 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.779 2.32 . . . . 0.0 112.993 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -44.67 71.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 111.21 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -85.57 -26.71 25.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.251 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.59 -33.2 68.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.481 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.858 HD13 HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -73.06 -50.83 20.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.349 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -65.36 -27.78 68.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.425 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -71.39 -50.35 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.805 ' HB3' HG21 ' A' ' 89' ' ' VAL . 8.1 mtm -54.87 -48.41 73.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.54 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 32' ' ' GLN . 28.9 m -62.65 -45.14 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 0.0 109.656 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.1 mt-30 -56.42 -35.91 68.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.071 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 tp -70.07 -21.41 63.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.928 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 7' ' ' ILE . 2.3 m -93.19 -3.24 54.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.706 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.93 25.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.777 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -71.59 174.33 6.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.485 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.08 136.93 52.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.547 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.3 p -71.88 123.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.711 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.0 t -93.86 146.51 6.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -42.82 62.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.154 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 -175.91 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.904 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.68 HD22 ' CB ' ' A' ' 75' ' ' CYS . 30.5 mt -63.64 -50.38 69.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.007 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -66.65 -19.16 65.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.413 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.705 ' HB2' HG12 ' A' ' 39' ' ' VAL . 56.5 m -61.67 -23.32 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.332 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 17.5 m-85 -49.33 110.83 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.25 127.59 53.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -79.21 110.39 14.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.81 -131.64 4.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.46 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -114.81 -44.73 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.354 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.647 ' O ' HG13 ' A' ' 51' ' ' VAL . . . -128.14 70.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.487 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 50' ' ' GLY . 1.3 m -163.52 107.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.002 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 130.55 34.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.737 ' O ' HD13 ' A' ' 54' ' ' ILE . 93.3 Cg_endo -78.57 135.36 13.01 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.54 2.16 . . . . 0.0 112.471 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.855 HG13 HD21 ' A' ' 11' ' ' LEU . 9.3 mm -144.3 151.35 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 77' ' ' ALA . 23.4 t -130.65 140.79 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -114.48 160.71 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 111.15 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' CG2' HG12 ' A' ' 79' ' ' VAL . 6.1 m -152.23 -177.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.507 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.475 ' NE2' ' HB2' ' A' ' 60' ' ' ASP . 0.0 OUTLIER 174.54 94.93 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.29 68.67 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.488 2.126 . . . . 0.0 112.334 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.475 ' HB2' ' NE2' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -128.05 -73.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 20' ' ' THR . . . -85.28 -17.78 35.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.25 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.59 -40.37 59.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 m 60.75 160.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -89.23 93.42 9.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.76 -65.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -101.03 -29.9 11.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.34 125.71 2.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.444 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.695 ' CD1' HD11 ' A' ' 71' ' ' ILE . 4.5 t80 -100.34 7.11 44.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.593 0.235 . . . . 0.0 111.524 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -90.44 51.41 2.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -172.35 35.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.027 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.695 HD11 ' CD1' ' A' ' 68' ' ' PHE . 29.1 mm -72.32 -65.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.75 -26.66 68.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -22.98 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 0.0 111.192 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtm -93.92 -43.85 8.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.68 ' CB ' HD22 ' A' ' 42' ' ' LEU . 31.4 p -86.97 162.33 17.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -113.08 33.85 4.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.988 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.68 166.32 18.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 55.4 Cg_endo -68.97 125.98 13.24 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.281 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.55 HG12 ' CG2' ' A' ' 57' ' ' VAL . 17.6 t -93.05 123.64 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.978 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.682 ' O ' HG12 ' A' ' 56' ' ' VAL . 35.8 m -141.16 134.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 1.9 p -54.76 159.99 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.472 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -54.37 -19.8 6.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.578 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.96 -40.58 10.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.9 t90 -58.93 -57.42 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.46 0.648 . . . . 0.0 110.145 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.858 HG11 HD13 ' A' ' 27' ' ' LEU . 58.9 t -57.69 -42.93 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.29 -56.24 8.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -57.99 -30.7 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 92' ' ' TYR . 69.3 m -76.99 -49.16 16.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.805 HG21 ' HB3' ' A' ' 30' ' ' MET . 48.8 t -71.32 -27.23 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.91 -54.69 19.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.177 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 91' ' ' LEU . 6.2 tt -97.41 -2.28 42.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.323 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 58.05 84.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 110.887 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -177.53 139.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.7 t -67.9 74.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.1 158.84 6.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.58 151.46 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.464 ' HB3' HD12 ' A' ' 101' ' ' LEU . 3.8 mp -95.98 -34.8 11.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.65 -25.51 39.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.511 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.5 HG23 ' CG ' ' A' ' 100' ' ' TYR . 13.4 t -74.88 -24.73 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.5 ' CG ' HG23 ' A' ' 99' ' ' THR . 9.8 m-85 -125.74 15.0 8.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.13 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.518 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -80.7 87.17 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.317 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 30.0 mt 56.4 108.14 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.496 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.16 172.72 11.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 112.087 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.52 -51.83 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.7 135.82 27.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.53 155.75 62.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.479 2.12 . . . . 0.0 112.32 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -137.95 88.16 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.49 163.79 13.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -159.44 31.65 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.865 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m 60.79 59.56 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 110.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -103.79 100.91 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.23 -46.11 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -76.29 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp 56.48 169.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.66 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.797 HD11 ' SG ' ' A' ' 34' ' ' CYS . 2.3 pt -110.44 -19.83 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.506 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 15.7 m-30 -93.7 -50.42 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.637 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 47.72 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.35 76.2 0.83 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.066 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -145.5 162.01 38.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 111.008 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.695 ' CG ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.22 109.82 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.334 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.678 HD12 ' HB1' ' A' ' 36' ' ' ALA . 1.8 mt -125.29 130.46 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.361 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 6.1 p -111.08 143.18 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.723 ' HB3' HD23 ' A' ' 27' ' ' LEU . 17.6 p -106.46 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.01 131.27 39.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.6 158.73 34.16 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.56 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.15 0.26 10.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.644 2.229 . . . . 0.0 112.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 19.9 m-85 62.77 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.734 0.302 . . . . 0.0 111.056 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 21' ' ' ASN . 4.6 t -143.71 -49.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.854 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 20' ' ' THR . 28.6 m120 -116.88 -78.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.714 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.453 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -170.48 55.78 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.046 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 22' ' ' MET . 65.5 Cg_endo -87.1 15.44 2.18 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.772 2.315 . . . . 0.0 112.751 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.524 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.11 -44.23 97.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.281 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -88.9 -25.78 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -77.96 -33.35 51.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.523 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.79 HD21 HG11 ' A' ' 56' ' ' VAL . 19.5 tp -75.07 -44.12 49.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.99 -27.48 67.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.507 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.548 ' CD1' HD23 ' A' ' 33' ' ' LEU . 10.3 t90 -69.24 -50.05 50.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.858 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.868 ' HB3' HG21 ' A' ' 89' ' ' VAL . 2.3 mtm -57.34 -48.61 78.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.575 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.4 m -60.51 -45.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.203 0.525 . . . . 0.0 109.621 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.57 -34.58 69.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.666 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.548 HD23 ' CD1' ' A' ' 29' ' ' TRP . 0.6 OUTLIER -70.28 -21.27 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.005 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.828 ' SG ' HG22 ' A' ' 89' ' ' VAL . 38.5 m -93.42 -3.08 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.667 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.3 -23.44 11.3 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.741 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.678 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.02 177.08 1.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.054 0.454 . . . . 0.0 111.231 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.61 138.6 51.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.6 p -71.82 114.77 10.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.782 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.695 HG22 ' CG ' ' A' ' 12' ' ' GLU . 3.0 t -93.91 121.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.022 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -58.44 -47.16 84.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.336 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 39' ' ' VAL . 17.5 mm-40 -132.69 176.03 8.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.086 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 75' ' ' CYS . 13.1 mt -70.87 -43.51 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -5.01 44.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -15.98 61.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.561 0.22 . . . . 0.0 111.389 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.669 ' CE1' HG21 ' A' ' 39' ' ' VAL . 21.2 m-85 -50.9 125.52 13.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 111.013 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 m -58.14 -35.31 71.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 mt 58.71 30.75 20.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.37 -140.39 2.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.552 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 m -114.34 -35.33 5.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.5 36.35 4.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.539 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.544 HG11 ' OE1' ' A' ' 12' ' ' GLU . 21.2 t -152.17 125.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 0.0 111.209 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.478 ' O ' HD23 ' A' ' 11' ' ' LEU . 3.2 t-80 -100.99 120.64 54.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.848 ' O ' HD13 ' A' ' 54' ' ' ILE . 79.6 Cg_endo -77.98 133.74 12.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.593 2.195 . . . . 0.0 112.635 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 53' ' ' PRO . 7.5 mm -142.49 162.31 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.622 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.616 HG23 ' HB3' ' A' ' 77' ' ' ALA . 33.9 t -137.99 150.74 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.666 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.79 HG11 HD21 ' A' ' 27' ' ' LEU . 4.1 t -121.85 158.43 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.32 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.868 HG22 HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -150.39 -179.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.473 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 1.1 tt0 176.52 66.93 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.579 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.58 94.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.47 -45.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.97 38.96 3.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -30.79 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.824 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m 78.54 -4.64 2.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.813 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.3 87.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 111.026 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -140.03 -56.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.2 -29.47 34.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.4 114.67 3.98 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.719 ' CD1' HD11 ' A' ' 71' ' ' ILE . 49.0 t80 -85.86 -2.31 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -84.29 56.93 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.953 0.406 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.96 38.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.102 HG22 HG21 ' A' ' 79' ' ' VAL . 24.0 mm -69.82 -67.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.01 -24.25 71.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.372 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.93 -27.82 64.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.311 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.0 mtm -93.92 -39.28 10.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.667 ' HB3' HD22 ' A' ' 42' ' ' LEU . 27.5 p -98.37 147.08 25.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 38.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -147.3 169.3 9.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.79 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 73.6 Cg_endo -74.94 125.87 9.64 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.741 2.294 . . . . 0.0 112.456 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.102 HG21 HG22 ' A' ' 71' ' ' ILE . 8.4 t -98.02 136.61 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.612 ' CG1' HD23 ' A' ' 97' ' ' LEU . 26.7 m -147.59 159.56 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.659 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.709 HG22 HD11 ' A' ' 102' ' ' ILE . 8.6 p -73.7 159.3 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.246 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -53.6 -22.51 8.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.446 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.45 -38.07 8.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 72.6 t90 -63.46 -57.23 10.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.492 0.663 . . . . 0.0 109.818 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 89' ' ' VAL . 60.6 t -54.3 -39.22 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.377 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -48.47 17.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -60.25 -35.72 76.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -77.05 -47.91 19.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.868 HG21 ' HB3' ' A' ' 30' ' ' MET . 73.7 t -71.22 -25.87 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.439 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.45 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 111.041 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tp -85.07 -18.48 34.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 73.44 77.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.672 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.465 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -177.43 136.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 t -61.17 86.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -67.34 163.42 20.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 99' ' ' THR . 0.4 OUTLIER -73.99 140.12 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.858 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.0 mp -83.33 -29.52 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.12 -29.15 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.473 HG23 ' HG3' ' A' ' 96' ' ' GLU . 1.1 p -72.08 -17.45 62.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.84 22.32 2.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.671 0.272 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -86.34 122.01 29.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.34 . . . . 0.0 110.789 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 81' ' ' THR . 33.2 mm -77.19 112.8 25.65 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.074 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.96 -158.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.429 2.086 . . . . 0.0 112.213 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -170.76 -49.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.32 113.49 26.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.49 -39.86 63.94 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.423 2.082 . . . . 0.0 112.368 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -127.52 142.96 51.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 t -129.09 100.57 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.11 105.28 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.901 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -122.97 89.75 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.96 163.62 27.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -106.33 -32.33 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.43 81.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 10.4 mmtm -78.98 137.44 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.512 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.3 pp -79.13 -21.16 12.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.738 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CD1' HD13 ' A' ' 11' ' ' LEU . 9.8 m-30 -93.8 -34.81 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.72 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 8' ' ' PHE . 2.3 ppt_? 28.54 79.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.795 0.438 . . . . 0.0 111.96 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.94 72.16 1.29 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.632 -0.795 . . . . 0.0 111.554 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.936 HD21 HG13 ' A' ' 54' ' ' ILE . 1.8 tt -144.68 152.67 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.71 0.29 . . . . 0.0 110.754 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.704 ' N ' HD23 ' A' ' 11' ' ' LEU . 6.8 mt-10 -129.07 119.64 24.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.647 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.711 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -129.07 123.56 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.54 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.666 ' SG ' HG13 ' A' ' 55' ' ' VAL . 24.6 p -110.09 137.7 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' SG ' HG22 ' A' ' 24' ' ' THR . 24.8 p -95.5 107.24 19.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -93.61 111.78 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.76 168.56 35.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.354 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.97 -0.55 10.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.739 2.292 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.7 m-85 63.18 -80.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -73.43 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -177.8 73.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.7 mtm -155.22 165.24 18.71 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.742 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.44 105.42 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.43 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -60.82 -17.25 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.242 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -20.59 38.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.244 0.545 . . . . 0.0 110.017 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -76.99 -32.5 57.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.291 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' CD1' HG11 ' A' ' 85' ' ' VAL . 68.1 tp -70.72 -50.14 39.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.384 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.9 -27.45 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -65.52 -50.41 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.254 0.549 . . . . 0.0 109.607 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.808 ' HB3' HG21 ' A' ' 89' ' ' VAL . 66.8 mtt -51.46 -51.53 54.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.866 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' CG1' HG13 ' A' ' 85' ' ' VAL . 31.4 m -61.9 -45.65 98.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.056 0.455 . . . . 0.0 110.181 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.473 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.63 -35.59 72.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.193 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 tp -69.97 -20.92 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.029 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.4 m -93.0 -3.2 54.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.988 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 118.23 -15.96 11.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.083 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.711 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -76.65 -179.12 5.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.58 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -134.89 135.23 41.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.404 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.1 p -71.88 118.59 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -93.85 118.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -42.63 85.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.13 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -148.69 177.26 9.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' A' ' 75' ' ' CYS . 23.9 mt -67.4 -46.53 72.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -23.48 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -24.37 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.633 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.1 m-85 -55.76 128.72 36.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -132.31 129.1 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.76 79.8 9.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.56 -124.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.54 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 50' ' ' GLY . 9.0 t -118.33 -45.3 2.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 110.831 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 49' ' ' THR . . . -124.15 27.33 5.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.91 112.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -95.37 127.82 40.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.585 ' O ' HD13 ' A' ' 54' ' ' ILE . 73.3 Cg_endo -75.89 135.39 17.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.129 . . . . 0.0 112.479 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.936 HG13 HD21 ' A' ' 11' ' ' LEU . 16.0 mm -142.24 150.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.803 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 77' ' ' ALA . 45.2 t -131.05 149.18 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' A' ' 13' ' ' ILE . 57.9 t -120.59 159.68 21.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.876 HG22 HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -149.14 -178.74 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.008 0.432 . . . . 0.0 111.494 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 169.47 81.11 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.873 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 110.59 2.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -172.45 -41.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.078 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.66 38.23 3.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -22.28 60.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.081 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.43 -67.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.64 167.45 13.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.87 70.75 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -85.2 -49.99 7.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.769 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.98 99.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.266 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD2' HD11 ' A' ' 71' ' ' ILE . 46.2 t80 -92.61 -5.99 50.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -81.72 56.39 3.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.165 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.85 30.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.454 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.913 HG21 HG11 ' A' ' 79' ' ' VAL . 18.3 mm -67.79 -66.85 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.896 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.06 76.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.382 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -25.51 61.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.027 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtp -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.807 ' HB2' HD13 ' A' ' 42' ' ' LEU . 53.9 t -104.29 155.93 18.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.49 35.46 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.679 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -142.47 165.96 23.83 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.679 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.7 Cg_endo -74.0 136.2 22.27 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.658 2.239 . . . . 0.0 112.39 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.913 HG11 HG21 ' A' ' 71' ' ' ILE . 2.4 t -105.94 126.11 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.628 ' CG1' HD23 ' A' ' 97' ' ' LEU . 35.0 m -138.18 159.24 32.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.494 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -72.04 166.0 23.12 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.442 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -59.44 -18.33 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.39 -42.0 30.58 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.507 ' CH2' ' CE1' ' A' ' 8' ' ' PHE . 73.9 t90 -60.43 -57.31 13.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 110.172 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.727 ' O ' HG23 ' A' ' 89' ' ' VAL . 74.2 t -55.12 -36.93 41.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.338 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -54.57 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.049 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -56.94 -31.14 64.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 92' ' ' TYR . 61.2 m -77.1 -50.11 13.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.808 HG21 ' HB3' ' A' ' 30' ' ' MET . 44.9 t -71.25 -25.99 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.619 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 -56.7 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.337 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 tp -90.11 -13.79 35.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.296 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 68.31 81.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.45 137.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.93 85.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.78 170.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.52 118.52 31.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.803 ' HB3' HD12 ' A' ' 101' ' ' LEU . 2.6 mp -61.08 -35.57 77.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.301 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.59 -24.36 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.4 m -80.63 -20.22 43.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.449 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -134.74 32.78 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.803 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -100.81 175.3 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.684 ' H ' HD23 ' A' ' 101' ' ' LEU . 3.5 mp -131.87 84.46 53.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.75 -168.23 0.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.866 2.378 . . . . 0.0 112.672 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.66 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.36 137.13 85.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.22 -44.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.499 2.133 . . . . 0.0 112.406 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.49 -169.06 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.945 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.7 135.37 40.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -108.15 132.84 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.927 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.75 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -119.36 90.54 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -36.77 10.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.943 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 57.39 31.78 20.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -98.35 131.32 44.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.682 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.2 pp -72.47 -23.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.681 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.682 ' CD1' HD12 ' A' ' 7' ' ' ILE . 13.2 m-30 -93.66 -46.18 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.78 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.631 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 76.93 1.02 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.028 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.501 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.35 162.09 38.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.949 0.404 . . . . 0.0 111.211 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.8 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -140.42 109.93 6.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.35 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.618 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -122.54 127.46 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 111.795 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.3 p -112.64 133.45 54.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.542 ' HB3' HD23 ' A' ' 27' ' ' LEU . 25.2 p -98.97 108.36 21.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -93.94 126.16 38.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.48 163.31 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.1 -5.02 12.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.696 2.264 . . . . 0.0 112.735 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 10.9 m-85 63.82 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.846 0.355 . . . . 0.0 111.033 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 36.2 p -143.69 -71.59 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -176.96 42.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.523 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.475 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -177.91 -61.11 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.934 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 22' ' ' MET . 12.0 Cg_endo -55.69 85.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.546 2.164 . . . . 0.0 112.408 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.11 -69.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.343 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -85.7 -29.24 24.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.735 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -27.5 60.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.054 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.614 HD12 HG11 ' A' ' 85' ' ' VAL . 36.5 tp -72.85 -51.2 19.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.578 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.43 ' OE2' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -64.77 -27.74 69.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.356 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -71.19 -50.77 29.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.849 ' HG2' HG11 ' A' ' 89' ' ' VAL . 2.8 mtm -53.88 -48.0 70.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 32' ' ' GLN . 29.3 m -61.86 -45.23 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.149 0.499 . . . . 0.0 109.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -56.56 -36.62 69.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.997 178.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.97 -20.97 63.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.769 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.602 ' SG ' HG22 ' A' ' 89' ' ' VAL . 95.0 m -92.95 -3.18 54.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.403 ' CA ' ' HB3' ' A' ' 6' ' ' LYS . . . 119.92 -31.96 5.14 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.69 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.618 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -62.51 -179.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.114 0.483 . . . . 0.0 111.358 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.3 139.17 40.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.585 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG21 ' OE2' ' A' ' 28' ' ' GLU . 10.1 p -71.8 122.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.874 HG21 ' CE1' ' A' ' 45' ' ' PHE . 3.2 t -99.11 123.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -58.86 -48.09 82.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.8 mt-10 -139.13 172.33 12.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.016 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 75' ' ' CYS . 15.8 mt -65.91 -50.56 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -58.94 -21.24 57.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.158 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -23.4 67.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.874 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.2 m-85 -53.77 112.68 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -69.31 -31.92 70.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tt 60.82 74.54 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.23 -173.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -81.18 -30.16 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.3 -27.27 12.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.609 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.97 116.7 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.43 133.51 22.71 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.856 ' O ' HD13 ' A' ' 54' ' ' ILE . 93.0 Cg_endo -80.59 135.56 10.45 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.149 . . . . 0.0 112.615 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.856 HD13 ' O ' ' A' ' 53' ' ' PRO . 9.6 mm -140.42 142.71 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.635 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.876 HG23 ' HB3' ' A' ' 77' ' ' ALA . 39.9 t -123.28 136.91 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 57' ' ' VAL . 42.6 t -122.12 158.51 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -152.43 -173.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.517 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.665 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -174.14 89.19 0.34 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.845 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.01 83.86 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.538 2.159 . . . . 0.0 112.271 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -148.95 -46.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 20' ' ' THR . . . -103.54 29.66 5.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.116 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 -29.34 26.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 69.54 -66.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 103.53 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.856 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -64.3 86.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.51 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.65 122.94 2.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.415 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.754 ' HB2' HD13 ' A' ' 105' ' ' ILE . 10.1 t80 -88.0 7.13 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.581 0.229 . . . . 0.0 111.416 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -80.53 -0.72 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.545 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.19 -9.59 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.653 0.263 . . . . 0.0 111.617 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.6 HG21 HG11 ' A' ' 79' ' ' VAL . 8.3 mm -64.37 -47.19 90.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.75 50.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.374 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.72 -17.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.628 0.252 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -93.87 -33.68 13.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.71 ' HB2' HD13 ' A' ' 42' ' ' LEU . 52.4 t -122.62 154.72 37.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.966 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.39 31.35 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.876 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -120.35 168.7 9.97 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.778 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 59.9 Cg_endo -73.07 121.59 7.4 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.605 2.204 . . . . 0.0 112.569 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.6 HG11 HG21 ' A' ' 71' ' ' ILE . 18.3 t -88.59 125.51 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 101' ' ' LEU . 27.7 m -143.21 177.15 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.835 0.35 . . . . 0.0 111.418 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 p -98.24 166.9 11.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.304 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -18.42 32.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.362 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.89 -47.86 51.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.499 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 59.3 t90 -50.72 -57.37 8.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.265 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.828 ' O ' HG23 ' A' ' 89' ' ' VAL . 84.3 t -53.84 -49.1 60.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.301 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -50.0 72.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -61.83 -32.48 72.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.752 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.2 m -77.07 -46.48 23.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.032 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.849 HG11 ' HG2' ' A' ' 30' ' ' MET . 33.0 t -71.16 -28.2 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.83 -56.65 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 93' ' ' GLN . 5.1 tt -93.28 -4.19 52.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 58.65 80.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.834 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.536 ' HB2' HD23 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -179.18 141.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.0 t -66.57 83.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.23 165.0 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.52 140.65 44.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.494 HD23 ' CG1' ' A' ' 80' ' ' VAL . 4.4 mp -88.04 -30.97 19.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.45 -32.55 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.105 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.1 m -77.29 -10.22 59.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.324 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.68 30.5 2.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 110.686 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.818 HD23 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -97.04 96.91 8.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.779 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.818 ' CD1' HD23 ' A' ' 101' ' ' LEU . 4.0 mp 59.69 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.82 -79.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.4 2.067 . . . . 0.0 112.464 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -81.78 -171.1 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.754 HD13 ' HB2' ' A' ' 68' ' ' PHE . 21.9 mt 61.98 71.14 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.89 178.39 5.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.41 116.5 29.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.39 114.54 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -91.58 -31.56 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.905 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 t -99.92 97.15 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -141.21 -46.99 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -151.24 -64.42 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.805 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.02 -73.13 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.938 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.5 mmtm 62.58 136.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.671 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.775 HG23 ' CE1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -76.4 -22.87 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.555 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.526 ' CE1' HD12 ' A' ' 7' ' ' ILE . 15.5 m-30 -93.64 -49.51 5.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 44.96 90.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.83 76.15 1.0 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.968 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.469 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -147.33 160.85 42.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.855 0.359 . . . . 0.0 111.118 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -140.8 109.8 6.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.727 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.7 mt -120.38 125.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.646 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.726 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 28.3 p -113.45 142.7 45.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 9.0 p -106.95 119.31 39.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.525 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.76 117.56 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 62' ' ' TRP . . . 72.36 146.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.473 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.69 150.42 28.76 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.543 2.162 . . . . 0.0 112.315 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 4.2 m-85 -103.2 -72.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -146.96 29.27 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.659 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -168.53 163.0 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -83.56 -46.53 0.79 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.406 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 22' ' ' MET . 71.1 Cg_exo -48.74 -64.76 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 112.702 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 76.47 -4.26 2.39 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.616 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 24.4 m-20 -80.92 -25.31 37.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.193 0.521 . . . . 0.0 109.983 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.21 -36.7 82.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.553 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.16 -55.61 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.171 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' CG ' ' HA ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.47 -27.3 67.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.007 0.432 . . . . 0.0 110.212 179.165 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -63.13 -49.34 74.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 109.556 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.783 ' HB3' HG21 ' A' ' 89' ' ' VAL . 2.2 mtt -51.15 -55.15 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.706 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG13 HG13 ' A' ' 85' ' ' VAL . 22.9 m -58.82 -45.04 91.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -59.57 -33.77 71.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.288 179.358 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.06 -21.17 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.931 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 7' ' ' ILE . 3.8 m -93.28 -3.16 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.753 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.62 -22.26 10.16 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.927 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.727 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.98 178.03 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.85 135.21 46.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -71.82 117.92 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.726 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.4 t -93.89 124.49 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -25.51 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.358 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -174.85 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.318 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.692 HD13 ' HB2' ' A' ' 75' ' ' CYS . 22.6 mt -63.07 -46.34 87.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.973 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -11.38 60.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.426 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.1 m -96.0 24.73 5.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.674 0.273 . . . . 0.0 111.312 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 39' ' ' VAL . 3.4 m-85 -85.67 97.98 10.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.861 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.9 159.77 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mt -136.04 72.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -117.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -140.67 25.49 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 0.0 111.007 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.96 36.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.611 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 m -129.31 116.64 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.725 0.298 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -94.09 136.26 23.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.973 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.896 ' O ' HD13 ' A' ' 54' ' ' ILE . 87.7 Cg_endo -83.16 132.89 6.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.705 2.27 . . . . 0.0 112.787 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 53' ' ' PRO . 10.8 mm -137.73 151.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 77' ' ' ALA . 22.4 t -129.07 149.96 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.955 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 80' ' ' VAL . 7.3 t -128.2 146.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.339 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.819 HG22 HG12 ' A' ' 79' ' ' VAL . 1.9 m -133.1 173.03 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -176.95 88.08 0.25 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.68 64.04 3.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.549 2.166 . . . . 0.0 112.28 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.38 -67.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 19' ' ' PHE . . . -98.76 23.92 8.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.337 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.511 ' O ' HG22 ' A' ' 63' ' ' THR . 0.2 OUTLIER -67.28 -16.71 64.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.254 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 62' ' ' TRP . 14.8 t 46.16 -168.58 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.863 0.363 . . . . 0.0 111.319 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.14 132.32 53.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.44 -177.04 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.37 -47.36 15.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 138.68 2.9 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.41 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CD1' HD11 ' A' ' 71' ' ' ILE . 65.6 t80 -102.04 -4.9 25.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.554 0.216 . . . . 0.0 111.52 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.52 56.92 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.397 . . . . 0.0 110.91 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.49 34.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.856 HG22 HG21 ' A' ' 79' ' ' VAL . 23.3 mm -69.31 -64.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.4 -15.35 81.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -79.03 -24.22 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mtm -93.97 -27.3 16.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.692 ' HB2' HD13 ' A' ' 42' ' ' LEU . 49.5 t -118.94 156.22 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.77 32.33 4.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.829 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.777 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -125.77 172.32 6.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.087 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.777 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 95.1 Cg_endo -82.71 127.1 4.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.786 2.324 . . . . 0.0 112.888 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.856 HG21 HG22 ' A' ' 71' ' ' ILE . 18.8 t -98.57 130.96 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.329 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.756 ' O ' HG13 ' A' ' 56' ' ' VAL . 28.7 m -145.26 136.88 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.639 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 p -50.82 168.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.772 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -63.94 -16.44 61.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.07 -39.19 55.45 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.86 0.362 . . . . 0.0 110.608 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.505 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 79.0 t90 -62.7 -57.3 11.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 109.888 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 89' ' ' VAL . 98.0 t -54.66 -38.18 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.222 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.06 -47.79 19.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.78 -33.53 73.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.742 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -77.16 -49.53 15.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -71.38 -27.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.42 -55.09 17.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 111.104 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 91' ' ' LEU . 5.9 tt -95.65 -3.08 46.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.315 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.775 ' CE1' HG23 ' A' ' 7' ' ' ILE . 6.7 t80 57.64 76.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' HB3' ' NE2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -176.59 133.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.674 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.15 97.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.099 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' A' ' 93' ' ' GLN . 61.7 mm-40 -81.6 163.67 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HG3' ' CG2' ' A' ' 99' ' ' THR . 0.4 OUTLIER -71.53 142.09 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.69 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD23 ' CG1' ' A' ' 80' ' ' VAL . 1.6 mp -87.13 -34.28 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.27 -22.88 32.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.401 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -76.26 -15.29 60.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.61 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -139.4 20.58 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.701 0.286 . . . . 0.0 111.235 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -81.23 163.46 22.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.19 138.07 89.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.54 -178.35 3.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.467 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.01 -64.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -148.88 110.6 3.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.99 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.38 90.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -176.71 122.22 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 m -143.69 83.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 -71.72 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.922 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.0 t80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.863 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -107.73 -57.34 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -76.59 113.41 14.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -137.92 -62.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 82.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.996 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.4 mmtp -99.29 134.42 42.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.506 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.604 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -76.64 -23.83 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.559 ' CD1' HD12 ' A' ' 7' ' ' ILE . 14.3 m-30 -93.37 -50.88 5.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 110.555 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.8 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.374 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.61 75.12 1.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.817 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -149.43 162.66 39.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.934 0.397 . . . . 0.0 111.241 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.716 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.7 mt-10 -138.64 109.68 6.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.653 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.3 mt -124.54 138.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' O ' HG23 ' A' ' 56' ' ' VAL . 29.1 p -126.54 144.62 50.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.741 ' HB3' HD23 ' A' ' 27' ' ' LEU . 14.8 p -97.62 104.5 16.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.0 102.63 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.61 162.59 17.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.44 -2.7 10.61 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.762 2.308 . . . . 0.0 112.801 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 6.0 m-85 63.27 -81.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.037 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -139.56 -54.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' H ' HG23 ' A' ' 20' ' ' THR . 0.6 OUTLIER -111.51 -74.9 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.429 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 5.7 ttt -174.2 57.8 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.157 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 22' ' ' MET . 64.9 Cg_endo -88.62 23.19 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.845 2.363 . . . . 0.0 112.597 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.683 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.54 -47.84 83.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.341 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.8 -27.51 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 0.0 110.513 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -34.46 65.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.57 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 15' ' ' CYS . 44.6 tp -73.18 -48.34 36.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.355 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' O ' HG22 ' A' ' 31' ' ' VAL . 32.6 mt-10 -62.56 -27.42 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.504 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -65.32 -49.28 70.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 109.802 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.876 ' HB3' HG21 ' A' ' 89' ' ' VAL . 5.8 mtt -52.97 -52.33 58.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.853 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 28' ' ' GLU . 35.3 m -58.8 -46.5 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 110.615 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.479 ' N ' HG23 ' A' ' 31' ' ' VAL . 16.5 tt0 -57.95 -34.47 69.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.2 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.14 -21.51 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.551 ' SG ' HD11 ' A' ' 7' ' ' ILE . 1.8 m -93.59 -3.35 52.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.782 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 115.9 -34.84 4.55 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.653 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -56.15 169.16 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.486 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.37 134.62 54.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.4 m -72.1 125.75 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 111.18 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 12' ' ' GLU . 17.6 t -114.67 128.08 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -33.52 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.926 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.1 mt-10 -121.85 155.3 35.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.364 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 75' ' ' CYS . 16.2 mt -70.78 -32.47 69.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.676 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -21.03 59.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.554 ' O ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -60.83 -20.46 61.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.189 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 20.3 m-85 -56.99 100.72 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 44' ' ' SER . 4.0 t -177.27 148.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' HB2' HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -174.27 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.02 60.46 0.27 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.446 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 p 56.07 30.51 16.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.85 -28.01 4.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 47' ' ' LEU . 30.1 m -130.57 147.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 111.073 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -93.8 126.06 50.93 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.874 ' O ' HD13 ' A' ' 54' ' ' ILE . 73.1 Cg_endo -77.43 129.59 10.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.568 2.179 . . . . 0.0 112.707 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 53' ' ' PRO . 7.5 mm -141.66 154.71 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.818 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' SG ' ' A' ' 14' ' ' CYS . 30.9 t -138.21 140.31 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.86 156.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 111.115 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.615 ' CG2' HG12 ' A' ' 79' ' ' VAL . 3.2 m -144.01 -179.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.538 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.502 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.89 67.18 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.754 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.02 107.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -167.21 -43.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.01 29.4 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.579 ' O ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -68.07 -49.11 63.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -177.45 -77.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.22 31.97 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 61.33 72.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.833 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.42 -66.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.964 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.06 92.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.41 ' CD1' HD11 ' A' ' 71' ' ' ILE . 4.5 t80 -92.7 7.26 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.611 0.243 . . . . 0.0 111.411 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -87.62 49.2 1.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 111.037 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.93 22.4 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.538 HG21 HG11 ' A' ' 79' ' ' VAL . 12.1 mm -69.59 -34.27 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 110.804 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.27 -20.91 59.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.312 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -77.32 -25.25 51.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 mtp -93.85 -29.28 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.828 ' HB2' HD13 ' A' ' 42' ' ' LEU . 54.0 t -132.35 153.5 50.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.753 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.88 -36.69 12.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.805 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -55.56 170.26 0.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.805 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.0 Cg_endo -77.11 161.82 32.19 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.615 HG12 ' CG2' ' A' ' 57' ' ' VAL . 12.1 t -127.04 121.49 58.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.733 ' O ' HG12 ' A' ' 56' ' ' VAL . 33.8 m -141.32 140.09 32.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.5 p -55.21 163.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.705 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -20.05 15.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -47.0 -40.98 15.59 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.464 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.7 t90 -58.84 -57.35 13.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.368 0.604 . . . . 0.0 110.106 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 89' ' ' VAL . 47.9 t -55.93 -42.37 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.225 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.59 -56.56 6.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -56.7 -30.87 63.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -77.19 -50.5 12.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.087 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.876 HG21 ' HB3' ' A' ' 30' ' ' MET . 47.4 t -71.27 -28.53 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.431 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -58.15 5.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.882 0.372 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.79 -10.63 47.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.203 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.604 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 64.9 79.77 0.25 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.857 0.36 . . . . 0.0 110.708 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.457 ' N ' HG21 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -177.07 129.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -64.14 85.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -68.69 172.45 6.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.94 157.53 29.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.635 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.721 HD21 ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -96.7 -25.06 15.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.057 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -21.66 66.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.412 ' HB ' ' CE1' ' A' ' 100' ' ' TYR . 25.5 m -77.08 -17.76 58.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.465 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE1' ' HB ' ' A' ' 99' ' ' THR . 1.6 m-85 -138.91 23.61 2.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.661 0.267 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -83.03 101.12 10.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.004 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 22.1 mt 56.79 103.56 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.279 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.37 -173.67 1.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.501 2.134 . . . . 0.0 112.363 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -149.1 31.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.34 118.18 52.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.049 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.19 61.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.373 2.048 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.37 115.38 30.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 p -96.19 -71.65 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -102.29 119.4 38.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.7 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.941 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 34.32 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.836 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.29 85.69 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -177.63 -179.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.9 54.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 9.0 mmtm -81.36 138.08 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.555 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.629 HD12 ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -80.26 -20.19 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.748 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' HD12 ' A' ' 7' ' ' ILE . 18.0 m-30 -93.63 -48.12 6.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 39.3 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.23 68.85 1.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.772 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -137.2 160.66 38.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.666 ' H ' HD23 ' A' ' 11' ' ' LEU . 2.0 mt-10 -137.64 111.11 8.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.718 HD11 HD22 ' A' ' 11' ' ' LEU . 3.0 mt -122.2 121.84 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.804 ' SG ' HG13 ' A' ' 55' ' ' VAL . 19.4 p -107.51 132.02 53.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 m -95.31 101.65 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.535 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.473 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -93.88 102.73 14.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.108 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.91 144.02 7.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.801 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 23.9 Cg_exo -63.1 -13.41 35.29 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.8 2.334 . . . . 0.0 112.515 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.6 m-30 67.73 -76.54 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 21' ' ' ASN . 1.1 t -133.89 -56.61 0.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.47 ' H ' HG23 ' A' ' 20' ' ' THR . 20.6 m120 -126.17 -80.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.783 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.489 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -158.62 50.48 0.39 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.106 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 22' ' ' MET . 68.4 Cg_endo -85.34 10.75 3.6 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.672 2.248 . . . . 0.0 112.708 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -36.12 67.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.296 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -88.93 -27.18 21.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 110.558 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.87 -31.36 51.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -74.55 -45.89 42.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.346 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -63.03 -27.72 69.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -66.77 -52.05 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 109.776 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.889 ' HB3' HG21 ' A' ' 89' ' ' VAL . 11.9 mtm -53.71 -50.52 65.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.668 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 32' ' ' GLN . 28.0 m -60.78 -45.46 97.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt-30 -56.74 -34.77 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.019 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.5 tp -70.19 -21.57 63.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.705 ' SG ' HG22 ' A' ' 89' ' ' VAL . 21.3 m -93.41 -3.53 53.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.729 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 105.82 15.67 17.81 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.156 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.655 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -101.69 173.53 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.145 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.57 132.52 51.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.655 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 13.8 p -71.98 122.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 45' ' ' PHE . 1.1 t -93.91 127.55 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -59.27 -40.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.67 -177.13 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 75' ' ' CYS . 20.2 mt -72.74 -38.86 67.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.04 -8.71 56.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -92.89 18.17 9.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.0 m-85 -81.2 95.26 6.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.9 174.18 11.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.11 158.1 44.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.7 -112.99 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.589 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.78 -42.03 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -121.7 27.21 6.32 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.526 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.2 t -93.95 147.76 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.965 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.31 118.46 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.726 ' O ' HD13 ' A' ' 54' ' ' ILE . 95.8 Cg_endo -80.02 128.55 7.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.567 2.178 . . . . 0.0 112.643 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.918 HG13 HD21 ' A' ' 11' ' ' LEU . 7.6 mm -144.76 156.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.804 HG13 ' SG ' ' A' ' 14' ' ' CYS . 14.7 t -137.98 144.49 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.029 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.6 HG23 ' CG2' ' A' ' 13' ' ' ILE . 22.0 t -128.21 159.32 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 111.246 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.913 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -152.45 -169.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.631 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -179.17 72.25 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.25 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.645 2.23 . . . . 0.0 112.439 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.8 -40.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.95 30.76 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.025 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -32.03 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m 61.84 153.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.74 123.33 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.74 -63.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -96.21 -29.77 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.6 122.91 4.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.423 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.913 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 37.8 t80 -95.74 7.17 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.477 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -91.83 52.68 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.23 34.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.34 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.735 HD11 ' CD1' ' A' ' 68' ' ' PHE . 31.2 mm -68.69 -60.19 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.5 -21.83 65.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.478 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.96 -16.2 45.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.686 0.279 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -27.45 16.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.957 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' ' 42' ' ' LEU . 42.6 t -133.08 156.64 47.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.943 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -100.61 30.27 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -124.16 156.51 66.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.018 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 30.3 Cg_endo -64.11 150.11 89.01 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.298 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 71' ' ' ILE . 34.2 t -121.14 128.49 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.566 ' CG1' HD23 ' A' ' 97' ' ' LEU . 28.6 m -144.0 177.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.9 p -93.7 173.98 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.721 ' HB3' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -67.68 -11.64 58.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.243 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -56.86 -40.62 76.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.887 0.375 . . . . 0.0 110.242 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.518 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.5 t90 -56.82 -57.42 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 110.029 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 89' ' ' VAL . 66.3 t -56.09 -46.53 80.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.113 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -56.59 12.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.45 -31.55 67.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -77.14 -48.89 16.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.954 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 30' ' ' MET . 49.0 t -71.32 -28.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.66 -59.07 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.064 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 tp -88.48 -11.99 44.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.74 83.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 tt0 -177.11 133.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.23 78.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.83 169.01 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.788 ' HG3' HG23 ' A' ' 99' ' ' THR . 2.3 pt-20 -82.68 142.23 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.643 HD21 ' CG2' ' A' ' 54' ' ' ILE . 4.1 mp -79.85 -28.87 39.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.97 -30.49 47.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.788 HG23 ' HG3' ' A' ' 96' ' ' GLU . 41.3 p -76.11 -13.39 60.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.6 27.88 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.553 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -93.37 106.58 18.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.3 mt 59.59 107.98 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.72 -77.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.324 2.016 . . . . 0.0 112.435 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.18 116.67 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.866 0.365 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 tp -101.99 129.7 25.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.36 157.22 57.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.454 2.102 . . . . 0.0 112.304 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -127.64 168.44 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 p -131.96 33.33 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -93.54 155.36 17.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.892 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.521 ' N ' HD11 ' A' ' 33' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -104.52 150.91 24.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -76.15 105.01 6.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.39 -43.7 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -142.49 84.57 1.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp -86.48 154.59 21.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.559 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.623 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -101.9 -20.91 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 17.1 m-30 -93.49 -47.9 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.782 0.325 . . . . 0.0 110.446 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.74 87.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.555 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.54 72.64 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.077 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.506 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -144.31 162.4 36.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.6 mt-10 -138.41 109.77 6.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.157 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -126.01 141.1 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.5 p -126.43 147.46 49.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.078 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.631 ' SG ' HD23 ' A' ' 27' ' ' LEU . 14.9 m -105.61 113.42 26.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.609 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.58 120.0 33.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.9 168.75 45.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.579 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.79 1.23 9.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.821 2.348 . . . . 0.0 112.738 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 62.96 -81.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.048 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 21' ' ' ASN . 1.1 t -173.1 -55.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.341 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.458 ' H ' HG23 ' A' ' 20' ' ' THR . 4.3 m-20 -115.06 -39.38 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.159 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.04 138.05 94.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.812 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 24' ' ' THR . 97.6 Cg_endo -80.17 5.84 5.74 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.703 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER 84.09 -32.41 0.07 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.6 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.66 -29.18 25.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.172 0.51 . . . . 0.0 110.105 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.7 -32.13 67.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.371 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.631 HD23 ' SG ' ' A' ' 15' ' ' CYS . 18.0 tp -70.94 -50.31 36.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.364 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' HG22 ' A' ' 31' ' ' VAL . 14.5 mt-10 -59.83 -27.42 66.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.979 0.418 . . . . 0.0 110.547 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -64.88 -50.08 67.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.238 0.542 . . . . 0.0 109.646 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.86 ' HB3' HG21 ' A' ' 89' ' ' VAL . 14.5 mtt -51.22 -51.29 55.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.072 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 28' ' ' GLU . 28.6 m -59.38 -45.67 93.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.923 0.392 . . . . 0.0 110.528 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.7 tm0? -58.5 -34.47 70.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.044 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 1' ' ' GLY . 16.5 tp -70.01 -21.09 63.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.78 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 89' ' ' VAL . 1.7 m -93.1 -3.25 54.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.615 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 112.91 -20.9 19.27 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.982 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -70.49 174.61 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 111.314 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.84 135.48 55.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.1 m -71.77 123.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 14.4 t -102.99 122.39 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -49.48 76.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.576 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 39' ' ' VAL . 3.6 mm-40 -140.15 177.7 7.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.375 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 75' ' ' CYS . 14.5 mt -67.36 -48.17 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.793 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 m -59.06 -21.13 58.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.54 ' HB3' HG13 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -65.9 -21.01 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.218 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HZ ' ' HG ' ' A' ' 14' ' ' CYS . 17.9 m-85 -52.65 132.19 35.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 111.063 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 46' ' ' THR . 6.4 t -150.61 116.24 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.78 103.92 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.99 -105.41 3.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 m -83.28 -60.19 2.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.542 ' O ' HG13 ' A' ' 51' ' ' VAL . . . -145.88 83.48 0.19 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.56 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 50' ' ' GLY . 3.3 m -159.0 110.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.994 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -94.03 136.03 24.09 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.827 ' O ' HD13 ' A' ' 54' ' ' ILE . 89.5 Cg_endo -80.71 138.51 11.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.677 2.252 . . . . 0.0 112.565 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 53' ' ' PRO . 8.5 mm -144.29 150.89 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.976 HG23 ' HB3' ' A' ' 77' ' ' ALA . 41.6 t -131.21 139.0 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 57' ' ' VAL . 60.9 t -124.67 157.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 0.0 111.371 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.775 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -156.68 -173.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 -179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.637 ' H ' HG12 ' A' ' 57' ' ' VAL . 4.7 tt0 178.66 80.47 0.16 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.574 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.53 112.24 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.649 2.232 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.52 -42.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.731 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.37 30.43 6.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.97 -29.19 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m 63.88 159.02 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.912 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.09 86.4 3.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.44 -49.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.819 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -80.86 -29.22 35.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.79 107.51 3.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.775 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 36.0 t80 -97.27 7.1 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.509 0.195 . . . . 0.0 111.389 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 51.28 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -175.82 40.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.746 HG21 HG11 ' A' ' 79' ' ' VAL . 25.4 mm -71.42 -60.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.38 -22.95 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.691 0.282 . . . . 0.0 111.103 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -30.66 14.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.714 ' HB2' HD22 ' A' ' 42' ' ' LEU . 31.2 p -105.6 162.9 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -116.05 37.64 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.976 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -148.79 168.22 11.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.777 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 56.6 Cg_endo -70.22 112.48 3.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.656 2.237 . . . . 0.0 112.517 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.746 HG11 HG21 ' A' ' 71' ' ' ILE . 34.8 t -81.3 127.1 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.784 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.623 ' CG1' HD23 ' A' ' 97' ' ' LEU . 28.2 m -140.27 176.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 11.6 p -94.4 159.24 15.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.14 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -22.06 6.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.312 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.81 -40.59 21.46 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.95 0.405 . . . . 0.0 110.684 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 84.4 t90 -62.16 -57.23 12.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.363 0.602 . . . . 0.0 110.027 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 89' ' ' VAL . 60.3 t -56.1 -37.09 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.17 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 -54.55 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.83 -30.44 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.772 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.4 m -77.17 -50.96 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.86 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.7 t -71.19 -28.56 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.365 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.17 -54.33 22.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 93' ' ' GLN . 4.5 tt -97.52 2.7 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.339 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.623 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 53.5 82.86 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 111.054 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.527 ' HB2' HD23 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -178.68 128.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 p -66.08 86.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.91 170.71 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.9 125.96 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.815 HD21 ' CG2' ' A' ' 54' ' ' ILE . 3.7 mp -64.11 -29.53 70.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -54.47 -29.29 49.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.247 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -77.56 -17.28 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -134.31 29.49 3.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -98.31 136.8 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.812 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.4 mt -76.17 111.89 17.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.86 176.3 10.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.396 2.064 . . . . 0.0 112.437 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -129.25 -45.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.432 HD12 ' HD2' ' A' ' 106' ' ' PRO . 3.1 tp -149.03 134.93 9.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 105' ' ' ILE . 25.1 Cg_endo -61.79 -43.72 24.57 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.464 2.109 . . . . 0.0 112.259 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -77.96 79.97 4.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.0 p -113.92 -43.23 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -69.9 -178.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.949 179.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.749 0.309 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.749 HD11 ' SG ' ' A' ' 34' ' ' CYS . 5.6 pt -76.44 -21.08 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.711 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 13.1 m-30 -93.74 -48.25 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.609 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 45.32 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.09 77.47 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.205 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.915 HD21 HG13 ' A' ' 54' ' ' ILE . 0.8 OUTLIER -144.22 158.76 43.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.689 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -136.95 113.37 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.722 HD11 HD22 ' A' ' 11' ' ' LEU . 2.2 mt -127.17 128.97 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 0.0 111.443 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.5 p -115.97 131.42 56.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HB3' HD23 ' A' ' 27' ' ' LEU . 25.9 p -97.07 106.33 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.526 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 130.03 39.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.56 164.03 28.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.42 -16.19 10.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.748 2.299 . . . . 0.0 112.726 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.854 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 . . . . . 0 CA--C 1.52 -0.211 0 CA-C-O 121.227 0.536 . . . . 0.0 109.693 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.43 -24.84 50.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.95 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 15' ' ' CYS . 15.9 tp -74.15 -48.75 27.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.801 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -65.02 -27.61 68.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 0.0 110.462 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.44 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.1 t90 -69.56 -49.82 50.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.831 ' HB3' HG21 ' A' ' 89' ' ' VAL . 34.5 mtp -54.3 -48.57 71.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.783 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.3 m -62.31 -45.16 99.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.191 0.519 . . . . 0.0 109.863 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.473 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.86 -36.52 72.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.156 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -70.07 -21.11 63.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.778 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.749 ' SG ' HD11 ' A' ' 7' ' ' ILE . 10.3 m -92.98 -3.21 54.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.738 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 -14.66 17.43 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.113 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.661 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -76.21 179.71 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.167 0.508 . . . . 0.0 111.537 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 135.77 46.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.452 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -71.74 114.44 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.928 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.736 HG21 ' CE1' ' A' ' 45' ' ' PHE . 5.3 t -95.26 123.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -49.55 74.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.8 mt-10 -141.22 -176.9 4.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.278 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.733 HD13 ' HB3' ' A' ' 75' ' ' CYS . 19.2 mt -72.19 -39.02 68.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -7.05 52.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.49 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -23.71 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.61 0.243 . . . . 0.0 111.23 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.736 ' CE1' HG21 ' A' ' 39' ' ' VAL . 29.6 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 111.11 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.836 0.35 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -93.96 135.43 24.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.733 ' O ' HD13 ' A' ' 54' ' ' ILE . 85.6 Cg_endo -82.14 137.12 9.41 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 0.0 112.713 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.915 HG13 HD21 ' A' ' 11' ' ' LEU . 8.8 mm -144.44 152.43 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.783 HG23 ' HB3' ' A' ' 77' ' ' ALA . 42.4 t -128.28 151.14 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 13' ' ' ILE . 85.6 t -129.09 146.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.838 HG22 HG12 ' A' ' 79' ' ' VAL . 2.8 m -139.1 -175.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.49 93.29 0.28 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 61.78 2.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.357 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.71 179.8 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.667 0.27 . . . . 0.0 111.302 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 79' ' ' VAL . 30.7 mm -71.75 -63.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.83 -25.24 58.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.313 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.29 -24.81 50.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.991 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 mtp -93.92 -31.07 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.733 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.9 p -106.73 150.66 26.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.83 31.61 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.45 168.61 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 73.7 Cg_endo -74.9 121.74 6.81 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.693 2.262 . . . . 0.0 112.464 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.024 HG21 HG22 ' A' ' 71' ' ' ILE . 12.1 t -92.87 124.0 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.538 HG11 ' CB ' ' A' ' 97' ' ' LEU . 3.9 m -137.16 131.75 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.699 0.285 . . . . 0.0 111.431 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -50.87 157.2 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.9 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -24.32 2.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.355 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 1.3 tp10 -45.55 -39.82 7.94 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.765 0.317 . . . . 0.0 110.673 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.9 t90 -60.7 -57.29 13.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.517 0.675 . . . . 0.0 109.903 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.754 ' O ' HG23 ' A' ' 89' ' ' VAL . 81.5 t -54.23 -41.46 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -50.5 27.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -60.02 -33.08 71.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' TYR . 51.0 m -77.1 -47.44 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.831 HG21 ' HB3' ' A' ' 30' ' ' MET . 57.9 t -71.16 -26.21 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.291 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -58.52 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.85 -13.42 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.533 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 69.22 80.91 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.759 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.651 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.9 OUTLIER 179.16 129.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.93 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -68.67 159.08 32.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.7 126.02 27.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.78 HD21 ' CG2' ' A' ' 54' ' ' ILE . 3.0 mp -66.03 -32.17 73.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.339 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -23.21 13.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.555 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.0 m -75.48 -19.75 59.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.617 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 21.1 m-85 -134.66 19.8 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 0.0 111.306 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.585 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.969 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.0 mmtt . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.794 0.331 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.588 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -82.38 -17.94 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.624 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 14.6 m-30 -93.63 -42.81 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 5.1 ptm180 35.85 84.34 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 111.854 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.95 66.77 1.55 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.772 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.923 HD21 HG13 ' A' ' 54' ' ' ILE . 1.5 tt -138.78 152.52 47.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.312 . . . . 0.0 110.792 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.78 ' HG2' HG22 ' A' ' 39' ' ' VAL . 2.5 mt-10 -130.85 119.36 22.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.756 HD11 HD22 ' A' ' 11' ' ' LEU . 2.6 mt -130.51 123.8 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.709 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.841 ' SG ' HG13 ' A' ' 55' ' ' VAL . 31.9 p -107.64 135.33 49.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.714 ' HB3' HD23 ' A' ' 27' ' ' LEU . 22.7 p -94.33 99.2 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.676 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -93.82 112.84 24.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.31 159.73 11.9 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.49 -13.53 9.69 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.791 2.327 . . . . 0.0 112.827 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.0 m-85 . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.857 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 CA--C 1.519 -0.214 0 CA-C-O 121.296 0.57 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 -28.23 58.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.998 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 15' ' ' CYS . 14.1 tp -72.11 -50.94 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -63.62 -27.54 69.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.564 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.4 t90 -69.93 -50.17 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.9 ' HB3' HG21 ' A' ' 89' ' ' VAL . 37.3 mtp -54.04 -48.37 70.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.774 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.1 m -61.89 -44.6 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.189 0.518 . . . . 0.0 109.947 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.463 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.9 mt-30 -58.33 -35.23 71.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.198 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.009 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.496 ' SG ' HG22 ' A' ' 89' ' ' VAL . 19.4 m -93.04 -3.44 54.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.851 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 115.05 -3.96 22.43 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.253 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.699 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -86.67 -179.61 6.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 111.402 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -133.54 133.95 42.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.32 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.3 p -71.62 114.39 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.78 HG22 ' HG2' ' A' ' 12' ' ' GLU . 1.6 t -93.66 134.4 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -80.51 -36.01 33.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.256 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -131.99 164.74 25.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.137 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.832 HD13 ' HB3' ' A' ' 75' ' ' CYS . 37.8 mt -73.29 -37.07 66.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -75.95 -6.05 49.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.427 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.02 2.08 36.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.669 ' CE1' HG21 ' A' ' 39' ' ' VAL . 13.7 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG11 ' CD ' ' A' ' 12' ' ' GLU . 21.2 t . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.84 122.44 62.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.582 ' O ' HD13 ' A' ' 54' ' ' ILE . 89.3 Cg_endo -80.84 126.78 5.97 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.559 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.923 HG13 HD21 ' A' ' 11' ' ' LEU . 12.6 mm -142.91 160.5 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.841 HG13 ' SG ' ' A' ' 14' ' ' CYS . 6.9 t -142.31 151.18 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 13' ' ' ILE . 3.0 t -117.42 157.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 111.107 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.724 HG13 HG12 ' A' ' 79' ' ' VAL . 4.9 m -147.01 -178.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.68 92.66 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 59.48 5.92 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.576 2.184 . . . . 0.0 112.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.749 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.785 0.326 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.596 HG21 HG11 ' A' ' 79' ' ' VAL . 29.7 mm -72.84 -61.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.143 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.06 -27.24 62.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.44 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -78.43 -23.26 46.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.007 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -93.96 -29.19 15.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.881 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.832 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.4 p -114.94 151.5 33.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.9 -26.01 17.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.608 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -84.15 159.46 59.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 49.6 Cg_endo -67.99 147.95 75.02 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.14 . . . . 0.0 112.432 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.724 HG12 HG13 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -118.16 128.76 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 97' ' ' LEU . 27.2 m -140.1 157.05 25.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 111.263 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.4 p -70.19 158.91 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.321 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -22.19 3.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.428 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.15 -43.7 21.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.85 0.357 . . . . 0.0 110.77 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.51 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 78.0 t90 -55.16 -57.25 12.53 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.54 0.686 . . . . 0.0 110.102 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.783 ' O ' HG23 ' A' ' 89' ' ' VAL . 85.2 t -53.63 -46.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.176 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -49.72 66.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -61.82 -33.0 73.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -77.08 -46.81 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.9 HG21 ' HB3' ' A' ' 30' ' ' MET . 43.9 t -71.08 -31.45 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.4 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 tp -82.51 -19.53 38.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.588 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 71.46 76.89 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.045 0.45 . . . . 0.0 110.613 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.401 ' C ' HD13 ' A' ' 7' ' ' ILE . 23.4 tt0 -177.68 132.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.772 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.38 83.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.85 168.79 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -77.2 133.84 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.735 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.799 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.1 mp -74.52 -32.03 62.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -22.66 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.426 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.9 m -73.54 -20.67 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.467 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -140.09 28.24 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.952 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 12.8 pttm . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.837 0.351 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.68 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -123.73 -14.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.018 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.595 ' CD1' HD13 ' A' ' 11' ' ' LEU . 9.4 m-30 -93.45 -44.07 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.535 0.207 . . . . 0.0 110.648 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 41.05 87.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.259 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.22 72.72 0.98 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.382 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.939 HD21 HG13 ' A' ' 54' ' ' ILE . 2.4 tt -146.23 125.15 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.648 0.261 . . . . 0.0 110.838 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.719 ' HG2' HG22 ' A' ' 39' ' ' VAL . 1.2 mt-10 -104.31 123.33 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.699 0.285 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.742 HD11 HD22 ' A' ' 11' ' ' LEU . 2.6 mt -129.96 123.77 57.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.864 0.364 . . . . 0.0 111.449 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.694 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.1 p -110.77 144.08 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 m -107.13 114.16 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -97.18 110.0 22.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.0 148.47 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.26 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.608 2.205 . . . . 0.0 112.261 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 . . . . . 0 CA--C 1.52 -0.179 0 CA-C-O 121.149 0.499 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.36 -30.57 60.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.236 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.635 HD12 HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -72.58 -50.83 22.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.348 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -68.7 -51.61 39.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 89' ' ' VAL . 54.9 mtm -53.11 -49.61 66.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.815 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 32' ' ' GLN . 29.7 m -62.01 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.136 0.493 . . . . 0.0 109.844 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.478 ' N ' HG23 ' A' ' 31' ' ' VAL . 7.8 mt-30 -57.16 -35.54 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.002 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.54 -21.4 63.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.699 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HG22 ' A' ' 89' ' ' VAL . 1.8 m -93.42 -3.25 53.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.58 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.86 25.24 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.87 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -72.25 178.11 4.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.48 150.9 49.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.462 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 28' ' ' GLU . 13.9 p -86.51 120.66 36.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.828 0.346 . . . . 0.0 111.214 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.719 HG22 ' HG2' ' A' ' 12' ' ' GLU . 1.3 t -93.89 128.47 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -48.42 81.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -144.71 179.95 6.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 75' ' ' CYS . 30.3 mt -66.16 -42.8 88.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -70.02 -20.8 63.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.271 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.642 ' HB2' HG12 ' A' ' 39' ' ' VAL . 61.5 m -66.82 -15.28 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.606 ' CE1' HG21 ' A' ' 39' ' ' VAL . 9.7 m-85 . . . . . 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.222 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.743 0.306 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -94.09 127.6 44.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.613 ' O ' HD13 ' A' ' 54' ' ' ILE . 92.9 Cg_endo -80.3 131.38 8.61 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.639 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.939 HG13 HD21 ' A' ' 11' ' ' LEU . 8.1 mm -143.44 161.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.617 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 77' ' ' ALA . 21.3 t -138.11 151.2 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 80' ' ' VAL . 4.0 t -126.31 149.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.316 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 79' ' ' VAL . 3.6 m -144.43 -177.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 3.6 tp60 178.06 70.73 0.11 Allowed Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.77 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.07 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.248 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.762 0.315 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.784 HG22 HG21 ' A' ' 79' ' ' VAL . 33.8 mm -75.66 -59.44 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.02 -21.91 70.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.544 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -85.97 -19.79 29.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.2 ttp -93.92 -29.08 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.607 ' HB3' HD13 ' A' ' 42' ' ' LEU . 29.8 p -107.49 151.35 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.25 30.25 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -139.81 159.22 65.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.47 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.3 Cg_endo -75.0 123.16 7.68 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.75 2.3 . . . . 0.0 112.248 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 57' ' ' VAL . 5.5 t -91.62 140.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.7 m -152.11 133.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.788 0.327 . . . . 0.0 111.629 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 14.7 p -47.64 159.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.793 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.17 -21.01 11.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.273 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 3.0 tt0 -47.34 -41.24 19.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.888 0.375 . . . . 0.0 110.714 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.516 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.2 t90 -57.43 -57.37 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 110.07 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.735 ' O ' HG23 ' A' ' 89' ' ' VAL . 59.0 t -53.65 -44.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -53.12 21.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -57.87 -29.98 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 92' ' ' TYR . 64.8 m -76.94 -49.15 16.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 30' ' ' MET . 26.9 t -71.14 -28.38 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.366 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.21 -57.27 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 tp -90.25 -11.44 40.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.68 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 62.53 76.96 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.652 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -178.67 132.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.78 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.993 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -69.06 166.62 17.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 156.85 35.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.654 HD21 ' CG2' ' A' ' 54' ' ' ILE . 1.0 OUTLIER -101.94 -20.93 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -25.59 65.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.011 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.4 m -74.71 -14.88 60.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.579 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 14.0 m-85 -139.23 16.55 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.566 0.222 . . . . 0.0 111.269 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.409 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.147 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 3.2 mmtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.746 0.308 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.728 HD13 ' N ' ' A' ' 93' ' ' GLN . 5.8 pt -63.36 -20.6 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.533 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.769 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 4.8 m-30 -93.83 -49.7 5.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.418 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 45.21 90.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.351 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.95 75.7 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.303 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.548 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -143.0 159.3 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.798 0.333 . . . . 0.0 111.039 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -142.3 109.89 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.508 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.654 HD12 ' HB1' ' A' ' 36' ' ' ALA . 1.6 mt -121.96 125.55 73.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.941 0.4 . . . . 0.0 111.558 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.9 p -101.28 144.33 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.996 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 25.0 p -101.48 102.93 13.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.806 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -93.87 136.34 34.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.495 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . 87.01 144.72 8.78 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 16.5 Cg_exo -66.65 -9.63 25.09 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.826 2.35 . . . . 0.0 112.757 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 17' ' ' GLY . 69.5 m-85 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.713 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 CA--C 1.521 -0.158 0 CA-C-O 121.275 0.559 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.26 -27.2 56.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.317 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 85' ' ' VAL . 3.0 tm? -73.81 -48.84 28.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.44 -27.68 68.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.679 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -71.12 -49.68 41.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.963 ' HB3' HG21 ' A' ' 89' ' ' VAL . 53.7 mtm -54.52 -48.32 72.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.9 m -62.08 -44.92 99.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.3 0.571 . . . . 0.0 109.881 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.487 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.2 mt-30 -58.91 -35.52 73.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.2 tp -70.13 -21.9 63.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.407 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.883 ' SG ' HG22 ' A' ' 89' ' ' VAL . 23.4 m -94.02 -3.44 51.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.919 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 109.1 31.41 3.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.769 ' HB2' ' HD2' ' A' ' 8' ' ' PHE . . . -116.23 175.61 5.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.01 0.433 . . . . 0.0 111.038 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.9 38.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 38' ' ' VAL . 11.9 p -71.68 116.13 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -93.81 120.3 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.964 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -33.67 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -155.46 177.48 11.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.712 HD22 ' HB2' ' A' ' 75' ' ' CYS . 15.6 mt -68.89 -39.95 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -18.5 63.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.32 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -77.11 -4.33 43.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.58 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.605 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.3 m-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.77 128.42 41.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.905 ' O ' HD13 ' A' ' 54' ' ' ILE . 83.9 Cg_endo -80.94 127.34 6.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.601 2.201 . . . . 0.0 112.781 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.905 HD13 ' O ' ' A' ' 53' ' ' PRO . 11.6 mm -134.96 161.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.69 HG23 ' HB3' ' A' ' 77' ' ' ALA . 38.5 t -139.05 139.76 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.576 HG23 ' CG2' ' A' ' 13' ' ' ILE . 53.6 t -115.75 158.59 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.809 HG22 HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -150.39 175.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.555 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.443 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER 177.27 63.06 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.684 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.03 115.08 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.615 2.21 . . . . 0.0 112.395 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.083 0 CA-C-O 120.728 0.299 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.777 HG22 HG21 ' A' ' 79' ' ' VAL . 28.2 mm -80.56 -48.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.11 -18.79 73.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.273 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -14.63 20.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.463 0.173 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 mtp -93.6 -28.46 16.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.712 ' HB2' HD22 ' A' ' 42' ' ' LEU . 25.4 p -115.85 149.22 38.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.93 30.08 3.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.69 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -141.24 164.4 35.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 57.2 Cg_endo -71.16 131.69 19.72 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.657 2.238 . . . . 0.0 112.771 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.809 HG12 HG22 ' A' ' 57' ' ' VAL . 1.8 t -101.07 128.91 52.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.665 ' CG1' HD23 ' A' ' 97' ' ' LEU . 27.2 m -143.7 154.94 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 0.0 111.667 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.6 p -62.55 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.457 ' HD3' ' CD2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -88.61 -15.1 35.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.127 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -55.5 -34.59 64.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -57.98 -57.56 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.289 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 89' ' ' VAL . 43.5 t -58.34 -48.22 85.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.132 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -45.22 94.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.57 -36.46 83.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 92' ' ' TYR . 22.5 m -77.05 -44.72 29.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.963 HG21 ' HB3' ' A' ' 30' ' ' MET . 38.7 t -71.22 -26.66 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.397 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.42 -52.74 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.36 . . . . 0.0 111.441 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.94 -2.14 47.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.58 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.433 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 57.0 80.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 110.894 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.728 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -178.88 126.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.3 t -59.31 87.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.7 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.57 130.96 35.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.838 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.2 mp -66.4 -29.07 69.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.25 -24.82 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.336 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -80.29 -12.03 59.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.536 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -142.18 29.77 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.768 0.318 . . . . 0.0 111.018 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.806 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.1 mmtp . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.755 0.312 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.695 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -91.23 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.916 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.683 ' CD1' HD13 ' A' ' 11' ' ' LEU . 11.3 m-85 -93.43 -47.4 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.28 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 38.96 86.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.377 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.45 66.47 1.68 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.503 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.997 HD21 HG13 ' A' ' 54' ' ' ILE . 3.9 tt -145.64 122.21 11.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.489 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.733 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.7 mt-10 -94.63 123.6 38.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.331 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.709 HD12 ' CB ' ' A' ' 36' ' ' ALA . 3.6 mt -132.77 136.18 56.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.261 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.0 p -135.61 142.82 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.832 ' HB3' HD23 ' A' ' 27' ' ' LEU . 7.9 p -107.01 109.4 21.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.13 103.51 15.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.98 161.96 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.657 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.23 -15.84 14.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.599 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD2' ' HB3' ' A' ' 58' ' ' GLN . 5.4 m-85 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.016 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 41.8 m-20 . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.084 0.468 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -31.29 56.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.832 HD23 ' HB3' ' A' ' 15' ' ' CYS . 12.4 tp -74.96 -46.37 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -64.69 -27.35 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.483 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -68.72 -50.84 47.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.187 0.518 . . . . 0.0 109.84 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.871 ' HB3' HG21 ' A' ' 89' ' ' VAL . 74.0 mtm -55.11 -48.21 73.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.6 m -60.52 -44.84 97.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 0.0 110.17 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' N ' HG23 ' A' ' 31' ' ' VAL . 12.5 tt0 -58.39 -33.47 69.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -70.02 -21.44 63.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.749 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' SG ' HD11 ' A' ' 7' ' ' ILE . 2.6 m -93.28 -3.25 53.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 110.84 -29.74 8.67 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.435 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.709 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -58.3 156.98 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 132.17 45.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.044 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 38' ' ' VAL . 15.1 m -71.76 114.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.053 0.454 . . . . 0.0 110.898 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 12' ' ' GLU . 24.8 t -100.27 117.93 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.907 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -47.24 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.3 mt-10 -134.34 171.0 14.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.072 0.463 . . . . 0.0 111.448 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 75' ' ' CYS . 9.4 mt -65.37 -44.59 87.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.854 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 m -60.69 -27.22 67.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.715 ' HB3' HG13 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -58.76 -23.28 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 16.2 m-85 . . . . . 0 C--N 1.332 -0.185 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.915 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.31 134.69 24.09 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.66 125.53 5.59 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.639 2.226 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.997 HG13 HD21 ' A' ' 11' ' ' LEU . 29.3 mm -134.71 148.34 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.755 ' HB ' HG12 ' A' ' 79' ' ' VAL . 58.7 t -126.58 151.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.362 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.749 HG11 HD21 ' A' ' 27' ' ' LEU . 16.4 t -123.71 131.26 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 71' ' ' ILE . 5.2 m -143.26 120.39 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.556 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -140.82 86.06 12.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.16 135.24 39.57 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.515 2.143 . . . . 0.0 112.314 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t70 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.854 0.359 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.828 ' CG2' HG11 ' A' ' 79' ' ' VAL . 14.1 mm -62.84 -39.36 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.25 -25.65 61.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -27.91 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.5 mtp -93.83 -30.7 14.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.767 ' HB2' HD13 ' A' ' 42' ' ' LEU . 42.1 t -134.58 145.59 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.56 31.34 4.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -112.51 166.15 11.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.08 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 83.8 Cg_endo -79.08 108.43 2.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.788 2.325 . . . . 0.0 112.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.828 HG11 ' CG2' ' A' ' 71' ' ' ILE . 3.2 m -91.12 127.44 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.588 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 56' ' ' VAL . 35.9 m -137.09 139.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.793 0.33 . . . . 0.0 111.736 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 p -52.02 161.97 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -21.51 9.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.476 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.26 -43.92 15.97 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.521 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.4 t90 -56.57 -57.42 12.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.931 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 89' ' ' VAL . 52.9 t -54.34 -43.75 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.269 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -69.12 -56.34 7.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.016 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.3 -31.37 63.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.0 m -77.1 -49.92 14.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.5 t -71.24 -27.27 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.467 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.05 -58.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.7 tp -89.45 -12.16 40.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.271 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.695 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 66.05 77.83 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 110.776 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.436 ' N ' HG21 ' A' ' 7' ' ' ILE . 20.9 tt0 -177.82 134.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 t -59.6 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -72.69 159.05 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -63.67 153.02 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.574 HD21 HG23 ' A' ' 54' ' ' ILE . 2.4 mp -102.15 -33.38 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.281 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -57.2 -21.67 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.595 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.9 m -80.51 -20.48 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.564 0.221 . . . . 0.0 111.482 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.8 23.75 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 111.068 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.6 mmtt . . . . . 0 CA--C 1.528 0.096 0 CA-C-O 120.739 0.304 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.666 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.1 pp -76.33 -23.49 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.92 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.666 ' CD1' HD12 ' A' ' 7' ' ' ILE . 16.4 m-30 -93.71 -47.68 6.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 45.54 90.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.333 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.21 76.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.931 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.18 162.27 38.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -140.65 109.78 6.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.657 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.5 mt -121.11 130.72 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 111.666 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.641 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 21.9 p -115.04 139.03 50.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.748 ' HB3' HD23 ' A' ' 27' ' ' LEU . 8.6 p -107.12 108.49 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.597 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.98 119.66 33.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.94 166.38 25.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.594 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.35 -10.38 9.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.864 2.376 . . . . 0.0 112.75 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.5 m-85 . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.058 0.456 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -31.48 41.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.415 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 15' ' ' CYS . 33.6 tp -75.91 -44.24 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.396 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -65.44 -27.54 68.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.431 ' NE1' ' CD2' ' A' ' 33' ' ' LEU . 18.4 t90 -67.47 -51.94 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.162 0.506 . . . . 0.0 109.734 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.788 ' HB3' HG21 ' A' ' 89' ' ' VAL . 6.2 mtm -55.03 -50.52 68.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.615 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 32' ' ' GLN . 26.1 m -58.98 -45.02 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.48 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.96 -33.83 67.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.497 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -70.44 -21.46 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.021 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 4.0 m -93.45 -3.26 53.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.745 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.51 -18.21 17.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.851 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.657 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -72.63 177.93 4.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.28 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -131.98 139.18 48.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.565 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 p -71.93 122.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.72 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.2 t -93.92 130.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.04 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -65.3 -42.3 93.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -147.73 -179.59 7.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 75' ' ' CYS . 33.1 mt -71.43 -41.1 69.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 t -72.95 -9.11 58.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.428 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 -19.11 60.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.607 0.241 . . . . 0.0 111.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.72 ' CE1' HG21 ' A' ' 39' ' ' VAL . 24.1 m-85 . . . . . 0 C--N 1.332 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 111.09 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.76 0.314 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -93.87 126.84 47.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.879 ' O ' HD13 ' A' ' 54' ' ' ILE . 91.4 Cg_endo -78.53 130.73 10.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.697 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.879 HD13 ' O ' ' A' ' 53' ' ' PRO . 8.1 mm -138.82 147.74 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.666 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 77' ' ' ALA . 39.9 t -123.01 151.1 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.81 HG13 ' O ' ' A' ' 80' ' ' VAL . 15.2 t -129.95 144.41 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 m -135.3 -177.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 172.98 78.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.05 88.06 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.644 2.23 . . . . 0.0 112.402 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.836 0.35 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 79' ' ' VAL . 23.0 mm -74.3 -54.3 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.39 -20.76 71.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.42 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -18.09 40.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.92 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.0 ttp -93.67 -25.53 17.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.801 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.503 ' HB2' HD13 ' A' ' 42' ' ' LEU . 46.0 t -133.5 156.41 47.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.856 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -103.34 32.63 3.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -123.91 164.52 28.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.62 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 94.0 Cg_endo -78.39 120.87 5.01 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.037 HG21 HG22 ' A' ' 71' ' ' ILE . 10.7 t -94.62 121.29 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.81 ' O ' HG13 ' A' ' 56' ' ' VAL . 28.0 m -137.58 135.57 46.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.586 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.8 p -50.65 170.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.668 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -16.32 60.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.36 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -42.24 52.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 110.664 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.511 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 80.2 t90 -59.46 -57.26 13.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.491 0.663 . . . . 0.0 109.766 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 89' ' ' VAL . 63.2 t -55.06 -43.48 69.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.424 HD22 ' HE1' ' A' ' 30' ' ' MET . 0.5 OUTLIER -69.87 -46.14 66.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -64.48 -32.94 74.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.518 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -77.11 -47.13 21.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 85' ' ' VAL . 42.1 t -71.24 -30.92 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.38 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.73 -56.79 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.84 -16.54 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.522 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 67.57 77.76 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.02 136.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.707 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -58.93 91.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -74.57 160.39 30.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.66 139.04 56.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.702 ' HB3' HD12 ' A' ' 101' ' ' LEU . 1.6 mp -88.34 -33.06 18.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.349 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -22.25 24.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.583 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.7 m -77.74 -23.38 49.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.433 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -128.1 18.46 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.618 0.247 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 7.5 pttm . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.654 0.264 . . . . 0.0 110.775 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.496 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -111.56 -16.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 9.7 m-30 -93.78 -43.84 8.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.893 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 49.26 92.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 75.38 0.51 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -139.58 162.04 36.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.142 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.76 109.81 5.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.5 mt -118.05 124.96 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.413 . . . . 0.0 111.762 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.669 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.9 p -108.35 129.5 55.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 27' ' ' LEU . 14.2 m -97.33 115.06 26.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -93.52 108.71 20.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.097 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.67 168.77 33.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.3 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.681 2.254 . . . . 0.0 112.621 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.9 m-85 . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.946 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 CA--C 1.521 -0.138 0 CA-C-O 121.105 0.478 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -75.88 -30.96 59.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.146 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD23 ' SG ' ' A' ' 15' ' ' CYS . 65.0 tp -72.37 -50.58 25.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.95 -27.44 68.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 110.465 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -64.0 -49.16 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.765 ' HB3' HG21 ' A' ' 89' ' ' VAL . 3.1 mtm -51.67 -55.57 18.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.704 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 85' ' ' VAL . 20.1 m -57.06 -44.26 82.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.079 0.466 . . . . 0.0 110.222 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.436 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt-30 -59.72 -36.87 77.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.079 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.08 -21.04 63.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.883 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 1.4 m -93.23 -3.31 53.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.839 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 6' ' ' LYS . . . 108.33 25.4 5.81 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.118 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -116.35 178.42 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.102 0.477 . . . . 0.0 111.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.64 132.57 44.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.612 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.4 p -71.88 119.43 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.755 HG12 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -93.92 124.29 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.862 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -45.47 77.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -146.73 -179.21 6.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 75' ' ' CYS . 29.6 mt -67.26 -44.13 80.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -17.57 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.276 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.755 ' HB2' HG12 ' A' ' 39' ' ' VAL . 39.3 m -65.66 -17.36 64.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.444 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 39' ' ' VAL . 14.0 m-85 . . . . . 0 C--N 1.332 -0.185 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.458 -0.034 0 CA-C-O 120.921 0.391 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -131.96 120.17 17.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.845 ' O ' HD13 ' A' ' 54' ' ' ILE . 92.3 Cg_endo -78.76 133.18 11.25 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.561 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.845 HD13 ' O ' ' A' ' 53' ' ' PRO . 9.4 mm -139.79 146.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.929 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.977 HG23 ' HB3' ' A' ' 77' ' ' ALA . 30.6 t -124.5 138.22 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 57' ' ' VAL . 24.0 t -124.16 158.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 111.404 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 58' ' ' GLN . 1.4 t -152.89 177.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.689 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.629 ' H ' HG12 ' A' ' 57' ' ' VAL . 6.4 tm0? -179.2 86.89 0.21 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.75 116.91 3.95 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.488 2.125 . . . . 0.0 112.33 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB1' ' NE2' ' A' ' 73' ' ' GLN . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.697 0.284 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.759 HG21 HG11 ' A' ' 79' ' ' VAL . 11.3 mm -74.2 -53.62 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.265 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.31 -27.85 68.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.421 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.493 ' NE2' ' HB1' ' A' ' 70' ' ' ALA . 17.0 pt20 -88.36 -13.47 40.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.579 0.228 . . . . 0.0 111.334 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -28.89 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.615 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.2 p -117.44 157.19 26.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -107.03 41.93 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.977 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -154.33 165.95 16.93 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 37.1 Cg_endo -65.5 124.26 12.6 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.496 2.131 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.759 HG11 HG21 ' A' ' 71' ' ' ILE . 25.7 t -92.53 128.37 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' HD23 ' A' ' 97' ' ' LEU . 31.2 m -143.15 177.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 10.5 p -96.86 163.99 12.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 109.941 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -19.39 17.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.349 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -47.87 -45.09 30.0 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.502 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 63.4 t90 -55.99 -57.26 12.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.39 0.614 . . . . 0.0 110.114 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.758 ' O ' HG23 ' A' ' 89' ' ' VAL . 55.0 t -54.07 -43.16 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -50.46 38.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.09 -32.84 71.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.772 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -77.03 -48.49 17.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.1 t -71.01 -25.91 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.334 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.66 -55.09 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.315 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 93' ' ' GLN . 3.5 tt -98.07 2.95 49.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.585 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.496 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 53.36 83.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.474 ' C ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -178.8 131.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.56 79.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.82 173.05 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.03 153.49 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.742 HD21 ' CG2' ' A' ' 54' ' ' ILE . 1.8 mp -94.07 -27.34 16.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -58.79 -31.86 68.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.93 -16.63 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.43 29.55 3.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER . . . . . 0 CA--C 1.528 0.117 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.503 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.1 pp -111.95 -20.72 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.522 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 14.6 m-30 -93.7 -46.16 7.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 43.15 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.039 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.32 73.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.303 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.855 HD21 HG13 ' A' ' 54' ' ' ILE . 2.1 tt -148.36 119.01 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.707 0.289 . . . . 0.0 110.82 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.89 124.06 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.777 HD12 ' HB1' ' A' ' 36' ' ' ALA . 3.2 mt -132.66 129.78 58.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.711 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.1 p -121.52 146.4 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.211 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' HG23 ' A' ' 56' ' ' VAL . 25.1 p -106.92 127.86 53.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE1' HD11 ' A' ' 42' ' ' LEU . 2.1 t80 -93.89 105.07 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.065 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.86 44.22 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.667 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -166.71 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.42 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 26.3 m-85 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 121.102 0.477 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.59 -33.2 68.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.481 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.858 HD13 HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -73.06 -50.83 20.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.349 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -65.36 -27.78 68.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.425 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -71.39 -50.35 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.805 ' HB3' HG21 ' A' ' 89' ' ' VAL . 8.1 mtm -54.87 -48.41 73.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.54 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 32' ' ' GLN . 28.9 m -62.65 -45.14 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 0.0 109.656 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.1 mt-30 -56.42 -35.91 68.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.071 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 tp -70.07 -21.41 63.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.928 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 7' ' ' ILE . 2.3 m -93.19 -3.24 54.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.706 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.93 25.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.777 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -71.59 174.33 6.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.485 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.08 136.93 52.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.547 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.3 p -71.88 123.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.711 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.0 t -93.86 146.51 6.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -42.82 62.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.154 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 -175.91 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.904 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.68 HD22 ' CB ' ' A' ' 75' ' ' CYS . 30.5 mt -63.64 -50.38 69.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.007 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -66.65 -19.16 65.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.413 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.705 ' HB2' HG12 ' A' ' 39' ' ' VAL . 56.5 m -61.67 -23.32 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.332 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 17.5 m-85 . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.791 0.329 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 130.55 34.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.737 ' O ' HD13 ' A' ' 54' ' ' ILE . 93.3 Cg_endo -78.57 135.36 13.01 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.54 2.16 . . . . 0.0 112.471 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.855 HG13 HD21 ' A' ' 11' ' ' LEU . 9.3 mm -144.3 151.35 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 77' ' ' ALA . 23.4 t -130.65 140.79 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -114.48 160.71 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 111.15 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' CG2' HG12 ' A' ' 79' ' ' VAL . 6.1 m -152.23 -177.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.507 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.45 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 174.54 94.93 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.29 68.67 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.488 2.126 . . . . 0.0 112.334 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.804 0.335 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.536 HG21 HG11 ' A' ' 79' ' ' VAL . 29.1 mm -72.32 -65.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.75 -26.66 68.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -22.98 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 0.0 111.192 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtm -93.92 -43.85 8.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.68 ' CB ' HD22 ' A' ' 42' ' ' LEU . 31.4 p -86.97 162.33 17.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -113.08 33.85 4.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.988 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.68 166.32 18.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 55.4 Cg_endo -68.97 125.98 13.24 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.281 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.55 HG12 ' CG2' ' A' ' 57' ' ' VAL . 17.6 t -93.05 123.64 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.978 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.682 ' O ' HG12 ' A' ' 56' ' ' VAL . 35.8 m -141.16 134.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 1.9 p -54.76 159.99 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.472 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -54.37 -19.8 6.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.578 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.96 -40.58 10.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.9 t90 -58.93 -57.42 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.46 0.648 . . . . 0.0 110.145 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.858 HG11 HD13 ' A' ' 27' ' ' LEU . 58.9 t -57.69 -42.93 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.29 -56.24 8.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -57.99 -30.7 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 92' ' ' TYR . 69.3 m -76.99 -49.16 16.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.805 HG21 ' HB3' ' A' ' 30' ' ' MET . 48.8 t -71.32 -27.23 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.91 -54.69 19.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.177 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 91' ' ' LEU . 6.2 tt -97.41 -2.28 42.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.323 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 58.05 84.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 110.887 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -177.53 139.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.7 t -67.9 74.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.1 158.84 6.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.58 151.46 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.464 ' HB3' HD12 ' A' ' 101' ' ' LEU . 3.8 mp -95.98 -34.8 11.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.65 -25.51 39.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.511 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.5 HG23 ' CG ' ' A' ' 100' ' ' TYR . 13.4 t -74.88 -24.73 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.5 ' CG ' HG23 ' A' ' 99' ' ' THR . 9.8 m-85 -125.74 15.0 8.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.13 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.518 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.317 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp . . . . . 0 CA--C 1.528 0.129 0 CA-C-O 120.69 0.281 . . . . 0.0 110.66 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.797 HD11 ' SG ' ' A' ' 34' ' ' CYS . 2.3 pt -110.44 -19.83 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.506 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 15.7 m-30 -93.7 -50.42 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.637 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 47.72 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.35 76.2 0.83 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.066 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -145.5 162.01 38.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 111.008 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.695 ' CG ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.22 109.82 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.334 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.678 HD12 ' HB1' ' A' ' 36' ' ' ALA . 1.8 mt -125.29 130.46 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.361 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 6.1 p -111.08 143.18 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.723 ' HB3' HD23 ' A' ' 27' ' ' LEU . 17.6 p -106.46 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.01 131.27 39.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.6 158.73 34.16 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.56 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.15 0.26 10.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.644 2.229 . . . . 0.0 112.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 19.9 m-85 . . . . . 0 C--N 1.331 -0.201 0 CA-C-O 120.734 0.302 . . . . 0.0 111.056 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -77.96 -33.35 51.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.523 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.79 HD21 HG11 ' A' ' 56' ' ' VAL . 19.5 tp -75.07 -44.12 49.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.99 -27.48 67.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.507 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.548 ' CD1' HD23 ' A' ' 33' ' ' LEU . 10.3 t90 -69.24 -50.05 50.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.858 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.868 ' HB3' HG21 ' A' ' 89' ' ' VAL . 2.3 mtm -57.34 -48.61 78.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.575 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.4 m -60.51 -45.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.203 0.525 . . . . 0.0 109.621 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.57 -34.58 69.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.666 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.548 HD23 ' CD1' ' A' ' 29' ' ' TRP . 0.6 OUTLIER -70.28 -21.27 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.005 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.828 ' SG ' HG22 ' A' ' 89' ' ' VAL . 38.5 m -93.42 -3.08 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.667 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.3 -23.44 11.3 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.741 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.678 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.02 177.08 1.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.054 0.454 . . . . 0.0 111.231 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.61 138.6 51.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.6 p -71.82 114.77 10.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.782 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.695 HG22 ' CG ' ' A' ' 12' ' ' GLU . 3.0 t -93.91 121.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.022 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -58.44 -47.16 84.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.336 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 39' ' ' VAL . 17.5 mm-40 -132.69 176.03 8.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.086 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 75' ' ' CYS . 13.1 mt -70.87 -43.51 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -5.01 44.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -15.98 61.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.561 0.22 . . . . 0.0 111.389 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.669 ' CE1' HG21 ' A' ' 39' ' ' VAL . 21.2 m-85 . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 111.013 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.544 HG11 ' OE1' ' A' ' 12' ' ' GLU . 21.2 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.718 0.294 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.478 ' O ' HD23 ' A' ' 11' ' ' LEU . 3.2 t-80 -100.99 120.64 54.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.848 ' O ' HD13 ' A' ' 54' ' ' ILE . 79.6 Cg_endo -77.98 133.74 12.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.593 2.195 . . . . 0.0 112.635 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 53' ' ' PRO . 7.5 mm -142.49 162.31 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.622 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.616 HG23 ' HB3' ' A' ' 77' ' ' ALA . 33.9 t -137.99 150.74 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.666 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.79 HG11 HD21 ' A' ' 27' ' ' LEU . 4.1 t -121.85 158.43 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.32 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.868 HG22 HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -150.39 -179.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.473 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 1.1 tt0 176.52 66.93 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.579 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.58 94.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.102 HG22 HG21 ' A' ' 79' ' ' VAL . 24.0 mm -69.82 -67.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.01 -24.25 71.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.372 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.93 -27.82 64.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.311 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.0 mtm -93.92 -39.28 10.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.667 ' HB3' HD22 ' A' ' 42' ' ' LEU . 27.5 p -98.37 147.08 25.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 38.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -147.3 169.3 9.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.79 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 73.6 Cg_endo -74.94 125.87 9.64 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.741 2.294 . . . . 0.0 112.456 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.102 HG21 HG22 ' A' ' 71' ' ' ILE . 8.4 t -98.02 136.61 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.612 ' CG1' HD23 ' A' ' 97' ' ' LEU . 26.7 m -147.59 159.56 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.659 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 p -73.7 159.3 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.246 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -53.6 -22.51 8.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.446 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.45 -38.07 8.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 72.6 t90 -63.46 -57.23 10.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.492 0.663 . . . . 0.0 109.818 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 89' ' ' VAL . 60.6 t -54.3 -39.22 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.377 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -48.47 17.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -60.25 -35.72 76.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -77.05 -47.91 19.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.868 HG21 ' HB3' ' A' ' 30' ' ' MET . 73.7 t -71.22 -25.87 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.439 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.45 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 111.041 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tp -85.07 -18.48 34.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 73.44 77.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.672 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.465 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -177.43 136.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 t -61.17 86.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -67.34 163.42 20.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 99' ' ' THR . 0.4 OUTLIER -73.99 140.12 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.858 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.0 mp -83.33 -29.52 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.12 -29.15 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.473 HG23 ' HG3' ' A' ' 96' ' ' GLU . 1.1 p -72.08 -17.45 62.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.84 22.32 2.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.671 0.272 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.34 . . . . 0.0 110.789 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 10.4 mmtm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.855 0.359 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.512 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.3 pp -79.13 -21.16 12.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.738 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CD1' HD13 ' A' ' 11' ' ' LEU . 9.8 m-30 -93.8 -34.81 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.72 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 8' ' ' PHE . 2.3 ppt_? 28.54 79.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.795 0.438 . . . . 0.0 111.96 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.94 72.16 1.29 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.632 -0.795 . . . . 0.0 111.554 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.936 HD21 HG13 ' A' ' 54' ' ' ILE . 1.8 tt -144.68 152.67 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.71 0.29 . . . . 0.0 110.754 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.704 ' N ' HD23 ' A' ' 11' ' ' LEU . 6.8 mt-10 -129.07 119.64 24.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.647 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.711 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -129.07 123.56 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.54 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.666 ' SG ' HG13 ' A' ' 55' ' ' VAL . 24.6 p -110.09 137.7 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.8 p -95.5 107.24 19.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -93.61 111.78 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.76 168.56 35.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.354 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.97 -0.55 10.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.739 2.292 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.7 m-85 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 121.244 0.545 . . . . 0.0 110.017 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -76.99 -32.5 57.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.291 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' CD1' HG11 ' A' ' 85' ' ' VAL . 68.1 tp -70.72 -50.14 39.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.384 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.9 -27.45 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -65.52 -50.41 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.254 0.549 . . . . 0.0 109.607 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.808 ' HB3' HG21 ' A' ' 89' ' ' VAL . 66.8 mtt -51.46 -51.53 54.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.866 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.619 ' CG1' HG13 ' A' ' 85' ' ' VAL . 31.4 m -61.9 -45.65 98.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.056 0.455 . . . . 0.0 110.181 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.473 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.63 -35.59 72.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.193 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 tp -69.97 -20.92 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.029 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.4 m -93.0 -3.2 54.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.988 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 118.23 -15.96 11.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.083 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.711 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -76.65 -179.12 5.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.58 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -134.89 135.23 41.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.404 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.1 p -71.88 118.59 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -93.85 118.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -42.63 85.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.13 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -148.69 177.26 9.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' A' ' 75' ' ' CYS . 23.9 mt -67.4 -46.53 72.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -23.48 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -24.37 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.633 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.1 m-85 . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.024 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.439 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 2.6 t-80 -95.37 127.82 40.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.585 ' O ' HD13 ' A' ' 54' ' ' ILE . 73.3 Cg_endo -75.89 135.39 17.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.129 . . . . 0.0 112.479 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.936 HG13 HD21 ' A' ' 11' ' ' LEU . 16.0 mm -142.24 150.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.803 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 77' ' ' ALA . 45.2 t -131.05 149.18 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' A' ' 13' ' ' ILE . 57.9 t -120.59 159.68 21.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.876 HG22 HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -149.14 -178.74 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.008 0.432 . . . . 0.0 111.494 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 169.47 81.11 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.873 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 110.59 2.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 t0 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.078 179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.729 0.3 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.913 HG21 HG11 ' A' ' 79' ' ' VAL . 18.3 mm -67.79 -66.85 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.896 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.06 76.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.382 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -25.51 61.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.027 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtp -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.807 ' HB2' HD13 ' A' ' 42' ' ' LEU . 53.9 t -104.29 155.93 18.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.49 35.46 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.679 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -142.47 165.96 23.83 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.679 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.7 Cg_endo -74.0 136.2 22.27 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.658 2.239 . . . . 0.0 112.39 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.913 HG11 HG21 ' A' ' 71' ' ' ILE . 2.4 t -105.94 126.11 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.628 ' CG1' HD23 ' A' ' 97' ' ' LEU . 35.0 m -138.18 159.24 32.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.494 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -72.04 166.0 23.12 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.442 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -59.44 -18.33 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.39 -42.0 30.58 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.507 ' CH2' ' CE1' ' A' ' 8' ' ' PHE . 73.9 t90 -60.43 -57.31 13.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 110.172 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.727 ' O ' HG23 ' A' ' 89' ' ' VAL . 74.2 t -55.12 -36.93 41.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.338 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -54.57 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.049 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -56.94 -31.14 64.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 92' ' ' TYR . 61.2 m -77.1 -50.11 13.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.808 HG21 ' HB3' ' A' ' 30' ' ' MET . 44.9 t -71.25 -25.99 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.619 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 -56.7 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.337 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 tp -90.11 -13.79 35.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.296 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 68.31 81.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.45 137.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.93 85.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.78 170.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.52 118.52 31.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.803 ' HB3' HD12 ' A' ' 101' ' ' LEU . 2.6 mp -61.08 -35.57 77.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.301 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.59 -24.36 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.4 m -80.63 -20.22 43.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.449 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -134.74 32.78 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.803 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.755 0.312 . . . . 0.0 110.737 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.682 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.2 pp -72.47 -23.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.681 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.682 ' CD1' HD12 ' A' ' 7' ' ' ILE . 13.2 m-30 -93.66 -46.18 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.78 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.631 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 76.93 1.02 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.028 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.501 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.35 162.09 38.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.949 0.404 . . . . 0.0 111.211 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.8 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -140.42 109.93 6.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.35 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.618 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -122.54 127.46 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 111.795 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.3 p -112.64 133.45 54.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.542 ' HB3' HD23 ' A' ' 27' ' ' LEU . 25.2 p -98.97 108.36 21.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -93.94 126.16 38.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.48 163.31 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.1 -5.02 12.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.696 2.264 . . . . 0.0 112.735 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 10.9 m-85 . . . . . 0 C--N 1.333 -0.141 0 CA-C-O 120.846 0.355 . . . . 0.0 111.033 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.167 0.508 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -27.5 60.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.054 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.614 HD12 HG11 ' A' ' 85' ' ' VAL . 36.5 tp -72.85 -51.2 19.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.578 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.43 ' OE2' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -64.77 -27.74 69.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.356 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -71.19 -50.77 29.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.849 ' HG2' HG11 ' A' ' 89' ' ' VAL . 2.8 mtm -53.88 -48.0 70.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 32' ' ' GLN . 29.3 m -61.86 -45.23 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.149 0.499 . . . . 0.0 109.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -56.56 -36.62 69.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.997 178.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.97 -20.97 63.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.769 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.602 ' SG ' HG22 ' A' ' 89' ' ' VAL . 95.0 m -92.95 -3.18 54.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.403 ' CA ' ' HB3' ' A' ' 6' ' ' LYS . . . 119.92 -31.96 5.14 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.69 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.618 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -62.51 -179.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.114 0.483 . . . . 0.0 111.358 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.3 139.17 40.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.585 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG21 ' OE2' ' A' ' 28' ' ' GLU . 10.1 p -71.8 122.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.874 HG21 ' CE1' ' A' ' 45' ' ' PHE . 3.2 t -99.11 123.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -58.86 -48.09 82.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.8 mt-10 -139.13 172.33 12.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.016 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 75' ' ' CYS . 15.8 mt -65.91 -50.56 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -58.94 -21.24 57.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.158 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -23.4 67.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.874 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.2 m-85 . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.43 133.51 22.71 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.856 ' O ' HD13 ' A' ' 54' ' ' ILE . 93.0 Cg_endo -80.59 135.56 10.45 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.149 . . . . 0.0 112.615 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.856 HD13 ' O ' ' A' ' 53' ' ' PRO . 9.6 mm -140.42 142.71 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.635 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.876 HG23 ' HB3' ' A' ' 77' ' ' ALA . 39.9 t -123.28 136.91 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 57' ' ' VAL . 42.6 t -122.12 158.51 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -152.43 -173.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.517 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.665 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -174.14 89.19 0.34 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.845 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.01 83.86 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.538 2.159 . . . . 0.0 112.271 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t70 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.962 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.653 0.263 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.6 HG21 HG11 ' A' ' 79' ' ' VAL . 8.3 mm -64.37 -47.19 90.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.75 50.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.374 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.72 -17.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.628 0.252 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -93.87 -33.68 13.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.71 ' HB2' HD13 ' A' ' 42' ' ' LEU . 52.4 t -122.62 154.72 37.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.966 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.39 31.35 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.876 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -120.35 168.7 9.97 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.778 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 59.9 Cg_endo -73.07 121.59 7.4 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.605 2.204 . . . . 0.0 112.569 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.6 HG11 HG21 ' A' ' 71' ' ' ILE . 18.3 t -88.59 125.51 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 101' ' ' LEU . 27.7 m -143.21 177.15 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.835 0.35 . . . . 0.0 111.418 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 p -98.24 166.9 11.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.304 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -18.42 32.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.362 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.89 -47.86 51.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.499 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 59.3 t90 -50.72 -57.37 8.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.265 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.828 ' O ' HG23 ' A' ' 89' ' ' VAL . 84.3 t -53.84 -49.1 60.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.301 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -50.0 72.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -61.83 -32.48 72.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.752 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.2 m -77.07 -46.48 23.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.032 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.849 HG11 ' HG2' ' A' ' 30' ' ' MET . 33.0 t -71.16 -28.2 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.83 -56.65 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 93' ' ' GLN . 5.1 tt -93.28 -4.19 52.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.618 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 58.65 80.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.834 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.536 ' HB2' HD23 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -179.18 141.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.0 t -66.57 83.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.23 165.0 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.52 140.65 44.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.494 HD23 ' CG1' ' A' ' 80' ' ' VAL . 4.4 mp -88.04 -30.97 19.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.45 -32.55 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.105 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.1 m -77.29 -10.22 59.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.324 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.68 30.5 2.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 110.686 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.512 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.779 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.5 mmtm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.834 0.349 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.775 HG23 ' CE1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -76.4 -22.87 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.555 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.526 ' CE1' HD12 ' A' ' 7' ' ' ILE . 15.5 m-30 -93.64 -49.51 5.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 44.96 90.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.83 76.15 1.0 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.968 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.469 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -147.33 160.85 42.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.855 0.359 . . . . 0.0 111.118 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -140.8 109.8 6.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.727 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.7 mt -120.38 125.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.646 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.726 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 28.3 p -113.45 142.7 45.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 9.0 p -106.95 119.31 39.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.525 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.76 117.56 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.36 146.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.473 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.69 150.42 28.76 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.543 2.162 . . . . 0.0 112.315 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 4.2 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 24.4 m-20 . . . . . 0 CA--C 1.52 -0.184 0 CA-C-O 121.193 0.521 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.21 -36.7 82.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.553 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.16 -55.61 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.171 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' CG ' ' HA ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.47 -27.3 67.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.007 0.432 . . . . 0.0 110.212 179.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -63.13 -49.34 74.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 109.556 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.783 ' HB3' HG21 ' A' ' 89' ' ' VAL . 2.2 mtt -51.15 -55.15 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.706 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.609 HG13 HG13 ' A' ' 85' ' ' VAL . 22.9 m -58.82 -45.04 91.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.453 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -59.57 -33.77 71.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.288 179.358 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.06 -21.17 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.931 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 7' ' ' ILE . 3.8 m -93.28 -3.16 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.753 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.62 -22.26 10.16 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.927 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.727 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.98 178.03 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.85 135.21 46.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -71.82 117.92 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.726 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.4 t -93.89 124.49 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -25.51 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.358 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -174.85 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.318 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.692 HD13 ' HB2' ' A' ' 75' ' ' CYS . 22.6 mt -63.07 -46.34 87.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.973 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -11.38 60.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.426 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.1 m -96.0 24.73 5.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.674 0.273 . . . . 0.0 111.312 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 39' ' ' VAL . 3.4 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.725 0.298 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -94.09 136.26 23.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.973 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.896 ' O ' HD13 ' A' ' 54' ' ' ILE . 87.7 Cg_endo -83.16 132.89 6.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.705 2.27 . . . . 0.0 112.787 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 53' ' ' PRO . 10.8 mm -137.73 151.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 77' ' ' ALA . 22.4 t -129.07 149.96 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.955 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 80' ' ' VAL . 7.3 t -128.2 146.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.339 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.819 HG22 HG12 ' A' ' 79' ' ' VAL . 1.9 m -133.1 173.03 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -176.95 88.08 0.25 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.68 64.04 3.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.549 2.166 . . . . 0.0 112.28 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.776 0.322 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.856 HG22 HG21 ' A' ' 79' ' ' VAL . 23.3 mm -69.31 -64.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.4 -15.35 81.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -79.03 -24.22 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mtm -93.97 -27.3 16.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.692 ' HB2' HD13 ' A' ' 42' ' ' LEU . 49.5 t -118.94 156.22 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.77 32.33 4.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.829 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.777 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -125.77 172.32 6.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.087 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.777 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 95.1 Cg_endo -82.71 127.1 4.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.786 2.324 . . . . 0.0 112.888 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.856 HG21 HG22 ' A' ' 71' ' ' ILE . 18.8 t -98.57 130.96 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.329 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.756 ' O ' HG13 ' A' ' 56' ' ' VAL . 28.7 m -145.26 136.88 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.639 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 p -50.82 168.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.772 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -63.94 -16.44 61.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.07 -39.19 55.45 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.86 0.362 . . . . 0.0 110.608 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.505 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 79.0 t90 -62.7 -57.3 11.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 109.888 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 89' ' ' VAL . 98.0 t -54.66 -38.18 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.222 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.06 -47.79 19.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.78 -33.53 73.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.742 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -77.16 -49.53 15.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.783 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -71.38 -27.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.42 -55.09 17.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 111.104 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 91' ' ' LEU . 5.9 tt -95.65 -3.08 46.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.315 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.775 ' CE1' HG23 ' A' ' 7' ' ' ILE . 6.7 t80 57.64 76.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.59 133.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.674 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.15 97.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.099 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.6 163.67 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HG3' ' CG2' ' A' ' 99' ' ' THR . 0.4 OUTLIER -71.53 142.09 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.69 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD23 ' CG1' ' A' ' 80' ' ' VAL . 1.6 mp -87.13 -34.28 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.27 -22.88 32.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.401 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -76.26 -15.29 60.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.61 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -139.4 20.58 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.701 0.286 . . . . 0.0 111.235 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.4 mmtp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.604 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -76.64 -23.83 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.559 ' CD1' HD12 ' A' ' 7' ' ' ILE . 14.3 m-30 -93.37 -50.88 5.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 110.555 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.8 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.374 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.61 75.12 1.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.817 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.498 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -149.43 162.66 39.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.934 0.397 . . . . 0.0 111.241 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.716 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.7 mt-10 -138.64 109.68 6.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.653 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.3 mt -124.54 138.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.546 ' O ' HG23 ' A' ' 56' ' ' VAL . 29.1 p -126.54 144.62 50.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.741 ' HB3' HD23 ' A' ' 27' ' ' LEU . 14.8 p -97.62 104.5 16.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.0 102.63 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.61 162.59 17.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.44 -2.7 10.61 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.762 2.308 . . . . 0.0 112.801 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 6.0 m-85 . . . . . 0 C--N 1.332 -0.164 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.037 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 . . . . . 0 CA--C 1.521 -0.148 0 CA-C-O 121.057 0.456 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -34.46 65.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.57 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 15' ' ' CYS . 44.6 tp -73.18 -48.34 36.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.355 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' O ' HG22 ' A' ' 31' ' ' VAL . 32.6 mt-10 -62.56 -27.42 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.504 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -65.32 -49.28 70.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 109.802 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.876 ' HB3' HG21 ' A' ' 89' ' ' VAL . 5.8 mtt -52.97 -52.33 58.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.853 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 28' ' ' GLU . 35.3 m -58.8 -46.5 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 110.615 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.479 ' N ' HG23 ' A' ' 31' ' ' VAL . 16.5 tt0 -57.95 -34.47 69.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.2 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.14 -21.51 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.551 ' SG ' HD11 ' A' ' 7' ' ' ILE . 1.8 m -93.59 -3.35 52.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.782 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 115.9 -34.84 4.55 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.653 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -56.15 169.16 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.486 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.37 134.62 54.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.4 m -72.1 125.75 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 111.18 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 12' ' ' GLU . 17.6 t -114.67 128.08 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -33.52 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.926 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.1 mt-10 -121.85 155.3 35.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.364 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 75' ' ' CYS . 16.2 mt -70.78 -32.47 69.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.676 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -21.03 59.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.83 -20.46 61.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.189 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 20.3 m-85 . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.42 HG21 ' HG3' ' A' ' 12' ' ' GLU . 30.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.71 0.29 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -93.8 126.06 50.93 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.874 ' O ' HD13 ' A' ' 54' ' ' ILE . 73.1 Cg_endo -77.43 129.59 10.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.568 2.179 . . . . 0.0 112.707 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 53' ' ' PRO . 7.5 mm -141.66 154.71 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.818 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' SG ' ' A' ' 14' ' ' CYS . 30.9 t -138.21 140.31 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.86 156.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 111.115 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.615 ' CG2' HG12 ' A' ' 79' ' ' VAL . 3.2 m -144.01 -179.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.538 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.502 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.89 67.18 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.754 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.02 107.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t70 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.911 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.715 0.293 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.538 HG21 HG11 ' A' ' 79' ' ' VAL . 12.1 mm -69.59 -34.27 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 110.804 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.27 -20.91 59.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.312 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -77.32 -25.25 51.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 mtp -93.85 -29.28 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.828 ' HB2' HD13 ' A' ' 42' ' ' LEU . 54.0 t -132.35 153.5 50.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.753 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.88 -36.69 12.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.805 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -55.56 170.26 0.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.805 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.0 Cg_endo -77.11 161.82 32.19 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.615 HG12 ' CG2' ' A' ' 57' ' ' VAL . 12.1 t -127.04 121.49 58.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.733 ' O ' HG12 ' A' ' 56' ' ' VAL . 33.8 m -141.32 140.09 32.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.5 p -55.21 163.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.705 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -20.05 15.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -47.0 -40.98 15.59 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.464 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.7 t90 -58.84 -57.35 13.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.368 0.604 . . . . 0.0 110.106 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 89' ' ' VAL . 47.9 t -55.93 -42.37 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.225 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.59 -56.56 6.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -56.7 -30.87 63.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -77.19 -50.5 12.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.087 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.876 HG21 ' HB3' ' A' ' 30' ' ' MET . 47.4 t -71.27 -28.53 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.431 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -58.15 5.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.882 0.372 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.79 -10.63 47.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.203 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.604 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 64.9 79.77 0.25 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.857 0.36 . . . . 0.0 110.708 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.457 ' N ' HG21 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -177.07 129.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -64.14 85.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -68.69 172.45 6.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.94 157.53 29.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.635 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.721 HD21 ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -96.7 -25.06 15.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.057 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -21.66 66.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.412 ' HB ' ' CE1' ' A' ' 100' ' ' TYR . 25.5 m -77.08 -17.76 58.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.465 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE1' ' HB ' ' A' ' 99' ' ' THR . 1.6 m-85 -138.91 23.61 2.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.661 0.267 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.004 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 9.0 mmtm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.733 0.302 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.629 HD12 ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -80.26 -20.19 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.748 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' HD12 ' A' ' 7' ' ' ILE . 18.0 m-30 -93.63 -48.12 6.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 39.3 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.23 68.85 1.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.772 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -137.2 160.66 38.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.666 ' H ' HD23 ' A' ' 11' ' ' LEU . 2.0 mt-10 -137.64 111.11 8.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.718 HD11 HD22 ' A' ' 11' ' ' LEU . 3.0 mt -122.2 121.84 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.804 ' SG ' HG13 ' A' ' 55' ' ' VAL . 19.4 p -107.51 132.02 53.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 m -95.31 101.65 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.535 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.473 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -93.88 102.73 14.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.108 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.91 144.02 7.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.801 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 23.9 Cg_exo -63.1 -13.41 35.29 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.8 2.334 . . . . 0.0 112.515 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.6 m-30 . . . . . 0 C--N 1.333 -0.142 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.144 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 121.025 0.44 . . . . 0.0 110.558 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.87 -31.36 51.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -74.55 -45.89 42.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.346 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -63.03 -27.72 69.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -66.77 -52.05 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 109.776 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.889 ' HB3' HG21 ' A' ' 89' ' ' VAL . 11.9 mtm -53.71 -50.52 65.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.668 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 32' ' ' GLN . 28.0 m -60.78 -45.46 97.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.483 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt-30 -56.74 -34.77 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.019 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.5 tp -70.19 -21.57 63.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.705 ' SG ' HG22 ' A' ' 89' ' ' VAL . 21.3 m -93.41 -3.53 53.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.729 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 105.82 15.67 17.81 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.156 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.655 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -101.69 173.53 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.145 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.57 132.52 51.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.655 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 13.8 p -71.98 122.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 45' ' ' PHE . 1.1 t -93.91 127.55 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -59.27 -40.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.67 -177.13 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 75' ' ' CYS . 20.2 mt -72.74 -38.86 67.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.04 -8.71 56.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -92.89 18.17 9.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.0 m-85 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.2 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.802 0.334 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.31 118.46 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.726 ' O ' HD13 ' A' ' 54' ' ' ILE . 95.8 Cg_endo -80.02 128.55 7.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.567 2.178 . . . . 0.0 112.643 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.918 HG13 HD21 ' A' ' 11' ' ' LEU . 7.6 mm -144.76 156.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.804 HG13 ' SG ' ' A' ' 14' ' ' CYS . 14.7 t -137.98 144.49 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.029 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.6 HG23 ' CG2' ' A' ' 13' ' ' ILE . 22.0 t -128.21 159.32 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 111.246 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -152.45 -169.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.631 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -179.17 72.25 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.25 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.645 2.23 . . . . 0.0 112.439 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.716 0.293 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.529 HG22 HG21 ' A' ' 79' ' ' VAL . 31.2 mm -68.69 -60.19 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.5 -21.83 65.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.478 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.96 -16.2 45.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.686 0.279 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -27.45 16.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.957 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' ' 42' ' ' LEU . 42.6 t -133.08 156.64 47.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.943 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -100.61 30.27 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -124.16 156.51 66.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.018 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 30.3 Cg_endo -64.11 150.11 89.01 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.298 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 71' ' ' ILE . 34.2 t -121.14 128.49 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.566 ' CG1' HD23 ' A' ' 97' ' ' LEU . 28.6 m -144.0 177.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.9 p -93.7 173.98 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.721 ' HB3' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -67.68 -11.64 58.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.243 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -56.86 -40.62 76.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.887 0.375 . . . . 0.0 110.242 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.518 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.5 t90 -56.82 -57.42 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 110.029 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 89' ' ' VAL . 66.3 t -56.09 -46.53 80.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.113 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -56.59 12.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.45 -31.55 67.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -77.14 -48.89 16.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.954 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 30' ' ' MET . 49.0 t -71.32 -28.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.66 -59.07 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.064 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 tp -88.48 -11.99 44.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.74 83.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.474 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 tt0 -177.11 133.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.23 78.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.83 169.01 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.788 ' HG3' HG23 ' A' ' 99' ' ' THR . 2.3 pt-20 -82.68 142.23 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.643 HD21 ' CG2' ' A' ' 54' ' ' ILE . 4.1 mp -79.85 -28.87 39.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.97 -30.49 47.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.788 HG23 ' HG3' ' A' ' 96' ' ' GLU . 41.3 p -76.11 -13.39 60.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.6 27.88 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.553 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.735 0.302 . . . . 0.0 110.559 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.623 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -101.9 -20.91 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 17.1 m-30 -93.49 -47.9 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.782 0.325 . . . . 0.0 110.446 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.74 87.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.555 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.54 72.64 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.077 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.506 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -144.31 162.4 36.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.6 mt-10 -138.41 109.77 6.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.157 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -126.01 141.1 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.5 p -126.43 147.46 49.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.078 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.631 ' SG ' HD23 ' A' ' 27' ' ' LEU . 14.9 m -105.61 113.42 26.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.609 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.58 120.0 33.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.9 168.75 45.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.579 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.79 1.23 9.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.821 2.348 . . . . 0.0 112.738 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.048 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.172 0.51 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.7 -32.13 67.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.371 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.631 HD23 ' SG ' ' A' ' 15' ' ' CYS . 18.0 tp -70.94 -50.31 36.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.364 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' HG22 ' A' ' 31' ' ' VAL . 14.5 mt-10 -59.83 -27.42 66.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.979 0.418 . . . . 0.0 110.547 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -64.88 -50.08 67.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.238 0.542 . . . . 0.0 109.646 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.86 ' HB3' HG21 ' A' ' 89' ' ' VAL . 14.5 mtt -51.22 -51.29 55.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.072 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 28' ' ' GLU . 28.6 m -59.38 -45.67 93.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.923 0.392 . . . . 0.0 110.528 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.7 tm0? -58.5 -34.47 70.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.044 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.01 -21.09 63.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.78 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 89' ' ' VAL . 1.7 m -93.1 -3.25 54.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.615 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 112.91 -20.9 19.27 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.982 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -70.49 174.61 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 111.314 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.84 135.48 55.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.1 m -71.77 123.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 14.4 t -102.99 122.39 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -49.48 76.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.576 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 39' ' ' VAL . 3.6 mm-40 -140.15 177.7 7.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.375 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 75' ' ' CYS . 14.5 mt -67.36 -48.17 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.793 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 m -59.06 -21.13 58.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.54 ' HB3' HG13 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -65.9 -21.01 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.218 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HZ ' ' HG ' ' A' ' 14' ' ' CYS . 17.9 m-85 . . . . . 0 C--N 1.332 -0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 111.063 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.81 0.338 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -94.03 136.03 24.09 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.827 ' O ' HD13 ' A' ' 54' ' ' ILE . 89.5 Cg_endo -80.71 138.51 11.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.677 2.252 . . . . 0.0 112.565 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 53' ' ' PRO . 8.5 mm -144.29 150.89 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.976 HG23 ' HB3' ' A' ' 77' ' ' ALA . 41.6 t -131.21 139.0 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 57' ' ' VAL . 60.9 t -124.67 157.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 0.0 111.371 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.637 HG12 ' H ' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -156.68 -173.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 -179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.637 ' H ' HG12 ' A' ' 57' ' ' VAL . 4.7 tt0 178.66 80.47 0.16 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.574 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.53 112.24 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.649 2.232 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.731 179.983 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.746 HG21 HG11 ' A' ' 79' ' ' VAL . 25.4 mm -71.42 -60.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.38 -22.95 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.691 0.282 . . . . 0.0 111.103 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -30.66 14.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.714 ' HB2' HD22 ' A' ' 42' ' ' LEU . 31.2 p -105.6 162.9 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -116.05 37.64 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.976 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -148.79 168.22 11.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.777 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 56.6 Cg_endo -70.22 112.48 3.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.656 2.237 . . . . 0.0 112.517 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.746 HG11 HG21 ' A' ' 71' ' ' ILE . 34.8 t -81.3 127.1 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.784 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.623 ' CG1' HD23 ' A' ' 97' ' ' LEU . 28.2 m -140.27 176.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 11.6 p -94.4 159.24 15.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.14 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -22.06 6.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.312 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.81 -40.59 21.46 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.95 0.405 . . . . 0.0 110.684 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 84.4 t90 -62.16 -57.23 12.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.363 0.602 . . . . 0.0 110.027 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 89' ' ' VAL . 60.3 t -56.1 -37.09 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.17 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 -54.55 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.83 -30.44 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.772 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.4 m -77.17 -50.96 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.86 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.7 t -71.19 -28.56 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.365 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.17 -54.33 22.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 93' ' ' GLN . 4.5 tt -97.52 2.7 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.339 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.623 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 53.5 82.86 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 111.054 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.527 ' HB2' HD23 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -178.68 128.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 p -66.08 86.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.91 170.71 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.9 125.96 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.815 HD21 ' CG2' ' A' ' 54' ' ' ILE . 3.7 mp -64.11 -29.53 70.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -54.47 -29.29 49.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.247 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -77.56 -17.28 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -134.31 29.49 3.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.2 p -119.2 -64.81 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.889 0.376 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -125.45 26.88 6.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -147.7 176.05 10.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.873 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.92 -62.52 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.022 0.439 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.7 OUTLIER 64.08 134.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.644 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.749 HD11 ' SG ' ' A' ' 34' ' ' CYS . 5.6 pt -76.44 -21.08 15.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.711 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 13.1 m-30 -93.74 -48.25 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.609 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 45.32 91.96 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 71.09 77.47 0.5 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.205 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.915 HD21 HG13 ' A' ' 54' ' ' ILE . 0.8 OUTLIER -144.22 158.76 43.55 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.741 0.305 . . . . 0.0 111.079 -178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.689 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.6 OUTLIER -136.95 113.37 10.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.799 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.722 HD11 HD22 ' A' ' 11' ' ' LEU . 2.2 mt -127.17 128.97 70.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.884 0.373 . . . . 0.0 111.443 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.607 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.5 p -115.97 131.42 56.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HB3' HD23 ' A' ' 27' ' ' LEU . 25.9 p -97.07 106.33 18.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.526 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -93.8 130.03 39.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.56 164.03 28.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.487 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.615 ' HG2' ' HB3' ' A' ' 61' ' ' ALA . 90.0 Cg_endo -80.42 -16.19 10.83 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.748 2.299 . . . . 0.0 112.726 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CD2' ' HB2' ' A' ' 23' ' ' PRO . 5.5 m-85 63.22 -80.8 0.03 OUTLIER 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.854 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.1 -78.03 0.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -172.41 51.4 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.421 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 4.2 ttm 178.95 -51.1 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.968 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.493 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 21.3 Cg_exo -66.0 64.11 0.45 Allowed 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.734 2.289 . . . . 0.0 112.429 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.67 -73.1 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.441 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -87.24 -31.33 20.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.227 0.536 . . . . 0.0 109.693 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.43 -24.84 50.32 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.95 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 15' ' ' CYS . 15.9 tp -74.15 -48.75 27.27 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.801 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER -65.02 -27.61 68.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.883 0.373 . . . . 0.0 110.462 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.44 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.1 t90 -69.56 -49.82 50.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 109.562 178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.831 ' HB3' HG21 ' A' ' 89' ' ' VAL . 34.5 mtp -54.3 -48.57 71.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.783 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.3 m -62.31 -45.16 99.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.191 0.519 . . . . 0.0 109.863 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.473 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.86 -36.52 72.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.156 179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.3 tp -70.07 -21.11 63.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.778 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.749 ' SG ' HD11 ' A' ' 7' ' ' ILE . 10.3 m -92.98 -3.21 54.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.738 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.65 -14.66 17.43 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.113 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.661 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -76.21 179.71 5.56 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.167 0.508 . . . . 0.0 111.537 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.41 135.77 46.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.452 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -71.74 114.44 10.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.928 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.736 HG21 ' CE1' ' A' ' 45' ' ' PHE . 5.3 t -95.26 123.92 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.978 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -49.55 74.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.595 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.467 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.8 mt-10 -141.22 -176.9 4.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.278 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.733 HD13 ' HB3' ' A' ' 75' ' ' CYS . 19.2 mt -72.19 -39.02 68.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.22 -7.05 52.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.49 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.01 -23.71 59.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.61 0.243 . . . . 0.0 111.23 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.736 ' CE1' HG21 ' A' ' 39' ' ' VAL . 29.6 m-85 -52.58 135.77 33.73 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.739 0.304 . . . . 0.0 111.11 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 m -132.04 129.75 40.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 47' ' ' LEU . 0.3 OUTLIER -78.61 85.64 4.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.1 -105.5 0.27 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.575 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.7 p -127.96 -45.42 1.43 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.91 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -135.86 30.08 2.79 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.513 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -107.29 111.59 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 111.203 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -93.96 135.43 24.77 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.811 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.733 ' O ' HD13 ' A' ' 54' ' ' ILE . 85.6 Cg_endo -82.14 137.12 9.41 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.687 2.258 . . . . 0.0 112.713 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.915 HG13 HD21 ' A' ' 11' ' ' LEU . 8.8 mm -144.44 152.43 15.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.658 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.783 HG23 ' HB3' ' A' ' 77' ' ' ALA . 42.4 t -128.28 151.14 34.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.597 HG23 ' CG2' ' A' ' 13' ' ' ILE . 85.6 t -129.09 146.96 33.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.256 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.838 HG22 HG12 ' A' ' 79' ' ' VAL . 2.8 m -139.1 -175.97 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.472 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -175.49 93.29 0.28 Allowed Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.88 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.52 61.78 2.82 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.6 2.2 . . . . 0.0 112.357 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -120.33 -67.96 0.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.71 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HG2' ' A' ' 18' ' ' PRO . . . -84.3 -24.11 30.0 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.106 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.501 ' O ' HG22 ' A' ' 63' ' ' THR . 0.0 OUTLIER -56.68 -29.84 62.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.069 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 62' ' ' TRP . 14.8 t 45.96 -168.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.35 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.03 126.88 55.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.969 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -177.34 -42.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -97.49 -50.09 4.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 127.93 115.03 1.86 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.741 ' CD1' HD11 ' A' ' 71' ' ' ILE . 43.1 t80 -102.08 7.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.573 0.225 . . . . 0.0 111.483 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 19.8 t-160 -91.38 55.27 2.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.876 0.369 . . . . 0.0 111.031 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -176.26 36.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.302 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.024 HG22 HG21 ' A' ' 79' ' ' VAL . 30.7 mm -71.75 -63.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.961 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.83 -25.24 58.81 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.313 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -77.29 -24.81 50.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.82 0.343 . . . . 0.0 110.991 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.8 mtp -93.92 -31.07 14.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.733 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.9 p -106.73 150.66 26.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.904 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -101.83 31.61 3.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.45 168.61 11.95 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.763 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 73.7 Cg_endo -74.9 121.74 6.81 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.693 2.262 . . . . 0.0 112.464 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.024 HG21 HG22 ' A' ' 71' ' ' ILE . 12.1 t -92.87 124.0 45.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.823 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.538 HG11 ' CB ' ' A' ' 97' ' ' LEU . 3.9 m -137.16 131.75 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.699 0.285 . . . . 0.0 111.431 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 p -50.87 157.2 0.84 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.9 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.23 -24.32 2.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.355 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 1.3 tp10 -45.55 -39.82 7.94 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 120.765 0.317 . . . . 0.0 110.673 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.501 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.9 t90 -60.7 -57.29 13.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.517 0.675 . . . . 0.0 109.903 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.754 ' O ' HG23 ' A' ' 89' ' ' VAL . 81.5 t -54.23 -41.46 51.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.751 -1.113 . . . . 0.0 111.251 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -50.5 27.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -60.02 -33.08 71.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.892 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 92' ' ' TYR . 51.0 m -77.1 -47.44 20.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.064 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.831 HG21 ' HB3' ' A' ' 30' ' ' MET . 57.9 t -71.16 -26.21 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.291 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.74 -58.52 4.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 0.0 111.127 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.85 -13.42 33.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.3 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.533 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 69.22 80.91 0.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 0.0 110.759 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.651 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.9 OUTLIER 179.16 129.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 9.1 t -60.93 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -68.67 159.08 32.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -66.7 126.02 27.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.706 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.78 HD21 ' CG2' ' A' ' 54' ' ' ILE . 3.0 mp -66.03 -32.17 73.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.339 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.18 -23.21 13.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.555 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 87.0 m -75.48 -19.75 59.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.617 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 21.1 m-85 -134.66 19.8 3.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 0.0 111.306 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 102' ' ' ILE . 0.2 OUTLIER -86.63 173.72 9.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.969 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.616 HD11 ' HB ' ' A' ' 79' ' ' VAL . 4.6 mt -59.98 110.08 2.52 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.027 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.97 -63.89 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.37 2.047 . . . . 0.0 112.304 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.42 88.97 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.944 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 pt -141.54 156.23 66.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.72 154.5 60.11 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.68 2.253 . . . . 0.0 112.146 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.62 -174.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.1 t -152.5 -57.99 0.14 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -117.0 115.89 26.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.006 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.875 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.542 -0.223 . . . . 0.0 112.542 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.1 p -107.16 157.34 17.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.838 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 59.0 98.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.29 -51.26 2.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.099 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 4.8 mmt85 56.93 94.57 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.735 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.0 mmtt -116.05 138.98 50.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.952 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.588 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -82.38 -17.94 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.624 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.6 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 14.6 m-30 -93.63 -42.81 8.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.81 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HG3' ' O ' ' A' ' 8' ' ' PHE . 5.1 ptm180 35.85 84.34 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.86 0.362 . . . . 0.0 111.854 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.95 66.77 1.55 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.772 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.923 HD21 HG13 ' A' ' 54' ' ' ILE . 1.5 tt -138.78 152.52 47.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.754 0.312 . . . . 0.0 110.792 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.78 ' HG2' HG22 ' A' ' 39' ' ' VAL . 2.5 mt-10 -130.85 119.36 22.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.775 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.756 HD11 HD22 ' A' ' 11' ' ' LEU . 2.6 mt -130.51 123.8 55.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.709 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.841 ' SG ' HG13 ' A' ' 55' ' ' VAL . 31.9 p -107.64 135.33 49.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.714 ' HB3' HD23 ' A' ' 27' ' ' LEU . 22.7 p -94.33 99.2 11.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.676 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -93.82 112.84 24.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.924 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.31 159.73 11.9 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.33 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.49 -13.53 9.69 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.791 2.327 . . . . 0.0 112.827 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.0 m-85 63.87 -79.2 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.857 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -130.72 -76.38 0.53 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -178.2 39.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.405 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.2 OUTLIER 178.23 -52.14 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.979 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.405 ' CD ' ' N ' ' A' ' 22' ' ' MET . 47.1 Cg_exo -56.58 83.84 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.499 2.133 . . . . 0.0 112.464 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.42 -54.32 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.531 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.75 -27.95 24.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.296 0.57 . . . . 0.0 109.845 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 -28.23 58.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.998 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.714 HD23 ' HB3' ' A' ' 15' ' ' CYS . 14.1 tp -72.11 -50.94 23.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.62 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -63.62 -27.54 69.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.878 0.37 . . . . 0.0 110.564 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CE3' ' HG3' ' A' ' 30' ' ' MET . 9.4 t90 -69.93 -50.17 44.66 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.9 ' HB3' HG21 ' A' ' 89' ' ' VAL . 37.3 mtp -54.04 -48.37 70.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.774 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.1 m -61.89 -44.6 99.1 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 CA-C-O 121.189 0.518 . . . . 0.0 109.947 179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.463 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.9 mt-30 -58.33 -35.23 71.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.198 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -20.97 63.17 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.009 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.496 ' SG ' HG22 ' A' ' 89' ' ' VAL . 19.4 m -93.04 -3.44 54.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.851 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 115.05 -3.96 22.43 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.253 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.699 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -86.67 -179.61 6.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.257 0.551 . . . . 0.0 111.402 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -133.54 133.95 42.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.32 179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.3 p -71.62 114.39 9.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.861 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.78 HG22 ' HG2' ' A' ' 12' ' ' GLU . 1.6 t -93.66 134.4 31.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.016 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.2 pttm -80.51 -36.01 33.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.256 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -131.99 164.74 25.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.137 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.832 HD13 ' HB3' ' A' ' 75' ' ' CYS . 37.8 mt -73.29 -37.07 66.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.761 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.8 m -75.95 -6.05 49.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.427 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.02 2.08 36.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.547 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.669 ' CE1' HG21 ' A' ' 39' ' ' VAL . 13.7 m-85 -68.06 157.15 35.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 110.947 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.71 96.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.895 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.17 -32.44 10.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -135.71 -98.21 0.54 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.556 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.6 m -140.21 -45.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.73 0.3 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -93.86 70.03 1.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.521 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG11 ' CD ' ' A' ' 12' ' ' GLU . 21.2 t -146.27 123.98 4.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.853 0.359 . . . . 0.0 110.943 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.84 122.44 62.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.88 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' O ' HD13 ' A' ' 54' ' ' ILE . 89.3 Cg_endo -80.84 126.78 5.97 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.559 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.923 HG13 HD21 ' A' ' 11' ' ' LEU . 12.6 mm -142.91 160.5 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.841 HG13 ' SG ' ' A' ' 14' ' ' CYS . 6.9 t -142.31 151.18 18.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 HG22 ' A' ' 13' ' ' ILE . 3.0 t -117.42 157.99 18.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 0.0 111.107 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.724 HG13 HG12 ' A' ' 79' ' ' VAL . 4.9 m -147.01 -178.14 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.68 92.66 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.079 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.1 59.48 5.92 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.576 2.184 . . . . 0.0 112.339 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -41.85 3.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.749 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -119.58 30.18 7.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.967 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -97.7 -49.06 4.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 61.26 154.84 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.93 86.31 5.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -132.41 -61.57 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -83.55 -46.34 12.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.74 104.76 1.46 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.407 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.74 ' CD1' HD11 ' A' ' 71' ' ' ILE . 41.0 t80 -101.23 7.06 43.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.521 0.201 . . . . 0.0 111.407 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.47 49.6 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.874 0.369 . . . . 0.0 110.892 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.51 36.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.203 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.74 HD11 ' CD1' ' A' ' 68' ' ' PHE . 29.7 mm -72.84 -61.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.143 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.06 -27.24 62.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.44 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -78.43 -23.26 46.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 111.007 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -93.96 -29.19 15.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.881 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.832 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.4 p -114.94 151.5 33.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -93.9 -26.01 17.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.608 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -84.15 159.46 59.52 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.034 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 49.6 Cg_endo -67.99 147.95 75.02 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.509 2.14 . . . . 0.0 112.432 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.724 HG12 HG13 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -118.16 128.76 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 97' ' ' LEU . 27.2 m -140.1 157.05 25.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.768 0.318 . . . . 0.0 111.263 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.4 p -70.19 158.91 34.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.321 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.03 -22.19 3.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.428 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -47.15 -43.7 21.21 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.85 0.357 . . . . 0.0 110.77 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.51 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 78.0 t90 -55.16 -57.25 12.53 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.54 0.686 . . . . 0.0 110.102 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.783 ' O ' HG23 ' A' ' 89' ' ' VAL . 85.2 t -53.63 -46.68 61.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.176 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.22 -49.72 66.3 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.793 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -61.82 -33.0 73.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.3 m -77.08 -46.81 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.054 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.9 HG21 ' HB3' ' A' ' 30' ' ' MET . 43.9 t -71.08 -31.45 44.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.03 -60.4 2.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.089 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 14.0 tp -82.51 -19.53 38.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.197 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.588 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 71.46 76.89 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.045 0.45 . . . . 0.0 110.613 -179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.401 ' C ' HD13 ' A' ' 7' ' ' ILE . 23.4 tt0 -177.68 132.89 0.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.772 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 14.5 p -64.38 83.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.046 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -64.85 168.79 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -77.2 133.84 38.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.735 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.799 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.1 mp -74.52 -32.03 62.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.39 -22.66 32.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.426 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.9 m -73.54 -20.67 60.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.467 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -140.09 28.24 2.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 111.063 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.518 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -88.7 152.2 21.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.952 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.492 HG12 HG23 ' A' ' 79' ' ' VAL . 1.1 pp -61.28 149.23 83.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.18 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.9 -179.44 4.61 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.577 2.185 . . . . 0.0 112.382 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -169.72 90.02 0.19 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.804 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 4.0 pt -74.75 121.69 85.82 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.16 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.87 -30.31 9.4 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.414 2.076 . . . . 0.0 112.323 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.95 144.05 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.9 t -113.06 83.13 1.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.953 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.62 111.43 7.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.868 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.873 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.397 -0.281 . . . . 0.0 112.397 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 t -170.31 -42.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -83.1 96.45 8.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.942 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.15 -44.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 69.64 0.69 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.595 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 12.8 pttm -80.83 174.51 11.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.194 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.68 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -123.73 -14.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.018 -179.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.595 ' CD1' HD13 ' A' ' 11' ' ' LEU . 9.4 m-30 -93.45 -44.07 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.535 0.207 . . . . 0.0 110.648 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 41.05 87.55 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.259 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.22 72.72 0.98 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.463 -0.875 . . . . 0.0 111.382 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.939 HD21 HG13 ' A' ' 54' ' ' ILE . 2.4 tt -146.23 125.15 12.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.648 0.261 . . . . 0.0 110.838 -178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.719 ' HG2' HG22 ' A' ' 39' ' ' VAL . 1.2 mt-10 -104.31 123.33 47.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.699 0.285 . . . . 0.0 110.939 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.742 HD11 HD22 ' A' ' 11' ' ' LEU . 2.6 mt -129.96 123.77 57.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.864 0.364 . . . . 0.0 111.449 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.694 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 26.1 p -110.77 144.08 40.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 m -107.13 114.16 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.83 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -97.18 110.0 22.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.004 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.0 148.47 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.26 -171.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.608 2.205 . . . . 0.0 112.261 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 5.5 m-85 -127.11 -78.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -121.4 -43.35 2.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.664 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 51.5 m-20 -129.58 -75.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.476 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.486 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -167.71 54.59 0.28 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.0 179.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 22' ' ' MET . 61.4 Cg_endo -88.46 20.28 1.17 Allowed 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.82 2.347 . . . . 0.0 112.865 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -56.73 -41.67 77.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.772 0.32 . . . . 0.0 111.138 -179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -85.45 -25.27 27.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.499 . . . . 0.0 110.165 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.36 -30.57 60.26 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.236 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.635 HD12 HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -72.58 -50.83 22.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.348 179.486 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' HB3' HG23 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -62.65 -27.85 69.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.497 179.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -68.7 -51.61 39.77 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.744 ' HB3' HG21 ' A' ' 89' ' ' VAL . 54.9 mtm -53.11 -49.61 66.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.815 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG23 ' N ' ' A' ' 32' ' ' GLN . 29.7 m -62.01 -45.23 99.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-O 121.136 0.493 . . . . 0.0 109.844 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.478 ' N ' HG23 ' A' ' 31' ' ' VAL . 7.8 mt-30 -57.16 -35.54 69.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.002 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.5 tp -69.54 -21.4 63.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.699 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.535 ' SG ' HG22 ' A' ' 89' ' ' VAL . 1.8 m -93.42 -3.25 53.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.58 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.64 -17.86 25.24 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.87 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.648 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -72.25 178.11 4.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.221 0.534 . . . . 0.0 111.648 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.48 150.9 49.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.462 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 28' ' ' GLU . 13.9 p -86.51 120.66 36.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.828 0.346 . . . . 0.0 111.214 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.719 HG22 ' HG2' ' A' ' 12' ' ' GLU . 1.3 t -93.89 128.47 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -48.42 81.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.124 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -144.71 179.95 6.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.962 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 75' ' ' CYS . 30.3 mt -66.16 -42.8 88.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.904 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.8 t -70.02 -20.8 63.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.271 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.642 ' HB2' HG12 ' A' ' 39' ' ' VAL . 61.5 m -66.82 -15.28 63.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.422 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.606 ' CE1' HG21 ' A' ' 39' ' ' VAL . 9.7 m-85 -51.97 104.52 0.09 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.857 0.36 . . . . 0.0 111.222 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -137.43 155.82 48.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -153.5 136.88 15.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -113.05 -28.57 3.32 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.411 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -114.81 -60.27 1.91 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 0.0 110.851 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.56 86.57 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.635 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.85 131.67 72.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.743 0.306 . . . . 0.0 110.979 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -94.09 127.6 44.31 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.613 ' O ' HD13 ' A' ' 54' ' ' ILE . 92.9 Cg_endo -80.3 131.38 8.61 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.585 2.19 . . . . 0.0 112.639 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.939 HG13 HD21 ' A' ' 11' ' ' LEU . 8.1 mm -143.44 161.89 16.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.617 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 77' ' ' ALA . 21.3 t -138.11 151.2 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.747 0.308 . . . . 0.0 111.193 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 80' ' ' VAL . 4.0 t -126.31 149.95 31.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.316 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.805 HG22 HG12 ' A' ' 79' ' ' VAL . 3.6 m -144.43 -177.64 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 3.6 tp60 178.06 70.73 0.11 Allowed Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.77 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.07 92.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.57 2.18 . . . . 0.0 112.248 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -161.74 -44.28 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -120.76 42.67 2.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.153 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.411 ' O ' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -76.91 -5.99 50.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.349 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 62' ' ' TRP . 84.8 m 65.38 -76.16 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.861 0.362 . . . . 0.0 111.075 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -90.91 131.45 36.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.85 79.21 1.5 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -89.13 -59.38 2.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.769 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.41 104.1 0.18 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.324 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.725 ' CD1' HD11 ' A' ' 71' ' ' ILE . 4.7 t80 -96.35 7.25 46.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.63 50.66 1.94 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.97 0.414 . . . . 0.0 111.001 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -171.53 34.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.234 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.784 HG22 HG21 ' A' ' 79' ' ' VAL . 33.8 mm -75.66 -59.44 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.02 -21.91 70.12 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.544 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -85.97 -19.79 29.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.671 0.272 . . . . 0.0 111.041 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.2 ttp -93.92 -29.08 15.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.928 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.607 ' HB3' HD13 ' A' ' 42' ' ' LEU . 29.8 p -107.49 151.35 25.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.835 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.25 30.25 2.88 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.986 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -139.81 159.22 65.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.47 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.3 Cg_endo -75.0 123.16 7.68 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.75 2.3 . . . . 0.0 112.248 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.805 HG12 HG22 ' A' ' 57' ' ' VAL . 5.5 t -91.62 140.42 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.785 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.7 m -152.11 133.38 4.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.788 0.327 . . . . 0.0 111.629 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 14.7 p -47.64 159.23 0.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.793 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.414 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.17 -21.01 11.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.273 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 100' ' ' TYR . 3.0 tt0 -47.34 -41.24 19.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.888 0.375 . . . . 0.0 110.714 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.516 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.2 t90 -57.43 -57.37 12.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.537 0.684 . . . . 0.0 110.07 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.735 ' O ' HG23 ' A' ' 89' ' ' VAL . 59.0 t -53.65 -44.03 56.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.323 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -53.12 21.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -57.87 -29.98 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 92' ' ' TYR . 64.8 m -76.94 -49.15 16.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.109 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.744 HG21 ' HB3' ' A' ' 30' ' ' MET . 26.9 t -71.14 -28.38 32.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.366 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -69.21 -57.27 5.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.354 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 69.3 tp -90.25 -11.44 40.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.468 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.68 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 62.53 76.96 0.35 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.938 0.399 . . . . 0.0 110.652 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -178.67 132.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.78 86.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.993 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -69.06 166.62 17.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.853 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.45 156.85 35.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.753 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.654 HD21 ' CG2' ' A' ' 54' ' ' ILE . 1.0 OUTLIER -101.94 -20.93 14.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.176 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -25.59 65.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.011 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.4 m -74.71 -14.88 60.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.579 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.413 ' CD1' ' HB3' ' A' ' 83' ' ' GLU . 14.0 m-85 -139.23 16.55 2.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.566 0.222 . . . . 0.0 111.269 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.409 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -76.47 98.51 4.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.147 -179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 23.3 mt 63.62 128.36 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -73.64 -178.44 3.74 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.364 2.043 . . . . 0.0 112.293 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -177.43 153.79 0.95 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.59 136.45 96.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.068 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -73.25 164.88 34.11 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.519 2.146 . . . . 0.0 112.35 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.48 105.2 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 5.6 t -150.28 123.89 9.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.9 m80 60.56 44.57 11.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.805 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.47 -175.75 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.801 0.334 . . . . 0.0 110.896 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -81.46 60.32 4.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.8 -34.15 5.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 -69.5 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 3.2 mmtt 63.87 123.35 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.728 HD13 ' N ' ' A' ' 93' ' ' GLN . 5.8 pt -63.36 -20.6 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.533 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.769 ' HD2' ' HB2' ' A' ' 36' ' ' ALA . 4.8 m-30 -93.83 -49.7 5.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.891 0.377 . . . . 0.0 110.418 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 45.21 90.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.351 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.95 75.7 0.99 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.303 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.548 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -143.0 159.3 42.49 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.798 0.333 . . . . 0.0 111.039 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -142.3 109.89 5.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.508 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.654 HD12 ' HB1' ' A' ' 36' ' ' ALA . 1.6 mt -121.96 125.55 73.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.941 0.4 . . . . 0.0 111.558 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.629 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.9 p -101.28 144.33 30.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.996 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 25.0 p -101.48 102.93 13.78 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.806 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -93.87 136.34 34.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.789 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' O ' ' CD1' ' A' ' 19' ' ' PHE . . . 87.01 144.72 8.78 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.311 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 16.5 Cg_exo -66.65 -9.63 25.09 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.826 2.35 . . . . 0.0 112.757 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 17' ' ' GLY . 69.5 m-85 67.56 -74.39 0.07 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.929 0.395 . . . . 0.0 110.713 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.704 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 39.9 p -153.71 -75.52 0.12 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.734 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 177.85 39.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.629 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.42 ' CB ' ' CD ' ' A' ' 23' ' ' PRO . 1.7 mtm -173.35 -62.42 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.966 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.42 ' CD ' ' CB ' ' A' ' 22' ' ' MET . 30.7 Cg_endo -63.48 89.62 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.452 2.102 . . . . 0.0 112.47 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.8 -54.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.656 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -84.63 -27.06 27.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.275 0.559 . . . . 0.0 109.985 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -76.26 -27.2 56.62 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.317 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 85' ' ' VAL . 3.0 tm? -73.81 -48.84 28.49 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.44 -27.68 68.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.679 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.8 t90 -71.12 -49.68 41.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.963 ' HB3' HG21 ' A' ' 89' ' ' VAL . 53.7 mtm -54.52 -48.32 72.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.769 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.487 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.9 m -62.08 -44.92 99.62 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 121.3 0.571 . . . . 0.0 109.881 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.487 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.2 mt-30 -58.91 -35.52 73.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.441 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 35.2 tp -70.13 -21.9 63.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.407 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.883 ' SG ' HG22 ' A' ' 89' ' ' VAL . 23.4 m -94.02 -3.44 51.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.919 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 109.1 31.41 3.33 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.498 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.769 ' HB2' ' HD2' ' A' ' 8' ' ' PHE . . . -116.23 175.61 5.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.01 0.433 . . . . 0.0 111.038 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.56 128.9 38.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.422 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG13 ' O ' ' A' ' 38' ' ' VAL . 11.9 p -71.68 116.13 12.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.565 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -93.81 120.3 43.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.964 -179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.18 -33.67 67.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.093 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -155.46 177.48 11.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.712 HD22 ' HB2' ' A' ' 75' ' ' CYS . 15.6 mt -68.89 -39.95 79.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.39 -18.5 63.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.32 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.539 ' O ' HD12 ' A' ' 47' ' ' LEU . 1.2 m -77.11 -4.33 43.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.58 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.605 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.3 m-85 -56.96 -178.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 111.015 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 t 43.4 86.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.486 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 44' ' ' SER . 11.5 mt -146.69 98.16 3.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.943 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 139.41 -113.18 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.27 -66.52 0.54 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 0.0 110.92 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -128.25 91.45 0.34 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.49 139.94 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.164 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -93.77 128.42 41.81 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.829 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.905 ' O ' HD13 ' A' ' 54' ' ' ILE . 83.9 Cg_endo -80.94 127.34 6.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.601 2.201 . . . . 0.0 112.781 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.905 HD13 ' O ' ' A' ' 53' ' ' PRO . 11.6 mm -134.96 161.64 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.704 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.69 HG23 ' HB3' ' A' ' 77' ' ' ALA . 38.5 t -139.05 139.76 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.576 HG23 ' CG2' ' A' ' 13' ' ' ILE . 53.6 t -115.75 158.59 16.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.502 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.809 HG22 HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -150.39 175.26 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.943 0.402 . . . . 0.0 111.555 -179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.443 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER 177.27 63.06 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.684 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.03 115.08 1.66 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.615 2.21 . . . . 0.0 112.395 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.9 -41.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.704 ' HB2' ' HA ' ' A' ' 20' ' ' THR . . . -98.67 27.65 4.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.218 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.405 ' CE3' ' O ' ' A' ' 66' ' ' ASN . 4.0 m95 -90.72 -38.43 13.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.707 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.55 176.2 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.156 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 62.89 -79.6 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.126 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -140.2 173.34 11.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.932 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.405 ' O ' ' CE3' ' A' ' 62' ' ' TRP . 2.8 t30 -80.04 -65.75 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.871 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.09 27.14 68.41 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.672 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.54 ' CZ ' HG13 ' A' ' 71' ' ' ILE . 14.0 t80 -93.59 7.33 45.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.628 0.251 . . . . 0.0 111.389 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -88.2 35.66 0.76 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.713 0.292 . . . . 0.0 111.539 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -161.91 24.69 0.12 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.777 HG22 HG21 ' A' ' 79' ' ' VAL . 28.2 mm -80.56 -48.61 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.11 -18.79 73.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.273 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -97.74 -14.63 20.73 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.463 0.173 . . . . 0.0 111.225 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.1 mtp -93.6 -28.46 16.01 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.693 0.282 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.712 ' HB2' HD22 ' A' ' 42' ' ' LEU . 25.4 p -115.85 149.22 38.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.816 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -97.93 30.08 3.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.884 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.69 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -141.24 164.4 35.74 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.068 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.657 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 57.2 Cg_endo -71.16 131.69 19.72 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.657 2.238 . . . . 0.0 112.771 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.809 HG12 HG22 ' A' ' 57' ' ' VAL . 1.8 t -101.07 128.91 52.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.471 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.665 ' CG1' HD23 ' A' ' 97' ' ' LEU . 27.2 m -143.7 154.94 16.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 120.885 0.374 . . . . 0.0 111.667 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.425 HG22 HD11 ' A' ' 102' ' ' ILE . 5.6 p -62.55 -166.99 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.457 ' HD3' ' CD2' ' A' ' 19' ' ' PHE . 0.4 OUTLIER -88.61 -15.1 35.91 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.07 -0.252 . . . . 0.0 111.127 179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -55.5 -34.59 64.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.754 0.311 . . . . 0.0 110.919 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 62.9 t90 -57.98 -57.56 12.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.377 0.608 . . . . 0.0 110.289 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.829 ' O ' HG23 ' A' ' 89' ' ' VAL . 43.5 t -58.34 -48.22 85.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.132 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.38 -45.22 94.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.928 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.57 -36.46 83.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.803 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 92' ' ' TYR . 22.5 m -77.05 -44.72 29.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.963 HG21 ' HB3' ' A' ' 30' ' ' MET . 38.7 t -71.22 -26.66 27.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.397 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.42 -52.74 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.857 0.36 . . . . 0.0 111.441 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.94 -2.14 47.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.58 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.433 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 57.0 80.07 0.17 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 110.894 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.728 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -178.88 126.49 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.803 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 6.3 t -59.31 87.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.958 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.7 166.8 10.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.57 130.96 35.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.838 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.2 mp -66.4 -29.07 69.15 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.281 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.25 -24.82 57.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.336 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.1 m -80.29 -12.03 59.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.536 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -142.18 29.77 1.62 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.768 0.318 . . . . 0.0 111.018 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.539 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -92.73 150.6 20.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.806 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 81' ' ' THR . 28.0 mt -118.11 93.0 43.83 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.08 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -78.71 -168.42 0.62 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.638 2.225 . . . . 0.0 112.362 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -97.05 128.17 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 mp 59.69 97.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.065 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -49.54 -59.97 1.03 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.544 2.163 . . . . 0.0 112.449 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -94.13 101.69 13.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.14 -47.23 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -153.01 -62.87 0.15 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.92 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.31 -0.852 . . . . 0.0 110.925 179.921 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -98.35 140.6 32.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.93 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -59.93 114.61 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -158.73 -45.4 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.03 92.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.1 mmtp -111.74 147.12 36.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.59 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.695 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -91.23 -21.11 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.916 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.683 ' CD1' HD13 ' A' ' 11' ' ' LEU . 11.3 m-85 -93.43 -47.4 6.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.28 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 38.96 86.08 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.377 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.45 66.47 1.68 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.537 -0.839 . . . . 0.0 111.503 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.997 HD21 HG13 ' A' ' 54' ' ' ILE . 3.9 tt -145.64 122.21 11.09 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.489 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.733 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.7 mt-10 -94.63 123.6 38.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 111.331 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.709 HD12 ' CB ' ' A' ' 36' ' ' ALA . 3.6 mt -132.77 136.18 56.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.261 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.0 p -135.61 142.82 45.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.831 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.832 ' HB3' HD23 ' A' ' 27' ' ' LEU . 7.9 p -107.01 109.4 21.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.938 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -94.13 103.51 15.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.98 161.96 11.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.657 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.23 -15.84 14.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.599 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.455 ' CD2' ' HB3' ' A' ' 58' ' ' GLN . 5.4 m-85 63.47 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.016 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -128.0 -79.82 0.58 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.983 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -105.82 -71.25 0.75 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.867 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.459 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 46.5 ttm -163.47 53.33 0.37 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.937 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 22' ' ' MET . 95.3 Cg_endo -83.57 10.27 3.75 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.65 2.233 . . . . 0.0 112.803 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -40.62 84.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.755 0.312 . . . . 0.0 111.172 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 41.8 m-20 -87.36 -26.2 23.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.084 0.468 . . . . 0.0 110.4 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -31.29 56.49 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.832 HD23 ' HB3' ' A' ' 15' ' ' CYS . 12.4 tp -74.96 -46.37 35.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.538 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.3 OUTLIER -64.69 -27.35 68.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.483 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 10.0 t90 -68.72 -50.84 47.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.187 0.518 . . . . 0.0 109.84 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.871 ' HB3' HG21 ' A' ' 89' ' ' VAL . 74.0 mtm -55.11 -48.21 73.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.84 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG23 ' N ' ' A' ' 32' ' ' GLN . 23.6 m -60.52 -44.84 97.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 0.0 110.17 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' N ' HG23 ' A' ' 31' ' ' VAL . 12.5 tt0 -58.39 -33.47 69.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.079 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.8 tp -70.02 -21.44 63.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.749 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' SG ' HD11 ' A' ' 7' ' ' ILE . 2.6 m -93.28 -3.25 53.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.636 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 110.84 -29.74 8.67 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.435 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.709 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -58.3 156.98 9.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 0.0 111.464 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 132.17 45.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.044 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 38' ' ' VAL . 15.1 m -71.76 114.6 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.053 0.454 . . . . 0.0 110.898 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.733 HG21 ' HB3' ' A' ' 12' ' ' GLU . 24.8 t -100.27 117.93 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.907 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 -47.24 85.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.916 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' O ' HG12 ' A' ' 39' ' ' VAL . 2.3 mt-10 -134.34 171.0 14.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.072 0.463 . . . . 0.0 111.448 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.767 HD13 ' HB2' ' A' ' 75' ' ' CYS . 9.4 mt -65.37 -44.59 87.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.854 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.9 m -60.69 -27.22 67.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.715 ' HB3' HG13 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -58.76 -23.28 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.173 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 16.2 m-85 -53.72 123.57 12.67 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.9 t -144.12 108.73 4.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.498 ' HA ' HG23 ' A' ' 51' ' ' VAL . 6.1 mp -60.42 149.66 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -143.24 -116.78 1.17 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.494 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.9 p -82.66 -30.86 29.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 111.021 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -176.95 36.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.673 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 47' ' ' LEU . 5.4 m -93.94 118.77 40.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.774 0.321 . . . . 0.0 111.145 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -95.31 134.69 24.09 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.66 125.53 5.59 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.639 2.226 . . . . 0.0 112.546 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.997 HG13 HD21 ' A' ' 11' ' ' LEU . 29.3 mm -134.71 148.34 29.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.763 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.755 ' HB ' HG12 ' A' ' 79' ' ' VAL . 58.7 t -126.58 151.95 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.362 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.749 HG11 HD21 ' A' ' 27' ' ' LEU . 16.4 t -123.71 131.26 73.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 71' ' ' ILE . 5.2 m -143.26 120.39 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.556 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.455 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -140.82 86.06 12.13 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.806 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.16 135.24 39.57 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.515 2.143 . . . . 0.0 112.314 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -177.42 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 20' ' ' THR . . . -104.67 30.02 5.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.125 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.431 ' CZ2' ' CD1' ' A' ' 68' ' ' PHE . 4.8 m95 -87.66 -34.19 18.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.17 -67.84 0.21 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -89.79 164.32 14.69 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.931 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -103.72 65.43 0.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -59.0 -29.98 67.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.952 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.86 84.09 0.57 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.395 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.573 ' CD1' HD11 ' A' ' 71' ' ' ILE . 5.9 t80 -100.48 7.1 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.548 0.213 . . . . 0.0 111.433 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -91.69 49.74 1.61 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -158.18 29.52 0.25 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.055 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.828 ' CG2' HG11 ' A' ' 79' ' ' VAL . 14.1 mm -62.84 -39.36 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.987 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.25 -25.65 61.15 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.462 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.12 -27.91 66.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.933 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.5 mtp -93.83 -30.7 14.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.767 ' HB2' HD13 ' A' ' 42' ' ' LEU . 42.1 t -134.58 145.59 48.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.56 31.34 4.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.89 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.646 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -112.51 166.15 11.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.08 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.646 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 83.8 Cg_endo -79.08 108.43 2.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.788 2.325 . . . . 0.0 112.524 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.828 HG11 ' CG2' ' A' ' 71' ' ' ILE . 3.2 m -91.12 127.44 43.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.588 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.653 ' O ' HG13 ' A' ' 56' ' ' VAL . 35.9 m -137.09 139.48 44.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.793 0.33 . . . . 0.0 111.736 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 p -52.02 161.97 0.52 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.722 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -21.51 9.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.476 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.26 -43.92 15.97 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.934 0.397 . . . . 0.0 110.595 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.521 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 73.4 t90 -56.57 -57.42 12.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.523 0.678 . . . . 0.0 109.931 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.757 ' O ' HG23 ' A' ' 89' ' ' VAL . 52.9 t -54.34 -43.75 63.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.269 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 HD22 ' HA ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -69.12 -56.34 7.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.016 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -56.3 -31.37 63.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 74.0 m -77.1 -49.92 14.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.871 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.5 t -71.24 -27.27 28.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.467 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.05 -58.02 5.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.945 0.402 . . . . 0.0 111.07 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.7 tp -89.45 -12.16 40.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.271 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.695 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 66.05 77.83 0.28 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.958 0.409 . . . . 0.0 110.776 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.436 ' N ' HG21 ' A' ' 7' ' ' ILE . 20.9 tt0 -177.82 134.69 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.864 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.0 t -59.6 89.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.782 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -72.69 159.05 34.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.055 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -63.67 153.02 37.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.883 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.574 HD21 HG23 ' A' ' 54' ' ' ILE . 2.4 mp -102.15 -33.38 9.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.281 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -57.2 -21.67 35.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.595 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.9 m -80.51 -20.48 43.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.564 0.221 . . . . 0.0 111.482 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -132.8 23.75 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.16 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -88.61 144.96 25.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 111.068 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 101' ' ' LEU . 1.9 mp 63.66 135.81 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.098 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.74 -172.44 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.398 2.065 . . . . 0.0 112.184 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.17 85.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.593 ' O ' HD12 ' A' ' 105' ' ' ILE . 2.1 pp -152.67 120.95 3.18 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.033 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.24 121.88 8.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.398 2.065 . . . . 0.0 112.366 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -161.49 30.45 0.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.867 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.2 p -140.21 37.08 1.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.848 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -145.1 92.93 2.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.895 179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.66 111.72 14.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.758 0.313 . . . . 0.0 110.847 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -122.71 120.77 34.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -140.29 176.44 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -166.19 90.69 0.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.94 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 5.6 mmtt -74.42 136.81 42.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.341 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.666 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.1 pp -76.33 -23.49 15.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.92 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.666 ' CD1' HD12 ' A' ' 7' ' ' ILE . 16.4 m-30 -93.71 -47.68 6.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.636 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 38.4 ttt180 45.54 90.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.333 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.21 76.47 0.81 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.931 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.18 162.27 38.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -140.65 109.78 6.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.363 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.657 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.5 mt -121.11 130.72 74.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.964 0.412 . . . . 0.0 111.666 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.641 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 21.9 p -115.04 139.03 50.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.163 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.748 ' HB3' HD23 ' A' ' 27' ' ' LEU . 8.6 p -107.12 108.49 19.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.597 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.98 119.66 33.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.07 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.94 166.38 25.07 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.594 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.35 -10.38 9.98 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.864 2.376 . . . . 0.0 112.75 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.436 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 6.5 m-85 62.88 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.3 p -125.15 -71.7 0.7 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -110.98 -70.99 0.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.452 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.8 OUTLIER -167.89 56.1 0.32 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.983 179.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 22' ' ' MET . 69.2 Cg_endo -86.94 17.09 1.82 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.828 2.352 . . . . 0.0 112.847 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.473 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -62.92 -41.76 99.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.807 0.337 . . . . 0.0 111.154 -179.724 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -89.36 -25.17 21.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.058 0.456 . . . . 0.0 110.476 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.73 -31.48 41.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.415 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.748 HD23 ' HB3' ' A' ' 15' ' ' CYS . 33.6 tp -75.91 -44.24 41.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.396 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -65.44 -27.54 68.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.405 179.486 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.431 ' NE1' ' CD2' ' A' ' 33' ' ' LEU . 18.4 t90 -67.47 -51.94 45.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.162 0.506 . . . . 0.0 109.734 179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.788 ' HB3' HG21 ' A' ' 89' ' ' VAL . 6.2 mtm -55.03 -50.52 68.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.615 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 32' ' ' GLN . 26.1 m -58.98 -45.02 92.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.184 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.48 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.96 -33.83 67.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.497 178.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HA ' HD13 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -70.44 -21.46 62.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.021 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 4.0 m -93.45 -3.26 53.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.745 -179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.51 -18.21 17.86 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.851 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.657 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -72.63 177.93 4.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.28 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.425 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.2 OUTLIER -131.98 139.18 48.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.565 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 14.7 p -71.93 122.8 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.025 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.72 HG21 ' CE1' ' A' ' 45' ' ' PHE . 2.2 t -93.92 130.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.04 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -65.3 -42.3 93.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -147.73 -179.59 7.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 75' ' ' CYS . 33.1 mt -71.43 -41.1 69.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 t -72.95 -9.11 58.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.428 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -74.01 -19.11 60.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.607 0.241 . . . . 0.0 111.254 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.72 ' CE1' HG21 ' A' ' 39' ' ' VAL . 24.1 m-85 -53.31 113.8 1.27 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.851 0.358 . . . . 0.0 111.09 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 p -110.57 128.03 55.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.43 126.39 40.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -144.59 28.34 1.91 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.458 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.76 36.8 22.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.383 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -161.72 -42.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.522 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 t -97.42 118.88 44.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -93.87 126.84 47.75 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.832 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.879 ' O ' HD13 ' A' ' 54' ' ' ILE . 91.4 Cg_endo -78.53 130.73 10.04 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.578 2.185 . . . . 0.0 112.697 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.879 HD13 ' O ' ' A' ' 53' ' ' PRO . 8.1 mm -138.82 147.74 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.666 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 77' ' ' ALA . 39.9 t -123.01 151.1 27.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.81 HG13 ' O ' ' A' ' 80' ' ' VAL . 15.2 t -129.95 144.41 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.217 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 79' ' ' VAL . 2.5 m -135.3 -177.86 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.436 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 172.98 78.64 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.05 88.06 1.13 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.644 2.23 . . . . 0.0 112.402 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -148.12 -51.82 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.88 33.57 2.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.153 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -83.32 -30.26 27.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.931 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 89.3 m 65.01 -75.74 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.112 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.78 158.7 31.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -111.08 88.07 2.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.833 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -81.26 -47.97 12.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.921 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.53 94.36 0.16 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.734 ' CD1' HD11 ' A' ' 71' ' ' ILE . 42.3 t80 -91.56 7.13 42.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.506 0.193 . . . . 0.0 111.508 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 15.2 m170 -91.35 52.47 2.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 111.032 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -170.39 33.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.201 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 79' ' ' VAL . 23.0 mm -74.3 -54.3 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.847 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.39 -20.76 71.34 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.42 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.34 -18.09 40.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.756 0.313 . . . . 0.0 110.92 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 34.0 ttp -93.67 -25.53 17.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.801 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.503 ' HB2' HD13 ' A' ' 42' ' ' LEU . 46.0 t -133.5 156.41 47.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.856 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -103.34 32.63 3.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.939 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -123.91 164.52 28.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.62 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 94.0 Cg_endo -78.39 120.87 5.01 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.696 2.264 . . . . 0.0 112.608 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.037 HG21 HG22 ' A' ' 71' ' ' ILE . 10.7 t -94.62 121.29 45.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.554 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.81 ' O ' HG13 ' A' ' 56' ' ' VAL . 28.0 m -137.58 135.57 46.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.586 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.8 p -50.65 170.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.668 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.49 -16.32 60.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.36 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.3 -42.24 52.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 110.664 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.511 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 80.2 t90 -59.46 -57.26 13.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.491 0.663 . . . . 0.0 109.766 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 89' ' ' VAL . 63.2 t -55.06 -43.48 69.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.424 HD22 ' HE1' ' A' ' 30' ' ' MET . 0.5 OUTLIER -69.87 -46.14 66.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -64.48 -32.94 74.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.518 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 64.0 m -77.11 -47.13 21.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.179 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 85' ' ' VAL . 42.1 t -71.24 -30.92 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.38 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.73 -56.79 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.368 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 40.4 tp -87.84 -16.54 33.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.391 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.522 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 67.57 77.76 0.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.903 0.382 . . . . 0.0 110.55 -179.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 179.02 136.44 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.707 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -58.93 91.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.959 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -74.57 160.39 30.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -67.66 139.04 56.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.702 ' HB3' HD12 ' A' ' 101' ' ' LEU . 1.6 mp -88.34 -33.06 18.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.349 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -22.25 24.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.583 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 99.7 m -77.74 -23.38 49.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.433 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -128.1 18.46 6.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.618 0.247 . . . . 0.0 111.194 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -87.2 173.93 8.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.655 ' H ' HD23 ' A' ' 101' ' ' LEU . 31.5 mm -111.45 97.29 35.57 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.18 -171.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.52 2.147 . . . . 0.0 112.209 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -177.36 -63.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.797 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.18 154.31 32.18 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.151 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.66 107.03 1.94 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.536 2.157 . . . . 0.0 112.293 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -140.35 85.11 1.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 9.6 t -118.66 98.25 6.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.95 -32.09 8.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.864 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.8 p -110.5 -33.15 6.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 0.0 110.944 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 61.0 30.24 19.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -134.41 178.59 6.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -161.44 75.89 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.949 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 7.5 pttm -94.16 171.25 8.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.775 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.496 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.1 pp -111.56 -16.06 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.558 ' HB3' ' HB2' ' A' ' 11' ' ' LEU . 9.7 m-30 -93.78 -43.84 8.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.893 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 49.26 92.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.28 75.38 0.51 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.458 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -139.58 162.04 36.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.991 0.424 . . . . 0.0 111.142 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -142.76 109.81 5.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.676 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.5 mt -118.05 124.96 73.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.966 0.413 . . . . 0.0 111.762 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.669 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.9 p -108.35 129.5 55.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.903 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.506 ' SG ' HD23 ' A' ' 27' ' ' LEU . 14.2 m -97.33 115.06 26.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.318 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -93.52 108.71 20.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.097 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.67 168.77 33.9 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.586 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.3 -0.97 11.17 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.681 2.254 . . . . 0.0 112.621 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.9 m-85 63.57 -79.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.946 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.606 HG23 ' OE1' ' A' ' 58' ' ' GLN . 0.6 OUTLIER -124.98 -78.68 0.6 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.882 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -155.0 31.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.699 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -97.63 147.94 33.74 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 24' ' ' THR . 41.9 Cg_exo -56.83 -18.74 28.5 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.569 2.179 . . . . 0.0 112.5 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.447 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER 85.51 -18.05 0.38 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.355 -179.796 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.33 -25.24 25.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.105 0.478 . . . . 0.0 110.116 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -75.88 -30.96 59.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.146 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD23 ' SG ' ' A' ' 15' ' ' CYS . 65.0 tp -72.37 -50.58 25.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.279 179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.95 -27.44 68.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.964 0.411 . . . . 0.0 110.465 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -64.0 -49.16 73.53 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.765 ' HB3' HG21 ' A' ' 89' ' ' VAL . 3.1 mtm -51.67 -55.57 18.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.704 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG1' HG13 ' A' ' 85' ' ' VAL . 20.1 m -57.06 -44.26 82.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.079 0.466 . . . . 0.0 110.222 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.436 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.0 mt-30 -59.72 -36.87 77.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.079 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.5 tp -70.08 -21.04 63.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.883 179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 1.4 m -93.23 -3.31 53.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.839 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA3' ' HD2' ' A' ' 6' ' ' LYS . . . 108.33 25.4 5.81 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.118 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -116.35 178.42 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.102 0.477 . . . . 0.0 111.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.64 132.57 44.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.612 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.4 p -71.88 119.43 18.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.928 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.755 HG12 ' HB2' ' A' ' 44' ' ' SER . 1.0 OUTLIER -93.92 124.29 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.862 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.71 -45.47 77.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.317 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -146.73 -179.21 6.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.977 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.615 HD13 ' HB3' ' A' ' 75' ' ' CYS . 29.6 mt -67.26 -44.13 80.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.93 -17.57 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.276 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.755 ' HB2' HG12 ' A' ' 39' ' ' VAL . 39.3 m -65.66 -17.36 64.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.444 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 39' ' ' VAL . 14.0 m-85 -51.48 113.21 0.9 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.787 0.327 . . . . 0.0 111.07 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.8 p -96.27 177.41 5.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.893 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.18 -172.84 2.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.85 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 154.06 -123.31 1.37 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.9 p -125.7 -52.24 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.44 73.41 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.493 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 t -154.51 138.56 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.921 0.391 . . . . 0.0 110.947 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -131.96 120.17 17.23 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.845 ' O ' HD13 ' A' ' 54' ' ' ILE . 92.3 Cg_endo -78.76 133.18 11.25 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.563 2.175 . . . . 0.0 112.561 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.845 HD13 ' O ' ' A' ' 53' ' ' PRO . 9.4 mm -139.79 146.65 24.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.929 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.977 HG23 ' HB3' ' A' ' 77' ' ' ALA . 30.6 t -124.5 138.22 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.712 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 57' ' ' VAL . 24.0 t -124.16 158.94 30.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.913 0.387 . . . . 0.0 111.404 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.748 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 1.4 t -152.89 177.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.689 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.629 ' H ' HG12 ' A' ' 57' ' ' VAL . 6.4 tm0? -179.2 86.89 0.21 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.75 116.91 3.95 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.488 2.125 . . . . 0.0 112.33 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.886 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.96 32.62 6.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.142 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -75.65 -32.72 60.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 68.87 -67.5 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.033 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -86.35 129.9 34.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.996 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.39 77.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -81.59 -41.67 21.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.868 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.3 113.23 0.58 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.343 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.748 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 28.0 t80 -99.98 7.15 44.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -91.79 55.83 2.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.864 0.364 . . . . 0.0 111.081 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.493 ' HB1' ' NE2' ' A' ' 73' ' ' GLN . . . -174.71 34.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.37 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.759 HG21 HG11 ' A' ' 79' ' ' VAL . 11.3 mm -74.2 -53.62 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.265 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.31 -27.85 68.32 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.421 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.493 ' NE2' ' HB1' ' A' ' 70' ' ' ALA . 17.0 pt20 -88.36 -13.47 40.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.579 0.228 . . . . 0.0 111.334 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -93.77 -28.89 15.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.836 0.35 . . . . 0.0 110.909 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.615 ' HB3' HD13 ' A' ' 42' ' ' LEU . 31.2 p -117.44 157.19 26.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.932 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -107.03 41.93 1.39 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.977 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -154.33 165.95 16.93 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.119 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.715 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 37.1 Cg_endo -65.5 124.26 12.6 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.496 2.131 . . . . 0.0 112.323 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.759 HG11 HG21 ' A' ' 71' ' ' ILE . 25.7 t -92.53 128.37 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.593 ' CG1' HD23 ' A' ' 97' ' ' LEU . 31.2 m -143.15 177.11 2.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.8 0.333 . . . . 0.0 111.072 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 10.5 p -96.86 163.99 12.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.319 -0.401 . . . . 0.0 109.941 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -19.39 17.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.739 -0.21 . . . . 0.0 111.349 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -47.87 -45.09 30.0 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.703 0.287 . . . . 0.0 110.684 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.502 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 63.4 t90 -55.99 -57.26 12.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.39 0.614 . . . . 0.0 110.114 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.758 ' O ' HG23 ' A' ' 89' ' ' VAL . 55.0 t -54.07 -43.16 58.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.359 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.36 -50.46 38.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -60.09 -32.84 71.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.772 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 63.1 m -77.03 -48.49 17.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.053 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.1 t -71.01 -25.91 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.334 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.66 -55.09 8.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.315 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.472 HD23 ' HB2' ' A' ' 93' ' ' GLN . 3.5 tt -98.07 2.95 49.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.585 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.496 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 53.36 83.04 0.07 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.814 0.34 . . . . 0.0 110.964 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' C ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -178.8 131.43 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 15.5 t -68.56 79.15 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.987 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.82 173.05 1.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.817 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.03 153.49 34.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.742 HD21 ' CG2' ' A' ' 54' ' ' ILE . 1.8 mp -94.07 -27.34 16.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -58.79 -31.86 68.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.93 -16.63 61.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.132 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -135.43 29.55 3.28 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.532 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -97.27 165.52 11.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.769 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.494 HD11 HG11 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -134.19 95.9 16.28 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.237 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 -168.12 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.539 2.16 . . . . 0.0 112.332 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -108.27 170.52 7.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.925 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.8 pt -126.15 107.32 24.69 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.21 147.77 15.24 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.471 2.114 . . . . 0.0 112.344 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -171.36 -54.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 81.1 p -176.06 165.59 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.46 134.1 49.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.853 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 48.4 t80 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.845 179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -66.82 -68.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -99.01 98.71 9.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.867 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -164.76 -172.89 2.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.689 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.92 -67.17 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 1.0 OUTLIER 59.95 168.84 0.08 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.325 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.503 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.1 pp -111.95 -20.72 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.522 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 14.6 m-30 -93.7 -46.16 7.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.518 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 43.15 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.039 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.32 73.62 0.83 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.394 -0.908 . . . . 0.0 111.303 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.855 HD21 HG13 ' A' ' 54' ' ' ILE . 2.1 tt -148.36 119.01 7.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.707 0.289 . . . . 0.0 110.82 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.89 124.06 38.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.821 0.343 . . . . 0.0 111.174 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.777 HD12 ' HB1' ' A' ' 36' ' ' ALA . 3.2 mt -132.66 129.78 58.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.165 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.711 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.1 p -121.52 146.4 46.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.211 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.509 ' HA ' HG23 ' A' ' 56' ' ' VAL . 25.1 p -106.92 127.86 53.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.898 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE1' HD11 ' A' ' 42' ' ' LEU . 2.1 t80 -93.89 105.07 17.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.065 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.11 179.86 44.22 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.667 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.14 -166.71 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.66 2.24 . . . . 0.0 112.42 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 26.3 m-85 -139.85 -53.1 0.53 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.736 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 0.7 OUTLIER -149.11 -67.06 0.22 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.794 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.97 -74.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.679 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.451 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -167.44 54.82 0.29 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.918 179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 22' ' ' MET . 69.0 Cg_endo -85.89 15.17 2.26 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.779 2.32 . . . . 0.0 112.993 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -44.67 71.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.821 0.343 . . . . 0.0 111.21 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -85.57 -26.71 25.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.251 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -71.59 -33.2 68.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.481 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.858 HD13 HG11 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -73.06 -50.83 20.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.349 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -65.36 -27.78 68.81 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.425 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -71.39 -50.35 32.92 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.805 ' HB3' HG21 ' A' ' 89' ' ' VAL . 8.1 mtm -54.87 -48.41 73.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.54 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 32' ' ' GLN . 28.9 m -62.65 -45.14 99.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 121.264 0.554 . . . . 0.0 109.656 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 31' ' ' VAL . 5.1 mt-30 -56.42 -35.91 68.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.071 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.9 tp -70.07 -21.41 63.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.928 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' SG ' HD11 ' A' ' 7' ' ' ILE . 2.3 m -93.19 -3.24 54.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.706 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.06 -15.93 25.51 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.814 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.777 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -71.59 174.33 6.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.91 0.386 . . . . 0.0 111.485 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -127.08 136.93 52.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.547 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 38' ' ' VAL . 14.3 p -71.88 123.97 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.206 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.711 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.0 t -93.86 146.51 6.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.751 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -42.82 62.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.154 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -159.05 -175.91 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.904 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.68 HD22 ' CB ' ' A' ' 75' ' ' CYS . 30.5 mt -63.64 -50.38 69.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.007 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 m -66.65 -19.16 65.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.413 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.705 ' HB2' HG12 ' A' ' 39' ' ' VAL . 56.5 m -61.67 -23.32 66.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.332 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 17.5 m-85 -49.33 110.83 0.41 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.791 0.329 . . . . 0.0 111.165 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.25 127.59 53.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.9 tp -79.21 110.39 14.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -118.81 -131.64 4.36 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.46 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.7 p -114.81 -44.73 3.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.354 . . . . 0.0 110.927 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.647 ' O ' HG13 ' A' ' 51' ' ' VAL . . . -128.14 70.42 0.51 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.487 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.647 HG13 ' O ' ' A' ' 50' ' ' GLY . 1.3 m -163.52 107.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.791 0.329 . . . . 0.0 111.002 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.9 130.55 34.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.837 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.737 ' O ' HD13 ' A' ' 54' ' ' ILE . 93.3 Cg_endo -78.57 135.36 13.01 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.54 2.16 . . . . 0.0 112.471 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.855 HG13 HD21 ' A' ' 11' ' ' LEU . 9.3 mm -144.3 151.35 16.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.904 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 77' ' ' ALA . 23.4 t -130.65 140.79 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.608 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -114.48 160.71 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 111.15 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' CG2' HG12 ' A' ' 79' ' ' VAL . 6.1 m -152.23 -177.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.507 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.45 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 174.54 94.93 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.159 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.707 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.29 68.67 1.42 Allowed 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.488 2.126 . . . . 0.0 112.334 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.05 -73.99 0.59 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 20' ' ' THR . . . -85.28 -17.78 35.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.25 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.59 -40.37 59.68 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 m 60.75 160.5 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -89.23 93.42 9.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.76 -65.29 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -101.03 -29.9 11.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.34 125.71 2.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.444 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.695 ' CD1' HD11 ' A' ' 71' ' ' ILE . 4.5 t80 -100.34 7.11 44.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.593 0.235 . . . . 0.0 111.524 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -90.44 51.41 2.01 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.938 0.399 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -172.35 35.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.027 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.695 HD11 ' CD1' ' A' ' 68' ' ' PHE . 29.1 mm -72.32 -65.18 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.75 -26.66 68.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -76.76 -22.98 52.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.708 0.29 . . . . 0.0 111.192 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.4 mtm -93.92 -43.85 8.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.979 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.68 ' CB ' HD22 ' A' ' 42' ' ' LEU . 31.4 p -86.97 162.33 17.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -113.08 33.85 4.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.988 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.68 166.32 18.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.096 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.717 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 55.4 Cg_endo -68.97 125.98 13.24 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.638 2.225 . . . . 0.0 112.281 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.55 HG12 ' CG2' ' A' ' 57' ' ' VAL . 17.6 t -93.05 123.64 45.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.978 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.682 ' O ' HG12 ' A' ' 56' ' ' VAL . 35.8 m -141.16 134.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 1.9 p -54.76 159.99 2.04 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.472 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.407 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -54.37 -19.8 6.18 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.578 -179.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.96 -40.58 10.52 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.834 0.35 . . . . 0.0 110.869 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 68.9 t90 -58.93 -57.42 13.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.46 0.648 . . . . 0.0 110.145 179.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.858 HG11 HD13 ' A' ' 27' ' ' LEU . 58.9 t -57.69 -42.93 82.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.29 -56.24 8.12 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -57.99 -30.7 66.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.834 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 92' ' ' TYR . 69.3 m -76.99 -49.16 16.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.041 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.805 HG21 ' HB3' ' A' ' 30' ' ' MET . 48.8 t -71.32 -27.23 28.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.91 -54.69 19.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.177 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 91' ' ' LEU . 6.2 tt -97.41 -2.28 42.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.323 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.414 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 58.05 84.74 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.737 0.303 . . . . 0.0 110.887 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -177.53 139.67 0.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.972 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.7 t -67.9 74.62 0.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.891 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -58.1 158.84 6.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -68.58 151.46 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.675 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.464 ' HB3' HD12 ' A' ' 101' ' ' LEU . 3.8 mp -95.98 -34.8 11.65 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.067 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.65 -25.51 39.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.511 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.5 HG23 ' CG ' ' A' ' 100' ' ' TYR . 13.4 t -74.88 -24.73 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.304 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.5 ' CG ' HG23 ' A' ' 99' ' ' THR . 9.8 m-85 -125.74 15.0 8.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.13 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.518 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -80.7 87.17 5.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 0.0 111.317 -179.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 30.0 mt 56.4 108.14 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.496 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.16 172.72 11.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.317 2.011 . . . . 0.0 112.087 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -104.52 -51.83 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.851 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 mt -126.7 135.82 27.85 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.53 155.75 62.76 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.479 2.12 . . . . 0.0 112.32 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -137.95 88.16 2.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.933 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.49 163.79 13.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -159.44 31.65 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.91 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.865 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.396 -0.282 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.4 m 60.79 59.56 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.943 0.402 . . . . 0.0 110.676 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -103.79 100.91 10.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.942 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.23 -46.11 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.96 -76.29 0.14 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp 56.48 169.74 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.66 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.797 HD11 ' SG ' ' A' ' 34' ' ' CYS . 2.3 pt -110.44 -19.83 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.552 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.506 ' CZ ' ' CH2' ' A' ' 84' ' ' TRP . 15.7 m-30 -93.7 -50.42 5.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.637 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.4 ttm105 47.72 91.87 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.205 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.35 76.2 0.83 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.066 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -145.5 162.01 38.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 111.008 -179.627 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.695 ' CG ' HG22 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -142.22 109.82 5.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.334 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.678 HD12 ' HB1' ' A' ' 36' ' ' ALA . 1.8 mt -125.29 130.46 72.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.361 . . . . 0.0 111.615 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.518 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 6.1 p -111.08 143.18 42.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.723 ' HB3' HD23 ' A' ' 27' ' ' LEU . 17.6 p -106.46 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.756 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.01 131.27 39.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.977 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.6 158.73 34.16 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.56 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.15 0.26 10.17 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.644 2.229 . . . . 0.0 112.711 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD2' ' CB ' ' A' ' 58' ' ' GLN . 19.9 m-85 62.77 -82.07 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.734 0.302 . . . . 0.0 111.056 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 21' ' ' ASN . 4.6 t -143.71 -49.2 0.3 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.854 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.414 ' N ' HG23 ' A' ' 20' ' ' THR . 28.6 m120 -116.88 -78.53 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.714 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.453 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -170.48 55.78 0.24 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.046 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HD3' ' N ' ' A' ' 22' ' ' MET . 65.5 Cg_endo -87.1 15.44 2.18 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.772 2.315 . . . . 0.0 112.751 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.524 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.11 -44.23 97.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.281 -179.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 0.7 OUTLIER -88.9 -25.78 21.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -77.96 -33.35 51.57 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.523 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.79 HD21 HG11 ' A' ' 56' ' ' VAL . 19.5 tp -75.07 -44.12 49.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.522 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.99 -27.48 67.47 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.507 179.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.548 ' CD1' HD23 ' A' ' 33' ' ' LEU . 10.3 t90 -69.24 -50.05 50.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.858 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.868 ' HB3' HG21 ' A' ' 89' ' ' VAL . 2.3 mtm -57.34 -48.61 78.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.575 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 32' ' ' GLN . 30.4 m -60.51 -45.23 97.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-O 121.203 0.525 . . . . 0.0 109.621 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.492 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.57 -34.58 69.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.666 178.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.548 HD23 ' CD1' ' A' ' 29' ' ' TRP . 0.6 OUTLIER -70.28 -21.27 62.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.005 179.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.828 ' SG ' HG22 ' A' ' 89' ' ' VAL . 38.5 m -93.42 -3.08 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.667 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.3 -23.44 11.3 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.741 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.678 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.02 177.08 1.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.054 0.454 . . . . 0.0 111.231 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -129.61 138.6 51.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.572 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 38' ' ' VAL . 9.6 p -71.82 114.77 10.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.782 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.695 HG22 ' CG ' ' A' ' 12' ' ' GLU . 3.0 t -93.91 121.16 44.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.022 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -58.44 -47.16 84.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.336 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.532 ' O ' HG12 ' A' ' 39' ' ' VAL . 17.5 mm-40 -132.69 176.03 8.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.086 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.667 HD22 ' HB3' ' A' ' 75' ' ' CYS . 13.1 mt -70.87 -43.51 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.05 -5.01 44.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.36 -15.98 61.36 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.561 0.22 . . . . 0.0 111.389 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.669 ' CE1' HG21 ' A' ' 39' ' ' VAL . 21.2 m-85 -50.9 125.52 13.72 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.806 0.336 . . . . 0.0 111.013 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.0 m -58.14 -35.31 71.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.043 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.1 mt 58.71 30.75 20.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -79.37 -140.39 2.03 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.552 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.3 m -114.34 -35.33 5.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 110.948 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -101.5 36.35 4.28 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.539 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.544 HG11 ' OE1' ' A' ' 12' ' ' GLU . 21.2 t -152.17 125.2 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.718 0.294 . . . . 0.0 111.209 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.478 ' O ' HD23 ' A' ' 11' ' ' LEU . 3.2 t-80 -100.99 120.64 54.8 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.938 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.848 ' O ' HD13 ' A' ' 54' ' ' ILE . 79.6 Cg_endo -77.98 133.74 12.65 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.593 2.195 . . . . 0.0 112.635 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.848 HD13 ' O ' ' A' ' 53' ' ' PRO . 7.5 mm -142.49 162.31 18.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.622 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.616 HG23 ' HB3' ' A' ' 77' ' ' ALA . 33.9 t -137.99 150.74 25.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.666 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.79 HG11 HD21 ' A' ' 27' ' ' LEU . 4.1 t -121.85 158.43 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.833 0.349 . . . . 0.0 111.32 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.868 HG22 HG12 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -150.39 -179.47 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.432 -179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.473 ' CB ' ' CD2' ' A' ' 19' ' ' PHE . 1.1 tt0 176.52 66.93 0.07 OUTLIER Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.579 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.58 94.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.487 2.125 . . . . 0.0 112.301 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.47 -45.47 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.985 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -115.97 38.96 3.18 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.224 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -86.59 -30.79 21.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.824 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.9 m 78.54 -4.64 2.14 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.813 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.3 87.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.821 0.343 . . . . 0.0 111.026 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -140.03 -56.18 0.55 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.89 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -81.2 -29.47 34.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.4 114.67 3.98 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.449 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.719 ' CD1' HD11 ' A' ' 71' ' ' ILE . 49.0 t80 -85.86 -2.31 58.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.559 0.218 . . . . 0.0 111.513 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -84.29 56.93 3.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.953 0.406 . . . . 0.0 110.921 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -178.96 38.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.968 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.102 HG22 HG21 ' A' ' 79' ' ' VAL . 24.0 mm -69.82 -67.47 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.956 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.01 -24.25 71.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.372 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.93 -27.82 64.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.311 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.0 mtm -93.92 -39.28 10.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.055 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.667 ' HB3' HD22 ' A' ' 42' ' ' LEU . 27.5 p -98.37 147.08 25.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.92 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.24 38.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -147.3 169.3 9.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.79 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 73.6 Cg_endo -74.94 125.87 9.64 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.741 2.294 . . . . 0.0 112.456 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.102 HG21 HG22 ' A' ' 71' ' ' ILE . 8.4 t -98.02 136.61 28.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.689 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.612 ' CG1' HD23 ' A' ' 97' ' ' LEU . 26.7 m -147.59 159.56 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.804 0.335 . . . . 0.0 111.659 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.709 HG22 HD11 ' A' ' 102' ' ' ILE . 8.6 p -73.7 159.3 33.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.246 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.3 ppt_? -53.6 -22.51 8.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.446 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.45 -38.07 8.62 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.891 0.377 . . . . 0.0 110.776 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.506 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 72.6 t90 -63.46 -57.23 10.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.492 0.663 . . . . 0.0 109.818 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 89' ' ' VAL . 60.6 t -54.3 -39.22 42.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.377 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.96 -48.47 17.98 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.986 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -60.25 -35.72 76.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.812 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.9 m -77.05 -47.91 19.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.243 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.868 HG21 ' HB3' ' A' ' 30' ' ' MET . 73.7 t -71.22 -25.87 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.439 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -70.45 -60.45 2.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.874 0.369 . . . . 0.0 111.041 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.4 tp -85.07 -18.48 34.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.151 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 73.44 77.98 0.13 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.672 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.465 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -177.43 136.1 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.812 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.7 t -61.17 86.23 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -67.34 163.42 20.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.922 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HG3' HG23 ' A' ' 99' ' ' THR . 0.4 OUTLIER -73.99 140.12 45.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.858 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.623 HD21 ' CG2' ' A' ' 54' ' ' ILE . 2.0 mp -83.33 -29.52 28.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.12 -29.15 65.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.473 HG23 ' HG3' ' A' ' 96' ' ' GLU . 1.1 p -72.08 -17.45 62.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -137.84 22.32 2.86 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.671 0.272 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.516 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -86.34 122.01 29.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.815 0.34 . . . . 0.0 110.789 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 81' ' ' THR . 33.2 mm -77.19 112.8 25.65 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.074 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -61.96 -158.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.429 2.086 . . . . 0.0 112.213 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -170.76 -49.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.862 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.4 pt -75.32 113.49 26.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.136 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -51.49 -39.86 63.94 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.423 2.082 . . . . 0.0 112.368 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -127.52 142.96 51.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.3 t -129.09 100.57 5.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.11 105.28 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.3 t80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.901 -179.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.495 -0.242 . . . . 0.0 112.495 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -122.97 89.75 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.96 163.62 27.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.941 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -106.33 -32.33 8.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.43 81.95 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.833 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 10.4 mmtm -78.98 137.44 37.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.769 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.512 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.3 pp -79.13 -21.16 12.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.738 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.692 ' CD1' HD13 ' A' ' 11' ' ' LEU . 9.8 m-30 -93.8 -34.81 13.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.72 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 8' ' ' PHE . 2.3 ppt_? 28.54 79.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 122.795 0.438 . . . . 0.0 111.96 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.94 72.16 1.29 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.632 -0.795 . . . . 0.0 111.554 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.936 HD21 HG13 ' A' ' 54' ' ' ILE . 1.8 tt -144.68 152.67 40.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.71 0.29 . . . . 0.0 110.754 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.704 ' N ' HD23 ' A' ' 11' ' ' LEU . 6.8 mt-10 -129.07 119.64 24.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.647 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.711 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -129.07 123.56 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.967 0.413 . . . . 0.0 111.54 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.666 ' SG ' HG13 ' A' ' 55' ' ' VAL . 24.6 p -110.09 137.7 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.905 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.43 ' SG ' HG22 ' A' ' 24' ' ' THR . 24.8 p -95.5 107.24 19.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.56 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -93.61 111.78 23.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 95.76 168.56 35.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.354 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.97 -0.55 10.38 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.739 2.292 . . . . 0.0 112.746 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.451 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.7 m-85 63.18 -80.16 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.23 -73.43 0.46 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.832 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -177.8 73.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 2.7 mtm -155.22 165.24 18.71 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.742 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.44 105.42 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.475 2.117 . . . . 0.0 112.293 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.43 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.1 OUTLIER -60.82 -17.25 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.242 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -20.59 38.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.244 0.545 . . . . 0.0 110.017 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -76.99 -32.5 57.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.291 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' CD1' HG11 ' A' ' 85' ' ' VAL . 68.1 tp -70.72 -50.14 39.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.384 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -60.9 -27.45 68.17 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.2 t90 -65.52 -50.41 65.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.254 0.549 . . . . 0.0 109.607 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.808 ' HB3' HG21 ' A' ' 89' ' ' VAL . 66.8 mtt -51.46 -51.53 54.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.866 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.619 ' CG1' HG13 ' A' ' 85' ' ' VAL . 31.4 m -61.9 -45.65 98.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.056 0.455 . . . . 0.0 110.181 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.473 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -58.63 -35.59 72.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.193 179.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.9 tp -69.97 -20.92 63.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.029 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 1.4 m -93.0 -3.2 54.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.988 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 118.23 -15.96 11.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.083 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.711 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -76.65 -179.12 5.11 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.184 0.516 . . . . 0.0 111.58 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.421 ' N ' ' O ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -134.89 135.23 41.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.404 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.1 p -71.88 118.59 17.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.04 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.659 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -93.85 118.81 40.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.05 -42.63 85.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.13 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -148.69 177.26 9.66 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.807 HD13 ' HB2' ' A' ' 75' ' ' CYS . 23.9 mt -67.4 -46.53 72.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.8 -23.48 52.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.983 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.37 -24.37 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.062 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.633 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.1 m-85 -55.76 128.72 36.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.024 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 t -132.31 129.1 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 mp -82.76 79.8 9.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.56 -124.73 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.54 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 50' ' ' GLY . 9.0 t -118.33 -45.3 2.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.825 0.345 . . . . 0.0 110.831 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 49' ' ' THR . . . -124.15 27.33 5.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.477 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.91 112.93 38.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.439 ' CD2' ' HD2' ' A' ' 53' ' ' PRO . 2.6 t-80 -95.37 127.82 40.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.877 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.585 ' O ' HD13 ' A' ' 54' ' ' ILE . 73.3 Cg_endo -75.89 135.39 17.43 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.493 2.129 . . . . 0.0 112.479 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.936 HG13 HD21 ' A' ' 11' ' ' LEU . 16.0 mm -142.24 150.91 18.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.803 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.672 HG23 ' HB3' ' A' ' 77' ' ' ALA . 45.2 t -131.05 149.18 33.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.595 HG23 ' CG2' ' A' ' 13' ' ' ILE . 57.9 t -120.59 159.68 21.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.876 HG22 HG12 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -149.14 -178.74 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.008 0.432 . . . . 0.0 111.494 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.451 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 169.47 81.11 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.873 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.89 110.59 2.83 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.597 2.198 . . . . 0.0 112.316 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -172.45 -41.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.078 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -117.66 38.23 3.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.212 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -22.28 60.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.081 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.43 -67.97 0.22 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.898 0.38 . . . . 0.0 110.977 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -87.64 167.45 13.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.931 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.87 70.75 1.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 -85.2 -49.99 7.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.769 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.98 99.33 0.13 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.266 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.45 ' CD2' HD11 ' A' ' 71' ' ' ILE . 46.2 t80 -92.61 -5.99 50.39 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.595 0.22 . . . . 0.0 111.595 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -81.72 56.39 3.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.867 0.365 . . . . 0.0 111.165 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -169.85 30.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.454 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.913 HG21 HG11 ' A' ' 79' ' ' VAL . 18.3 mm -67.79 -66.85 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.896 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.06 76.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.382 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.24 -25.51 61.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 111.027 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 32.7 mtp -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.964 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.807 ' HB2' HD13 ' A' ' 42' ' ' LEU . 53.9 t -104.29 155.93 18.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.909 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -101.49 35.46 2.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.895 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.679 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -142.47 165.96 23.83 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.679 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.7 Cg_endo -74.0 136.2 22.27 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.658 2.239 . . . . 0.0 112.39 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.913 HG11 HG21 ' A' ' 71' ' ' ILE . 2.4 t -105.94 126.11 61.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.638 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.628 ' CG1' HD23 ' A' ' 97' ' ' LEU . 35.0 m -138.18 159.24 32.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.73 0.3 . . . . 0.0 111.494 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 p -72.04 166.0 23.12 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.442 ' HG2' ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -59.44 -18.33 38.52 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.629 0.233 . . . . 0.0 111.629 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.39 -42.0 30.58 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.816 0.341 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.507 ' CH2' ' CE1' ' A' ' 8' ' ' PHE . 73.9 t90 -60.43 -57.31 13.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.471 0.653 . . . . 0.0 110.172 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.727 ' O ' HG23 ' A' ' 89' ' ' VAL . 74.2 t -55.12 -36.93 41.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.977 -1.01 . . . . 0.0 111.338 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.04 -54.57 6.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.049 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -56.94 -31.14 64.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 92' ' ' TYR . 61.2 m -77.1 -50.11 13.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.144 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.808 HG21 ' HB3' ' A' ' 30' ' ' MET . 44.9 t -71.25 -25.99 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.619 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.21 -56.7 5.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.337 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.2 tp -90.11 -13.79 35.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.296 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.401 ' N ' ' O ' ' A' ' 88' ' ' SER . 0.1 OUTLIER 68.31 81.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 110.62 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.45 137.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.777 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 2.5 t -64.93 85.29 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -58.78 170.34 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.52 118.52 31.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.771 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.803 ' HB3' HD12 ' A' ' 101' ' ' LEU . 2.6 mp -61.08 -35.57 77.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.301 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -53.59 -24.36 13.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.431 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 69.4 m -80.63 -20.22 43.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.449 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -134.74 32.78 3.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.779 0.323 . . . . 0.0 111.029 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.803 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -100.81 175.3 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.684 ' H ' HD23 ' A' ' 101' ' ' LEU . 3.5 mp -131.87 84.46 53.99 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.778 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.75 -168.23 0.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.866 2.378 . . . . 0.0 112.672 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.66 -40.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.36 137.13 85.29 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.122 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.22 -44.44 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.499 2.133 . . . . 0.0 112.406 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.49 -169.06 2.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.945 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.7 135.37 40.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.882 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -108.15 132.84 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 11.6 t80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.927 179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.43 -0.268 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.75 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -119.36 90.54 3.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -36.77 10.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.943 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 57.39 31.78 20.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 0.3 OUTLIER -98.35 131.32 44.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.737 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.682 HD12 ' CD1' ' A' ' 8' ' ' PHE . 1.2 pp -72.47 -23.03 20.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.681 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.682 ' CD1' HD12 ' A' ' 7' ' ' ILE . 13.2 m-30 -93.66 -46.18 7.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 41.78 88.87 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.631 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 81.01 76.93 1.02 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.028 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.501 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -146.35 162.09 38.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.949 0.404 . . . . 0.0 111.211 -179.576 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.8 ' HG2' HG22 ' A' ' 39' ' ' VAL . 0.8 OUTLIER -140.42 109.93 6.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.35 179.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.618 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.6 mt -122.54 127.46 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.923 0.392 . . . . 0.0 111.795 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.645 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 27.3 p -112.64 133.45 54.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.996 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.542 ' HB3' HD23 ' A' ' 27' ' ' LEU . 25.2 p -98.97 108.36 21.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.731 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -93.94 126.16 38.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.969 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.48 163.31 32.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.476 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.1 -5.02 12.82 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.696 2.264 . . . . 0.0 112.735 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 10.9 m-85 63.82 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.846 0.355 . . . . 0.0 111.033 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' A' ' 61' ' ' ALA . 36.2 p -143.69 -71.59 0.3 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.938 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -176.96 42.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.523 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.475 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -177.91 -61.11 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.934 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 22' ' ' MET . 12.0 Cg_endo -55.69 85.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.546 2.164 . . . . 0.0 112.408 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.11 -69.02 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.343 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -85.7 -29.24 24.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.735 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.66 -27.5 60.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.054 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.614 HD12 HG11 ' A' ' 85' ' ' VAL . 36.5 tp -72.85 -51.2 19.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.578 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.43 ' OE2' HG21 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -64.77 -27.74 69.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.928 0.394 . . . . 0.0 110.356 179.533 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.3 t90 -71.19 -50.77 29.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.849 ' HG2' HG11 ' A' ' 89' ' ' VAL . 2.8 mtm -53.88 -48.0 70.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.728 179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' N ' ' A' ' 32' ' ' GLN . 29.3 m -61.86 -45.23 99.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.149 0.499 . . . . 0.0 109.693 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.485 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -56.56 -36.62 69.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.997 178.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 14.6 tp -69.97 -20.97 63.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.769 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.602 ' SG ' HG22 ' A' ' 89' ' ' VAL . 95.0 m -92.95 -3.18 54.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.628 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.403 ' CA ' ' HB3' ' A' ' 6' ' ' LYS . . . 119.92 -31.96 5.14 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.69 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.618 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -62.51 -179.29 0.24 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.114 0.483 . . . . 0.0 111.358 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -137.3 139.17 40.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.585 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG21 ' OE2' ' A' ' 28' ' ' GLU . 10.1 p -71.8 122.99 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.874 HG21 ' CE1' ' A' ' 45' ' ' PHE . 3.2 t -99.11 123.87 52.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -58.86 -48.09 82.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.089 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' O ' HG12 ' A' ' 39' ' ' VAL . 45.8 mt-10 -139.13 172.33 12.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.016 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.71 HD13 ' HB2' ' A' ' 75' ' ' CYS . 15.8 mt -65.91 -50.56 64.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.786 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.1 t -58.94 -21.24 57.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.158 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.6 -23.4 67.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.261 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.874 ' CE1' HG21 ' A' ' 39' ' ' VAL . 25.2 m-85 -53.77 112.68 0.98 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.2 m -69.31 -31.92 70.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tt 60.82 74.54 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.23 -173.95 16.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.3 p -81.18 -30.16 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 110.911 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -94.3 -27.27 12.21 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.609 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.97 116.7 53.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.863 0.363 . . . . 0.0 111.172 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -98.43 133.51 22.71 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.754 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.856 ' O ' HD13 ' A' ' 54' ' ' ILE . 93.0 Cg_endo -80.59 135.56 10.45 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.524 2.149 . . . . 0.0 112.615 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.856 HD13 ' O ' ' A' ' 53' ' ' PRO . 9.6 mm -140.42 142.71 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.635 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.876 HG23 ' HB3' ' A' ' 77' ' ' ALA . 39.9 t -123.28 136.91 58.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.628 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 57' ' ' VAL . 42.6 t -122.12 158.51 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.906 0.384 . . . . 0.0 111.411 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 58' ' ' GLN . 0.9 OUTLIER -152.43 -173.96 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.517 -179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.665 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -174.14 89.19 0.34 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 120.705 0.288 . . . . 0.0 110.845 179.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.01 83.86 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.538 2.159 . . . . 0.0 112.271 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -148.95 -46.71 0.14 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 20' ' ' THR . . . -103.54 29.66 5.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.116 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 -29.34 26.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.963 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m 69.54 -66.94 0.24 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.957 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -110.12 103.53 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.856 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -64.3 86.06 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -63.51 -30.37 71.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.65 122.94 2.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.415 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.754 ' HB2' HD13 ' A' ' 105' ' ' ILE . 10.1 t80 -88.0 7.13 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.581 0.229 . . . . 0.0 111.416 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -80.53 -0.72 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.726 -0.216 . . . . 0.0 111.545 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -106.19 -9.59 16.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.653 0.263 . . . . 0.0 111.617 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.6 HG21 HG11 ' A' ' 79' ' ' VAL . 8.3 mm -64.37 -47.19 90.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.795 0.331 . . . . 0.0 111.025 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.75 50.24 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.374 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -79.72 -17.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.628 0.252 . . . . 0.0 111.189 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.1 mtp -93.87 -33.68 13.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.828 0.347 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.71 ' HB2' HD13 ' A' ' 42' ' ' LEU . 52.4 t -122.62 154.72 37.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.966 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.39 31.35 5.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.748 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.876 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -120.35 168.7 9.97 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.106 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.778 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 59.9 Cg_endo -73.07 121.59 7.4 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.605 2.204 . . . . 0.0 112.569 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.6 HG11 HG21 ' A' ' 71' ' ' ILE . 18.3 t -88.59 125.51 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.635 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 101' ' ' LEU . 27.7 m -143.21 177.15 2.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.835 0.35 . . . . 0.0 111.418 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.2 p -98.24 166.9 11.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.304 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -18.42 32.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.362 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -49.89 -47.86 51.77 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.814 0.34 . . . . 0.0 110.781 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.499 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 59.3 t90 -50.72 -57.37 8.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.473 0.654 . . . . 0.0 110.265 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.828 ' O ' HG23 ' A' ' 89' ' ' VAL . 84.3 t -53.84 -49.1 60.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.301 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -50.0 72.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -61.83 -32.48 72.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.752 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.2 m -77.07 -46.48 23.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.032 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.849 HG11 ' HG2' ' A' ' 30' ' ' MET . 33.0 t -71.16 -28.2 31.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.339 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.83 -56.65 8.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 93' ' ' GLN . 5.1 tt -93.28 -4.19 52.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.431 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.618 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 58.65 80.0 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.857 0.36 . . . . 0.0 110.834 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.536 ' HB2' HD23 ' A' ' 91' ' ' LEU . 0.9 OUTLIER -179.18 141.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.0 t -66.57 83.06 0.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.83 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.23 165.0 7.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -74.52 140.65 44.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.494 HD23 ' CG1' ' A' ' 80' ' ' VAL . 4.4 mp -88.04 -30.97 19.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.038 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -53.45 -32.55 50.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.105 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.1 m -77.29 -10.22 59.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.324 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -138.68 30.5 2.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.926 0.393 . . . . 0.0 110.686 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.818 HD23 ' CD1' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -97.04 96.91 8.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.779 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.818 ' CD1' HD23 ' A' ' 101' ' ' LEU . 4.0 mp 59.69 95.79 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.01 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -70.82 -79.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.4 2.067 . . . . 0.0 112.464 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -81.78 -171.1 3.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.91 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.754 HD13 ' HB2' ' A' ' 68' ' ' PHE . 21.9 mt 61.98 71.14 0.76 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.147 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.89 178.39 5.32 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.617 2.211 . . . . 0.0 112.318 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.41 116.5 29.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.39 114.54 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -91.58 -31.56 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.905 -179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.6 t -99.92 97.15 8.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -141.21 -46.99 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.035 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -151.24 -64.42 0.19 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.805 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.02 -73.13 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.938 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 7.5 mmtm 62.58 136.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.671 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.775 HG23 ' CE1' ' A' ' 92' ' ' TYR . 0.9 OUTLIER -76.4 -22.87 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.555 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.526 ' CE1' HD12 ' A' ' 7' ' ' ILE . 15.5 m-30 -93.64 -49.51 5.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.542 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 44.96 90.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.83 76.15 1.0 Allowed Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.968 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.469 HD13 ' CG ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -147.33 160.85 42.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.855 0.359 . . . . 0.0 111.118 -179.429 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -140.8 109.8 6.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.727 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.7 mt -120.38 125.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.646 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.726 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 28.3 p -113.45 142.7 45.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.225 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 9.0 p -106.95 119.31 39.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.525 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -93.76 117.56 30.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA3' ' CE2' ' A' ' 62' ' ' TRP . . . 72.36 146.83 0.66 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.473 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.69 150.42 28.76 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.543 2.162 . . . . 0.0 112.315 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.544 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 4.2 m-85 -103.2 -72.23 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.624 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.1 p -146.96 29.27 0.99 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.659 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -168.53 163.0 12.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.481 ' N ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -83.56 -46.53 0.79 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.406 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 22' ' ' MET . 71.1 Cg_exo -48.74 -64.76 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 112.702 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 76.47 -4.26 2.39 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.616 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.44 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 24.4 m-20 -80.92 -25.31 37.58 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.193 0.521 . . . . 0.0 109.983 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -67.21 -36.7 82.25 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.553 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.16 -55.61 10.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.171 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' CG ' ' HA ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -60.47 -27.3 67.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.007 0.432 . . . . 0.0 110.212 179.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -63.13 -49.34 74.78 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 109.556 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.783 ' HB3' HG21 ' A' ' 89' ' ' VAL . 2.2 mtt -51.15 -55.15 19.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.706 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.609 HG13 HG13 ' A' ' 85' ' ' VAL . 22.9 m -58.82 -45.04 91.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.453 ' N ' HG23 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -59.57 -33.77 71.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.288 179.358 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.3 tp -70.06 -21.17 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.931 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.609 ' SG ' HD11 ' A' ' 7' ' ' ILE . 3.8 m -93.28 -3.16 54.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.753 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.62 -22.26 10.16 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.927 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.727 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -67.98 178.03 1.95 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.85 135.21 46.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.635 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 38' ' ' VAL . 12.4 p -71.82 117.92 15.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.726 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 2.4 t -93.89 124.49 46.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -25.51 43.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.358 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 178.3 -174.85 0.17 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.415 0.626 . . . . 0.0 111.318 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.692 HD13 ' HB2' ' A' ' 75' ' ' CYS . 22.6 mt -63.07 -46.34 87.92 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.973 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.54 -11.38 60.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.426 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.431 ' O ' HG13 ' A' ' 39' ' ' VAL . 4.1 m -96.0 24.73 5.28 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.674 0.273 . . . . 0.0 111.312 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.425 ' CE1' HG21 ' A' ' 39' ' ' VAL . 3.4 m-85 -85.67 97.98 10.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.832 0.349 . . . . 0.0 110.861 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.9 159.77 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mt -136.04 72.2 1.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.926 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.84 -117.03 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.0 t -140.67 25.49 2.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.289 . . . . 0.0 111.007 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 175.96 36.31 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.611 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.6 m -129.31 116.64 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.725 0.298 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -94.09 136.26 23.8 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.973 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.896 ' O ' HD13 ' A' ' 54' ' ' ILE . 87.7 Cg_endo -83.16 132.89 6.28 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.705 2.27 . . . . 0.0 112.787 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.896 HD13 ' O ' ' A' ' 53' ' ' PRO . 10.8 mm -137.73 151.83 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.686 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 77' ' ' ALA . 22.4 t -129.07 149.96 34.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.955 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 80' ' ' VAL . 7.3 t -128.2 146.07 34.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.906 0.384 . . . . 0.0 111.339 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.819 HG22 HG12 ' A' ' 79' ' ' VAL . 1.9 m -133.1 173.03 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.006 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -176.95 88.08 0.25 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.68 64.04 3.06 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.549 2.166 . . . . 0.0 112.28 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -133.38 -67.28 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 19' ' ' PHE . . . -98.76 23.92 8.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.337 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.511 ' O ' HG22 ' A' ' 63' ' ' THR . 0.2 OUTLIER -67.28 -16.71 64.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.254 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.511 HG22 ' O ' ' A' ' 62' ' ' TRP . 14.8 t 46.16 -168.58 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.863 0.363 . . . . 0.0 111.319 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.14 132.32 53.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.44 -177.04 5.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.835 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -79.37 -47.36 15.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.89 138.68 2.9 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.41 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.736 ' CD1' HD11 ' A' ' 71' ' ' ILE . 65.6 t80 -102.04 -4.9 25.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.554 0.216 . . . . 0.0 111.52 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.52 56.92 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.933 0.397 . . . . 0.0 110.91 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.49 34.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.258 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.856 HG22 HG21 ' A' ' 79' ' ' VAL . 23.3 mm -69.31 -64.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.839 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.4 -15.35 81.25 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -79.03 -24.22 43.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 3.6 mtm -93.97 -27.3 16.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.982 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.692 ' HB2' HD13 ' A' ' 42' ' ' LEU . 49.5 t -118.94 156.22 29.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.0 111.022 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -105.77 32.33 4.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.829 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.777 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -125.77 172.32 6.45 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.087 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.777 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 95.1 Cg_endo -82.71 127.1 4.8 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.786 2.324 . . . . 0.0 112.888 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.856 HG21 HG22 ' A' ' 71' ' ' ILE . 18.8 t -98.57 130.96 46.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.329 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.756 ' O ' HG13 ' A' ' 56' ' ' VAL . 28.7 m -145.26 136.88 20.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.639 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.8 p -50.82 168.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.772 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.421 ' HB3' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -63.94 -16.44 61.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.299 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -51.07 -39.19 55.45 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.86 0.362 . . . . 0.0 110.608 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.505 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 79.0 t90 -62.7 -57.3 11.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.528 0.68 . . . . 0.0 109.888 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.705 ' O ' HG23 ' A' ' 89' ' ' VAL . 98.0 t -54.66 -38.18 42.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.222 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.5 tp -77.06 -47.79 19.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.934 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -60.78 -33.53 73.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.742 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -77.16 -49.53 15.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.065 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.783 HG21 ' HB3' ' A' ' 30' ' ' MET . 45.2 t -71.38 -27.67 29.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.387 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.42 -55.09 17.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 111.104 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 91' ' ' LEU . 5.9 tt -95.65 -3.08 46.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.315 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.775 ' CE1' HG23 ' A' ' 7' ' ' ILE . 6.7 t80 57.64 76.63 0.32 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.913 0.387 . . . . 0.0 110.781 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.59 133.87 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.674 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 3.1 t -59.15 97.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.099 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.6 163.67 22.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.835 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HG3' ' CG2' ' A' ' 99' ' ' THR . 0.4 OUTLIER -71.53 142.09 50.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.69 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD23 ' CG1' ' A' ' 80' ' ' VAL . 1.6 mp -87.13 -34.28 19.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.351 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.27 -22.88 32.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.42 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.401 ' CG2' ' HG3' ' A' ' 96' ' ' GLU . 0.7 OUTLIER -76.26 -15.29 60.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.61 -179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -139.4 20.58 2.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.701 0.286 . . . . 0.0 111.235 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -81.23 163.46 22.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.792 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.6 pp -69.19 138.07 89.44 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.54 -178.35 3.97 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.501 2.134 . . . . 0.0 112.467 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -144.01 -64.5 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.888 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 105' ' ' ILE . 0.5 OUTLIER -148.88 110.6 3.54 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.99 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -51.38 90.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.419 2.079 . . . . 0.0 112.36 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -176.71 122.22 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.843 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.1 m -143.69 83.81 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.33 -71.72 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.922 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.0 t80 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.863 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 p -107.73 -57.34 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.769 0.318 . . . . 0.0 110.875 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -76.59 113.41 14.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -137.92 -62.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.848 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.91 82.87 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.996 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.4 mmtp -99.29 134.42 42.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.506 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.604 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -76.64 -23.83 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.559 ' CD1' HD12 ' A' ' 7' ' ' ILE . 14.3 m-30 -93.37 -50.88 5.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.687 0.28 . . . . 0.0 110.555 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 40.8 86.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.374 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.61 75.12 1.29 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.817 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.498 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -149.43 162.66 39.68 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.934 0.397 . . . . 0.0 111.241 -179.162 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.716 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.7 mt-10 -138.64 109.68 6.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.533 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.653 HD12 ' HB1' ' A' ' 36' ' ' ALA . 2.3 mt -124.54 138.19 54.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.546 ' O ' HG23 ' A' ' 56' ' ' VAL . 29.1 p -126.54 144.62 50.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.215 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.741 ' HB3' HD23 ' A' ' 27' ' ' LEU . 14.8 p -97.62 104.5 16.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.783 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -94.0 102.63 14.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.811 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 111.61 162.59 17.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.522 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -83.44 -2.7 10.61 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.762 2.308 . . . . 0.0 112.801 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.602 ' CZ ' HD22 ' A' ' 27' ' ' LEU . 6.0 m-85 63.27 -81.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.037 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.449 HG23 ' H ' ' A' ' 21' ' ' ASN . 1.0 OUTLIER -139.56 -54.89 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.986 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.449 ' H ' HG23 ' A' ' 20' ' ' THR . 0.6 OUTLIER -111.51 -74.9 0.62 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.429 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 5.7 ttt -174.2 57.8 0.2 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.157 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 22' ' ' MET . 64.9 Cg_endo -88.62 23.19 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.845 2.363 . . . . 0.0 112.597 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.683 HG22 ' SG ' ' A' ' 15' ' ' CYS . 0.0 OUTLIER -61.54 -47.84 83.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.341 -179.599 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -87.8 -27.51 22.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.057 0.456 . . . . 0.0 110.513 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.32 -34.46 65.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.57 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.741 HD23 ' HB3' ' A' ' 15' ' ' CYS . 44.6 tp -73.18 -48.34 36.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.355 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' O ' HG22 ' A' ' 31' ' ' VAL . 32.6 mt-10 -62.56 -27.42 69.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.504 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -65.32 -49.28 70.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.144 0.497 . . . . 0.0 109.802 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.876 ' HB3' HG21 ' A' ' 89' ' ' VAL . 5.8 mtt -52.97 -52.33 58.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.853 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 28' ' ' GLU . 35.3 m -58.8 -46.5 90.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.904 0.383 . . . . 0.0 110.615 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.479 ' N ' HG23 ' A' ' 31' ' ' VAL . 16.5 tt0 -57.95 -34.47 69.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.2 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.3 tp -70.14 -21.51 63.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.837 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.551 ' SG ' HD11 ' A' ' 7' ' ' ILE . 1.8 m -93.59 -3.35 52.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.782 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 115.9 -34.84 4.55 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.653 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -56.15 169.16 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.87 0.367 . . . . 0.0 111.486 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.37 134.62 54.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.373 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.4 m -72.1 125.75 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.94 0.4 . . . . 0.0 111.18 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.716 HG21 ' HB3' ' A' ' 12' ' ' GLU . 17.6 t -114.67 128.08 71.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.632 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 -33.52 21.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.926 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.486 ' O ' HG12 ' A' ' 39' ' ' VAL . 1.1 mt-10 -121.85 155.3 35.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.965 0.412 . . . . 0.0 111.364 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.828 HD13 ' HB2' ' A' ' 75' ' ' CYS . 16.2 mt -70.78 -32.47 69.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.676 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -21.03 59.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.554 ' O ' HG22 ' A' ' 46' ' ' THR . 0.4 OUTLIER -60.83 -20.46 61.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.189 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD2' ' O ' ' A' ' 42' ' ' LEU . 20.3 m-85 -56.99 100.72 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 44' ' ' SER . 4.0 t -177.27 148.86 0.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.794 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.43 ' HB2' HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -174.27 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 119.02 60.46 0.27 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.446 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.4 p 56.07 30.51 16.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.85 -28.01 4.09 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.482 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 47' ' ' LEU . 30.1 m -130.57 147.66 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.71 0.29 . . . . 0.0 111.073 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -93.8 126.06 50.93 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.705 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.874 ' O ' HD13 ' A' ' 54' ' ' ILE . 73.1 Cg_endo -77.43 129.59 10.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.568 2.179 . . . . 0.0 112.707 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.874 HD13 ' O ' ' A' ' 53' ' ' PRO . 7.5 mm -141.66 154.71 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.818 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG13 ' SG ' ' A' ' 14' ' ' CYS . 30.9 t -138.21 140.31 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.569 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -112.86 156.0 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.818 0.342 . . . . 0.0 111.115 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.615 ' CG2' HG12 ' A' ' 79' ' ' VAL . 3.2 m -144.01 -179.78 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.538 -179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.502 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 173.89 67.18 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.754 179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.02 107.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.616 2.211 . . . . 0.0 112.309 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -167.21 -43.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.976 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.01 29.4 7.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.214 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.579 ' O ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -68.07 -49.11 63.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.579 HG23 ' O ' ' A' ' 62' ' ' TRP . 0.1 OUTLIER -177.45 -77.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.841 179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -161.22 31.97 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 61.33 72.4 0.52 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.833 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -93.42 -66.01 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.964 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.06 92.63 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.582 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.41 ' CD1' HD11 ' A' ' 71' ' ' ILE . 4.5 t80 -92.7 7.26 44.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.611 0.243 . . . . 0.0 111.411 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -87.62 49.2 1.76 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.917 0.389 . . . . 0.0 111.037 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -153.93 22.4 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.227 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.538 HG21 HG11 ' A' ' 79' ' ' VAL . 12.1 mm -69.59 -34.27 60.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.918 0.389 . . . . 0.0 110.804 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -83.27 -20.91 59.66 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.312 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -77.32 -25.25 51.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.6 mtp -93.85 -29.28 15.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.828 ' HB2' HD13 ' A' ' 42' ' ' LEU . 54.0 t -132.35 153.5 50.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.753 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -93.88 -36.69 12.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.805 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -55.56 170.26 0.42 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.23 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.805 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 72.0 Cg_endo -77.11 161.82 32.19 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.615 HG12 ' CG2' ' A' ' 57' ' ' VAL . 12.1 t -127.04 121.49 58.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.703 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.733 ' O ' HG12 ' A' ' 56' ' ' VAL . 33.8 m -141.32 140.09 32.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.788 0.327 . . . . 0.0 111.545 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 6.5 p -55.21 163.29 1.16 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.705 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.12 -20.05 15.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.398 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -47.0 -40.98 15.59 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.913 0.387 . . . . 0.0 110.876 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.464 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.7 t90 -58.84 -57.35 13.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.368 0.604 . . . . 0.0 110.106 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.728 ' O ' HG23 ' A' ' 89' ' ' VAL . 47.9 t -55.93 -42.37 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.225 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.59 -56.56 6.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.005 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -56.7 -30.87 63.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.0 m -77.19 -50.5 12.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.087 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.876 HG21 ' HB3' ' A' ' 30' ' ' MET . 47.4 t -71.27 -28.53 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.431 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.63 -58.15 5.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.882 0.372 . . . . 0.0 110.988 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.79 -10.63 47.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.203 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.604 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 64.9 79.77 0.25 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.857 0.36 . . . . 0.0 110.708 -179.849 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.457 ' N ' HG21 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -177.07 129.47 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.727 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.7 t -64.14 85.58 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.981 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -68.69 172.45 6.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.819 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -77.94 157.53 29.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.635 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.721 HD21 ' CG2' ' A' ' 54' ' ' ILE . 0.8 OUTLIER -96.7 -25.06 15.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.057 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -21.66 66.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.412 ' HB ' ' CE1' ' A' ' 100' ' ' TYR . 25.5 m -77.08 -17.76 58.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.465 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.412 ' CE1' ' HB ' ' A' ' 99' ' ' THR . 1.6 m-85 -138.91 23.61 2.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.661 0.267 . . . . 0.0 110.95 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -83.03 101.12 10.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.004 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 22.1 mt 56.79 103.56 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.279 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.37 -173.67 1.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.501 2.134 . . . . 0.0 112.363 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -149.1 31.4 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mt -108.34 118.18 52.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.049 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.19 61.39 4.94 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.373 2.048 . . . . 0.0 112.325 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.37 115.38 30.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 4.7 p -96.19 -71.65 0.67 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.878 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -102.29 119.4 38.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 73.7 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.941 179.921 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 m 60.25 34.32 20.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.836 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.29 85.69 2.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -177.63 -179.41 0.81 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.873 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -151.9 54.47 0.83 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 9.0 mmtm -81.36 138.08 35.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.555 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.629 HD12 ' CE1' ' A' ' 8' ' ' PHE . 1.0 OUTLIER -80.26 -20.19 11.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.748 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.629 ' CE1' HD12 ' A' ' 7' ' ' ILE . 18.0 m-30 -93.63 -48.12 6.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.498 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 39.3 86.46 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.556 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.23 68.85 1.42 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.772 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.918 HD21 HG13 ' A' ' 54' ' ' ILE . 0.7 OUTLIER -137.2 160.66 38.36 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.666 ' H ' HD23 ' A' ' 11' ' ' LEU . 2.0 mt-10 -137.64 111.11 8.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.767 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.718 HD11 HD22 ' A' ' 11' ' ' LEU . 3.0 mt -122.2 121.84 64.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.804 ' SG ' HG13 ' A' ' 55' ' ' VAL . 19.4 p -107.51 132.02 53.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.999 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.3 m -95.31 101.65 13.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.535 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.473 ' O ' HG13 ' A' ' 57' ' ' VAL . 0.6 OUTLIER -93.88 102.73 14.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.108 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.91 144.02 7.54 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.801 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 19' ' ' PHE . 23.9 Cg_exo -63.1 -13.41 35.29 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.8 2.334 . . . . 0.0 112.515 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 3.6 m-30 67.73 -76.54 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.144 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.47 HG23 ' H ' ' A' ' 21' ' ' ASN . 1.1 t -133.89 -56.61 0.88 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.47 ' H ' HG23 ' A' ' 20' ' ' THR . 20.6 m120 -126.17 -80.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.783 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.489 ' N ' ' HD3' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -158.62 50.48 0.39 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.106 179.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 22' ' ' MET . 68.4 Cg_endo -85.34 10.75 3.6 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.672 2.248 . . . . 0.0 112.708 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -36.12 67.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.723 0.296 . . . . 0.0 111.388 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -88.93 -27.18 21.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.025 0.44 . . . . 0.0 110.558 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.87 -31.36 51.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.721 HD21 ' HB3' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -74.55 -45.89 42.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.346 179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -63.03 -27.72 69.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.698 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 14.2 t90 -66.77 -52.05 48.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.055 0.455 . . . . 0.0 109.776 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.889 ' HB3' HG21 ' A' ' 89' ' ' VAL . 11.9 mtm -53.71 -50.52 65.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.668 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 32' ' ' GLN . 28.0 m -60.78 -45.46 97.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.196 0.522 . . . . 0.0 110.087 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.483 ' N ' HG23 ' A' ' 31' ' ' VAL . 8.8 mt-30 -56.74 -34.77 67.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.019 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 24.5 tp -70.19 -21.57 63.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.027 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.705 ' SG ' HG22 ' A' ' 89' ' ' VAL . 21.3 m -93.41 -3.53 53.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.729 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 105.82 15.67 17.81 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.156 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.655 ' HB1' HD12 ' A' ' 13' ' ' ILE . . . -101.69 173.53 6.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.145 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.57 132.52 51.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.655 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 28' ' ' GLU . 13.8 p -71.98 122.52 24.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.063 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.679 HG21 ' CE1' ' A' ' 45' ' ' PHE . 1.1 t -93.91 127.55 45.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -59.27 -40.63 86.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -152.67 -177.13 6.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.884 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 75' ' ' CYS . 20.2 mt -72.74 -38.86 67.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.04 -8.71 56.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.396 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -92.89 18.17 9.45 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.687 -0.233 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.679 ' CE1' HG21 ' A' ' 39' ' ' VAL . 6.0 m-85 -81.2 95.26 6.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.831 0.348 . . . . 0.0 110.654 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.9 174.18 11.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.11 158.1 44.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.934 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.7 -112.99 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.589 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.78 -42.03 2.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.815 0.341 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -121.7 27.21 6.32 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.526 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.2 t -93.95 147.76 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.802 0.334 . . . . 0.0 110.965 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.31 118.46 11.8 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.726 ' O ' HD13 ' A' ' 54' ' ' ILE . 95.8 Cg_endo -80.02 128.55 7.47 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.567 2.178 . . . . 0.0 112.643 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.918 HG13 HD21 ' A' ' 11' ' ' LEU . 7.6 mm -144.76 156.72 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.704 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.804 HG13 ' SG ' ' A' ' 14' ' ' CYS . 14.7 t -137.98 144.49 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.029 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.6 HG23 ' CG2' ' A' ' 13' ' ' ILE . 22.0 t -128.21 159.32 39.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.867 0.365 . . . . 0.0 111.246 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.913 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -152.45 -169.07 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 -179.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.631 ' H ' HG12 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -179.17 72.25 0.2 Allowed Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.715 0.293 . . . . 0.0 110.711 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.25 106.77 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.645 2.23 . . . . 0.0 112.439 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -174.8 -40.81 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.95 30.76 5.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.025 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -93.5 -32.03 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m 61.84 153.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.831 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -84.74 123.33 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -156.74 -63.52 0.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -96.21 -29.77 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.938 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.6 122.91 4.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.423 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.913 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 37.8 t80 -95.74 7.17 47.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 0.0 111.477 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -91.83 52.68 2.06 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.841 0.353 . . . . 0.0 110.993 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -173.23 34.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.34 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.735 HD11 ' CD1' ' A' ' 68' ' ' PHE . 31.2 mm -68.69 -60.19 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.96 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.5 -21.83 65.09 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.478 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.96 -16.2 45.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.686 0.279 . . . . 0.0 111.146 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.78 -27.45 16.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.957 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' ' 42' ' ' LEU . 42.6 t -133.08 156.64 47.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.943 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -100.61 30.27 4.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.001 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB1' ' HD2' ' A' ' 78' ' ' PRO . . . -124.16 156.51 66.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.018 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 30.3 Cg_endo -64.11 150.11 89.01 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.522 2.148 . . . . 0.0 112.298 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 71' ' ' ILE . 34.2 t -121.14 128.49 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.566 ' CG1' HD23 ' A' ' 97' ' ' LEU . 28.6 m -144.0 177.1 2.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.975 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.9 p -93.7 173.98 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.721 ' HB3' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -67.68 -11.64 58.74 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.243 -179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -56.86 -40.62 76.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.887 0.375 . . . . 0.0 110.242 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.518 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 69.5 t90 -56.82 -57.42 12.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.457 0.646 . . . . 0.0 110.029 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.756 ' O ' HG23 ' A' ' 89' ' ' VAL . 66.3 t -56.09 -46.53 80.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.113 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.85 -56.59 12.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -58.45 -31.55 67.89 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.716 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.2 m -77.14 -48.89 16.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.954 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.889 HG21 ' HB3' ' A' ' 30' ' ' MET . 49.0 t -71.32 -28.3 31.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.393 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -65.66 -59.07 4.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.919 0.39 . . . . 0.0 111.064 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 63.2 tp -88.48 -11.99 44.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.204 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 65.74 83.15 0.17 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.979 0.419 . . . . 0.0 110.711 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' HA ' HG21 ' A' ' 7' ' ' ILE . 44.9 tt0 -177.11 133.93 0.19 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.761 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 4.5 t -65.23 78.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -62.83 169.01 3.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.788 ' HG3' HG23 ' A' ' 99' ' ' THR . 2.3 pt-20 -82.68 142.23 31.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.834 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.643 HD21 ' CG2' ' A' ' 54' ' ' ILE . 4.1 mp -79.85 -28.87 39.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.063 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.97 -30.49 47.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.11 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.788 HG23 ' HG3' ' A' ' 96' ' ' GLU . 41.3 p -76.11 -13.39 60.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.363 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -139.6 27.88 2.23 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.785 0.326 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.553 ' HA ' HG12 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -93.37 106.58 18.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.3 mt 59.59 107.98 0.03 OUTLIER Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -64.72 -77.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.324 2.016 . . . . 0.0 112.435 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.18 116.67 22.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.866 0.365 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 tp -101.99 129.7 25.9 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.981 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.36 157.22 57.27 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.454 2.102 . . . . 0.0 112.304 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -127.64 168.44 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 p -131.96 33.33 3.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.963 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -93.54 155.36 17.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.892 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.521 ' N ' HD11 ' A' ' 33' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.1 p -104.52 150.91 24.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -76.15 105.01 6.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -144.39 -43.7 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.196 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.0 ttt-85 -142.49 84.57 1.86 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.93 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' CYS . 2.0 mmtp -86.48 154.59 21.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.559 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.623 HG21 ' C ' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -101.9 -20.91 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 36' ' ' ALA . 17.1 m-30 -93.49 -47.9 6.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.782 0.325 . . . . 0.0 110.446 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 42.74 87.97 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.555 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.54 72.64 1.27 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.077 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.506 ' CD2' HG13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -144.31 162.4 36.51 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' HB3' HG21 ' A' ' 39' ' ' VAL . 3.6 mt-10 -138.41 109.77 6.94 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.157 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.538 HD12 ' CB ' ' A' ' 36' ' ' ALA . 2.9 mt -126.01 141.1 46.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.632 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 30.5 p -126.43 147.46 49.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.078 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.631 ' SG ' HD23 ' A' ' 27' ' ' LEU . 14.9 m -105.61 113.42 26.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.609 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -93.58 120.0 33.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.145 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 86.9 168.75 45.21 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.579 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.79 1.23 9.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.821 2.348 . . . . 0.0 112.738 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 58' ' ' GLN . 5.5 m-85 62.96 -81.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.048 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.458 HG23 ' H ' ' A' ' 21' ' ' ASN . 1.1 t -173.1 -55.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.341 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.458 ' H ' HG23 ' A' ' 20' ' ' THR . 4.3 m-20 -115.06 -39.38 3.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.159 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.04 138.05 94.15 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.812 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' O ' ' CB ' ' A' ' 24' ' ' THR . 97.6 Cg_endo -80.17 5.84 5.74 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.561 2.174 . . . . 0.0 112.703 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.428 ' CB ' ' O ' ' A' ' 23' ' ' PRO . 0.4 OUTLIER 84.09 -32.41 0.07 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.6 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.66 -29.18 25.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.172 0.51 . . . . 0.0 110.105 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.7 -32.13 67.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.371 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.631 HD23 ' SG ' ' A' ' 15' ' ' CYS . 18.0 tp -70.94 -50.31 36.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.364 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' HG22 ' A' ' 31' ' ' VAL . 14.5 mt-10 -59.83 -27.42 66.61 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.979 0.418 . . . . 0.0 110.547 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 11.0 t90 -64.88 -50.08 67.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.238 0.542 . . . . 0.0 109.646 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.86 ' HB3' HG21 ' A' ' 89' ' ' VAL . 14.5 mtt -51.22 -51.29 55.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.072 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 28' ' ' GLU . 28.6 m -59.38 -45.67 93.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.923 0.392 . . . . 0.0 110.528 179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' N ' HG23 ' A' ' 31' ' ' VAL . 1.7 tm0? -58.5 -34.47 70.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.044 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD11 ' N ' ' A' ' 1' ' ' GLY . 16.5 tp -70.01 -21.09 63.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.78 179.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 89' ' ' VAL . 1.7 m -93.1 -3.25 54.48 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.615 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.405 ' HA3' ' HB3' ' A' ' 6' ' ' LYS . . . 112.91 -20.9 19.27 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.982 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.538 ' CB ' HD12 ' A' ' 13' ' ' ILE . . . -70.49 174.61 5.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 111.314 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -120.84 135.48 55.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.342 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.458 ' CG1' ' HB3' ' A' ' 28' ' ' GLU . 2.1 m -71.77 123.65 26.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 14' ' ' CYS . 14.4 t -102.99 122.39 55.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.996 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.03 -49.48 76.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.576 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' O ' HG12 ' A' ' 39' ' ' VAL . 3.6 mm-40 -140.15 177.7 7.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.375 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.714 HD22 ' HB2' ' A' ' 75' ' ' CYS . 14.5 mt -67.36 -48.17 68.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.793 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.2 m -59.06 -21.13 58.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.142 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.54 ' HB3' HG13 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -65.9 -21.01 66.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.218 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HZ ' ' HG ' ' A' ' 14' ' ' CYS . 17.9 m-85 -52.65 132.19 35.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.906 0.384 . . . . 0.0 111.063 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 46' ' ' THR . 6.4 t -150.61 116.24 5.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.914 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.78 103.92 16.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.969 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -105.99 -105.41 3.02 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.499 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.9 m -83.28 -60.19 2.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.833 0.349 . . . . 0.0 110.824 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.542 ' O ' HG13 ' A' ' 51' ' ' VAL . . . -145.88 83.48 0.19 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.56 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 50' ' ' GLY . 3.3 m -159.0 110.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.994 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -94.03 136.03 24.09 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.934 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.827 ' O ' HD13 ' A' ' 54' ' ' ILE . 89.5 Cg_endo -80.71 138.51 11.94 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.677 2.252 . . . . 0.0 112.565 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 53' ' ' PRO . 8.5 mm -144.29 150.89 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.854 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.976 HG23 ' HB3' ' A' ' 77' ' ' ALA . 41.6 t -131.21 139.0 51.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.669 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG12 ' N ' ' A' ' 57' ' ' VAL . 60.9 t -124.67 157.41 32.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.885 0.374 . . . . 0.0 111.371 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.775 HG11 ' CZ ' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -156.68 -173.17 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.631 -179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.637 ' H ' HG12 ' A' ' 57' ' ' VAL . 4.7 tt0 178.66 80.47 0.16 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.574 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -49.53 112.24 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.649 2.232 . . . . 0.0 112.461 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -173.52 -42.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.731 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.37 30.43 6.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.987 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -103.97 -29.19 11.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.939 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.8 m 63.88 159.02 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.912 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.09 86.4 3.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.44 -49.3 0.49 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.819 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -80.86 -29.22 35.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.966 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.79 107.51 3.06 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.401 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.775 ' CZ ' HG11 ' A' ' 57' ' ' VAL . 36.0 t80 -97.27 7.1 47.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.509 0.195 . . . . 0.0 111.389 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -91.31 51.28 1.88 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.92 0.39 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -175.82 40.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.746 HG21 HG11 ' A' ' 79' ' ' VAL . 25.4 mm -71.42 -60.77 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.076 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.462 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -78.38 -22.95 47.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.691 0.282 . . . . 0.0 111.103 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -30.66 14.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.837 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.714 ' HB2' HD22 ' A' ' 42' ' ' LEU . 31.2 p -105.6 162.9 13.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.923 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -116.05 37.64 3.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.769 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.976 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -148.79 168.22 11.48 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.176 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.777 ' HD2' ' HB1' ' A' ' 77' ' ' ALA . 56.6 Cg_endo -70.22 112.48 3.17 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.656 2.237 . . . . 0.0 112.517 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.746 HG11 HG21 ' A' ' 71' ' ' ILE . 34.8 t -81.3 127.1 39.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.784 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.623 ' CG1' HD23 ' A' ' 97' ' ' LEU . 28.2 m -140.27 176.03 5.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.932 0.396 . . . . 0.0 111.262 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 11.6 p -94.4 159.24 15.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.14 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.38 -22.06 6.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.312 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -47.81 -40.59 21.46 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.95 0.405 . . . . 0.0 110.684 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.517 ' CH2' ' CZ ' ' A' ' 8' ' ' PHE . 84.4 t90 -62.16 -57.23 12.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.363 0.602 . . . . 0.0 110.027 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.703 ' O ' HG23 ' A' ' 89' ' ' VAL . 60.3 t -56.1 -37.09 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.17 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.18 -54.55 6.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.953 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -57.83 -30.44 65.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.772 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 72.4 m -77.17 -50.96 11.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.86 HG21 ' HB3' ' A' ' 30' ' ' MET . 46.7 t -71.19 -28.56 33.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.365 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -67.17 -54.33 22.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 93' ' ' GLN . 4.5 tt -97.52 2.7 50.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.339 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.623 ' C ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER 53.5 82.86 0.07 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.793 0.33 . . . . 0.0 111.054 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.527 ' HB2' HD23 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -178.68 128.6 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 12.6 p -66.08 86.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.943 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.91 170.71 6.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -83.9 125.96 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.912 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.815 HD21 ' CG2' ' A' ' 54' ' ' ILE . 3.7 mp -64.11 -29.53 70.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.015 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -54.47 -29.29 49.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.247 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 85.2 m -77.56 -17.28 58.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.271 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -134.31 29.49 3.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.774 0.321 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.651 HD12 ' HB3' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -98.31 136.8 37.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.812 179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 34.4 mt -76.17 111.89 17.72 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.073 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.86 176.3 10.29 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.396 2.064 . . . . 0.0 112.437 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -129.25 -45.17 1.24 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.793 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.432 HD12 ' HD2' ' A' ' 106' ' ' PRO . 3.1 tp -149.03 134.93 9.87 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.902 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 105' ' ' ILE . 25.1 Cg_endo -61.79 -43.72 24.57 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.464 2.109 . . . . 0.0 112.259 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.4 m170 -77.96 79.97 4.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.0 p -113.92 -43.23 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -69.9 -178.87 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.232 -0.89 . . . . 0.0 110.949 179.878 . . . . . . . . 0 0 . 1 stop_ save_